##GENOME_BUILD=GRCh38
##CREATION_DATE=2025-04-16
##CALLING_DATE=2025-04-16
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 2025_03-48-g29809670
##SAMPLE=<ID=NA12878_03,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=Affected>
##FILTER=PASS=All filters passed
##FILTER=RefCall=Genotyping model thinks this site is reference.
##FILTER=LowQual=Confidence in this variant being real is below calling threshold.
##FILTER=NoCall=Site has depth=0 resulting in no call.
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_mappability=Variants in reads with low mapping score.
##FILTER=mosaic=Putative mosaic variants.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=NA12878_03=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), quality divided by depth (QD), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous/hemizygous case count of gnomAD project (genome data).
##DESCRIPTION=gnomAD_het=Heterozygous allele count of the gnomAD project (genome data).
##DESCRIPTION=gnomAD_wt=Wildtype allele count of the gnomAD project (genome data).
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=AlphaMissense=AlphaMissense pathogenicity score. Deleterious threshold > 0.564.
##DESCRIPTION=MaxEntScan=MaxEntScan reference score and alternate score for (1) native splice site, (2) acceptor gain and (3) donor gain. Comma-separated list if there are different predictions for several transcripts.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction. These include delta scores (DS) and delta positions (DP) for acceptor gain (AG), acceptor loss (AL), donor gain (DG), and donor loss (DL). Format: GENE|DS_AG|DS_AL|DS_DG|DS_DL|DP_AG|DP_AL|DP_DG|DP_DL.
##DESCRIPTION=PubMed=PubMed ids to publications on the given variant.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_mosaic=Mosaic variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	gnomAD	gnomAD_sub	gnomAD_hom_hemi	gnomAD_het	gnomAD_wt	phyloP	CADD	REVEL	AlphaMissense	MaxEntScan	COSMIC	SpliceAI	PubMed	NGSD_hom	NGSD_het	NGSD_mosaic	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	27355949	27355949	-	G	het	off-target	QUAL=24;DP=108;QD=0.22	MAP3K6,SYTL1	intron,downstream_gene	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron27/28:c.3711+76_3711+77insC::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron26/27:c.3687+76_3687+77insC::,SYTL1:ENST00000618673.4:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000318074.9:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000616558.5:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000543823.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region				L2 (LINE/L2)	rs36035221	0.42735	0.65689,0.34770,0.12461,0.36581,0.20208	15680,	33544	86970		14.18			/7.0>7.4/0.0>0.0		MAP3K6|0.04|0.00|0.00|0.00|-19|-35|-27|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SYTL1 (inh=n/a oe_syn=0.98 oe_mis=0.79 oe_lof=0.73), MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27355990	27355990	G	A	het	off-target	QUAL=24;DP=94;QD=0.26	MAP3K6,SYTL1	intron,downstream_gene	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron27/28:c.3711+36C>T::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron26/27:c.3687+36C>T::,SYTL1:ENST00000618673.4:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000318074.9:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000616558.5:downstream_gene_variant:MODIFIER::::,SYTL1:ENST00000543823.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region					rs12569127	0.27136	0.21473,0.26061,0.12336,0.32162,0.15858	5881,	29502	110800	-0.4890	0.41			/2.9>1.7/0.0>0.0	COSV58872155	MAP3K6|0.00|0.00|0.00|0.01|36|49|31|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"sdsds"	SYTL1 (inh=n/a oe_syn=0.98 oe_mis=0.79 oe_lof=0.73), MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27359572	27359572	G	C	hom	off-target	QUAL=24;DP=163;QD=0.15	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron17/28:c.2320-50C>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron16/27:c.2296-50C>G::	regulatory_region_variant:open_chromatin_region					rs7521552	0.98774	0.96527,0.99536,1.00000,0.99582,0.99689	74277,	1812	1866	-0.1950	7.16			/4.7>1.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27360975	27360975	G	T	het		QUAL=25;DP=238;QD=0.11	MAP3K6	missense	MAP3K6:ENST00000357582.3:missense_variant:MODERATE:exon14/29:c.1866C>A:p.Asn622Lys:,MAP3K6:ENST00000374040.7:missense_variant:MODERATE:exon13/28:c.1842C>A:p.Asn614Lys:	regulatory_region_variant:open_chromatin_region		403071 [benign DISEASE=not specified,not provided,MAP3K6-related disorder GENE=MAP3K6];			rs35659744	0.21031	0.05770,0.19854,0.09551,0.30290,0.14789	4302,	23412	120216	0.1830	12.70	0.051	0.13	/0.0>0.0/0.0>0.0	COSV62887042,COSV62889375	MAP3K6|0.00|0.00|0.00|0.00|33|14|-12|-47	24033266,34059054	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahchera1 17.06.2021"		"3"	MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363272	27363272	C	T	het	off-target	QUAL=24;DP=18;QD=1.33	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron6/28:c.971+170G>A::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron5/27:c.947+170G>A::						rs4525067	0.22593	0.06187,0.23245,0.12089,0.32047,0.15763	4910,	24511	117625	-0.2130	2.25			/0.0>3.7/0.0>2.2	COSV62890052	MAP3K6|0.00|0.00|0.00|0.00|-2|34|4|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363806	27363806	G	T	het	off-target	QUAL=24;DP=18;QD=1.33	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron5/28:c.864+111C>A::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron4/27:c.840+111C>A::					MIRb (SINE/MIR)	rs4075731	0.42488	0.67173,0.33397,0.12225,0.35601,0.19722	15802,	33057	87527	-0.5370	0.46			/0.0>0.0/0.0>0.0	COSV62890056	MAP3K6|0.00|0.00|0.00|0.00|-35|-39|-3|-29	23048207	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27363868	27363868	T	C	het	off-target	QUAL=25;DP=34;QD=0.74	MAP3K6	intron	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron5/28:c.864+49A>G::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron4/27:c.840+49A>G::					MIRb (SINE/MIR)	rs4307592	0.30431	0.32203,0.27700,0.12317,0.32371,0.16162	7285,	31751	105897	-0.0450	6.90			/0.0>0.0/5.2>4.9	COSV62890059	MAP3K6|0.00|0.00|0.00|0.00|49|6|49|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58)
chr1	27364153	27364153	A	G	het	off-target	QUAL=24;DP=22;QD=1.09	MAP3K6,FCN3	intron,downstream_gene	MAP3K6:ENST00000357582.3:intron_variant:MODIFIER:intron4/28:c.695+51T>C::,MAP3K6:ENST00000374040.7:intron_variant:MODIFIER:intron3/27:c.671+51T>C::,FCN3:ENST00000270879.9:downstream_gene_variant:MODIFIER::::,FCN3:ENST00000354982.2:downstream_gene_variant:MODIFIER::::		604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]				rs12727507	0.42484	0.67121,0.33394,0.12341,0.35626,0.19801	15791,	33061	87515	0.0210	3.10			/0.0>0.0/7.0>7.9	COSV54641801	MAP3K6|0.00|0.00|0.00|0.00|-24|-34|4|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	45330597	45330597	G	C	hom	off-target	QUAL=24;DP=10;QD=2.40	MUTYH,HPDL	intron,downstream_gene	MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000713750.1:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron15/16:c.1393-40C>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron14/15:c.1426-40C>G::,MUTYH:ENST00000483127.2:intron_variant:MODIFIER:intron15/16:c.1411-40C>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron14/15:c.1396-40C>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000412971.6:intron_variant:MODIFIER:intron9/10:c.1009-40C>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron14/15:c.1438-40C>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron14/15:c.1468-40C>G::,MUTYH:ENST00000710952.2:intron_variant:MODIFIER:intron14/15:c.1477-40C>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron5/6:c.478-40C>G::,MUTYH:ENST00000713751.1:intron_variant:MODIFIER:intron16/17:c.1414-40C>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-1160C>G::,MUTYH:ENST00000529892.6:intron_variant:MODIFIER:intron13/14:c.1246-40C>G::,MUTYH:ENST00000672314.2:intron_variant:MODIFIER:intron14/15:c.1393-40C>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron14/15:c.1435-40C>G::,HPDL:ENST00000334815.6:downstream_gene_variant:MODIFIER::::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	439920 [benign DISEASE=Familial adenomatous polyposis 2,not provided GENE=MUTYH];			rs3219493	0.92944	0.95667,0.92923,0.89985,0.91100,0.92646	65876,	9779	10745	0.2630	7.95			/3.7>2.1/0.0>0.0		MUTYH|0.00|0.00|0.00|0.00|-40|-13|-46|-40	27153553,26273655,28173856,22297469,24799981,17207658,34967580,32821650,33343895,36835215	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45331833	45331833	C	G	het		QUAL=24;DP=156;QD=0.15	MUTYH,HPDL	intron,missense,downstream_gene	MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000713750.1:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000372104.5:missense_variant:MODERATE:exon13/17:c.930G>C:p.Gln310His:,MUTYH:ENST00000448481.5:missense_variant:MODERATE:exon12/16:c.963G>C:p.Gln321His:,MUTYH:ENST00000483127.2:missense_variant:MODERATE:exon13/17:c.948G>C:p.Gln316His:,MUTYH:ENST00000456914.7:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000354383.10:missense_variant:MODERATE:exon12/16:c.933G>C:p.Gln311His:,MUTYH:ENST00000355498.6:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000412971.6:missense_variant:MODERATE:exon7/11:c.546G>C:p.Gln182His:,MUTYH:ENST00000372098.7:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000372110.7:missense_variant:MODERATE:exon12/16:c.975G>C:p.Gln325His:,MUTYH:ENST00000672818.3:missense_variant:MODERATE:exon12/16:c.1005G>C:p.Gln335His:,MUTYH:ENST00000710952.2:missense_variant:MODERATE:exon12/16:c.1014G>C:p.Gln338His:,MUTYH:ENST00000372115.7:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron3/6:c.188-277G>C::,MUTYH:ENST00000713751.1:missense_variant:MODERATE:exon14/18:c.951G>C:p.Gln317His:,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.116-2396G>C::,MUTYH:ENST00000529892.6:intron_variant:MODIFIER:intron11/14:c.955+190G>C::,MUTYH:ENST00000672314.2:missense_variant:MODERATE:exon12/16:c.930G>C:p.Gln310His:,MUTYH:ENST00000528013.6:missense_variant:MODERATE:exon12/16:c.972G>C:p.Gln324His:,HPDL:ENST00000334815.6:downstream_gene_variant:MODIFIER::::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	41767 [benign DISEASE=Hereditary cancer-predisposing syndrome,Carcinoma of colon,Familial adenomatous polyposis 2,not provided,not specified,Familial multiple polyposis syndrome GENE=MUTYH];	CM083726 [CLASS=DFP MUT=ALT PHEN="Reduced activity" GENE=MUTYH];		rs3219489	0.26961	0.26336,0.40072,0.41205,0.24320,0.23777	5852,	29313	111117	-0.2650	13.54	0.043	0.12	/1.2>0.0/0.0>0.0	COSV58343790	MUTYH|0.06|0.00|0.00|0.00|-28|-1|44|16	25741868,24728327,32265040,23946381,27713515,23757202,23202958,19536092,28391539,16465622,27588484,23565320,18547414,18271935,26273655,28173856,22297469,19443904,19902366,22703879,29458332,32072083,16774938,18823566,19781088,20149637,20843780,21195504,21777424,22466227,22469746,22641385,22720119,22922830,23443124,24039736,24799981,26074017,26159902,26900293,27217144,27471558,29664240,32461665,33942220,22926731,31374908,29445914,28749454,35117636,19888426,34295994,27105872,36632296,25998844,27209488,30564557,26511139,27324896,28628107,31031852,33240400,32821650,26528356,24058721,31027119,30271482,31924810,24377542,27081525,33343895,28599464,36835215,27630279,35628513,19161591,18848840,17055652,29844566,35770680	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"dfdfdfdf"	HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	45332883	45332883	T	C	hom	off-target	QUAL=24;DP=80;QD=0.30	MUTYH,HPDL	intron,downstream_gene	MUTYH:ENST00000529984.5:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000713750.1:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000372104.5:intron_variant:MODIFIER:intron7/16:c.420+35A>G::,MUTYH:ENST00000448481.5:intron_variant:MODIFIER:intron6/15:c.453+35A>G::,MUTYH:ENST00000483127.2:intron_variant:MODIFIER:intron7/16:c.438+35A>G::,MUTYH:ENST00000456914.7:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000354383.10:intron_variant:MODIFIER:intron6/15:c.423+35A>G::,MUTYH:ENST00000355498.6:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000412971.6:intron_variant:MODIFIER:intron1/10:c.37-49A>G::,MUTYH:ENST00000372098.7:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:ENST00000372110.7:intron_variant:MODIFIER:intron6/15:c.465+35A>G::,MUTYH:ENST00000672818.3:intron_variant:MODIFIER:intron6/15:c.495+35A>G::,MUTYH:ENST00000710952.2:intron_variant:MODIFIER:intron6/15:c.504+35A>G::,MUTYH:ENST00000372115.7:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,MUTYH:ENST00000488731.6:intron_variant:MODIFIER:intron2/6:c.116-49A>G::,MUTYH:ENST00000713751.1:intron_variant:MODIFIER:intron8/17:c.441+35A>G::,MUTYH:ENST00000531105.5:intron_variant:MODIFIER:intron2/2:c.115+1508A>G::,MUTYH:ENST00000529892.6:intron_variant:MODIFIER:intron6/14:c.462+35A>G::,MUTYH:ENST00000672314.2:intron_variant:MODIFIER:intron6/15:c.420+35A>G::,MUTYH:ENST00000528013.6:intron_variant:MODIFIER:intron6/15:c.462+35A>G::,HPDL:ENST00000334815.6:downstream_gene_variant:MODIFIER::::		618994_[GENE=HPDL_PHENOS=Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, 619026 (3), Autosomal recessive; Spastic paraplegia 83, autosomal recessive, 619027 (3), Autosomal recessive]&604933_[GENE=MUTYH_PHENOS=Adenomas, multiple colorectal, 608456 (3), Autosomal recessive; Gastric cancer, somatic, 613659 (3)]	257529 [benign DISEASE=Familial adenomatous polyposis 2,not specified,not provided GENE=MUTYH];			rs3219487	0.93268	0.96587,0.93234,0.89992,0.91148,0.92777	66325,	9337	10249	-1.2610	0.61			/0.0>0.0/0.0>0.0	COSV58343750	MUTYH|0.00|0.00|0.00|0.00|-49|-29|35|18	25741868,23565320,22297469,30218772,24799981,17207658,31031852,32821650,23504502,33343895	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HPDL (inh=AR oe_syn=0.86 oe_mis=0.83 oe_lof=0.80), MUTYH (inh=AR oe_syn=1.01 oe_mis=1.03 oe_lof=0.88)
chr1	62238462	62238462	A	G	het	off-target	QUAL=25;DP=137;QD=0.18	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2884-81T>C::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.298-81T>C::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.952-81T>C::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.1000-81T>C::			1249680 [benign DISEASE=not provided GENE=KANK4];			rs41289438	0.35654	0.35374,0.33399,0.17196,0.37416,0.24637	9851,	34454	97738	-1.2140	0.95			/0.0>0.0/0.0>0.0		KANK4|0.00|0.00|0.01|0.00|44|43|44|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247328	62247328	G	-	het	off-target	QUAL=24;DP=9;QD=2.67	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron9/9:c.2883+144del::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron3/3:c.297+144del::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron6/6:c.951+144del::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron8/8:c.999+144del::			1279369 [benign DISEASE=not provided GENE=KANK4];		FLAM_C (SINE/Alu)	rs111297754	0.43099	0.42887,0.41015,0.17196,0.45327,0.33853	13914,	35792	83994	0.1120	0.97			/0.0>0.0/0.0>0.0		KANK4|0.00|0.00|0.00|0.00|-27|-49|-4|-49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247574	62247574	G	A	het		QUAL=24;DP=117;QD=0.21	KANK4	synonymous	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon9/10:c.2781C>T:p.His927=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000317477.8:synonymous_variant:LOW:exon3/4:c.195C>T:p.His65=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000371150.5:synonymous_variant:LOW:exon6/7:c.849C>T:p.His283=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:synonymous_variant:LOW:exon8/9:c.897C>T:p.His299=:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:open_chromatin_region		1272744 [benign DISEASE=not provided GENE=KANK4];			rs10889315	0.38435	0.32416,0.36374,0.17180,0.42075,0.39722	11555,	35327	93603	-0.0850	0.23			/0.0>0.0/0.0>0.0	COSV58092010	KANK4|0.00|0.00|0.00|0.00|19|5|-21|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				"dfgdfgdfgdg"	KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62247797	62247797	T	C	het	off-target	QUAL=24;DP=41;QD=0.59	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron8/9:c.2683-125A>G::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron2/3:c.97-125A>G::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron5/6:c.751-125A>G::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron7/8:c.799-125A>G::			1243108 [benign DISEASE=not provided GENE=KANK4];			rs10789108	0.42936	0.43555,0.40623,0.17430,0.43926,0.43190	14143,	36728	86408	-0.1910	1.25			/3.3>0.0/0.0>0.0		KANK4|0.00|0.00|0.00|0.00|-8|-3|-29|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62262956	62262956	C	T	het	off-target	QUAL=25;DP=14;QD=1.79	KANK4	intron	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron7/9:c.2539+136G>A::,KANK4:ENST00000317477.8:intron_variant:MODIFIER:intron1/3:c.-48+136G>A::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron4/6:c.607+136G>A::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron6/8:c.655+136G>A::			1182710 [benign DISEASE=not provided GENE=KANK4];		L1PB3 (LINE/L1)	rs59025845	0.25242	0.12905,0.22453,0.13248,0.32424,0.28702	5446,	27510	113732	0.2060	4.47			/0.0>0.0/0.0>3.9		KANK4|0.00|0.00|0.00|0.00|43|50|3|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263112	62263112	A	G	hom		QUAL=24;DP=1208;QD=0.02	KANK4	missense,5'UTR	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon7/10:c.2519T>C:p.Val840Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-68T>C::,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon4/7:c.587T>C:p.Val196Ala:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.635T>C:p.Val212Ala:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:enhancer		1239401 [benign DISEASE=not provided GENE=KANK4];			rs2666472	0.70434	0.55745,0.78931,0.83514,0.74091,0.72227	38423,	30220	44944	2.8390	4.32	0.156	0.15	/3.6>2.7/0.0>0.0	COSV58093169	KANK4|0.00|0.00|0.00|0.00|26|-5|-27|-20		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263166	62263166	T	C	hom		QUAL=24;DP=1140;QD=0.02	KANK4	missense,5'UTR	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon7/10:c.2465A>G:p.His822Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-122A>G::,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon4/7:c.533A>G:p.His178Arg:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:missense_variant:MODERATE:exon6/9:c.581A>G:p.His194Arg:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:enhancer		1270534 [benign DISEASE=not provided GENE=KANK4];			rs2258470	0.70400	0.55654,0.78941,0.83528,0.74079,0.72151	38341,	30219	44947	2.7470	13.56	0.098	0.05	/0.0>0.0/0.0>0.0		KANK4|0.00|0.00|0.00|0.00|46|-28|-28|-4	28487959	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263189	62263189	T	C	hom		QUAL=15;DP=1143;QD=0.01	KANK4	synonymous,5'UTR	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon7/10:c.2442A>G:p.Lys814=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-145A>G::,KANK4:ENST00000371150.5:synonymous_variant:LOW:exon4/7:c.510A>G:p.Lys170=:PF12796 [Ankyrin repeats (3 copies)],KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.558A>G:p.Lys186=:PF12796 [Ankyrin repeats (3 copies)]	regulatory_region_variant:enhancer		1295500 [benign DISEASE=not provided GENE=KANK4];			rs2260581	0.70420	0.55713,0.78918,0.83457,0.74096,0.72160	38325,	30193	44879	0.5990	11.27			/0.0>5.3/0.0>0.0		KANK4|0.00|0.00|0.00|0.00|-1|-34|-1|30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263246	62263246	G	A	hom		QUAL=24;DP=187;QD=0.13	KANK4	synonymous,5'UTR	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon7/10:c.2385C>T:p.Pro795=:,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-202C>T::,KANK4:ENST00000371150.5:synonymous_variant:LOW:exon4/7:c.453C>T:p.Pro151=:,KANK4:ENST00000354381.3:synonymous_variant:LOW:exon6/9:c.501C>T:p.Pro167=:	regulatory_region_variant:enhancer		1262248 [benign DISEASE=not provided GENE=KANK4];			rs2262110	0.70443	0.55741,0.78930,0.83535,0.74108,0.72222	38397,	30181	44885	-1.7700	0.90			/0.0>0.0/0.0>0.0	COSV58094416	KANK4|0.00|0.00|0.00|0.00|-28|18|16|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62263343	62263343	G	A	hom	off-target	QUAL=24;DP=225;QD=0.11	KANK4	intron,5'UTR	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron6/9:c.2320-32C>T::,KANK4:ENST00000317477.8:5_prime_UTR_variant:MODIFIER:exon1/4:c.-299C>T::,KANK4:ENST00000371150.5:intron_variant:MODIFIER:intron3/6:c.388-32C>T::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron5/8:c.436-32C>T::	regulatory_region_variant:enhancer		1295474 [benign DISEASE=not provided GENE=KANK4];			rs2262106	0.69625	0.52878,0.78748,0.83586,0.74084,0.72165	37712,	30359	46149	0.5880	11.35			/0.0>0.0/0.0>0.0	COSV58091893	KANK4|0.00|0.00|0.00|0.00|-34|25|31|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62266749	62266749	T	C	het		QUAL=24;DP=840;QD=0.03	KANK4	missense,upstream_gene	KANK4:ENST00000371153.9:missense_variant:MODERATE:exon6/10:c.2302A>G:p.Thr768Ala:,KANK4:ENST00000371150.5:missense_variant:MODERATE:exon3/7:c.370A>G:p.Thr124Ala:,KANK4:ENST00000354381.3:missense_variant:MODERATE:exon5/9:c.418A>G:p.Thr140Ala:,KANK4:ENST00000317477.8:upstream_gene_variant:MODIFIER::::			1295514 [benign DISEASE=not provided GENE=KANK4];			rs11207949	0.26482	0.21375,0.35042,0.56223,0.25224,0.15504	5888,	28526	111886	2.3690	14.24	0.018	0.07	/0.6>0.4/0.0>0.0		KANK4|0.00|0.00|0.00|0.00|-7|-17|-17|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62268267	62268267	G	A	het	off-target	QUAL=13;DP=152;QD=0.09	KANK4	splice_region&intron,upstream_gene	KANK4:ENST00000371153.9:splice_region_variant&intron_variant:LOW:intron5/9:c.2231+20C>T::,KANK4:ENST00000371150.5:splice_region_variant&intron_variant:LOW:intron2/6:c.299+20C>T::,KANK4:ENST00000354381.3:splice_region_variant&intron_variant:LOW:intron4/8:c.347+20C>T::,KANK4:ENST00000317477.8:upstream_gene_variant:MODIFIER::::			1271177 [benign DISEASE=not provided GENE=KANK4];			rs11207950	0.45193	0.57506,0.39874,0.27253,0.40598,0.56606	16113,	36496	83342	-0.4840	0.11			/0.0>0.0/0.0>0.0	COSV58092900	KANK4|0.00|0.00|0.00|0.00|11|-26|20|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62271700	62271700	A	C	het	off-target	QUAL=24;DP=88;QD=0.27	KANK4	intron,5'UTR	KANK4:ENST00000371153.9:intron_variant:MODIFIER:intron3/9:c.1901-111T>G::,KANK4:ENST00000371150.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-143T>G::,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-111T>G::	regulatory_region_variant:enhancer		1225071 [benign DISEASE=not provided GENE=KANK4];			rs4609464	0.39108	0.43160,0.35991,0.27222,0.37581,0.51750	11762,	35898	92520	0.2410	3.26			/3.2>3.2/0.0>0.0	COSV62985665	KANK4|0.00|0.00|0.00|0.00|46|-39|1|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62273232	62273232	T	C	hom		QUAL=24;DP=45;QD=0.53	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.1872A>G:p.Pro624=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1643A>G::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter		1265012 [benign DISEASE=not provided GENE=KANK4];			rs7516290	0.75582	0.85980,0.76206,0.83753,0.68646,0.75249	43980,	27052	37156	-0.8210	1.71			/0.0>0.0/0.0>0.0		KANK4|0.00|0.00|0.00|0.00|-24|-26|-28|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62273526	62273526	G	A	het		QUAL=24;DP=72;QD=0.33	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.1578C>T:p.Ser526=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-1937C>T::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::			1270734 [benign DISEASE=not provided GENE=KANK4];			rs17855078	0.27820	0.18681,0.24689,0.13139,0.33083,0.40291	6377,	29535	109719	-1.1030	0.24			/2.0>1.7/0.0>0.0	COSV62990033	KANK4|0.00|0.00|0.00|0.00|-23|19|-23|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274393	62274393	A	G	het		QUAL=25;DP=74;QD=0.34	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.711T>C:p.Gly237=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-2804T>C::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::			1265023 [benign DISEASE=not provided GENE=KANK4];			rs12127930	0.48113	0.61934,0.40977,0.27326,0.43074,0.57113	18399,	36349	78885	-1.1560	0.40			/0.0>0.0/2.4>0.0	COSV105915634,COSV62986848	KANK4|0.00|0.00|0.00|0.00|-35|2|-9|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274774	62274774	T	C	hom		QUAL=24;DP=154;QD=0.16	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.330A>G:p.Pro110=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3185A>G::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::			1262658 [benign DISEASE=not provided GENE=KANK4];			rs2666506	0.75594	0.85983,0.76183,0.85145,0.68613,0.75302	43810,	26961	36993	-0.6950	2.82			/0.0>0.0/0.0>0.0	COSV62988812	KANK4|0.00|0.00|0.01|0.00|-7|-22|-42|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	62274777	62274777	T	C	hom		QUAL=24;DP=154;QD=0.16	KANK4	synonymous,intron,upstream_gene	KANK4:ENST00000371153.9:synonymous_variant:LOW:exon3/10:c.327A>G:p.Ser109=:,KANK4:ENST00000354381.3:intron_variant:MODIFIER:intron2/8:c.17-3188A>G::,KANK4:ENST00000371150.5:upstream_gene_variant:MODIFIER::::			1182584 [benign DISEASE=not provided GENE=KANK4];			rs2666507	0.73210	0.77735,0.75308,0.85142,0.68594,0.75209	40846,	29266	40604	-2.2680	0.06			/0.0>0.0/0.0>0.0	COSV62988817	KANK4|0.00|0.00|0.00|0.00|32|-25|-45|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KANK4 (inh=n/a oe_syn=0.93 oe_mis=0.98 oe_lof=0.55)
chr1	78112493	78112493	T	C	het		QUAL=24;DP=413;QD=0.06	GIPC2	intron	GIPC2:ENST00000370759.4:intron_variant:MODIFIER:intron3/5:c.608-6900T>C::	regulatory_region_variant:open_chromatin_region					rs6666954	0.37764	0.60781,0.28936,0.60990,0.27566,0.28100	12778,	31870	94638	-1.1960	0.54			/6.3>5.7/0.0>0.0	COSV66129252			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GIPC2 (inh=n/a oe_syn=1.00 oe_mis=1.06 oe_lof=1.01)
chr1	119915381	119915381	A	T	het		QUAL=24;DP=75;QD=0.32	NOTCH2	synonymous	NOTCH2:ENST00000256646.7:synonymous_variant:LOW:exon34/34:c.7341T>A:p.Gly2447=:		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	261705 [benign DISEASE=Hajdu-Cheney syndrome,not provided,not specified GENE=NOTCH2];			rs6685892	0.16803	0.32562,0.10649,0.03141,0.10628,0.18906	2979,	19601	126553	-0.7840	1.45			/0.0>0.0/0.0>0.0	COSV56683182	NOTCH2|0.00|0.00|0.00|0.00|28|-8|-10|34	25741868,34737607,29593342	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119918630	119918630	C	T	het	off-target	QUAL=24;DP=20;QD=1.20	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron31/33:c.5782-77G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1239541 [benign DISEASE=not provided GENE=NOTCH2];			rs2793829	0.16754	0.32489,0.10645,0.03162,0.10590,0.18890	2959,	19562	126608	1.7540	8.20			/1.3>1.4/0.0>0.0	COSV104375006	NOTCH2|0.00|0.00|0.00|0.00|13|-43|18|-42	30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119921542	119921542	C	T	het	off-target	QUAL=24;DP=226;QD=0.11	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron29/33:c.5310+171G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1239830 [benign DISEASE=not provided GENE=NOTCH2];			rs835573	0.21878	0.42441,0.16257,0.09738,0.12553,0.30083	5071,	23138	118840	-0.3850	1.15			/0.0>0.0/0.1>0.0	COSV56701749	NOTCH2|0.00|0.00|0.00|0.00|0|30|-14|1	28714469	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119923485	119923485	G	A	het	off-target	QUAL=24;DP=247;QD=0.10	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron26/33:c.4859+152C>T::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1230128 [benign DISEASE=not provided GENE=NOTCH2];			rs2793830	0.30693	0.72746,0.19226,0.10590,0.12682,0.31338	12492,	21712	105444	-3.2970	0.01			/1.9>2.0/0.0>0.0	COSV104375039	NOTCH2|0.00|0.00|0.00|0.00|-15|6|8|-8	36614156,32341527	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119929234	119929234	C	T	het	off-target	QUAL=24;DP=29;QD=0.83	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron22/33:c.3656-22G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1265981 [benign DISEASE=not provided GENE=NOTCH2];			rs2493392	0.16781	0.32528,0.10634,0.03157,0.10609,0.19084	2973,	19597	126667	0.4450	4.77			/0.0>0.0/0.0>0.0	COSV56687338	NOTCH2|0.00|0.00|0.00|0.00|-2|-22|24|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119935375	119935375	C	A	het	off-target	QUAL=24;DP=19;QD=1.26	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron22/33:c.3655+97G>T::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1179326 [benign DISEASE=not provided GENE=NOTCH2];			rs2453056	0.24448	0.51341,0.17201,0.09737,0.12593,0.30137	6835,	23525	114945	-0.0250	1.82			/0.0>0.0/1.3>4.7	COSV104375007	NOTCH2|0.00|0.00|0.00|0.00|-21|0|2|-39	29434720	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119935662	119935662	T	C	het	off-target	QUAL=24;DP=892;QD=0.03	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron21/33:c.3523-58A>G::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1260068 [benign DISEASE=not provided GENE=NOTCH2];			rs5025718	0.66922	0.18949,0.80058,0.90225,0.87221,0.68587	40970,	19875	50325	-1.1160	0.10			/7.5>7.0/2.9>1.1			37355909	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119938086	119938086	C	T	het	off-target	QUAL=24;DP=368;QD=0.07	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron19/33:c.3184-76G>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1235242 [benign DISEASE=not provided GENE=NOTCH2];			rs2453058	0.16794	0.32561,0.10675,0.03164,0.10607,0.18981	2971,	19575	126429	-0.2200	0.71			/0.5>0.7/0.0>0.0	COSV104375008	NOTCH2|0.00|0.00|0.00|0.00|-2|-34|23|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119941798	119941798	G	A	het	off-target	QUAL=24;DP=65;QD=0.37	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron17/33:c.2753-44C>T::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1293670 [benign DISEASE=Alagille syndrome due to a NOTCH2 point mutation,not provided,Hajdu-Cheney syndrome GENE=NOTCH2];			rs2493420	0.21884	0.42464,0.16274,0.09680,0.12551,0.30124	5079,	23139	118859	-0.0270	1.38			/2.8>2.5/0.0>0.0	COSV99862942	NOTCH2|0.00|0.00|0.00|0.00|-44|-17|31|-18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119953496	119953496	A	T	het	off-target	QUAL=25;DP=618;QD=0.04	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron14/33:c.2365+47T>A::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1265607 [benign DISEASE=not provided GENE=NOTCH2];			rs7534585	0.16698	0.32357,0.10644,0.03170,0.10564,0.18983	2902,	19580	126638	0.4620	1.90			/1.8>3.1/0.0>0.0	COSV56685993	NOTCH2|0.00|0.00|0.02|0.00|35|37|35|47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119953504	119953504	A	C	het	off-target	QUAL=24;DP=617;QD=0.04	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron14/33:c.2365+39T>G::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1245879 [benign DISEASE=not provided GENE=NOTCH2];			rs7534586	0.16692	0.32361,0.10645,0.03154,0.10555,0.18937	2899,	19571	126615	0.5980	4.85			/1.8>1.3/0.0>0.0	COSV56686003	NOTCH2|0.00|0.00|0.00|0.00|38|27|-36|27	25135348	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119963373	119963373	G	C	het	off-target	QUAL=24;DP=249;QD=0.10	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron11/33:c.1915+201C>G::	regulatory_region_variant:enhancer	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1274327 [benign DISEASE=not provided GENE=NOTCH2];			rs10923929	0.66515	0.17484,0.79885,0.90185,0.87252,0.68703	40875,	19504	50974	0.3540	1.57			/0.0>0.0/0.0>0.0	COSV56681705		18179887,28666004,34107879,31217584	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119963485	119963485	G	A	het	off-target	QUAL=25;DP=257;QD=0.10	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron11/33:c.1915+89C>T::	regulatory_region_variant:enhancer	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1276223 [benign DISEASE=not provided GENE=NOTCH2];			rs2934381	0.16765	0.32542,0.10629,0.03149,0.10580,0.18880	2970,	19564	126622	0.5720	1.20			/1.7>1.4/0.0>0.0	COSV56687347	NOTCH2|0.00|0.00|0.00|0.00|-18|25|27|25	18372903,18591388,19056611,19794065,21124985,24932614,30328613	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119969481	119969481	T	C	hom	off-target	QUAL=23;DP=571;QD=0.04	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron6/33:c.1108+30A>G::		600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1283582 [benign DISEASE=Hajdu-Cheney syndrome,Alagille syndrome due to a NOTCH2 point mutation,not provided GENE=NOTCH2];			rs2493409	0.97811	0.92369,0.99425,0.99981,0.99950,0.99876	72929,	3099	3333	-2.8650	0.05			/0.0>0.0/3.4>2.5	COSV99862551		26635871	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr1	119987127	119987127	A	C	het	off-target	QUAL=24;DP=686;QD=0.03	NOTCH2	intron	NOTCH2:ENST00000256646.7:intron_variant:MODIFIER:intron4/33:c.752-45T>G::	regulatory_region_variant:promoter,TF_binding_site_variant	600275_[GENE=NOTCH2_PHENOS=Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant]	1283883 [benign DISEASE=not provided GENE=NOTCH2];			rs2453040	0.16524	0.31888,0.10529,0.03144,0.10484,0.18939	2882,	19383	127039	-0.0060	2.47			/0.0>0.0/0.0>0.0	COSV56686013	NOTCH2|0.00|0.00|0.00|0.00|13|-45|-44|9	28652462	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NOTCH2 (inh=AD oe_syn=1.02 oe_mis=0.73 oe_lof=0.06)
chr2	17760156	17760156	T	G	hom	off-target	QUAL=25;DP=33;QD=0.76	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-14205A>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron2/13:c.161+52T>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron2/13:c.161+52T>G::	regulatory_region_variant:open_chromatin_region		1261547 [benign DISEASE=not provided GENE=GEN1];			rs2555072	0.61127	0.48565,0.72296,0.95509,0.61845,0.87116	29380,	34084	59042	-0.5730	0.20			/0.0>0.0/0.0>0.0,/0.0>0.0/0.7>0.0		GEN1|0.00|0.00|0.00|0.00|-39|-6|33|-50,SMC6|0.00|0.00|0.00|0.00|-32|-38|-47|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17761508	17761508	T	A	hom		QUAL=25;DP=92;QD=0.27	SMC6,GEN1	intron,missense	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-15557A>T::,GEN1:ENST00000317402.11:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain],GEN1:ENST00000381254.7:missense_variant:MODERATE:exon3/14:c.274T>A:p.Ser92Thr:PF00752 [XPG N-terminal domain]			1169875 [benign DISEASE=not provided GENE=GEN1];			rs1812152	0.69794	0.77042,0.75922,0.98553,0.62419,0.88691	37741,	30634	45926	0.6630	10.96	0.034	0.06	/0.0>0.0/0.0>0.0		GEN1|0.00|0.00|0.09|0.00|-47|36|4|-2,SMC6|0.00|0.00|0.00|0.00|12|30|2|-38	20512659	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17761748	17761748	T	C	hom	off-target	QUAL=24;DP=24;QD=1.00	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-5-15797A>G::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron3/13:c.348+166T>C::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron3/13:c.348+166T>C::			1231264 [benign DISEASE=not provided GENE=GEN1];		MIRb (SINE/MIR)	rs2615047	0.69566	0.76253,0.75900,0.98536,0.62420,0.88688	37512,	30798	46296	-0.0400	2.35			/0.0>0.0/0.0>1.3,/1.7>1.9/0.0>0.0		GEN1|0.00|0.00|0.00|0.00|-25|17|8|-2,SMC6|0.00|0.00|0.00|0.00|29|-34|-13|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17772760	17772760	G	A	hom		QUAL=24;DP=30;QD=0.80	SMC6,GEN1	intron,missense	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+15055C>T::,GEN1:ENST00000317402.11:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon8/14:c.929G>A:p.Ser310Asn:			1169876 [benign DISEASE=not provided GENE=GEN1];			rs300175	0.98690	0.95660,0.99613,1.00000,0.99990,0.97948	74103,	1921	1993	-2.3000	0.00	0.020	0.06	/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17772873	17772873	A	G	hom	off-target	QUAL=24;DP=32;QD=0.75	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14942T>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron8/13:c.953+89A>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron8/13:c.953+89A>G::			1234610 [benign DISEASE=not provided GENE=GEN1];			rs300176	0.66251	0.64744,0.74498,0.98535,0.62416,0.88645	33909,	32737	51225	-0.4490	0.96			/5.1>4.1/0.0>0.0,/7.3>6.9/0.0>0.0		GEN1|0.00|0.00|0.00|0.00|6|11|43|-32,SMC6|0.00|0.00|0.00|0.00|-36|1|-36|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17773154	17773154	C	G	hom	off-target	QUAL=24;DP=93;QD=0.26	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14661G>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron9/13:c.990+22C>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron9/13:c.990+22C>G::			1276608 [benign DISEASE=not provided GENE=GEN1];			rs300177	0.69608	0.76284,0.75892,0.98533,0.62467,0.88635	37456,	30751	46135	-2.1750	0.03			/1.3>1.9/0.0>0.0,/6.8>7.4/0.0>0.0		GEN1|0.00|0.00|0.00|0.00|40|35|-45|-12,SMC6|0.00|0.00|0.00|0.00|-3|-1|-1|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17773380	17773380	T	G	hom	off-target	QUAL=24;DP=30;QD=0.80	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+14435A>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron10/13:c.1071+81T>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron10/13:c.1071+81T>G::			1280388 [benign DISEASE=not provided GENE=GEN1];			rs300178	0.65138	0.61010,0.73843,0.98532,0.62367,0.88652	32871,	33145	52925	-1.6090	0.28			/2.3>6.3/0.0>0.0,/5.6>0.0/0.0>0.0		GEN1|0.00|0.00|0.00|0.00|29|5|-5|7,SMC6|0.00|0.00|0.00|0.00|-3|-39|-3|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17779783	17779783	A	G	hom	off-target	QUAL=24;DP=24;QD=1.00	SMC6,GEN1	intron	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+8032T>C::,GEN1:ENST00000317402.11:intron_variant:MODIFIER:intron12/13:c.1265-195A>G::,GEN1:ENST00000381254.7:intron_variant:MODIFIER:intron12/13:c.1265-195A>G::			1249180 [benign DISEASE=not provided GENE=GEN1];		AluSg (SINE/Alu)	rs300167	0.69617	0.76335,0.75894,0.98532,0.62475,0.88624	37492,	30744	46142	-0.7300	1.05			/0.0>0.0/0.0>0.0,/6.3>6.5/0.0>0.0		GEN1|0.01|0.00|0.00|0.00|4|50|-1|10,SMC6|0.00|0.00|0.00|0.00|-1|-19|-30|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781183	17781183	A	G	hom		QUAL=24;DP=29;QD=0.83	SMC6,GEN1	intron,synonymous	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6632T>C::,GEN1:ENST00000317402.11:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:,GEN1:ENST00000381254.7:synonymous_variant:LOW:exon14/14:c.1971A>G:p.Glu657=:			1169877 [benign DISEASE=not provided GENE=GEN1];			rs300168	0.46930	0.22988,0.61759,0.91883,0.51382,0.77828	19084,	33197	80703	0.7070	4.35			/1.2>1.1/0.0>0.0,/0.0>0.0/0.0>0.0	COSV58057416	GEN1|0.00|0.00|0.00|0.00|1|40|0|19,SMC6|0.00|0.00|0.00|0.00|6|46|-3|-44	20150382,20512659	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	17781251	17781251	C	T	hom		QUAL=24;DP=35;QD=0.69	SMC6,GEN1	intron,missense	SMC6:ENST00000402989.5:intron_variant:MODIFIER:intron4/29:c.-6+6564G>A::,GEN1:ENST00000317402.11:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:,GEN1:ENST00000381254.7:missense_variant:MODERATE:exon14/14:c.2039C>T:p.Thr680Ile:			1169878 [benign DISEASE=not provided GENE=GEN1];			rs300169	0.65087	0.60829,0.73838,0.98515,0.62366,0.88576	32870,	33223	53085	0.1650	7.01	0.047	0.08	/0.0>0.0/0.0>0.0,/6.0>6.9/0.0>0.0		GEN1|0.00|0.00|0.00|0.00|12|20|-14|20,SMC6|0.00|0.00|0.00|0.00|-22|43|-44|1	20512659	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMC6 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.34), GEN1 (inh=n/a oe_syn=0.97 oe_mis=0.99 oe_lof=0.70)
chr2	47369714	47369714	-	G	het	off-target	QUAL=24;DP=36;QD=0.67	EPCAM	intron	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron2/9:c.160+481dup::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron1/8:c.76+135dup::	regulatory_region_variant:open_chromatin_region	185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1225956 [benign DISEASE=not provided GENE=EPCAM];			rs144077629	0.09245	0.09914,0.11152,0.24543,0.07205,0.11961	786,	12505	138185		6.57			/0.0>0.0/8.0>6.5		EPCAM|0.00|0.00|0.00|0.00|-13|-42|-13|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73)
chr2	47373967	47373967	T	C	het		QUAL=16;DP=42;QD=0.38	EPCAM,MIR559	missense,upstream_gene	EPCAM:ENST00000405271.5:missense_variant:MODERATE:exon4/10:c.428T>C:p.Met143Thr:PF00086 [Thyroglobulin type-1 repeat],EPCAM:ENST00000263735.9:missense_variant:MODERATE:exon3/9:c.344T>C:p.Met115Thr:PF00086 [Thyroglobulin type-1 repeat],MIR559:ENST00000385188.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	183700 [benign DISEASE=Lynch syndrome 1,Hereditary cancer-predisposing syndrome,not specified,not provided,Congenital diarrhea 5 with tufting enteropathy,Lynch syndrome 8 GENE=EPCAM];			rs1126497	0.57708	0.83107,0.49382,0.81603,0.44250,0.49793	27738,	32173	64235	0.0500	13.51	0.183	0.04	/0.0>0.0/0.0>0.0	COSV55392922	EPCAM|0.00|0.00|0.00|0.00|-25|31|25|6	25741868,24033266,22938532,28652652,29458332,20683652,22322561,26115884,27900359,26318430,35070966,31511551,30089705,34967580,33240400,24304228,22781090,24718422,28366820,34573430,37563730	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47374118	47374118	T	C	het	off-target	QUAL=24;DP=544;QD=0.04	EPCAM,MIR559	intron,upstream_gene	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron4/9:c.509+70T>C::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron3/8:c.425+70T>C::,MIR559:ENST00000385188.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1297204 [benign DISEASE=not provided GENE=EPCAM];		L1ME4b (LINE/L1)	rs4399765	0.11211	0.08777,0.11608,0.25783,0.11002,0.12583	1058,	14940	135078	0.5230	8.64			/0.0>0.0/0.0>0.0	COSV55394939	EPCAM|0.00|0.00|0.00|0.00|10|25|2|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47375102	47375102	T	C	het	off-target	QUAL=24;DP=27;QD=0.89	EPCAM,MIR559	intron,upstream_gene	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron4/9:c.510-132T>C::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron3/8:c.426-132T>C::,MIR559:ENST00000385188.1:upstream_gene_variant:MODIFIER::::		185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1294299 [benign DISEASE=not provided GENE=EPCAM];			rs35079997	0.10799	0.15714,0.10434,0.25405,0.07204,0.11939	1066,	14302	135752	-0.5780	0.60			/0.0>0.0/0.0>0.0		EPCAM|0.00|0.00|0.00|0.00|-15|38|-15|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47379635	47379635	A	G	het	off-target	QUAL=24;DP=12;QD=2.00	EPCAM,MIR559,Metazoa_SRP	intron,downstream_gene,upstream_gene	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron7/9:c.742-134A>G::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron6/8:c.658-134A>G::,MIR559:ENST00000385188.1:downstream_gene_variant:MODIFIER::::,Metazoa_SRP:ENST00000622819.1:upstream_gene_variant:MODIFIER::::		185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1292215 [benign DISEASE=not provided GENE=EPCAM];			rs3923559	0.57194	0.83823,0.49338,0.81252,0.42915,0.48074	27553,	31885	65107	-0.5650	0.99			/1.2>1.7/0.0>0.0		EPCAM|0.00|0.00|0.00|0.00|41|-35|-48|-36	30089705	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73), MIR559 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47385017	47385017	A	G	het	off-target	QUAL=24;DP=75;QD=0.32	EPCAM,Metazoa_SRP	intron,downstream_gene	EPCAM:ENST00000405271.5:intron_variant:MODIFIER:intron8/9:c.943-149A>G::,EPCAM:ENST00000263735.9:intron_variant:MODIFIER:intron7/8:c.859-149A>G::,Metazoa_SRP:ENST00000622819.1:downstream_gene_variant:MODIFIER::::		185535_[GENE=EPCAM_PHENOS=Diarrhea 5, with tufting enteropathy, congenital, 613217 (3), Autosomal recessive; Lynch syndrome 8, 613244 (3), Autosomal dominant]	1244355 [benign DISEASE=not provided GENE=EPCAM];			rs4952886	0.10304	0.15232,0.10147,0.17278,0.07174,0.10825	919,	13845	136523	-0.2420	0.89			/2.7>4.0/0.0>0.0		EPCAM|0.00|0.00|0.00|0.00|1|-15|-33|-15	21093899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPCAM (inh=AR oe_syn=1.27 oe_mis=1.31 oe_lof=0.73)
chr2	47445430	47445430	G	A	het	off-target	QUAL=25;DP=206;QD=0.12	MSH2	intron	MSH2:ENST00000543555.6:intron_variant:MODIFIER:intron8/16:c.1079-118G>A::,MSH2:ENST00000645506.1:intron_variant:MODIFIER:intron7/16:c.1277-118G>A::,MSH2:ENST00000713854.1:intron_variant:MODIFIER:intron6/14:c.1127-118G>A::,MSH2:ENST00000406134.5:intron_variant:MODIFIER:intron7/15:c.1277-118G>A::,MSH2:ENST00000233146.7:intron_variant:MODIFIER:intron7/15:c.1277-118G>A::,MSH2:ENST00000713919.1:intron_variant:MODIFIER:intron6/14:c.998-118G>A::,MSH2:ENST00000713860.1:intron_variant:MODIFIER:intron7/8:c.1277-118G>A::,MSH2:ENST00000713861.1:intron_variant:MODIFIER:intron7/8:c.1277-118G>A::		609309_[GENE=MSH2_PHENOS=Lynch syndrome 1, 120435 (3), Autosomal dominant; Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 2, 619096 (3), Autosomal recessive]	90599 [benign DISEASE=not provided,Lynch syndrome,not specified GENE=MSH2];			rs1981929	0.71905	0.90742,0.73058,0.85295,0.60339,0.70456	40716,	27962	42742	0.0930	0.62			/0.0>0.0/0.0>0.0		MSH2|0.00|0.00|0.00|0.00|2|48|-17|11	29936769,23565320,20386703,21093899,19930554,27090025,32756484,32742474,28093084,24578158,21566726,24114314	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH2 (inh=AR+AD oe_syn=1.18 oe_mis=1.31 oe_lof=0.19)
chr2	47783349	47783349	G	A	het		QUAL=24;DP=14;QD=1.71	MSH6,U6	intron,missense,downstream_gene,upstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron3/11:c.-37-7578G>A::,MSH6:ENST00000234420.11:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000700004.2:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:,MSH6:ENST00000700000.1:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron1/9:c.-38+118G>A::,MSH6:ENST00000700002.1:missense_variant:MODERATE:exon1/10:c.116G>A:p.Gly39Glu:,MSH6:ENST00000540021.6:missense_variant:MODERATE:exon1/8:c.116G>A:p.Gly39Glu:,U6:ENST00000636749.1:downstream_gene_variant:MODIFIER::::,MSH6:ENST00000455383.6:upstream_gene_variant:MODIFIER::::,MSH6:ENST00000420813.6:upstream_gene_variant:MODIFIER::::,MSH6:ENST00000411819.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]	36581 [benign DISEASE=Lynch syndrome 5,Hereditary cancer-predisposing syndrome,Lynch syndrome 1,not specified,Breast carcinoma,Carcinoma of colon,Lynch syndrome,not provided,Hereditary nonpolyposis colorectal neoplasms GENE=MSH6];	CM092149 [CLASS=DP MUT=ALT PHEN="Colorectal cancer association with" GENE=MSH6];		rs1042821	0.18876	0.21512,0.14534,0.24581,0.18002,0.20673	2800,	23122	123436	1.7840	17.86	0.163	0.12	/10.3>8.9/0.0>0.0	COSV52274018	MSH6|0.00|0.00|0.00|0.00|18|-20|1|-25	25741868,24033266,25491747,26811195,30337837,23757202,22623965,18701435,21700777,23720673,21036793,22703879,29458332,19781088,20149637,26900293,29616133,32957448,19389263,10507723,10537275,10699937,15805151,24689082,1958276,8838326,16203774,16270383,16771955,17108146,17205513,18355840,18523027,19582761,19685280,22949387,25023197,26027715,27900359,31374908,35868444,25938433,32756484,28749454,22294770,24383517,28481244,32773772,37296718,21286719,29365312,37035153,31031852,32053874,30214228,35541922,23436172,18851982	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34)
chr2	47790891	47790891	A	G	het	off-target	QUAL=25;DP=777;QD=0.03	MSH6,FBXO11	intron	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron3/11:c.-37-36A>G::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:ENST00000700004.2:intron_variant:MODIFIER:intron1/7:c.261-36A>G::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron1/9:c.-37-36A>G::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron1/9:c.261-36A>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.237+7421A>G::,MSH6:ENST00000455383.6:intron_variant:MODIFIER:intron1/9:c.-37-36A>G::,MSH6:ENST00000420813.6:intron_variant:MODIFIER:intron1/9:c.-37-36A>G::,MSH6:ENST00000411819.2:intron_variant:MODIFIER:intron1/9:c.-37-36A>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-1451T>C::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89301 [benign DISEASE=Lynch syndrome 5,not specified,Lynch syndrome,not provided GENE=MSH6];			rs1800931	0.03565	0.01065,0.03790,0.02274,0.05517,0.01679	131,	5167	146873	0.4140	12.80			/0.0>0.0/0.0>0.0	COSV104579250	MSH6|0.00|0.00|0.00|0.00|-28|12|10|12		66	2633	0	14 / 490					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47795761	47795761	A	G	hom	off-target	QUAL=24;DP=7;QD=3.43	MSH6,FBXO11,RPL36AP15	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron4/11:c.161-133A>G::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron2/9:c.458-133A>G::,MSH6:ENST00000700004.2:intron_variant:MODIFIER:intron2/7:c.458-133A>G::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron2/9:c.458-133A>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron2/9:c.161-133A>G::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron2/9:c.458-133A>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.238-2850A>G::,MSH6:ENST00000455383.6:intron_variant:MODIFIER:intron2/9:c.161-133A>G::,MSH6:ENST00000420813.6:intron_variant:MODIFIER:intron2/9:c.161-133A>G::,MSH6:ENST00000411819.2:intron_variant:MODIFIER:intron2/9:c.161-133A>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-6321T>C::,RPL36AP15:ENST00000444514.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	676475 [benign DISEASE=not provided GENE=MSH6];		AluSz (SINE/Alu)	rs3136316	0.79903	0.92858,0.74045,0.89103,0.74663,0.80862	49036,	23207	30503	-2.9530	0.49			/0.0>0.0/0.0>0.0,/0.0>0.0/6.3>9.1		MSH6|0.00|0.00|0.00|0.00|-12|29|35|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02), RPL36AP15 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47795842	47795842	G	T	het	off-target	QUAL=24;DP=26;QD=0.92	MSH6,FBXO11,RPL36AP15	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron4/11:c.161-52G>T::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:ENST00000700004.2:intron_variant:MODIFIER:intron2/7:c.458-52G>T::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron2/9:c.161-52G>T::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron2/9:c.458-52G>T::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron1/7:c.238-2769G>T::,MSH6:ENST00000455383.6:intron_variant:MODIFIER:intron2/9:c.161-52G>T::,MSH6:ENST00000420813.6:intron_variant:MODIFIER:intron2/9:c.161-52G>T::,MSH6:ENST00000411819.2:intron_variant:MODIFIER:intron2/9:c.161-52G>T::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.170-6402C>A::,RPL36AP15:ENST00000444514.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89532 [benign DISEASE=not provided,Lynch syndrome GENE=MSH6];		FLAM_C (SINE/Alu)	rs1800934	0.20848	0.29396,0.15675,0.25087,0.17423,0.20519	3546,	24594	120302	0.3750	2.60			/1.9>0.5/2.4>2.9,/4.3>3.2/0.0>0.0	COSV52273967	MSH6|0.00|0.00|0.00|0.00|38|29|-46|-1	19906786,20386703,29290338,32858845,25329635	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02), RPL36AP15 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	47803319	47803319	G	C	hom	off-target	QUAL=24;DP=66;QD=0.36	MSH6,FBXO11	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron6/11:c.2876-101G>C::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron4/9:c.3173-101G>C::,MSH6:ENST00000700004.2:intron_variant:MODIFIER:intron4/7:c.3172+2164G>C::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron4/9:c.1607-101G>C::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron4/9:c.2876-101G>C::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron4/9:c.3179-101G>C::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron2/7:c.2783-101G>C::,MSH6:ENST00000455383.6:intron_variant:MODIFIER:intron4/9:c.2876-101G>C::,MSH6:ENST00000420813.6:intron_variant:MODIFIER:intron4/9:c.2876-101G>C::,MSH6:ENST00000411819.2:intron_variant:MODIFIER:intron4/9:c.2876-101G>C::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4876C>G::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89345 [benign DISEASE=not provided,not specified,Lynch syndrome GENE=MSH6];			rs2072447	0.78321	0.92140,0.72115,0.87882,0.73049,0.76287	47361,	24401	32973	-0.4200	1.76			/0.0>0.0/1.3>0.0,/6.8>5.0/0.0>0.6		MSH6|0.00|0.00|0.00|0.00|31|-48|14|-48	27090025,18851982	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47803553	47803553	T	A	het		QUAL=24;DP=17;QD=1.41	MSH6,FBXO11	synonymous,intron,downstream_gene	MSH6:ENST00000652107.1:synonymous_variant:LOW:exon7/12:c.3009T>A:p.Thr1003=:,MSH6:ENST00000234420.11:synonymous_variant:LOW:exon5/10:c.3306T>A:p.Thr1102=:,MSH6:ENST00000700004.2:intron_variant:MODIFIER:intron4/7:c.3173-2065T>A::,MSH6:ENST00000700000.1:synonymous_variant:LOW:exon5/10:c.1740T>A:p.Thr580=:,MSH6:ENST00000673637.1:synonymous_variant:LOW:exon5/10:c.3009T>A:p.Thr1003=:,MSH6:ENST00000700002.1:synonymous_variant:LOW:exon5/10:c.3312T>A:p.Thr1104=:,MSH6:ENST00000540021.6:synonymous_variant:LOW:exon3/8:c.2916T>A:p.Thr972=:,MSH6:ENST00000455383.6:synonymous_variant:LOW:exon5/10:c.3009T>A:p.Thr1003=:,MSH6:ENST00000420813.6:synonymous_variant:LOW:exon5/10:c.3009T>A:p.Thr1003=:,MSH6:ENST00000411819.2:synonymous_variant:LOW:exon5/10:c.3009T>A:p.Thr1003=:,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4642A>T::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	36589 [benign DISEASE=Lynch syndrome,Hereditary cancer-predisposing syndrome,not specified,not provided,Lynch syndrome 5,Carcinoma of colon,Hereditary nonpolyposis colorectal neoplasms GENE=MSH6];			rs2020910	0.01151	0.00718,0.00707,0.19671,0.00163,0.01329	112,	1528	150446	-2.3440	0.27			/1.7>1.5/0.0>0.0,/0.0>0.2/0.0>0.0	COSV52275019	MSH6|0.00|0.00|0.00|0.00|-37|41|-3|41	25741868,23757202,26900293,10537275,15805151,10413423,16010685,16638864,19685281,32742474,28093084,29434720,31660093	38	576	0	2 / 66	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47803699	47803699	A	T	het	off-target	QUAL=24;DP=238;QD=0.10	MSH6,FBXO11	splice_region&intron,intron,downstream_gene	MSH6:ENST00000652107.1:splice_region_variant&intron_variant:LOW:intron7/11:c.3141+14A>T::,MSH6:ENST00000234420.11:splice_region_variant&intron_variant:LOW:intron5/9:c.3438+14A>T::,MSH6:ENST00000700004.2:intron_variant:MODIFIER:intron4/7:c.3173-1919A>T::,MSH6:ENST00000700000.1:splice_region_variant&intron_variant:LOW:intron5/9:c.1872+14A>T::,MSH6:ENST00000673637.1:splice_region_variant&intron_variant:LOW:intron5/9:c.3141+14A>T::,MSH6:ENST00000700002.1:splice_region_variant&intron_variant:LOW:intron5/9:c.3444+14A>T::,MSH6:ENST00000540021.6:splice_region_variant&intron_variant:LOW:intron3/7:c.3048+14A>T::,MSH6:ENST00000455383.6:splice_region_variant&intron_variant:LOW:intron5/9:c.3141+14A>T::,MSH6:ENST00000420813.6:splice_region_variant&intron_variant:LOW:intron5/9:c.3141+14A>T::,MSH6:ENST00000411819.2:splice_region_variant&intron_variant:LOW:intron5/9:c.3141+14A>T::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+4496T>A::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	42471 [benign DISEASE=Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Hereditary nonpolyposis colorectal neoplasms,not specified,not provided,Lynch syndrome 5,Lynch syndrome,Endometrial carcinoma,Mismatch repair cancer syndrome 3 GENE=MSH6];			rs2020911	0.33401	0.17482,0.43489,0.61865,0.37393,0.49232	9378,	32028	101258	-0.0370	4.03			/4.2>4.9/0.0>0.0,/0.5>0.0/0.0>0.0	COSV52273834	MSH6|0.00|0.00|0.00|0.00|-43|-31|-14|50	25741868,24033266,23757202,20386703,16847180,24689082,25938433,28481244,31660093	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47805736	47805739	CTAT	-	het	off-target	QUAL=24;DP=44;QD=0.55	MSH6,FBXO11	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron9/11:c.3349+35_3349+38del::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron7/9:c.3646+35_3646+38del::,MSH6:ENST00000700004.2:intron_variant:MODIFIER:intron5/7:c.3262+35_3262+38del::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron7/9:c.2080+35_2080+38del::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron7/9:c.3349+35_3349+38del::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron7/9:c.3652+35_3652+38del::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron5/7:c.3256+35_3256+38del::,MSH6:ENST00000455383.6:intron_variant:MODIFIER:intron7/9:c.3349+35_3349+38del::,MSH6:ENST00000420813.6:intron_variant:MODIFIER:intron7/9:c.3349+35_3349+38del::,MSH6:ENST00000411819.2:intron_variant:MODIFIER:intron7/9:c.3349+35_3349+38del::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+2456_169+2459del::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89429 [benign DISEASE=not specified,not provided,Lynch syndrome GENE=MSH6];			rs1805181	0.70637	0.79729,0.59880,0.85878,0.67001,0.74023	38246,	30591	44513	1.3380	1.34			/4.4>4.4/0.0>0.0,/0.7>0.0/0.0>0.0		MSH6|0.00|0.00|0.00|0.00|-28|44|-33|-28	28481244	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47805798	47805798	T	C	hom	off-target	QUAL=23;DP=44;QD=0.52	MSH6,FBXO11	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron9/11:c.3349+91T>C::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron7/9:c.3646+91T>C::,MSH6:ENST00000700004.2:intron_variant:MODIFIER:intron5/7:c.3262+91T>C::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron7/9:c.2080+91T>C::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron7/9:c.3349+91T>C::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron7/9:c.3652+91T>C::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron5/7:c.3256+91T>C::,MSH6:ENST00000455383.6:intron_variant:MODIFIER:intron7/9:c.3349+91T>C::,MSH6:ENST00000420813.6:intron_variant:MODIFIER:intron7/9:c.3349+91T>C::,MSH6:ENST00000411819.2:intron_variant:MODIFIER:intron7/9:c.3349+91T>C::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+2397A>G::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89432 [benign DISEASE=Hereditary nonpolyposis colorectal neoplasms,not specified,Lynch syndrome,not provided,Lynch syndrome 5 GENE=MSH6];	CS1714498 [CLASS=R MUT=ALT PHEN="Colorectal cancer non-polyposis" GENE=MSH6];		rs3136359	0.77768	0.91946,0.66608,0.86395,0.73013,0.75860	46772,	24772	33824	-2.1920	0.13			/0.0>0.0/0.0>0.0,/6.3>5.9/0.0>0.0	COSV52273843	MSH6|0.00|0.00|0.00|0.00|23|5|-16|-7	34967580	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47806412	47806412	C	G	hom	off-target	QUAL=24;DP=33;QD=0.73	MSH6,FBXO11	intron,downstream_gene	MSH6:ENST00000652107.1:intron_variant:MODIFIER:intron10/11:c.3505-40C>G::,MSH6:ENST00000234420.11:intron_variant:MODIFIER:intron8/9:c.3802-40C>G::,MSH6:ENST00000700004.2:intron_variant:MODIFIER:intron6/7:c.3418-40C>G::,MSH6:ENST00000700000.1:intron_variant:MODIFIER:intron8/9:c.2236-40C>G::,MSH6:ENST00000673637.1:intron_variant:MODIFIER:intron8/9:c.3505-40C>G::,MSH6:ENST00000700002.1:intron_variant:MODIFIER:intron8/9:c.3808-40C>G::,MSH6:ENST00000540021.6:intron_variant:MODIFIER:intron6/7:c.3412-40C>G::,MSH6:ENST00000455383.6:intron_variant:MODIFIER:intron8/9:c.3505-40C>G::,MSH6:ENST00000420813.6:intron_variant:MODIFIER:intron8/9:c.3505-40C>G::,MSH6:ENST00000411819.2:intron_variant:MODIFIER:intron8/9:c.3505-40C>G::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+1783G>C::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	36594 [benign DISEASE=not specified,Lynch syndrome,Lynch syndrome 5,not provided GENE=MSH6];			rs3136367	0.77248	0.91494,0.65988,0.87495,0.72531,0.75456	46154,	25180	34604	-1.0020	0.42			/3.1>1.5/0.0>0.0,/0.0>0.0/0.0>0.0	COSV52273637	MSH6|0.00|0.00|0.00|0.00|19|8|-50|12	25741868,16847180,10699937,14520694,11807791,21155762	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	47806752	47806752	T	-	het	off-target;low_conf_region	QUAL=19;DP=27;QD=0.70	MSH6,FBXO11	splice_region&intron,intron,downstream_gene	MSH6:ENST00000652107.1:splice_region_variant&intron_variant:LOW:intron11/11:c.3705-10del::,MSH6:ENST00000234420.11:splice_region_variant&intron_variant:LOW:intron9/9:c.4002-10del::,MSH6:ENST00000700004.2:splice_region_variant&intron_variant:LOW:intron7/7:c.3618-10del::,MSH6:ENST00000700000.1:splice_region_variant&intron_variant:LOW:intron9/9:c.2436-10del::,MSH6:ENST00000673637.1:splice_region_variant&intron_variant:LOW:intron9/9:c.3705-10del::,MSH6:ENST00000700002.1:splice_region_variant&intron_variant:LOW:intron9/9:c.4008-10del::,MSH6:ENST00000540021.6:splice_region_variant&intron_variant:LOW:intron7/7:c.3612-10del::,MSH6:ENST00000455383.6:splice_region_variant&intron_variant:LOW:intron9/9:c.3705-10del::,MSH6:ENST00000420813.6:splice_region_variant&intron_variant:LOW:intron9/9:c.3705-10del::,MSH6:ENST00000411819.2:splice_region_variant&intron_variant:LOW:intron9/9:c.3705-10del::,FBXO11:ENST00000405808.5:intron_variant:MODIFIER:intron3/3:c.169+1443del::,FBXO11:ENST00000402508.5:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000403359.8:downstream_gene_variant:MODIFIER::::,FBXO11:ENST00000683894.1:downstream_gene_variant:MODIFIER::::		600678_[GENE=MSH6_PHENOS=Lynch syndrome 5, 614350 (3), Autosomal dominant; Mismatch repair cancer syndrome 3, 619097 (3), Autosomal recessive; {Endometrial cancer, familial}, 608089 (3), Autosomal dominant, Somatic mutation]&607871_[GENE=FBXO11_PHENOS=Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominant]	89508 [likely benign DISEASE=not specified,Lynch syndrome 5,not provided,Lynch syndrome,Breast and/or ovarian cancer GENE=MSH6];		(T)n (Simple_repeat)	rs59056100	0.27624	0.30161,0.20018,0.23910,0.28070,0.21686	4792,	28628	100116	-1.0800	0.00			/2.5>2.4/0.0>0.0,/8.9>8.9/0.0>0.0		MSH6|0.00|0.00|0.00|0.00|2|33|28|22	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH6 (inh=AR+AD oe_syn=1.50 oe_mis=1.29 oe_lof=0.34), FBXO11 (inh=AD oe_syn=1.25 oe_mis=0.44 oe_lof=0.02)
chr2	146839405	146839405	A	G	het		QUAL=24;DP=819;QD=0.03	LINC01911	intron&non_coding_transcript	LINC01911:ENST00000696349.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.259-7224A>G::,LINC01911:ENST00000656564.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.320+1359A>G::,LINC01911:ENST00000450667.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/10:n.229+1200A>G::,LINC01911:ENST00000670621.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.291+1359A>G::,LINC01911:ENST00000669097.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.280+1359A>G::,LINC01911:ENST00000696350.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/11:n.77+1200A>G::						rs4411641	0.48163	0.63759,0.52056,0.45643,0.39974,0.43397	18569,	36024	78742	0.2300	2.72			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LINC01911 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	189805813	189805813	-	A	het	off-target	QUAL=20;DP=44;QD=0.45	PMS1	intron,frameshift	PMS1:ENST00000418224.7:intron_variant:MODIFIER:intron4/10:c.418+70dup::,PMS1:ENST00000432292.7:intron_variant:MODIFIER:intron2/10:c.-110-12193dup::,PMS1:ENST00000618056.4:intron_variant:MODIFIER:intron4/5:c.418+70dup::,PMS1:ENST00000624204.3:intron_variant:MODIFIER:intron3/11:c.-111+9873dup::,PMS1:ENST00000409985.5:frameshift_variant:HIGH:exon4/4:c.488dup:p.Leu164ValfsTer4:,PMS1:ENST00000441310.7:intron_variant:MODIFIER:intron4/12:c.418+70dup::,PMS1:ENST00000409823.7:intron_variant:MODIFIER:intron4/11:c.418+70dup::,PMS1:ENST00000374826.8:intron_variant:MODIFIER:intron4/4:c.418+70dup::,PMS1:ENST00000447232.6:intron_variant:MODIFIER:intron4/11:c.418+70dup::			1228750 [benign DISEASE=not provided GENE=PMS1];	CI229062 [CLASS=DM MUT=ALT PHEN="Constitutional mismatch repair deficiency syndrome" GENE=PMS1];		rs3214425	0.22849	0.28957,0.25225,0.22974,0.19877,0.12250	3958,	26120	114926		0.22			/0.0>0.0/0.0>0.0		PMS1|0.00|0.00|0.00|0.00|-49|26|-43|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS1 (inh=AD oe_syn=0.84 oe_mis=0.92 oe_lof=0.76)
chr2	189817906	189817906	G	C	het	off-target	QUAL=24;DP=316;QD=0.08	PMS1	intron	PMS1:ENST00000418224.7:intron_variant:MODIFIER:intron4/10:c.419-111G>C::,PMS1:ENST00000432292.7:intron_variant:MODIFIER:intron2/10:c.-110-111G>C::,PMS1:ENST00000618056.4:intron_variant:MODIFIER:intron4/5:c.419-111G>C::,PMS1:ENST00000624204.3:intron_variant:MODIFIER:intron3/11:c.-110-111G>C::,PMS1:ENST00000441310.7:intron_variant:MODIFIER:intron4/12:c.419-111G>C::,PMS1:ENST00000409823.7:intron_variant:MODIFIER:intron4/11:c.419-111G>C::,PMS1:ENST00000447232.6:intron_variant:MODIFIER:intron4/11:c.419-111G>C::			1283805 [benign DISEASE=not provided GENE=PMS1];			rs3791773	0.22463	0.28357,0.24925,0.22674,0.19660,0.11965	4035,	26075	117861	0.7580	11.26			/0.0>0.0/0.0>0.0		PMS1|0.00|0.00|0.00|0.00|-5|26|3|27	25162662	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS1 (inh=AD oe_syn=0.84 oe_mis=0.92 oe_lof=0.76)
chr2	214728509	214728509	T	C	het	off-target	QUAL=24;DP=202;QD=0.12	BARD1	3'UTR,downstream_gene	BARD1:ENST00000260947.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*167A>G::,BARD1:ENST00000619009.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000617164.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000613374.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000613706.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000620057.4:downstream_gene_variant:MODIFIER::::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1222105 [benign DISEASE=not provided GENE=BARD1];			rs5020511	0.64564	0.77068,0.54471,0.44423,0.61210,0.58284	31816,	33106	53094	-1.4770	1.75			/5.8>6.0/0.0>0.0		BARD1|0.00|0.00|0.00|0.00|-15|-2|-35|-50	37645774	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214728537	214728537	-	T	het	off-target	QUAL=24;DP=398;QD=0.06	BARD1	3'UTR,downstream_gene	BARD1:ENST00000260947.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*138dup::,BARD1:ENST00000619009.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000617164.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000613374.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000613706.5:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:downstream_gene_variant:MODIFIER::::,BARD1:ENST00000620057.4:downstream_gene_variant:MODIFIER::::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1292322 [benign DISEASE=not provided GENE=BARD1];			rs113789798	0.38737	0.26514,0.47767,0.64501,0.41582,0.47961	11459,	32827	88163		0.42			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214729127	214729127	G	C	het	off-target	QUAL=24;DP=46;QD=0.52	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron10/10:c.2002-119C>G::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron4/4:c.463-119C>G::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron9/9:c.1945-119C>G::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron5/5:c.592-119C>G::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron10/10:c.1594-119C>G::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron6/6:c.649-119C>G::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron9/9:c.*668-119C>G::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1292323 [benign DISEASE=not provided GENE=BARD1];		Tigger4b (DNA/TcMar-Tigger)	rs2075623	0.64171	0.76509,0.53607,0.43460,0.61122,0.57724	32003,	33583	54487	-0.8080	0.67			/10.0>9.2/0.0>0.0		BARD1|0.00|0.00|0.01|0.00|18|-15|-14|-19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214729147	214729147	T	G	het	off-target	QUAL=24;DP=46;QD=0.52	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron10/10:c.2002-139A>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron4/4:c.463-139A>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron9/9:c.1945-139A>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron5/5:c.592-139A>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron10/10:c.1594-139A>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron6/6:c.649-139A>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron9/9:c.*668-139A>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1292324 [benign DISEASE=not provided GENE=BARD1];		Tigger4b (DNA/TcMar-Tigger)	rs2075622	0.64176	0.76512,0.53612,0.43371,0.61141,0.57691	32023,	33585	54499	-0.2930	0.61			/0.0>0.0/0.0>0.0		BARD1|0.00|0.00|0.02|0.00|-35|-2|-34|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214730440	214730440	G	A	het		QUAL=24;DP=27;QD=0.89	BARD1	missense,3'UTR	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys:,BARD1:ENST00000619009.5:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys:,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys:,BARD1:ENST00000613374.5:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys:,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon10/11:c.1564C>T:p.Arg522Cys:,BARD1:ENST00000421162.2:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys:,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon9/10:c.*638C>T::	regulatory_region_variant:enhancer	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	136500 [benign/likely benign DISEASE=Triple-Negative Breast Cancer Finding,Malignant tumor of breast,not specified,Familial cancer of breast,Hereditary breast ovarian cancer syndrome,not provided,Hereditary cancer,Hereditary cancer-predisposing syndrome GENE=BARD1];	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1];		rs3738888	0.00731	0.00219,0.00667,0.00986,0.00844,0.00374	15,	1083	151055	5.2690	25.20	0.104	0.10	/0.0>0.0/0.0>0.5	COSV53616840	BARD1|0.00|0.00|0.00|0.01|46|-25|43|-29	25741868,29458332,27153395,19412175,23056176,31258718,32708251,35084806,32039725,16061562,20077502,9425226,15342711,16333312,16741161,19584272,25994375,26315354,26350354,35650591,26307947,26329992,26010302	2	601	0	0 / 96	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214745589	214745589	G	T	het	off-target	QUAL=25;DP=59;QD=0.42	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron8/10:c.1810+133C>A::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.365-15081C>A::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron7/9:c.1753+133C>A::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron3/5:c.400+133C>A::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron8/10:c.1402+133C>A::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron4/6:c.457+133C>A::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron7/9:c.*476+133C>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1251354 [benign DISEASE=not provided GENE=BARD1];			rs6730040	0.48904	0.51798,0.53968,0.56538,0.46869,0.45773	18332,	37652	77648	-0.5570	0.12			/6.5>4.9/0.0>0.0		BARD1|0.00|0.00|0.00|0.00|25|-19|46|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214745914	214745914	A	G	het	off-target	QUAL=24;DP=272;QD=0.09	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron7/10:c.1678-60T>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.365-15406T>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron6/9:c.1621-60T>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron2/5:c.268-60T>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron7/10:c.1270-60T>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron3/6:c.325-60T>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron6/9:c.*344-60T>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	676478 [likely benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided GENE=BARD1];			rs4986842	0.00699	0.00221,0.00673,0.00116,0.00839,0.00331	15,	1035	151301	-1.4830	0.57			/6.6>6.1/0.0>0.0		BARD1|0.00|0.00|0.00|0.00|-34|-16|-37|39		2	584	0	0 / 89					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767401	214767402	TT	-	het	off-target	QUAL=25;DP=109;QD=0.23	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron6/10:c.1568+80_1568+81del::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24895_364+24896del::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron5/9:c.1511+80_1511+81del::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14847_159-14846del::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron6/10:c.1160+80_1160+81del::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14847_216-14846del::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron5/9:c.*234+80_*234+81del::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1292325 [benign DISEASE=not provided GENE=BARD1];			rs5031008	0.37114	0.37125,0.31813,0.37171,0.36410,0.41166	10582,	35211	95521	0.6430	1.82			/0.0>0.0/0.0>0.0		BARD1|0.00|0.00|0.00|0.00|25|-43|26|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767431	214767431	T	C	het	off-target	QUAL=25;DP=109;QD=0.23	BARD1	intron	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron6/10:c.1568+51A>G::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24866A>G::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron5/9:c.1511+51A>G::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14876A>G::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron6/10:c.1160+51A>G::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14876A>G::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron5/9:c.*234+51A>G::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1230936 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided GENE=BARD1];			rs5031009	0.37132	0.37100,0.31837,0.37210,0.36429,0.41087	10646,	35106	95486	-3.4800	0.23			/4.6>0.4/0.0>0.0	COSV53611189	BARD1|0.00|0.00|0.00|0.00|-19|-6|47|37	29879995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767468	214767468	G	A	het	off-target	QUAL=25;DP=114;QD=0.22	BARD1	splice_region&intron,intron	BARD1:ENST00000260947.9:splice_region_variant&intron_variant:LOW:intron6/10:c.1568+14C>T::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24829C>T::,BARD1:ENST00000617164.5:splice_region_variant&intron_variant:LOW:intron5/9:c.1511+14C>T::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14913C>T::,BARD1:ENST00000613706.5:splice_region_variant&intron_variant:LOW:intron6/10:c.1160+14C>T::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14913C>T::,BARD1:ENST00000620057.4:splice_region_variant&intron_variant:LOW:intron5/9:c.*234+14C>T::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	256214 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not provided,Hereditary cancer-predisposing syndrome,not specified GENE=BARD1];			rs5031011	0.35079	0.34606,0.30435,0.37296,0.34172,0.40420	9520,	34237	98601	-0.2950	1.69			/0.0>0.0/0.0>0.0	COSV53615058	BARD1|0.00|0.00|0.01|0.00|16|22|16|-42	25741868,24033266,29879995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767531	214767531	C	T	het		QUAL=16;DP=110;QD=0.15	BARD1	missense,intron,3'UTR	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon6/11:c.1519G>A:p.Val507Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24766G>A::,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon5/10:c.1462G>A:p.Val488Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14976G>A::,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon6/11:c.1111G>A:p.Val371Met:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14976G>A::,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon5/10:c.*185G>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	140757 [benign/likely benign DISEASE=not specified,Familial cancer of breast,not provided,Hereditary cancer-predisposing syndrome GENE=BARD1];	CM034384 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=BARD1];		rs2070094	0.37129	0.37117,0.31863,0.37185,0.36392,0.41190	10608,	35246	95606	-5.2200	0.01	0.108	0.07	/0.0>0.0/0.0>0.0	COSV53610001	BARD1|0.00|0.00|0.00|0.00|-2|14|-47|-49	25741868,23222812,29458332,19412175,19482343,25785002,29879995,33623049,35084806,14550946,23966609,33240400,35768791,17399677,37645774,37561379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214767532	214767532	A	G	hom		QUAL=25;DP=110;QD=0.23	BARD1	synonymous,intron,3'UTR	BARD1:ENST00000260947.9:synonymous_variant:LOW:exon6/11:c.1518T>C:p.His506=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+24765T>C::,BARD1:ENST00000617164.5:synonymous_variant:LOW:exon5/10:c.1461T>C:p.His487=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-14977T>C::,BARD1:ENST00000613706.5:synonymous_variant:LOW:exon6/11:c.1110T>C:p.His370=:PF12796 [Ankyrin repeats (3 copies)],BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-14977T>C::,BARD1:ENST00000620057.4:3_prime_UTR_variant:MODIFIER:exon5/10:c.*184T>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	183704 [benign DISEASE=not specified,Hereditary cancer-predisposing syndrome,Hereditary breast ovarian cancer syndrome,Familial cancer of breast,not provided GENE=BARD1];			rs2070093	0.75559	0.59939,0.75373,0.94876,0.80491,0.83920	44244,	26436	37174	-0.2410	1.97			/0.0>0.0/0.0>0.0	COSV53617490	BARD1|0.00|0.00|0.00|0.00|13|-11|-48|46	25741868,24033266,19536092,35084806,17399677	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214769331	214769331	C	T	het	off-target	QUAL=24;DP=270;QD=0.09	BARD1	splice_region&intron,intron	BARD1:ENST00000260947.9:splice_region_variant&intron_variant:LOW:intron4/10:c.1315-19G>A::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+22966G>A::,BARD1:ENST00000617164.5:splice_region_variant&intron_variant:LOW:intron3/9:c.1258-19G>A::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-16776G>A::,BARD1:ENST00000613706.5:splice_region_variant&intron_variant:LOW:intron4/10:c.907-19G>A::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.216-16776G>A::,BARD1:ENST00000620057.4:splice_region_variant&intron_variant:LOW:intron3/9:c.365-19G>A::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	256213 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,Familial cancer of breast,Hereditary cancer-predisposing syndrome,not provided GENE=BARD1];			rs6704780	0.37155	0.37168,0.31897,0.37182,0.36430,0.40852	10615,	35240	95516	0.1260	1.14			10.1>9.7/10.1>9.7/0.0>0.0,/10.1>9.7/0.0>0.0	COSV53612311	BARD1|0.00|0.01|0.00|0.00|-27|-19|-19|-38	25741868,29879995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214780740	214780740	C	G	het		QUAL=24;DP=68;QD=0.35	BARD1	missense,intron	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon4/11:c.1134G>C:p.Arg378Ser:,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron3/4:c.364+11557G>C::,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon3/10:c.1077G>C:p.Arg359Ser:,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.159-28185G>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron4/10:c.906+228G>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron2/6:c.215+16321G>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron3/9:c.365-11428G>C::		601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	142769 [benign DISEASE=not provided,Hereditary cancer-predisposing syndrome,not specified,Hereditary breast ovarian cancer syndrome,Familial cancer of breast GENE=BARD1];	CM076014 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs2229571	0.52999	0.39843,0.46906,0.37301,0.61170,0.48174	22198,	36093	71379	-0.3950	1.39	0.111	0.23	/0.0>0.0/2.1>0.0	COSV53612030	BARD1|0.00|0.00|0.01|0.00|-43|-33|-43|26	25741868,23554684,23222812,29458332,19412175,19482343,23056176,25785002,29879995,31258718,32708251,33623049,35084806,30071039,17028982,30976110,23966609,33603458,18059179,35650591,33240400,35768791,37645774,37561379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03)
chr2	214809366	214809366	T	G	hom	off-target	QUAL=24;DP=122;QD=0.20	BARD1,SNHG31	intron,upstream_gene	BARD1:ENST00000260947.9:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:ENST00000619009.5:intron_variant:MODIFIER:intron1/4:c.158+46A>C::,BARD1:ENST00000617164.5:intron_variant:MODIFIER:intron1/9:c.158+46A>C::,BARD1:ENST00000613374.5:intron_variant:MODIFIER:intron1/5:c.158+46A>C::,BARD1:ENST00000613706.5:intron_variant:MODIFIER:intron1/10:c.158+46A>C::,BARD1:ENST00000421162.2:intron_variant:MODIFIER:intron1/6:c.158+46A>C::,BARD1:ENST00000620057.4:intron_variant:MODIFIER:intron1/9:c.158+46A>C::,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1174423 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided GENE=BARD1];			rs35933323	0.73755	0.75995,0.78395,0.80522,0.71112,0.66860	41457,	29311	39935	0.1910	7.23			/0.9>0.7/0.0>0.0		BARD1|0.00|0.00|0.00|0.00|-37|-32|49|50	22328350,35131881	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809500	214809500	G	A	het		QUAL=24;DP=821;QD=0.03	BARD1,SNHG31	missense,upstream_gene	BARD1:ENST00000260947.9:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000619009.5:missense_variant:MODERATE:exon1/5:c.70C>T:p.Pro24Ser:,BARD1:ENST00000617164.5:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:,BARD1:ENST00000613374.5:missense_variant:MODERATE:exon1/6:c.70C>T:p.Pro24Ser:,BARD1:ENST00000613706.5:missense_variant:MODERATE:exon1/11:c.70C>T:p.Pro24Ser:,BARD1:ENST00000421162.2:missense_variant:MODERATE:exon1/7:c.70C>T:p.Pro24Ser:,BARD1:ENST00000620057.4:missense_variant:MODERATE:exon1/10:c.70C>T:p.Pro24Ser:,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	183698 [benign DISEASE=not provided,Familial cancer of breast,Hereditary cancer-predisposing syndrome,not specified GENE=BARD1];	CM076015 [CLASS=DP MUT=ALT PHEN="Breast cancer reduced risk association with" GENE=BARD1];		rs1048108	0.33268	0.21210,0.38614,0.36061,0.36986,0.40862	8919,	32778	101532	0.9900	15.74	0.260	0.10	/0.0>0.0/0.0>0.0	COSV53608734	BARD1|0.00|0.00|0.00|0.00|36|-41|2|31	25741868,23554684,21514219,23222812,29484706,29458332,19412175,19482343,23056176,24293394,25785002,29879995,30132831,31123171,31258718,32708251,33623049,35084806,23966609,34094541,35768791,37561379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809599	214809599	C	G	hom	off-target	QUAL=23;DP=107;QD=0.21	BARD1,SNHG31	5'UTR,upstream_gene	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:ENST00000617164.5:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::,BARD1:ENST00000613374.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-30G>C::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-30G>C::,BARD1:ENST00000620057.4:5_prime_UTR_variant:MODIFIER:exon1/10:c.-30G>C::,BARD1:ENST00000619009.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:upstream_gene_variant:MODIFIER::::,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	334199 [benign DISEASE=Familial cancer of breast,Hereditary breast ovarian cancer syndrome,not provided GENE=BARD1];			rs1129804	0.73699	0.75919,0.78410,0.80050,0.71087,0.66805	41389,	29338	40012	-0.2340	5.95			/4.6>4.0/0.0>0.0		BARD1|0.00|0.00|0.00|0.00|-22|20|-21|1	19252927,31258718,32708251,18059179	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809617	214809617	A	G	hom	off-target	QUAL=24;DP=106;QD=0.23	BARD1,SNHG31	5'UTR,upstream_gene	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:ENST00000617164.5:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::,BARD1:ENST00000613374.5:5_prime_UTR_variant:MODIFIER:exon1/6:c.-48T>C::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-48T>C::,BARD1:ENST00000620057.4:5_prime_UTR_variant:MODIFIER:exon1/10:c.-48T>C::,BARD1:ENST00000619009.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:upstream_gene_variant:MODIFIER::::,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	334200 [benign DISEASE=Familial cancer of breast,Hereditary breast ovarian cancer syndrome,not provided GENE=BARD1];			rs17489363	0.73711	0.75922,0.78395,0.80368,0.71090,0.66784	41405,	29326	39994	-2.5770	1.74			/4.0>2.4/0.0>0.0		BARD1|0.00|0.00|0.00|0.00|-40|2|-39|2	23056176,30132831,31123171,31258718,32708251,32021290,35650591,30793172,35768791	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809647	214809647	C	T	hom	off-target	QUAL=25;DP=9;QD=2.78	BARD1,SNHG31	5'UTR,upstream_gene	BARD1:ENST00000260947.9:5_prime_UTR_variant:MODIFIER:exon1/11:c.-78G>A::,BARD1:ENST00000613706.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-78G>A::,BARD1:ENST00000619009.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000617164.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000613374.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000620057.4:upstream_gene_variant:MODIFIER::::,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	334201 [benign DISEASE=Familial cancer of breast,Hereditary breast ovarian cancer syndrome,not provided GENE=BARD1];			rs34732883	0.63856	0.60707,0.66970,0.80229,0.63185,0.60837	31168,	34858	55014	-0.0320	6.35			/2.2>2.4/0.0>0.0		BARD1|0.00|0.00|0.00|0.00|-28|-44|-28|1	31258718	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	214809712	214809712	C	T	hom	off-target	QUAL=24;DP=2;QD=12.00	BARD1,SNHG31	upstream_gene	BARD1:ENST00000260947.9:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000619009.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000617164.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000613374.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000613706.5:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000421162.2:upstream_gene_variant:MODIFIER::::,BARD1:ENST00000620057.4:upstream_gene_variant:MODIFIER::::,SNHG31:ENST00000670391.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	601593_[GENE=BARD1_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1287291 [benign DISEASE=not provided GENE=BARD1];		(GGCGG)n (Simple_repeat)	rs13022992	0.99957	0.99959,0.99987,0.99981,0.99976,0.99420	75946,	66	66	-0.2790	6.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BARD1 (inh=AD oe_syn=1.11 oe_mis=1.08 oe_lof=1.03), SNHG31 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr2	219550874	219550875	GA	-	hom	off-target	QUAL=23;DP=162;QD=0.14	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5684-33_5684-32del::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5408-33_5408-32del::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1276422 [benign DISEASE=3M syndrome 2,not provided GENE=OBSL1];			rs146790993	0.43768	0.40125,0.48250,0.40257,0.45936,0.25259	14817,	36815	85371	1.2180	17.75			/10.2>6.8/0.0>0.0		OBSL1|0.00|0.00|0.00|0.00|-31|-5|-31|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219550924	219550924	T	C	hom	off-target	QUAL=24;DP=162;QD=0.15	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5684-82A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5408-82A>G::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1287989 [benign DISEASE=not provided GENE=OBSL1];			rs1043582	0.43846	0.40208,0.48324,0.40623,0.45973,0.25280	14883,	36809	85265	0.2580	6.75			/5.1>5.7/0.0>0.0	COSV54706169	OBSL1|0.00|0.00|0.00|0.00|-42|-12|35|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551442	219551442	T	C	hom	off-target	QUAL=24;DP=79;QD=0.30	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron20/20:c.5683+87A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron19/19:c.5407+87A>G::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1247466 [benign DISEASE=not provided GENE=OBSL1];			rs6761575	0.93972	0.80886,0.96396,0.99981,0.99334,0.99938	67572,	7684	9162	-1.7350	3.17			/0.0>0.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551848	219551848	C	T	hom	off-target	QUAL=24;DP=9;QD=2.67	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5414-50G>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5138-50G>A::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1274171 [benign DISEASE=not provided GENE=OBSL1];			rs4672931	0.93081	0.77860,0.95961,0.99981,0.99319,0.99876	66583,	8530	10532	-0.4130	12.27			/0.0>7.6/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219551869	219551869	C	T	hom	off-target	QUAL=24;DP=9;QD=2.67	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5414-71G>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5138-71G>A::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1229527 [benign DISEASE=not provided GENE=OBSL1];			rs4672932	0.93083	0.77864,0.95962,0.99981,0.99319,0.99896	66596,	8528	10532	0.6000	14.03			/0.0>0.0/2.4>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552081	219552081	A	T	hom	off-target	QUAL=23;DP=862;QD=0.03	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron19/20:c.5413+31T>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron18/19:c.5137+31T>A::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1261356 [benign DISEASE=3M syndrome 2,not provided GENE=OBSL1];			rs4672933	0.98161	0.93872,0.98772,1.00000,0.99957,1.00000	73464,	2642	2802	-0.6360	4.62			/0.0>0.0/0.2>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552220	219552220	G	C	hom		QUAL=24;DP=26;QD=0.92	OBSL1,TMEM198,MIR3132	splice_region&intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron18/20:c.5309-4C>G::,OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron17/19:c.5033-4C>G::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	194972 [benign DISEASE=3M syndrome 2,not provided,not specified GENE=OBSL1];			rs34490902	0.44494	0.40354,0.48733,0.40456,0.46679,0.25476	15420,	36919	84529	-0.2900	8.08			6.9>7.9/6.9>7.9/0.0>0.0	COSV54703179	OBSL1|0.00|0.00|0.00|0.00|-4|-29|-20|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552506	219552506	G	T	hom	off-target	QUAL=24;DP=79;QD=0.30	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron18/20:c.5308+30C>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron17/19:c.5032+30C>A::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1269748 [benign DISEASE=not provided GENE=OBSL1];			rs60549465	0.40133	0.25397,0.47048,0.40527,0.46539,0.25260	13127,	34673	90885	0.1300	8.69			/5.3>4.5/0.0>0.0		OBSL1|0.00|0.00|0.00|0.07|-28|-18|-17|30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219552544	219552544	C	T	hom		QUAL=24;DP=146;QD=0.16	OBSL1,TMEM198,MIR3132	missense,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon18/21:c.5300G>A:p.Arg1767Gln:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon17/20:c.5024G>A:p.Arg1675Gln:PF07679 [Immunoglobulin I-set domain],TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	288014 [benign DISEASE=3M syndrome 2,not specified,not provided GENE=OBSL1];			rs59332477	0.43182	0.37850,0.48234,0.40490,0.45968,0.25187	14507,	36628	86370	1.1840	23.80	0.235	0.15	/7.2>8.6/0.0>0.0	COSV54703732	OBSL1|0.00|0.00|0.00|0.02|-5|-8|11|-8	33230300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219553189	219553189	T	C	hom	off-target	QUAL=24;DP=4;QD=6.00	OBSL1,TMEM198,MIR3132	intron,downstream_gene,upstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron16/20:c.4990-165A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron15/19:c.4714-165A>G::,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,MIR3132:ENST00000581997.1:upstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1257901 [benign DISEASE=not provided GENE=OBSL1];			rs6436157	0.94191	0.81648,0.96597,0.99981,0.99327,0.99897	67964,	7493	8845	0.0930	8.10			/2.2>2.6/0.1>0.8				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), MIR3132 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554514	219554514	T	C	hom		QUAL=24;DP=471;QD=0.05	OBSL1,TMEM198	synonymous,downstream_gene	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon15/21:c.4836A>G:p.Thr1612=:,OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon14/20:c.4560A>G:p.Thr1520=:,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334466 [benign DISEASE=3M syndrome 2,not provided,not specified GENE=OBSL1];			rs10932813	0.98824	0.96161,0.99066,1.00000,0.99966,1.00000	74400,	1744	1792	-3.9870	0.36			/7.8>1.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219554617	219554617	T	C	hom		QUAL=24;DP=704;QD=0.03	OBSL1,TMEM198	missense,downstream_gene	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon15/21:c.4733A>G:p.Gln1578Arg:,OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon14/20:c.4457A>G:p.Gln1486Arg:,TMEM198:ENST00000344458.6:downstream_gene_variant:MODIFIER::::,TMEM198:ENST00000373883.4:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000603926.5:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334469 [benign DISEASE=3M syndrome 2,not provided,not specified GENE=OBSL1];			rs10932814	0.96338	0.88934,0.97719,1.00000,0.99366,0.99938	70819,	5038	5576	0.1340	5.72	0.090	0.05	/0.0>1.6/0.0>0.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM198 (inh=n/a oe_syn=1.06 oe_mis=0.81 oe_lof=0.22), OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556234	219556234	A	G	hom		QUAL=24;DP=41;QD=0.59	OBSL1	synonymous	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon14/21:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon13/20:c.4119T>C:p.Asp1373=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon14/14:c.4395T>C:p.Asp1465=:PF07679 [Immunoglobulin I-set domain]		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334475 [benign DISEASE=3M syndrome 2,not specified,not provided GENE=OBSL1];			rs10932816	0.97046	0.90021,0.98295,1.00000,0.99941,1.00000	71856,	4079	4499	-3.1400	0.12	0.099		/0.8>0.2/2.3>3.5	COSV54708888			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556695	219556695	C	G	hom		QUAL=24;DP=535;QD=0.04	OBSL1	missense	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon13/21:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon12/20:c.3819G>C:p.Glu1273Asp:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon13/14:c.4095G>C:p.Glu1365Asp:PF07679 [Immunoglobulin I-set domain]		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334483 [benign DISEASE=3M syndrome 2,not specified,not provided GENE=OBSL1];			rs1983210	0.70287	0.62198,0.68141,0.71794,0.73727,0.89287	37869,	31147	45185	0.6310	18.07	0.171	0.13	/0.0>0.0/0.0>0.0	COSV54706342	OBSL1|0.01|0.00|0.00|0.00|26|11|-44|-46	30400783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219556734	219556734	C	A	hom	off-target	QUAL=24;DP=496;QD=0.05	OBSL1	splice_region&intron,downstream_gene	OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron12/20:c.4067-11G>T::,OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron11/19:c.3791-11G>T::,OBSL1:ENST00000603926.5:splice_region_variant&intron_variant:LOW:intron12/13:c.4067-11G>T::,OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334484 [benign DISEASE=3M syndrome 2,not provided GENE=OBSL1];			rs1983211	0.13789	0.03603,0.17926,0.12471,0.18259,0.14558	1811,	17361	131189	-0.6670	2.85			7.3>8.4/7.3>8.4/0.0>0.0	COSV54703188	OBSL1|0.08|0.00|0.00|0.00|-13|14|-28|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557307	219557307	G	A	hom	off-target	QUAL=24;DP=92;QD=0.26	OBSL1	intron,downstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron12/20:c.4066+36C>T::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron11/19:c.3790+516C>T::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron12/13:c.4066+36C>T::,OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000289656.3:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1286959 [benign DISEASE=not provided GENE=OBSL1];			rs55873563	0.13808	0.03639,0.17941,0.12312,0.18305,0.14650	1824,	17374	131222	-0.1870	9.94			/2.2>3.0/0.0>2.3		OBSL1|0.00|0.00|0.00|0.00|-29|43|36|49	34610981	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557678	219557678	C	G	hom	off-target	QUAL=24;DP=210;QD=0.11	OBSL1	intron,downstream_gene	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron11/20:c.3791-60G>C::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron11/19:c.3790+145G>C::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron11/13:c.3791-60G>C::,OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000289656.3:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1286818 [benign DISEASE=not provided GENE=OBSL1];			rs2278200	0.45575	0.49532,0.49725,0.40695,0.44311,0.25404	16103,	37081	82743	-0.4970	6.38			/7.4>7.2/0.0>0.0	COSV54704518,COSV54704992	OBSL1|0.00|0.00|0.00|0.00|-15|-36|47|-36	30400783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219557964	219557964	C	T	het		QUAL=24;DP=22;QD=1.09	OBSL1	missense,downstream_gene	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon11/20:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000289656.3:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	193901 [benign/likely benign DISEASE=not provided,3M syndrome 2,not specified GENE=OBSL1];			rs72957510	0.00711	0.01378,0.00235,0.00000,0.00612,0.00269	3,	1077	151231	0.7730	13.95	0.032	0.07	/0.0>0.0/0.0>1.4	COSV105026433	OBSL1|0.00|0.00|0.00|0.00|-24|6|3|17	25741868	9	647	0	2 / 115					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219558052	219558052	A	G	hom		QUAL=24;DP=412;QD=0.06	OBSL1	synonymous,downstream_gene	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon11/21:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon11/20:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon11/14:c.3561T>C:p.Pro1187=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373873.8:downstream_gene_variant:MODIFIER::::,OBSL1:ENST00000289656.3:downstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334496 [benign DISEASE=3M syndrome 2,not specified,not provided GENE=OBSL1];			rs2278201	0.46483	0.52638,0.50268,0.40633,0.44321,0.25445	16879,	37006	81472	-4.6040	0.00	0.233		/1.9>1.6/0.4>1.0	COSV54706224	OBSL1|0.00|0.00|0.00|0.00|31|-37|31|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219563274	219563274	T	C	hom	off-target	QUAL=24;DP=111;QD=0.22	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron7/20:c.2680+81A>G::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron7/19:c.2680+81A>G::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron7/13:c.2680+81A>G::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron7/8:c.2680+81A>G::,OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron7/8:c.1441+81A>G::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1286679 [benign DISEASE=not provided GENE=OBSL1];			rs11904583	0.97908	0.93059,0.98667,1.00000,0.99949,0.99938	73018,	3017	3185	-2.5490	0.31			/7.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219563659	219563659	A	T	het	off-target	QUAL=24;DP=282;QD=0.09	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron6/20:c.2408-32T>A::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron6/19:c.2408-32T>A::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron6/13:c.2408-32T>A::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron6/8:c.2408-32T>A::,OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron6/8:c.1169-32T>A::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1226510 [benign DISEASE=3M syndrome 2,not provided GENE=OBSL1];			rs2303543	0.56615	0.30523,0.54464,0.67624,0.67801,0.74906	26448,	33022	65840	0.9790	6.13			/0.0>0.0/0.0>1.1		OBSL1|0.00|0.00|0.00|0.00|-32|27|4|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219565481	219565481	C	T	hom		QUAL=24;DP=565;QD=0.04	OBSL1	missense	OBSL1:ENST00000404537.6:missense_variant:MODERATE:exon6/21:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000373876.5:missense_variant:MODERATE:exon6/20:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000603926.5:missense_variant:MODERATE:exon6/14:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000373873.8:missense_variant:MODERATE:exon6/9:c.2168G>A:p.Arg723Lys:,OBSL1:ENST00000289656.3:missense_variant:MODERATE:exon6/9:c.929G>A:p.Arg310Lys:	regulatory_region_variant:promoter	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	334508 [benign DISEASE=3M syndrome 2,not specified,not provided GENE=OBSL1];			rs1039898	0.82110	0.63548,0.83360,0.90375,0.90449,0.83749	52394,	20154	27222	-0.3080	3.43	0.049	0.06	/0.0>0.0/0.0>2.9	COSV54726542,COSV54731761		22371699,30400783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219567197	219567197	A	G	hom	off-target	QUAL=24;DP=35;QD=0.69	OBSL1	intron	OBSL1:ENST00000404537.6:intron_variant:MODIFIER:intron4/20:c.1838-71T>C::,OBSL1:ENST00000373876.5:intron_variant:MODIFIER:intron4/19:c.1838-71T>C::,OBSL1:ENST00000603926.5:intron_variant:MODIFIER:intron4/13:c.1838-71T>C::,OBSL1:ENST00000373873.8:intron_variant:MODIFIER:intron4/8:c.1838-71T>C::,OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron4/8:c.599-71T>C::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1242247 [benign DISEASE=not provided GENE=OBSL1];			rs4674412	0.97923	0.92930,0.98890,1.00000,0.99974,1.00000	73098,	2984	3164	0.2210	1.29			/6.3>7.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70)
chr2	219567987	219567987	A	T	het	off-target	QUAL=24;DP=397;QD=0.06	OBSL1,INHA	splice_region&intron,upstream_gene	OBSL1:ENST00000404537.6:splice_region_variant&intron_variant:LOW:intron2/20:c.1283-18T>A::,OBSL1:ENST00000373876.5:splice_region_variant&intron_variant:LOW:intron2/19:c.1283-18T>A::,OBSL1:ENST00000603926.5:splice_region_variant&intron_variant:LOW:intron2/13:c.1283-18T>A::,OBSL1:ENST00000373873.8:splice_region_variant&intron_variant:LOW:intron2/8:c.1283-18T>A::,OBSL1:ENST00000289656.3:splice_region_variant&intron_variant:LOW:intron2/8:c.44-18T>A::,INHA:ENST00000243786.3:upstream_gene_variant:MODIFIER::::		610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	1174895 [benign DISEASE=not provided,3M syndrome 2,not specified GENE=OBSL1];			rs2292360	0.37192	0.18806,0.36635,0.49922,0.45156,0.43223	11501,	33544	95492	-1.0910	1.72			6.5>5.4/6.5>5.4/0.0>0.0	COSV54726835	OBSL1|0.00|0.00|0.00|0.00|-18|9|-4|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr2	219570653	219570653	G	A	het		QUAL=24;DP=19;QD=1.26	OBSL1,INHA	synonymous,intron,upstream_gene	OBSL1:ENST00000404537.6:synonymous_variant:LOW:exon1/21:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373876.5:synonymous_variant:LOW:exon1/20:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000603926.5:synonymous_variant:LOW:exon1/14:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000373873.8:synonymous_variant:LOW:exon1/9:c.580C>T:p.Leu194=:PF07679 [Immunoglobulin I-set domain],OBSL1:ENST00000289656.3:intron_variant:MODIFIER:intron1/8:c.-228+741C>T::,INHA:ENST00000243786.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	610991_[GENE=OBSL1_PHENOS=3-M syndrome 2, 612921 (3), Autosomal recessive]	290129 [benign DISEASE=3M syndrome 2,not provided,not specified GENE=OBSL1];			rs1061399	0.36301	0.16274,0.36240,0.49425,0.44888,0.43101	11144,	32709	96507	3.2570	12.46			/0.0>0.0/0.0>0.0	COSV54727864	OBSL1|0.00|0.00|0.00|0.00|-27|39|1|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OBSL1 (inh=AR oe_syn=1.01 oe_mis=1.00 oe_lof=0.70), INHA (inh=n/a oe_syn=1.26 oe_mis=0.91 oe_lof=0.48)
chr3	10034299	10034299	T	C	het	off-target	QUAL=24;DP=223;QD=0.11	FANCD2,RNU6-670P	intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron3/42:c.206-170T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron3/43:c.206-170T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron3/43:c.206-170T>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron2/7:c.206-170T>C::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1286016 [benign DISEASE=not provided GENE=FANCD2];		AluSc8 (SINE/Alu)	rs113771705	0.20844	0.33981,0.18157,0.06827,0.16509,0.16508	3042,	21117	103295	0.7930	4.24			/0.9>1.8/0.0>1.1		FANCD2|0.00|0.00|0.00|0.00|-44|48|2|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10034307	10034307	A	G	het	off-target	QUAL=24;DP=223;QD=0.11	FANCD2,RNU6-670P	intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron3/42:c.206-162A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron3/43:c.206-162A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron3/43:c.206-162A>G::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron2/7:c.206-162A>G::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1251762 [benign DISEASE=not provided GENE=FANCD2];		AluSc8 (SINE/Alu)	rs111392584	0.18298	0.29711,0.13023,0.05881,0.15737,0.14763	2951,	20671	118653	-0.9310	1.58			/0.0>0.0/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|-10|40|-6|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035159	10035160	TT	-	het	off-target	QUAL=24;DP=168;QD=0.14	FANCD2,RNU6-670P	splice_region&intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron5/42:c.378-6_378-5del::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron5/43:c.378-6_378-5del::,FANCD2:ENST00000431693.1:splice_region_variant&intron_variant:LOW:intron4/7:c.378-6_378-5del::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342255 [benign/likely benign DISEASE=not provided,Fanconi anemia complementation group D2,Fanconi anemia GENE=FANCD2];			rs55973240	0.22899	0.42244,0.15797,0.06626,0.16406,0.16582	4999,	24273	115391	0.3340	4.33			/8.8>6.9/0.0>0.0		FANCD2|0.11|0.08|0.00|0.00|-4|15|13|8	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035291	10035291	A	C	het	off-target	QUAL=25;DP=99;QD=0.25	FANCD2,RNU6-670P	intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.438+58A>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.438+58A>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.438+58A>C::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1271812 [benign DISEASE=not provided GENE=FANCD2];			rs17032276	0.19696	0.31946,0.14500,0.06501,0.16186,0.16086	3458,	23039	122135	2.2790	12.24			/0.6>4.7/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|28|45|28|-18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10035339	10035339	T	C	het	off-target	QUAL=24;DP=95;QD=0.25	FANCD2,RNU6-670P	intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron6/42:c.438+106T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron6/43:c.438+106T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron6/43:c.438+106T>C::,FANCD2:ENST00000431693.1:intron_variant:MODIFIER:intron5/7:c.438+106T>C::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1259039 [benign DISEASE=not provided GENE=FANCD2];			rs17032277	0.19713	0.31966,0.14513,0.06610,0.16190,0.16106	3461,	23037	122017	0.2960	11.22			/0.7>0.8/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|26|-3|3|-20		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10036271	10036271	A	G	het	off-target	QUAL=24;DP=46;QD=0.52	FANCD2,RNU6-670P	splice_region&intron,downstream_gene,upstream_gene	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron6/42:c.439-16A>G::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron6/43:c.439-16A>G::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron6/43:c.439-16A>G::,FANCD2:ENST00000431693.1:splice_region_variant&intron_variant:LOW:intron5/7:c.439-16A>G::,FANCD2:ENST00000625535.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257083 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,Fanconi anemia,Fanconi anemia complementation group D2,not provided GENE=FANCD2];			rs17032278	0.19656	0.31987,0.14418,0.06543,0.16124,0.15984	3423,	22861	121431	-0.7230	0.01			10.1>10.9/10.1>10.9/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|16|46|-29|16	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10041485	10041485	C	T	het	off-target	QUAL=24;DP=119;QD=0.20	FANCD2,RNU6-670P	intron,3'UTR,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron9/42:c.696-138C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron9/43:c.696-138C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron9/43:c.696-138C>T::,FANCD2:ENST00000431693.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1609C>T::,RNU6-670P:ENST00000364312.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	439691 [benign DISEASE=not provided,not specified GENE=FANCD2];			rs35220123	0.19705	0.31918,0.14485,0.06539,0.16199,0.16155	3449,	23065	122093	-1.3410	0.36			/0.0>0.0/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|5|-21|-2|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10041843	10041844	TT	-	het	off-target	QUAL=25;DP=30;QD=0.83	FANCD2,RNU6-670P	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron10/42:c.783+146_783+147del::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron10/43:c.783+146_783+147del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron10/43:c.783+146_783+147del::,FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1251282 [benign DISEASE=not provided GENE=FANCD2];			rs201603399	0.22876	0.42095,0.15798,0.06639,0.16694,0.16727	4579,	23045	108569	0.0510	0.45			/0.0>0.0/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|26|34|46|-23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10042540	10042540	C	T	het	off-target	QUAL=25;DP=511;QD=0.05	FANCD2,RNU6-670P	splice_region&intron,downstream_gene	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron10/42:c.784-19C>T::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron10/43:c.784-19C>T::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron10/43:c.784-19C>T::,FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::,RNU6-670P:ENST00000364312.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257087 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided,not specified,Fanconi anemia,Fanconi anemia complementation group D2 GENE=FANCD2];			rs9879080	0.22579	0.41899,0.15545,0.06547,0.16227,0.16128	5011,	24313	117729	0.8720	7.42			12.1>11.7/12.1>11.7/0.0>0.0	COSV55047416	FANCD2|0.00|0.00|0.00|0.00|28|-3|-28|-3	25741868,21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), RNU6-670P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10043351	10043351	G	T	hom	off-target	QUAL=24;DP=60;QD=0.40	FANCD2	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron12/42:c.990-133G>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron12/43:c.990-133G>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron12/43:c.990-133G>T::,FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1226898 [benign DISEASE=not provided GENE=FANCD2];			rs803335	0.93798	0.97381,0.92890,0.99807,0.91069,0.92344	67096,	8638	9444	0.2170	2.55			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10043446	10043446	C	G	het	off-target	QUAL=24;DP=10;QD=2.40	FANCD2	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron12/42:c.990-38C>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron12/43:c.990-38C>G::,FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257088 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided,not specified,Fanconi anemia complementation group D2 GENE=FANCD2];			rs9809061	0.22615	0.42017,0.15546,0.06535,0.16220,0.16273	5025,	24314	117590	-0.9250	3.84			/3.9>6.1/9.6>8.4		FANCD2|0.00|0.05|0.04|0.00|1|38|-4|-19	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10043852	10043852	A	G	het		QUAL=24;DP=311;QD=0.08	FANCD2	synonymous,downstream_gene	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon14/43:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon14/44:c.1122A>G:p.Val374=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000431693.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257065 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia,Fanconi anemia complementation group A,not provided,Fanconi anemia complementation group D2,not specified GENE=FANCD2];			rs34046352	0.19299	0.33530,0.14062,0.06032,0.14817,0.14771	236,	28768	122270	-0.0460	1.21			/0.0>0.4/0.0>0.0	COSV55037937	FANCD2|0.00|0.00|0.00|0.00|8|-23|12|-3	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10046838	10046838	G	A	het	off-target	QUAL=25;DP=34;QD=0.74	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron15/42:c.1278+115G>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron15/43:c.1278+115G>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron15/43:c.1278+115G>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1679038 [benign DISEASE=Hereditary breast ovarian cancer syndrome GENE=FANCD2];		L3 (LINE/CR1)	rs9825871	0.50890	0.58303,0.46018,0.43024,0.48923,0.45229	5058,	64454	71962	-0.3220	2.42			/0.0>0.0/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|13|40|-19|-35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10048089	10048089	A	C	het	off-target;low_conf_region	QUAL=24;DP=107;QD=0.22	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron16/42:c.1413+38A>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron16/43:c.1413+38A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257067 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,not provided,Fanconi anemia complementation group D2 GENE=FANCD2];			rs7615646	0.10749	0.16508,0.09114,0.04289,0.08841,0.10719	217,	15808	134864	0.4020	5.47			/0.0>0.0/0.0>0.0	COSV55031871	FANCD2|0.00|0.00|0.00|0.03|-10|-38|35|-38	25741868,22585858	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10049469	10049469	C	T	het	low_conf_region	QUAL=25;DP=27;QD=0.93	FANCD2	synonymous	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon17/43:c.1509C>T:p.Asn503=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon17/44:c.1509C>T:p.Asn503=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon17/44:c.1509C>T:p.Asn503=:PF14631 [Fanconi anaemia protein FancD2 nuclease]		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257070 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia,not provided,Fanconi anemia complementation group D2,not specified GENE=FANCD2];			rs6785756	0.15914	0.26119,0.11746,0.05189,0.13203,0.14351	1068,	18911	111209	0.8720	8.07			/0.0>0.0/0.0>0.0	COSV55032395	FANCD2|0.00|0.00|0.00|0.00|-16|37|-16|36	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10049715	10049715	C	G	het	off-target	QUAL=24;DP=26;QD=0.92	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron17/42:c.1545+210C>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron17/43:c.1545+210C>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron17/43:c.1545+210C>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1244631 [benign DISEASE=not provided GENE=FANCD2];		L2c (LINE/L2)	rs17032306	0.22585	0.41945,0.15522,0.06587,0.16209,0.16245	5017,	24327	117781	-0.0100	1.92			/4.5>3.4/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|-49|10|47|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10062350	10062350	C	T	het	off-target	QUAL=24;DP=49;QD=0.49	FANCD2,CYCSP11	intron,upstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron20/42:c.1827+139C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron20/43:c.1827+139C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron20/43:c.1827+139C>T::,CYCSP11:ENST00000436426.1:upstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1251257 [benign DISEASE=not provided GENE=FANCD2];		AluSz (SINE/Alu)	rs6804967	0.22409	0.41409,0.15507,0.06527,0.16179,0.16154	4898,	24186	117666	-0.2030	0.54			/2.9>3.0/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|10|-14|-15|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), CYCSP11 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	10064848	10064848	C	T	het		QUAL=24;DP=49;QD=0.49	FANCD2	missense	FANCD2:ENST00000287647.7:missense_variant:MODERATE:exon23/43:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:missense_variant:MODERATE:exon23/44:c.2141C>T:p.Pro714Leu:PF14631 [Fanconi anaemia protein FancD2 nuclease]		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	134315 [benign/likely benign DISEASE=Fanconi anemia complementation group D2,not specified,Hereditary breast ovarian cancer syndrome,Fanconi anemia,not provided,Fanconi anemia complementation group A GENE=FANCD2];	CM1814115 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia" GENE=FANCD2];		rs3864017	0.18806	0.28369,0.14273,0.06252,0.16247,0.16151	1870,	23929	119463	-0.0900	2.09	0.028	0.06	/5.8>5.3/3.3>2.0	COSV55033303	FANCD2|0.00|0.00|0.00|0.00|14|-22|28|-4	25741868,24728327,26822197,32107087	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10065836	10065836	G	T	het	off-target	QUAL=24;DP=506;QD=0.05	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron24/42:c.2270-28G>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron24/43:c.2270-28G>T::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257074 [benign DISEASE=not specified,Fanconi anemia complementation group D2,not provided GENE=FANCD2];			rs34608006	0.19371	0.30767,0.14384,0.06402,0.16169,0.16453	3260,	22942	122630	1.0360	6.74			/4.1>1.0/6.4>4.2		FANCD2|0.00|0.00|0.00|0.00|28|0|-2|-1	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10073118	10073118	T	C	het	off-target	QUAL=24;DP=11;QD=2.18	FANCD2	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron27/42:c.2606-135T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron27/43:c.2606-135T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron27/43:c.2606-135T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1252243 [benign DISEASE=not provided GENE=FANCD2];			rs9824585	0.23410	0.44789,0.15877,0.06539,0.16205,0.16605	5549,	24513	116511	-0.7750	0.38			/5.4>4.3/0.0>0.0	COSV55040085	FANCD2|0.00|0.00|0.00|0.00|-11|42|42|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71)
chr3	10077919	10077919	C	A	het	off-target	QUAL=24;DP=21;QD=1.14	FANCD2,FANCD2OS	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron29/42:c.2860-162C>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron29/43:c.2860-162C>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron29/43:c.2860-162C>A::,FANCD2OS:ENST00000524279.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1183813 [benign DISEASE=not provided GENE=FANCD2];		AluJr (SINE/Alu)	rs6792951	0.23496	0.44929,0.15947,0.06681,0.16259,0.16597	5560,	24478	115912	-0.2140	1.88			/0.0>0.0/0.0>0.0	COSV55037211	FANCD2|0.00|0.00|0.00|0.00|-4|42|-22|-35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10078233	10078233	T	C	het	off-target	QUAL=24;DP=72;QD=0.33	FANCD2,FANCD2OS	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron30/42:c.2976+36T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron30/43:c.2976+36T>C::,FANCD2OS:ENST00000524279.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257077 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,not provided,Fanconi anemia complementation group D2 GENE=FANCD2];			rs6805869	0.22589	0.41947,0.15562,0.06579,0.16208,0.16494	5016,	24298	117646	0.3540	5.89			/0.0>0.0/0.0>0.0	COSV55037214	FANCD2|0.00|0.00|0.00|0.00|-35|-36|19|-36	25741868,21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10080891	10080891	T	C	het	off-target	QUAL=24;DP=4;QD=6.00	FANCD2,FANCD2OS	intron,downstream_gene	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron30/42:c.2977-209T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron30/43:c.2977-209T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron30/43:c.2977-209T>C::,FANCD2OS:ENST00000524279.1:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1243119 [benign DISEASE=not provided GENE=FANCD2];			rs6442150	0.19594	0.31445,0.14522,0.06542,0.16200,0.16577	3390,	23045	122389	-0.1460	2.01			/1.6>1.2/0.0>0.0		FANCD2|0.00|0.00|0.00|0.00|-34|17|-34|17	34674889,35892315,21766209,32351390	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10086951	10086951	A	G	het	off-target	QUAL=24;DP=37;QD=0.65	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron33/42:c.3336-183A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron33/43:c.3336-183A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron33/43:c.3336-183A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-5420T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1231027 [benign DISEASE=not provided GENE=FANCD2];			rs33972700	0.06586	0.02458,0.05889,0.00116,0.09629,0.05199	434,	9156	142176	0.3280	2.42			/6.7>6.3/0.0>0.0,/0.0>0.0/0.0>0.0		FANCD2OS|0.00|0.00|0.00|0.00|43|40|20|2,FANCD2|0.00|0.00|0.00|0.00|-47|6|7|5	36168886	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10092265	10092265	A	G	het	off-target	QUAL=24;DP=178;QD=0.13	FANCD2,FANCD2OS	splice_region&intron,intron	FANCD2:ENST00000287647.7:splice_region_variant&intron_variant:LOW:intron38/42:c.3849+13A>G::,FANCD2:ENST00000675286.1:splice_region_variant&intron_variant:LOW:intron38/43:c.3849+13A>G::,FANCD2:ENST00000419585.5:splice_region_variant&intron_variant:LOW:intron38/43:c.3849+13A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-10734T>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257079 [benign DISEASE=Fanconi anemia,Fanconi anemia complementation group D2,not specified,Hereditary breast ovarian cancer syndrome,not provided GENE=FANCD2];			rs9811771	0.24917	0.48603,0.17641,0.08913,0.16256,0.21966	6451,	24952	114068	0.7300	14.76			/0.0>0.0/0.0>0.0	COSV55047434	FANCD2OS|0.00|0.00|0.00|0.00|25|19|12|19,FANCD2|0.00|0.00|0.00|0.00|-36|-34|-13|-9	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10092431	10092431	-	T	het	off-target	QUAL=24;DP=3;QD=8.00	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron38/42:c.3849+190dup::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron38/43:c.3849+190dup::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron38/43:c.3849+190dup::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*44-10901dup::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1270715 [benign DISEASE=not provided GENE=FANCD2];			rs35070534	0.17940	0.34517,0.13119,0.00545,0.12614,0.10794	3145,	19694	118852		0.23			/9.4>9.4/0.0>0.0,/0.0>0.0/0.0>0.0		FANCD2OS|0.00|0.00|0.00|0.00|33|-27|-27|-5,FANCD2|0.00|0.00|0.00|0.00|-2|44|6|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10094466	10094466	C	T	het	off-target	QUAL=24;DP=30;QD=0.80	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron40/42:c.3963+103C>T::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron40/43:c.3963+103C>T::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron40/43:c.3963+103C>T::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+9732G>A::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1235228 [benign DISEASE=not provided GENE=FANCD2];			rs7610821	0.24201	0.46378,0.17339,0.09031,0.16223,0.20212	5960,	24858	115192	-0.0590	3.82			/6.7>6.6/0.0>0.0,/0.0>0.0/0.0>0.0		FANCD2OS|0.00|0.00|0.00|0.00|-3|16|-7|-46,FANCD2|0.00|0.00|0.00|0.00|17|29|-40|18	21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10096385	10096385	T	G	het		QUAL=25;DP=635;QD=0.04	FANCD2,FANCD2OS	synonymous,intron	FANCD2:ENST00000287647.7:synonymous_variant:LOW:exon42/43:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000675286.1:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2:ENST00000419585.5:synonymous_variant:LOW:exon42/44:c.4098T>G:p.Leu1366=:PF14631 [Fanconi anaemia protein FancD2 nuclease],FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+7813A>C::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257081 [benign DISEASE=not provided,Fanconi anemia complementation group D2,not specified,Hereditary breast ovarian cancer syndrome,Fanconi anemia GENE=FANCD2];	CM066071 [CLASS=DP MUT=ALT PHEN="Breast cancer increased risk association with" GENE=FANCD2];		rs2272125	0.24180	0.46285,0.17321,0.08942,0.16217,0.20224	5950,	24882	115338	1.9740	4.19			/1.6>0.0/0.0>0.0,/0.0>3.2/0.0>0.0	COSV55037985	FANCD2OS|0.00|0.00|0.00|0.00|-24|2|-36|-40,FANCD2|0.00|0.00|0.00|0.00|-50|5|-1|12	25741868,21766209,16679306	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10096505	10096505	T	C	het	off-target	QUAL=24;DP=168;QD=0.14	FANCD2,FANCD2OS	intron	FANCD2:ENST00000287647.7:intron_variant:MODIFIER:intron42/42:c.4185+33T>C::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron42/43:c.4185+33T>C::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+7693A>G::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	257082 [benign DISEASE=not provided,Fanconi anemia complementation group D2,Hereditary breast ovarian cancer syndrome,not specified GENE=FANCD2];			rs2272124	0.24176	0.46307,0.17322,0.08936,0.16224,0.20137	5948,	24865	115295	-0.0720	2.84			/0.0>0.0/0.0>0.0,/0.0>1.3/0.0>0.0	COSV55047440	FANCD2OS|0.00|0.00|0.00|0.00|-16|-2|48|3,FANCD2|0.00|0.00|0.00|0.03|0|21|3|-33	25741868,21766209	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10098987	10098987	G	A	het	off-target	QUAL=25;DP=372;QD=0.07	FANCD2,FANCD2OS	3'UTR,intron,downstream_gene	FANCD2:ENST00000287647.7:3_prime_UTR_variant:MODIFIER:exon43/43:c.*37G>A::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4281+172G>A::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+5211C>T::,FANCD2OS:ENST00000450660.3:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342381 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided,Fanconi anemia complementation group D2 GENE=FANCD2];			rs7626117	0.33748	0.74800,0.22019,0.08961,0.18253,0.22822	13645,	24025	100739	-0.0220	4.25			/2.1>2.6/0.0>0.0,/4.1>4.2/0.0>0.0	COSV55047455	FANCD2OS|0.00|0.00|0.00|0.00|-31|48|13|-20,FANCD2|0.00|0.00|0.00|0.00|47|-33|-41|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10099012	10099012	A	G	het	off-target	QUAL=24;DP=316;QD=0.08	FANCD2,FANCD2OS	3'UTR,intron,downstream_gene	FANCD2:ENST00000287647.7:3_prime_UTR_variant:MODIFIER:exon43/43:c.*62A>G::,FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4281+197A>G::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4281+197A>G::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+5186T>C::,FANCD2OS:ENST00000450660.3:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	342383 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D2,not provided GENE=FANCD2];			rs7647987	0.24202	0.46311,0.17354,0.08976,0.16242,0.20170	5952,	24870	115170	-0.4240	0.65			/0.0>0.0/0.0>0.0	COSV55047463	FANCD2OS|0.00|0.00|0.00|0.00|23|-32|-45|2,FANCD2|0.00|0.00|0.00|0.00|-27|12|7|-6	21766209,29156695,18059179	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	10101066	10101066	A	-	het	off-target	QUAL=25;DP=96;QD=0.26	FANCD2,FANCD2OS	intron,downstream_gene	FANCD2:ENST00000675286.1:intron_variant:MODIFIER:intron43/43:c.4282-109del::,FANCD2:ENST00000419585.5:intron_variant:MODIFIER:intron43/43:c.4282-109del::,FANCD2OS:ENST00000524279.1:intron_variant:MODIFIER:intron2/2:c.*43+3132del::,FANCD2:ENST00000287647.7:downstream_gene_variant:MODIFIER::::,FANCD2OS:ENST00000450660.3:downstream_gene_variant:MODIFIER::::		613984_[GENE=FANCD2_PHENOS=Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive]	1234759 [benign DISEASE=not provided GENE=FANCD2];		AluSx (SINE/Alu)	rs78434344	0.22609	0.38989,0.16482,0.06849,0.16941,0.18410	4310,	24113	112049	-1.0440	0.09			/0.0>0.0/0.0>0.0,/9.1>7.7/0.0>0.0	COSV55044503	FANCD2OS|0.00|0.00|0.00|0.00|4|-4|23|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCD2 (inh=AR oe_syn=0.96 oe_mis=1.00 oe_lof=0.71), FANCD2OS (inh=AR oe_syn=0.82 oe_mis=0.91 oe_lof=0.56)
chr3	36993455	36993455	G	A	het	off-target	QUAL=25;DP=51;QD=0.49	MLH1,EPM2AIP1	5'UTR,upstream_gene	MLH1:ENST00000673673.2:5_prime_UTR_variant:MODIFIER:exon1/18:c.-93G>A::,MLH1:ENST00000536378.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-725G>A::,MLH1:ENST00000413740.2:5_prime_UTR_variant:MODIFIER:exon1/15:c.-93G>A::,EPM2AIP1:ENST00000322716.8:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000616768.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000673899.1:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000450420.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000456676.7:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000231790.8:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000673715.1:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000713802.1:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000674019.1:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000458205.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000673990.2:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000492474.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000455445.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000539477.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000435176.5:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000441265.6:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000485889.2:upstream_gene_variant:MODIFIER::::,MLH1:ENST00000466900.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	120436_[GENE=MLH1_PHENOS=Lynch syndrome 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	89600 [benign DISEASE=Colorectal cancer, hereditary nonpolyposis, type 2,Hereditary cancer-predisposing syndrome,Mismatch repair cancer syndrome 1,Muir-Torre syndrome,Lynch syndrome,not provided,not specified,Hereditary nonpolyposis colorectal neoplasms GENE=MLH1];	CR045225 [CLASS=DFP MUT=ALT PHEN="Lung cancer risk association with" GENE=MLH1];		rs1800734	0.23177	0.17202,0.27399,0.55446,0.21538,0.38318	4663,	25960	116962	-0.7370	3.56			/0.0>0.0/0.0>1.4	COSV99212309	MLH1|0.00|0.00|0.00|0.00|-8|-41|-14|29	25741868,24944790,23946381,34540891,30038702,28827732,22623965,26724419,30989434,23720673,29399184,23565320,21036793,21738611,24515656,29664240,24205329,29156846,24689082,18523027,21980013,25938433,21093899,19930554,22740958,25252909,31273068,32756484,31035658,32742474,29181059,22371642,24073290,29108386,20967208,23240038,25047469,17870204,18723338,20473912,20860725,22136435,22174852,25986311,26275295,29190978,17230510,17301300,17959715,18712731,21093954,21565826,22294770,22927776,24325908,25115745,26911399,26987333,28195176,28293327,28304185,28791697,29304767,30519050,30952131,31209889,31342644,31530880,31953835,32641106,33082400,33794988,19888426,33534415,35637613,22144422,23112559,36632296,22935517,25519377,37270516,20444249,24084575,36980643,37298294,37096036,32161499,25110415,18588460,34383893,31031852,22763379,34540665,36338767,27895767,19494183,18615680,35055016,33462484,26187503,18022218,36981012,33567514,26086992,25252713,31779681,33632709,25804231,31742432,25421847,25355167,25328415,26512054,3393113	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EPM2AIP1 (inh=n/a oe_syn=1.18 oe_mis=0.77 oe_lof=0.20), MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	37025606	37025606	A	T	het	off-target;low_conf_region	QUAL=18;DP=393;QD=0.05	MLH1	intron	MLH1:ENST00000673673.2:intron_variant:MODIFIER:intron11/17:c.1039-31A>T::,MLH1:ENST00000536378.5:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:ENST00000413740.2:intron_variant:MODIFIER:intron11/14:c.1039-31A>T::,MLH1:ENST00000616768.6:intron_variant:MODIFIER:intron11/17:c.1039-31A>T::,MLH1:ENST00000673899.1:intron_variant:MODIFIER:intron8/14:c.678-3178A>T::,MLH1:ENST00000450420.6:intron_variant:MODIFIER:intron11/13:c.1039-31A>T::,MLH1:ENST00000456676.7:intron_variant:MODIFIER:intron11/16:c.1039-31A>T::,MLH1:ENST00000231790.8:intron_variant:MODIFIER:intron11/18:c.1039-31A>T::,MLH1:ENST00000673715.1:intron_variant:MODIFIER:intron11/15:c.1039-31A>T::,MLH1:ENST00000713802.1:intron_variant:MODIFIER:intron10/17:c.940-31A>T::,MLH1:ENST00000674019.1:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000458205.6:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000673990.2:intron_variant:MODIFIER:intron10/17:c.16-31A>T::,MLH1:ENST00000492474.6:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000455445.6:intron_variant:MODIFIER:intron11/18:c.316-31A>T::,MLH1:ENST00000539477.6:intron_variant:MODIFIER:intron10/17:c.316-31A>T::,MLH1:ENST00000435176.5:intron_variant:MODIFIER:intron11/18:c.745-31A>T::,MLH1:ENST00000441265.6:intron_variant:MODIFIER:intron11/14:c.316-31A>T::,MLH1:ENST00000485889.2:intron_variant:MODIFIER:intron12/19:c.316-31A>T::,MLH1:ENST00000466900.6:intron_variant:MODIFIER:intron12/19:c.316-31A>T::	regulatory_region_variant:enhancer	120436_[GENE=MLH1_PHENOS=Lynch syndrome 2, 609310 (3); Muir-Torre syndrome, 158320 (3), Autosomal dominant; Mismatch repair cancer syndrome 1, 276300 (3), Autosomal recessive]	629888 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,not provided GENE=MLH1];		(TA)n (Simple_repeat)	rs59684491	0.33159	0.32861,0.30021,0.36408,0.34303,0.29848	1747,	14008	35280	-0.4710	0.99			/0.0>0.0/0.0>0.0	COSV51624244	MLH1|0.00|0.00|0.00|0.00|31|44|48|31	29434720	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLH1 (inh=AR+AD oe_syn=1.09 oe_mis=1.04 oe_lof=0.37)
chr3	142449489	142449489	C	T	hom		QUAL=24;DP=49;QD=0.49	ATR,XRN1,EIF2AK1P1	synonymous,upstream_gene	ATR:ENST00000350721.9:synonymous_variant:LOW:exon47/47:c.7875G>A:p.Gln2625=:PF02260 [FATC domain],ATR:ENST00000661310.1:synonymous_variant:LOW:exon46/46:c.7683G>A:p.Gln2561=:PF02260 [FATC domain],XRN1:ENST00000264951.8:upstream_gene_variant:MODIFIER::::,XRN1:ENST00000392981.7:upstream_gene_variant:MODIFIER::::,XRN1:ENST00000463916.5:upstream_gene_variant:MODIFIER::::,EIF2AK1P1:ENST00000481134.1:upstream_gene_variant:MODIFIER::::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	93669 [benign/likely benign DISEASE=Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not specified,not provided,Seckel syndrome 1 GENE=ATR];			rs1802904	0.88664	0.96962,0.80565,0.92893,0.86648,0.93918	60127,	14734	17258	1.2390	3.29			/6.1>0.0/0.0>0.0	COSV99377126	ATR|0.00|0.00|0.00|0.00|22|-1|-32|32	24033266,18414213,23757202,17010193,23844225,32724790	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					XRN1 (inh=n/a oe_syn=0.94 oe_mis=0.80 oe_lof=0.12), ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31), EIF2AK1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	142459302	142459302	C	T	het		QUAL=24;DP=77;QD=0.31	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon43/47:c.7274G>A:p.Arg2425Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase],ATR:ENST00000661310.1:missense_variant:MODERATE:exon42/46:c.7082G>A:p.Arg2361Gln:PF00454 [Phosphatidylinositol 3- and 4-kinase]		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	136470 [benign DISEASE=Seckel syndrome 1,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not specified,not provided GENE=ATR];	CM1010619 [CLASS=DP MUT=ALT PHEN="Acute rejection in kidney transplantation association with" GENE=ATR];		rs2229032	0.12737	0.08081,0.10964,0.10116,0.16021,0.09888	1344,	16687	132745	0.0370	0.68	0.168	0.07	/3.9>4.1/0.0>0.0	COSV63383988	ATR|0.00|0.00|0.00|0.00|-3|-19|49|-18	24033266,18414213,21085059,17010193,32597209,23313170,36233089,27905519,36969849	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142469495	142469495	A	C	het		QUAL=26;DP=681;QD=0.04	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp:,ATR:ENST00000661310.1:missense_variant:MODERATE:exon37/46:c.6202T>G:p.Tyr2068Asp:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	158000 [benign/likely benign DISEASE=not provided,not specified,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,ATR-related disorder,Seckel syndrome 1 GENE=ATR];	CM1725174 [CLASS=DP MUT=ALT PHEN="Haematological traits association with" GENE=ATR];		rs28910273	0.00340	0.00149,0.00144,0.00000,0.00603,0.00207	0,	518	151814	2.4040	20.10	0.048	0.07	/0.4>0.0/0.0>0.0	COSV63384218	ATR|0.00|0.00|0.00|0.00|21|-7|-10|36	25741868,18414213,17010193,28787443,32888494,30595370	0	448	0	0 / 70	2	"[2] Ilnaz Sepahi 29-03-2016 batch import"			ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496279	142496289	TATATATATAT	-	het	off-target;low_conf_region	QUAL=26;DP=15;QD=1.73	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+72_5898+82del::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+72_5706+82del::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]			(TA)n (Simple_repeat)	rs1256751241						0.8820				/2.2>0.0/0.0>0.0		ATR|0.00|0.00|0.00|0.00|-12|-1|50|38		404	1331	0	52 / 158					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496292	142496292	A	-	het	off-target;low_conf_region	QUAL=17;DP=15;QD=1.13	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+69del::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+69del::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]			(TA)n (Simple_repeat)	rs1553758649						0.1820				/2.2>2.5/0.0>0.0		ATR|0.00|0.00|0.00|0.00|-25|-40|11|25		398	1310	0	50 / 156					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496329	142496329	T	C	het	off-target;low_conf_region	QUAL=24;DP=8;QD=3.00	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+32A>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+32A>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157998 [likely benign DISEASE=not specified,not provided GENE=ATR];		(TA)n (Simple_repeat)	rs11719960	0.04381	0.00924,0.03050,0.03270,0.06899,0.03276	403,	3401	91831	-1.5210	0.09			/0.0>0.0/0.0>0.0	COSV63384221	ATR|0.00|0.00|0.00|0.00|32|31|32|21		601	5252	0	90 / 913					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142496336	142496336	A	C	het	off-target;low_conf_region	QUAL=24;DP=8;QD=3.00	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron34/46:c.5898+25T>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron33/45:c.5706+25T>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157997 [benign/likely benign DISEASE=Seckel syndrome 1,not specified,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not provided GENE=ATR];		(TA)n (Simple_repeat)	rs7620648	0.63274	0.79430,0.58055,0.51557,0.59016,0.43986	17187,	16186	29346	-0.6440	0.28			/0.0>0.0/0.0>0.0	COSV63391396	ATR|0.00|0.00|0.00|0.00|19|46|0|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142498695	142498695	A	G	het		QUAL=24;DP=350;QD=0.07	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon32/47:c.5460T>C:p.Tyr1820=:PF02259 [FAT domain],ATR:ENST00000661310.1:synonymous_variant:LOW:exon31/46:c.5268T>C:p.Tyr1756=:PF02259 [FAT domain]	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	136471 [benign/likely benign DISEASE=Seckel syndrome 1,not provided,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not specified GENE=ATR];			rs2227932	0.07863	0.01973,0.05815,0.00308,0.11194,0.15464	672,	10628	140278	1.4980	9.12			/1.0>1.3/0.0>0.0	COSV100637634	ATR|0.00|0.00|0.00|0.00|7|-47|-15|17	18414213,17010193,23844225	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142536248	142536248	T	C	het	off-target	QUAL=25;DP=111;QD=0.23	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron19/46:c.3726-47A>G::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron18/45:c.3534-47A>G::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157979 [benign/likely benign DISEASE=not specified,not provided,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome GENE=ATR];			rs73240314	0.13769	0.11594,0.11582,0.10097,0.16041,0.09959	1478,	17990	131176	-0.2480	7.83			/7.4>8.3/0.0>0.0	COSV63384224	ATR|0.00|0.00|0.00|0.00|-47|-18|1|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142540865	142540865	A	-	het	off-target;low_conf_region	QUAL=25;DP=912;QD=0.03	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron18/46:c.3581+39del::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron17/45:c.3389+39del::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1225553 [benign DISEASE=not provided GENE=ATR];			rs201551475	0.16068	0.15727,0.13317,0.11029,0.17380,0.11114	1549,	18951	115173	3.0930	12.29			/7.9>7.9/0.0>0.0		ATR|0.00|0.00|0.00|0.00|39|-42|44|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142553472	142553472	G	A	het	off-target	QUAL=24;DP=12;QD=2.00	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron12/46:c.2634-74C>T::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron11/45:c.2442-74C>T::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	670440 [benign DISEASE=not provided GENE=ATR];			rs9869842	0.62676	0.79347,0.53435,0.46763,0.58702,0.44456	30711,	33605	56589	-1.7890	0.08			/0.0>0.0/0.0>0.0	COSV63385113	ATR|0.00|0.00|0.00|0.00|-15|31|11|-10	17010193	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142555897	142555897	-	T	het	mosaic	QUAL=2;DP=100;QD=0.02;AF=0.10;MQM=60;SAP=3;ABP=142;SAR=5;SAF=5	ATR	frameshift	ATR:ENST00000350721.9:frameshift_variant:HIGH:exon10/47:c.2320dup:p.Ile774AsnfsTer3:,ATR:ENST00000661310.1:frameshift_variant:HIGH:exon9/46:c.2128dup:p.Ile710AsnfsTer3:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	938417 [pathogenic/likely pathogenic DISEASE=Seckel syndrome 1,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not provided GENE=ATR];	CI1925995 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=ATR];		rs757500301	0.00004	0.00005,0.00000,0.00000,0.00004,0.00000	0,	6	150360		21.20			/0.0>0.0/0.0>0.0		ATR|0.00|0.00|0.00|0.01|42|5|-24|-20	21228398,23144622,19470935	1	10	429	0 / 2					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558523	142558523	-	AAAT	het	off-target	QUAL=24;DP=310;QD=0.08	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron8/46:c.1885+97_1885+100dup::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron7/45:c.1693+97_1693+100dup::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	1248576 [benign DISEASE=not provided GENE=ATR];		AluSz (SINE/Alu)	rs56661838	0.09731	0.09233,0.08263,0.10548,0.10433,0.08879	653,	12685	129793		1.44			/1.5>1.5/0.0>0.0		ATR|0.00|0.00|0.00|0.00|-5|-41|-5|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558585	142558585	A	G	het	off-target;low_conf_region	QUAL=24;DP=587;QD=0.04	ATR	intron	ATR:ENST00000350721.9:intron_variant:MODIFIER:intron8/46:c.1885+39T>C::,ATR:ENST00000661310.1:intron_variant:MODIFIER:intron7/45:c.1693+39T>C::		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157967 [benign DISEASE=not specified,not provided GENE=ATR];		(TAGA)n (Simple_repeat)	rs73240318	0.10548	0.07268,0.08589,0.09307,0.12787,0.09574	835,	13586	129380	-0.5170	2.29			/0.6>0.8/0.0>0.0	COSV63383992	ATR|0.00|0.00|0.00|0.01|39|12|45|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142558733	142558733	A	T	het		QUAL=24;DP=274;QD=0.09	ATR	synonymous	ATR:ENST00000350721.9:synonymous_variant:LOW:exon8/47:c.1776T>A:p.Gly592=:,ATR:ENST00000661310.1:synonymous_variant:LOW:exon7/46:c.1584T>A:p.Gly528=:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	157965 [benign/likely benign DISEASE=Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not provided,not specified,Seckel syndrome 1 GENE=ATR];			rs2227930	0.62647	0.79428,0.53322,0.46495,0.58659,0.44338	30789,	33585	56741	-0.2640	5.57			/1.8>0.8/6.0>0.0	COSV63383320	ATR|0.00|0.00|0.00|0.00|43|2|-50|2	24033266,18414213,17010193,27863252,32888493,29403010	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	142562770	142562770	A	G	het		QUAL=25;DP=320;QD=0.08	ATR	missense	ATR:ENST00000350721.9:missense_variant:MODERATE:exon4/47:c.632T>C:p.Met211Thr:,ATR:ENST00000661310.1:missense_variant:MODERATE:exon4/46:c.632T>C:p.Met211Thr:		601215_[GENE=ATR_PHENOS=Seckel syndrome 1, 210600 (3), Autosomal recessive; ?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominant]	93668 [benign/likely benign DISEASE=not specified,Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,not provided,Seckel syndrome 1 GENE=ATR];			rs2227928	0.62563	0.79069,0.53358,0.46436,0.58706,0.44302	30706,	33708	56918	1.4770	10.47	0.089	0.06	/0.0>0.0/0.0>0.2	COSV63383325	ATR|0.00|0.00|0.00|0.00|-37|-40|-1|40	24033266,22938532,18414213,26743341,23757202,18191955,28415781,18551366,28238063,26920143,17010193,32597209,23313170,36233089,22767148,27905519,36969849,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATR (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.31)
chr3	156677540	156677540	G	T	het	off-target	QUAL=24;DP=20;QD=1.20	TIPARP,TIPARP-AS1	intron,upstream_gene	TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron1/5:c.-41-117G>T::,TIPARP-AS1:ENST00000478005.1:upstream_gene_variant:MODIFIER::::,TIPARP-AS1:ENST00000463449.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region					rs345986	0.35927	0.27579,0.31553,0.11000,0.42270,0.43509	10414,	33790	97406	0.3640	7.18			/0.0>0.0/0.0>0.0		TIPARP|0.00|0.00|0.00|0.00|7|1|-17|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	156696129	156696129	T	C	hom	off-target	QUAL=24;DP=577;QD=0.04	TIPARP	intron	TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::,TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron4/5:c.1247+104T>C::						rs344016	0.95492	0.93461,0.96991,0.96396,0.96671,0.90930	69440,	6502	6864	-1.2670	1.16			/0.0>0.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	156703736	156703736	G	T	het	off-target	QUAL=24;DP=480;QD=0.05	TIPARP	intron	TIPARP:ENST00000486483.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000295924.12:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000461166.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::,TIPARP:ENST00000542783.5:intron_variant:MODIFIER:intron5/5:c.1526+34G>T::	regulatory_region_variant:enhancer				AluYm1 (SINE/Alu)	rs34277251	0.33748	0.08475,0.50085,0.71031,0.40834,0.38263	10991,	29341	100755	-0.1810	1.00			/0.0>0.0/0.0>0.0		TIPARP|0.00|0.00|0.00|0.01|-24|-12|-38|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	156705283	156705283	A	T	het	off-target	QUAL=24;DP=7;QD=3.43	TIPARP	3'UTR,downstream_gene	TIPARP:ENST00000295924.12:3_prime_UTR_variant:MODIFIER:exon6/6:c.*152A>T::,TIPARP:ENST00000461166.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*152A>T::,TIPARP:ENST00000542783.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*152A>T::,TIPARP:ENST00000486483.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer					rs346003	0.35563	0.25211,0.31496,0.11196,0.42767,0.42480	10119,	33234	96888	0.2400	0.61			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TIPARP (inh=n/a oe_syn=1.12 oe_mis=0.74 oe_lof=0.00)
chr3	179199217	179199217	A	G	het	off-target	QUAL=24;DP=54;QD=0.44	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron2/20:c.352+40A>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron2/21:c.352+40A>G::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	873175 [benign DISEASE=not provided,Squamous cell lung carcinoma GENE=PIK3CA];			rs3729674	0.25679	0.42306,0.22857,0.10347,0.18873,0.24036	5951,	27157	113049	0.6980	9.46			/0.0>0.0/0.0>0.0	COSV55876899	PIK3CA|0.00|0.00|0.00|0.01|-40|-38|-46|-40	32368160,37273678,26587011,30569174	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179199300	179199300	-	ATT	het	off-target	QUAL=24;DP=2;QD=12.00	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron2/20:c.352+125_352+126insTAT::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron2/21:c.352+125_352+126insTAT::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1250283 [benign DISEASE=not provided GENE=PIK3CA];			rs10663584	0.25628	0.42200,0.22888,0.10290,0.18855,0.24045	5890,	27150	112974		7.27			/0.0>0.0/0.0>0.0		PIK3CA|0.00|0.00|0.00|0.00|-16|13|11|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179201609	179201609	-	TTTTTTT	het	off-target;low_conf_region	QUAL=28;DP=14;QD=2.00	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron4/20:c.813+79_813+85dup::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron4/21:c.813+79_813+85dup::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1246765 [benign DISEASE=not provided GENE=PIK3CA];			rs373901635	0.06109	0.08077,0.06117,0.08541,0.05326,0.06664	398,	7428	126398		3.49			/3.2>4.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179203370	179203370	G	A	het	off-target	QUAL=24;DP=8;QD=3.00	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron4/20:c.814-174G>A::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron4/21:c.814-174G>A::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1228928 [benign DISEASE=not provided GENE=PIK3CA];			rs7623154	0.24089	0.38952,0.22627,0.10012,0.18468,0.10734	5164,	26300	115424	-0.0980	5.99			/0.3>0.7/0.4>0.0	COSV104380944	PIK3CA|0.00|0.00|0.00|0.00|35|-28|6|12	31709530	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179203465	179203465	-	TAAA	het	off-target	QUAL=24;DP=16;QD=1.50	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron4/20:c.814-77_814-76insAATA::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron4/21:c.814-77_814-76insAATA::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1275985 [benign DISEASE=not provided GENE=PIK3CA];			rs17550640	0.25608	0.42168,0.22846,0.10316,0.18841,0.24068	5877,	27159	113045		4.08			/0.0>0.0/0.0>0.0		PIK3CA|0.03|0.00|0.00|0.00|49|-8|49|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179203851	179203851	C	A	hom	off-target	QUAL=25;DP=75;QD=0.33	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron5/20:c.1059+62C>A::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron5/21:c.1059+62C>A::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1227071 [benign DISEASE=not provided GENE=PIK3CA];			rs2699895	0.57345	0.76083,0.50975,0.22248,0.52631,0.46882	26252,	34665	64839	-0.2870	0.73			/5.2>3.9/0.0>0.0	COSV55874922	PIK3CA|0.00|0.00|0.00|0.00|39|10|-38|-50	30867801	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204434	179204434	G	T	het	off-target	QUAL=24;DP=480;QD=0.05	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron5/20:c.1060-69G>T::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron5/21:c.1060-69G>T::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1248893 [benign DISEASE=not provided GENE=PIK3CA];			rs3729676	0.25667	0.42292,0.22862,0.10375,0.18866,0.24003	5933,	27149	112989	0.9590	6.05			/0.1>0.0/0.0>0.0	COSV55898889	PIK3CA|0.00|0.00|0.00|0.00|45|33|-14|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204486	179204486	C	A	hom	off-target	QUAL=24;DP=480;QD=0.05	PIK3CA	splice_region&intron	PIK3CA:ENST00000263967.4:splice_region_variant&intron_variant:LOW:intron5/20:c.1060-17C>A::,PIK3CA:ENST00000643187.1:splice_region_variant&intron_variant:LOW:intron5/21:c.1060-17C>A::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	259957 [benign DISEASE=not provided,Cowden syndrome 5,Cowden syndrome,not specified GENE=PIK3CA];			rs2699896	0.63696	0.85752,0.54794,0.25880,0.58003,0.55083	32593,	31678	55208	-0.5230	0.48			11.0>10.4/11.0>10.4/0.0>0.0	COSV55874930	PIK3CA|0.04|0.00|0.00|0.00|33|-7|-44|32	25741868,28833756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179204642	179204642	A	G	hom	off-target	QUAL=24;DP=64;QD=0.38	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron6/20:c.1145+54A>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron6/21:c.1145+54A>G::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1236289 [benign DISEASE=not provided GENE=PIK3CA];			rs3729679	0.57269	0.75616,0.51075,0.22244,0.52729,0.46823	26129,	34722	64900	-1.2590	0.32			/0.0>0.0/1.2>0.0	COSV55874940	PIK3CA|0.00|0.00|0.00|0.00|-37|30|-46|-50	26585822	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179210061	179210061	T	-	het	off-target	QUAL=25;DP=255;QD=0.10	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron7/20:c.1252-114del::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron7/21:c.1252-114del::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1278006 [benign DISEASE=not provided GENE=PIK3CA];			rs67871207	0.24542	0.39296,0.23052,0.10122,0.18764,0.10968	5090,	26226	111938	0.3330	2.69			/8.9>8.5/0.0>0.0		PIK3CA|0.00|0.00|0.00|0.00|-30|15|14|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179218011	179218011	T	C	het	off-target	QUAL=24;DP=5;QD=4.80	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron9/20:c.1540-199T>C::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron9/21:c.1540-199T>C::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1228069 [benign DISEASE=not provided GENE=PIK3CA];			rs1568205	0.25642	0.42258,0.22871,0.10282,0.18828,0.23900	5926,	27100	112956	-0.7050	3.36			/6.0>5.9/0.0>0.0	COSV104380936	PIK3CA|0.00|0.00|0.00|0.00|19|3|4|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179218439	179218439	T	G	het	off-target	QUAL=24;DP=233;QD=0.10	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron10/20:c.1664+105T>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron10/21:c.1664+105T>G::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1274886 [benign DISEASE=not provided GENE=PIK3CA];			rs17849071	0.07974	0.10410,0.09252,0.09892,0.06365,0.08057	513,	11102	139966	0.3970	1.47			/0.0>0.0/0.0>0.0	COSV104381265	PIK3CA|0.00|0.00|0.00|0.00|1|-8|28|-2	24908061,26453385,33182378,31905960,23185308,26823876,36998605,20416519	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179220959	179220959	A	T	het	off-target;low_conf_region	QUAL=24;DP=376;QD=0.06	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron13/20:c.2016-27A>T::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron13/21:c.2016-27A>T::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1229619 [benign DISEASE=not provided GENE=PIK3CA];			rs6443625	0.25644	0.42150,0.22823,0.10313,0.18885,0.24460	5919,	27122	112966	-0.4160	0.13			/1.1>2.2/0.0>0.0	COSV55887980	PIK3CA|0.00|0.00|0.00|0.00|16|27|50|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr3	179224643	179224643	C	G	hom	off-target	QUAL=24;DP=7;QD=3.43	PIK3CA	intron	PIK3CA:ENST00000263967.4:intron_variant:MODIFIER:intron15/20:c.2295-57C>G::,PIK3CA:ENST00000643187.1:intron_variant:MODIFIER:intron15/21:c.2295-57C>G::		171834_[GENE=PIK3CA_PHENOS=Hemifacial myohyperplasia, somatic, 606773 (3); CLOVE syndrome, somatic, 612918 (3); Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Cerebral cavernous malformations 4, somatic, 619538 (3); Ovarian cancer, somatic, 167000 (3); Colorectal cancer, somatic, 114500 (3); Macrodactyly, somatic, 155500 (3); CLAPO syndrome, somatic, 613089 (3); Keratosis, seborrheic, somatic, 182000 (3); Nevus, epidermal, somatic, 162900 (3); Gastric cancer, somatic, 613659 (3); Nonsmall cell lung cancer, somatic, 211980 (3); Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3); Cowden syndrome 5, 615108 (3)]	1281921 [benign DISEASE=not provided GENE=PIK3CA];			rs2699889	0.66859	0.91330,0.57260,0.28306,0.59971,0.61861	36126,	29274	50326	0.2750	7.49			/6.2>0.0/0.0>0.0	COSV55874955	PIK3CA|0.00|0.00|0.00|0.00|34|39|39|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PIK3CA (inh=AD oe_syn=0.78 oe_mis=0.34 oe_lof=0.05)
chr4	185078433	185078433	T	A	het	off-target	QUAL=24;DP=71;QD=0.34	LINC02436	intron&non_coding_transcript,downstream_gene	LINC02436:ENST00000509017.6:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1499+6360T>A::,LINC02436:ENST00000671007.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/9:n.490-2665T>A::,LINC02436:ENST00000655383.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.1001+6360T>A::,LINC02436:ENST00000658467.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/5:n.1129-2665T>A::,LINC02436:ENST00000653833.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.889+6360T>A::,LINC02436:ENST00000669078.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.638+6360T>A::,LINC02436:ENST00000668759.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/7:n.529+6360T>A::,LINC02436:ENST00000655167.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron8/11:n.959+6360T>A::,LINC02436:ENST00000653945.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer					rs6818170	0.69879	0.83011,0.62513,0.43264,0.67046,0.65284	37950,	30388	45814	0.1640	3.66			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LINC02436 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	58321576	58321576	G	C	het		QUAL=24;DP=940;QD=0.03		intergenic	::intergenic_variant:MODIFIER::::	regulatory_region_variant:enhancer				MLT1E1A (LTR/ERVL-MaLR)	rs37535	0.59187	0.64317,0.56965,0.49496,0.59297,0.48651	26764,	36390	62004	0.8590	2.12							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr5	80654689	80654689	C	T	hom	off-target	QUAL=24;DP=109;QD=0.22	DHFR,MSH3	5'UTR,upstream_gene	DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-200G>A::,MSH3:ENST00000265081.7:5_prime_UTR_variant:MODIFIER:exon1/24:c.-39C>T::,DHFR:ENST00000505337.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000511032.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000504396.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000667069.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000658259.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1220684 [benign DISEASE=not provided GENE=DHFR];			rs1105525	0.13378	0.04776,0.11289,0.06774,0.17831,0.24167	1639,	16994	131256	-0.0080	7.16			/0.0>0.0/0.5>1.9,/4.1>4.3/0.0>0.0	COSV54143671	DHFR|0.00|0.00|0.00|0.00|-32|-25|3|33,MSH3|0.00|0.00|0.00|0.00|6|-35|-9|38	21629435,30967127,33256598,21317831,36292754	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80654693	80654693	A	G	hom	off-target	QUAL=24;DP=110;QD=0.22	DHFR,MSH3	5'UTR,upstream_gene	DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-204T>C::,MSH3:ENST00000265081.7:5_prime_UTR_variant:MODIFIER:exon1/24:c.-35A>G::,DHFR:ENST00000505337.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000511032.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000504396.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000667069.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000658259.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1237508 [benign DISEASE=not provided GENE=DHFR];			rs1105524	0.72459	0.91897,0.63086,0.39215,0.66678,0.75073	41001,	27504	41622	-4.8940	0.84			/0.0>0.0/0.5>1.6,/4.1>1.1/0.0>0.0	COSV54143681	DHFR|0.00|0.00|0.00|0.00|-36|29|-37|29,MSH3|0.00|0.00|0.00|0.00|50|2|-39|1	32756484,25966119,36292754,31216018	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80654962	80654962	A	G	het		QUAL=24;DP=38;QD=0.63	DHFR,MSH3	5'UTR,missense&splice_region,upstream_gene	DHFR:ENST00000439211.7:5_prime_UTR_variant:MODIFIER:exon1/6:c.-473T>C::,MSH3:ENST00000265081.7:missense_variant&splice_region_variant:MODERATE:exon1/24:c.235A>G:p.Ile79Val:,MSH3:ENST00000667069.1:missense_variant&splice_region_variant:MODERATE:exon1/22:c.235A>G:p.Ile79Val:,DHFR:ENST00000505337.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000511032.5:upstream_gene_variant:MODIFIER::::,DHFR:ENST00000504396.1:upstream_gene_variant:MODIFIER::::,MSH3:ENST00000658259.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	126060_[GENE=DHFR_PHENOS=Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessive]&600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	402591 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,Constitutional megaloblastic anemia with severe neurologic disease,not provided GENE=DHFR];			rs1650697	0.79397	0.91289,0.76377,0.66941,0.75655,0.69530	48085,	24030	31192	-0.2430	8.01	0.242	0.06	4.1>2.7/1.2>1.2/4.1>2.7,/2.5>1.7/0.0>0.5	COSV54144023	DHFR|0.00|0.00|0.00|0.00|9|-13|4|0,MSH3|0.00|0.00|0.43|0.00|6|39|-1|2	24033266,26811195,19493349,20472929,22495907,28266606,22103680,24846176,25759212,20737570,18551366,32756484,22450926,21629435,24732178,30583708,34354741,23313170,25966119,21317831,34050153,25592580,34881269,31216018,29844566,34910505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHFR (inh=AR oe_syn=0.88 oe_mis=0.71 oe_lof=0.39), MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80670359	80670359	G	A	het	off-target;low_conf_region	QUAL=24;DP=416;QD=0.06	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron4/23:c.792+50G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron4/21:c.792+50G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron4/23:c.624+50G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1288145 [benign DISEASE=not provided,not specified GENE=MSH3];			rs6151630	0.03825	0.01201,0.02864,0.00077,0.05460,0.03958	141,	5541	146415	0.0690	13.49			/3.5>4.9/0.0>0.0	COSV54144136	MSH3|0.00|0.00|0.00|0.00|-32|-5|-50|-40		82	2771	0	13 / 514					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80678827	80678827	T	C	hom	off-target	QUAL=24;DP=119;QD=0.20	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron7/23:c.1174-100T>C::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron7/21:c.1174-100T>C::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron7/23:c.1006-100T>C::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1244295 [benign DISEASE=not provided GENE=MSH3];			rs836807	0.99881	0.99947,0.99961,1.00000,0.99787,0.99876	75998,	182	182	-0.5450	0.10			/0.0>0.0/0.1>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80787812	80787812	G	A	hom	off-target	QUAL=24;DP=36;QD=0.67	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron18/23:c.2543+140G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron16/21:c.2348+140G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron18/23:c.2375+140G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1251794 [benign DISEASE=not provided GENE=MSH3];			rs33010	0.84565	0.83878,0.85874,0.99884,0.83320,0.86712	54469,	19820	23502	0.4410	5.16			/3.8>3.9/0.0>0.0		MSH3|0.00|0.00|0.00|0.00|-47|4|-49|-1	17903301	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80792643	80792644	AG	-	hom	off-target	QUAL=24;DP=159;QD=0.15	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron18/23:c.2544-88_2544-87del::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron16/21:c.2349-88_2349-87del::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron18/23:c.2376-88_2376-87del::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1262383 [benign DISEASE=not provided GENE=MSH3];			rs3830224	0.33006	0.20499,0.34264,0.36378,0.37945,0.41771	8682,	32669	101553	1.7540	1.06			/7.2>6.7/0.0>0.0		MSH3|0.00|0.00|0.00|0.00|5|3|5|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80854162	80854162	A	G	hom		QUAL=24;DP=904;QD=0.03	MSH3	missense	MSH3:ENST00000265081.7:missense_variant:MODERATE:exon21/24:c.2846A>G:p.Gln949Arg:PF00488 [MutS domain V],MSH3:ENST00000667069.1:missense_variant:MODERATE:exon19/22:c.2651A>G:p.Gln884Arg:PF00488 [MutS domain V],MSH3:ENST00000658259.1:missense_variant:MODERATE:exon21/24:c.2678A>G:p.Gln893Arg:PF00488 [MutS domain V]		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	821892 [benign DISEASE=not provided,Hereditary cancer-predisposing syndrome GENE=MSH3];			rs184967	0.86720	0.89201,0.86677,0.99865,0.84298,0.88644	57289,	17319	20199	0.4290	2.34	0.281	0.06	/0.0>0.0/0.0>0.0	COSV54143790	MSH3|0.00|0.00|0.00|0.00|-32|-27|-14|-32	31818908,23946381,25491747,26811195,18701435,21700777,20386703,28415781,19781088,25023197,31374908,32756484,23313170,23755158,36292754,27630279	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80864778	80864781	AATG	-	het	off-target	QUAL=24;DP=16;QD=1.50	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron21/23:c.3001-33_3001-30del::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron19/21:c.2806-33_2806-30del::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron21/23:c.2833-33_2833-30del::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1258155 [benign DISEASE=not provided GENE=MSH3];			rs3991216	0.44823	0.24032,0.40854,0.37548,0.55983,0.54011	16673,	34673	83731	3.5250	9.57			/0.0>0.0/0.0>0.0		MSH3|0.00|0.00|0.00|0.00|36|1|6|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80873118	80873118	G	A	hom		QUAL=24;DP=114;QD=0.21	MSH3	missense&splice_region	MSH3:ENST00000265081.7:missense_variant&splice_region_variant:MODERATE:exon23/24:c.3133G>A:p.Ala1045Thr:PF00488 [MutS domain V],MSH3:ENST00000667069.1:missense_variant&splice_region_variant:MODERATE:exon21/22:c.2938G>A:p.Ala980Thr:PF00488 [MutS domain V],MSH3:ENST00000658259.1:missense_variant&splice_region_variant:MODERATE:exon23/24:c.2965G>A:p.Ala989Thr:PF00488 [MutS domain V]		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	822964 [benign DISEASE=not provided,Hereditary cancer-predisposing syndrome GENE=MSH3];			rs26279	0.70595	0.66792,0.70253,0.75444,0.71618,0.79784	37907,	31549	44721	1.9220	4.66	0.108	0.07	10.9>10.9/10.9>10.9/0.0>0.9	COSV54143807	MSH3|0.02|0.00|0.00|0.00|4|-2|4|11	21514219,23946381,25491747,26811195,30038702,22454423,31428123,24086368,22623965,18701435,21700777,20386703,19781088,29616133,32957448,18355840,26027715,31374908,32756484,31035658,27335251,21974800,22294770,31342644,31953835,18364438,23313170,36632296,27902597,31114287,37296718,36980643,25966119,23755158,26617824,37035153,31031852,25586538,36338767,30271482,25592580,31216018,34997843,27630279,31973052,18851982	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	80873351	80873351	G	A	het	off-target	QUAL=24;DP=60;QD=0.40	MSH3	intron	MSH3:ENST00000265081.7:intron_variant:MODIFIER:intron23/23:c.3302+64G>A::,MSH3:ENST00000667069.1:intron_variant:MODIFIER:intron21/21:c.3107+64G>A::,MSH3:ENST00000658259.1:intron_variant:MODIFIER:intron23/23:c.3134+64G>A::		600887_[GENE=MSH3_PHENOS=Familial adenomatous polyposis 4, 617100 (3), Autosomal recessive; Endometrial carcinoma, somatic, 608089 (3)]	1244496 [benign DISEASE=not provided GENE=MSH3];			rs6151928	0.02380	0.00782,0.02060,0.00000,0.03094,0.01243	67,	3491	148669	0.8450	6.26			/0.0>0.0/0.2>1.3		MSH3|0.00|0.00|0.00|0.00|40|-14|40|26		35	1420	0	3 / 227					MSH3 (inh=AR oe_syn=1.00 oe_mis=1.09 oe_lof=0.91)
chr5	112781076	112781076	A	G	het	off-target	QUAL=24;DP=7;QD=3.43	APC,CBX3P3,RNU6-482P	intron,upstream_gene,downstream_gene	APC:ENST00000509732.6:intron_variant:MODIFIER:intron6/15:c.645+173A>G::,APC:ENST00000507379.6:intron_variant:MODIFIER:intron5/13:c.675+173A>G::,APC:ENST00000257430.9:intron_variant:MODIFIER:intron6/15:c.645+173A>G::,APC:ENST00000713638.1:intron_variant:MODIFIER:intron6/14:c.645+173A>G::,APC:ENST00000504915.3:intron_variant:MODIFIER:intron6/16:c.645+173A>G::,APC:ENST00000713639.1:intron_variant:MODIFIER:intron5/14:c.468+173A>G::,APC:ENST00000508376.6:intron_variant:MODIFIER:intron7/16:c.645+173A>G::,APC:ENST00000512211.7:intron_variant:MODIFIER:intron6/15:c.645+173A>G::,CBX3P3:ENST00000508108.2:upstream_gene_variant:MODIFIER::::,RNU6-482P:ENST00000391068.1:downstream_gene_variant:MODIFIER::::		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	82939 [benign DISEASE=Familial colorectal cancer,not provided GENE=APC];			rs2289484	0.42312	0.16126,0.57246,0.66763,0.50933,0.56172	15894,	32575	87753	-0.8280	0.02			/2.0>1.6/0.0>0.0		APC|0.00|0.00|0.00|0.00|-38|16|-1|2	29050326	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10), CBX3P3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RNU6-482P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	112818847	112818847	-	G	het	off-target;low_conf_region	QUAL=24;DP=10;QD=2.40	APC	intron	APC:ENST00000509732.6:intron_variant:MODIFIER:intron9/15:c.934-111dup::,APC:ENST00000507379.6:intron_variant:MODIFIER:intron7/13:c.880-111dup::,APC:ENST00000257430.9:intron_variant:MODIFIER:intron9/15:c.934-111dup::,APC:ENST00000713638.1:intron_variant:MODIFIER:intron9/14:c.934-111dup::,APC:ENST00000504915.3:intron_variant:MODIFIER:intron9/16:c.934-111dup::,APC:ENST00000713639.1:intron_variant:MODIFIER:intron8/14:c.757-252dup::,APC:ENST00000508376.6:intron_variant:MODIFIER:intron10/16:c.934-111dup::,APC:ENST00000512211.7:intron_variant:MODIFIER:intron9/15:c.934-111dup::		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	1292418 [benign DISEASE=not provided GENE=APC];			rs71590728	0.39487	0.13945,0.54431,0.64364,0.47989,0.53350	12035,	26895	78103		0.36			/1.5>1.5/0.0>0.0		APC|0.00|0.00|0.00|0.00|17|26|-29|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112827157	112827157	T	C	het		QUAL=24;DP=184;QD=0.13	APC	synonymous	APC:ENST00000509732.6:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:ENST00000507379.6:synonymous_variant:LOW:exon10/14:c.1404T>C:p.Tyr468=:,APC:ENST00000257430.9:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:,APC:ENST00000713638.1:synonymous_variant:LOW:exon12/15:c.1458T>C:p.Tyr486=:,APC:ENST00000504915.3:synonymous_variant:LOW:exon13/17:c.1512T>C:p.Tyr504=:,APC:ENST00000713639.1:synonymous_variant:LOW:exon11/15:c.1140T>C:p.Tyr380=:,APC:ENST00000508376.6:synonymous_variant:LOW:exon13/17:c.1458T>C:p.Tyr486=:,APC:ENST00000512211.7:synonymous_variant:LOW:exon12/16:c.1458T>C:p.Tyr486=:		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42238 [benign DISEASE=Familial adenomatous polyposis 1,Carcinoma of colon,Familial colorectal cancer,Hereditary cancer-predisposing syndrome,not specified,Hepatocellular carcinoma,Desmoid disease, hereditary,Neoplasm of stomach,not provided,APC-Associated Polyposis Disorders GENE=APC];	CS1822474 [CLASS=DFP MUT=ALT PHEN="Adenomatous polyposis coli predisposition to" GENE=APC];		rs2229992	0.48194	0.20628,0.62263,0.67092,0.58594,0.64621	20030,	33215	78767	1.2980	7.13			/0.0>0.0/3.4>4.1	COSV57321592	APC|0.00|0.00|0.00|0.00|-38|24|-4|-28	25741868,20844743,25324626,23757202,17267408,23940558,22532847,27217144,29434720,18708403,16569251,20333795,20510605,21995949,27028212,27087319,15768050,17221838,18849522,21279955,29050326,17963004,20685668,9487968,20434453,7959691,26493165,26092435,22528324,31383941,30809121,26511139,28010732,33352971,31018568,35422484,24666523,24403877,35477782,25992589,36828923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112828864	112828864	G	A	het		QUAL=24;DP=180;QD=0.13	APC	synonymous	APC:ENST00000509732.6:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000507379.6:synonymous_variant:LOW:exon12/14:c.1581G>A:p.Ala527=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000257430.9:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000713638.1:synonymous_variant:LOW:exon14/15:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000504915.3:synonymous_variant:LOW:exon15/17:c.1689G>A:p.Ala563=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000713639.1:synonymous_variant:LOW:exon13/15:c.1317G>A:p.Ala439=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon15/17:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat],APC:ENST00000512211.7:synonymous_variant:LOW:exon14/16:c.1635G>A:p.Ala545=:PF00514 [Armadillo/beta-catenin-like repeat]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42239 [benign DISEASE=Familial colorectal cancer,APC-Associated Polyposis Disorders,not provided,not specified,Familial adenomatous polyposis 1,Carcinoma of colon,Hereditary cancer-predisposing syndrome GENE=APC];	CM2410019 [CLASS=DP MUT=ALT PHEN="Reaction time association with" GENE=APC];		rs351771	0.60136	0.53415,0.66872,0.81894,0.61264,0.73209	27988,	35483	60629	1.6090	13.51			/0.0>0.0/0.0>0.8	COSV57321606	APC|0.00|0.00|0.00|0.00|3|12|3|33,CTC-554D6.1|0.00|0.00|0.00|0.00|3|12|3|33	25741868,20844743,23757202,23940558,27217144,24078348,16569251,20333795,21995949,27028212,27087319,14616385,18849522,34967580,33352971,35075162,27081525,35477782,36828923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112837409	112837409	-	AGAA	het	off-target	QUAL=24;DP=149;QD=0.16	APC	intron	APC:ENST00000509732.6:intron_variant:MODIFIER:intron15/15:c.1959-143_1959-140dup::,APC:ENST00000507379.6:intron_variant:MODIFIER:intron13/13:c.1905-143_1905-140dup::,APC:ENST00000257430.9:intron_variant:MODIFIER:intron15/15:c.1959-143_1959-140dup::,APC:ENST00000713638.1:intron_variant:MODIFIER:intron14/14:c.1744-143_1744-140dup::,APC:ENST00000504915.3:intron_variant:MODIFIER:intron16/16:c.2013-143_2013-140dup::,APC:ENST00000713639.1:intron_variant:MODIFIER:intron14/14:c.1641-143_1641-140dup::,APC:ENST00000508376.6:intron_variant:MODIFIER:intron16/16:c.1959-143_1959-140dup::,APC:ENST00000512211.7:intron_variant:MODIFIER:intron15/15:c.1959-143_1959-140dup::		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	1265993 [benign DISEASE=not provided GENE=APC];			rs3839284	0.61294	0.54417,0.68625,0.82169,0.62625,0.73515	28881,	35148	58670		13.56			/0.8>0.4/0.0>0.0		APC|0.00|0.00|0.00|0.00|0|-43|45|44,CTC-554D6.1|0.00|0.00|0.00|0.00|0|-43|45|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840073	112840073	G	A	het		QUAL=24;DP=294;QD=0.08	APC	synonymous,3'UTR	APC:ENST00000509732.6:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000507379.6:synonymous_variant:LOW:exon14/14:c.4425G>A:p.Thr1475=:PF05923 [APC repeat],APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000713638.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*2461G>A::,APC:ENST00000504915.3:synonymous_variant:LOW:exon17/17:c.4533G>A:p.Thr1511=:PF05923 [APC repeat],APC:ENST00000713639.1:synonymous_variant:LOW:exon15/15:c.4161G>A:p.Thr1387=:PF05923 [APC repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.4479G>A:p.Thr1493=:PF05923 [APC repeat],APC:ENST00000512211.7:synonymous_variant:LOW:exon16/16:c.4479G>A:p.Thr1493=:PF05923 [APC repeat]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42242 [benign DISEASE=not specified,Carcinoma of colon,not provided,Familial adenomatous polyposis 1,Familial colorectal cancer,Hepatocellular carcinoma,Desmoid disease, hereditary,Gastric adenocarcinoma and proximal polyposis of the stomach,Gastric cancer,Colorectal cancer,Hereditary cancer-predisposing syndrome,APC-Associated Polyposis Disorders GENE=APC];	CM2115758 [CLASS=R MUT=ALT PHEN="Adenomatous polyposis coli" GENE=APC];		rs41115	0.60156	0.53456,0.66918,0.81957,0.61260,0.73058	27967,	35459	60535	0.0920	2.58			/0.0>7.5/3.6>1.3	COSV57321403,COSV57381675	APC|0.00|0.00|0.00|0.00|2|36|-39|0,CTC-554D6.1|0.00|0.00|0.00|0.00|2|36|-39|0	25741868,20844743,23757202,23940558,14724163,27217144,16569251,19777185,20333795,20510605,21995949,24861525,27028212,27087319,27898031,26092435,35866738,33790997,34967580,28010732,27245242,33352971,25490678,37273678,37232746,27081525,28243320,35477782	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840628	112840628	G	A	het		QUAL=25;DP=17;QD=1.47	APC	synonymous,3'UTR	APC:ENST00000509732.6:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP],APC:ENST00000507379.6:synonymous_variant:LOW:exon14/14:c.4980G>A:p.Gly1660=:PF16634 [Unstructured region on APC between APC_crr and SAMP],APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP],APC:ENST00000713638.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*3016G>A::,APC:ENST00000504915.3:synonymous_variant:LOW:exon17/17:c.5088G>A:p.Gly1696=:PF16634 [Unstructured region on APC between APC_crr and SAMP],APC:ENST00000713639.1:synonymous_variant:LOW:exon15/15:c.4716G>A:p.Gly1572=:PF16634 [Unstructured region on APC between APC_crr and SAMP],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP],APC:ENST00000512211.7:synonymous_variant:LOW:exon16/16:c.5034G>A:p.Gly1678=:PF16634 [Unstructured region on APC between APC_crr and SAMP]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42243 [benign DISEASE=Hereditary cancer-predisposing syndrome,Carcinoma of colon,not specified,Familial colorectal cancer,APC-Associated Polyposis Disorders,not provided,Familial adenomatous polyposis 1 GENE=APC];			rs42427	0.60469	0.53610,0.67445,0.81952,0.61759,0.73021	28272,	35387	60099	0.4930	3.02			/0.0>0.0/0.0>0.0	COSV57321627	APC|0.00|0.00|0.00|0.00|-25|44|10|44,CTC-554D6.1|0.00|0.00|0.00|0.00|-25|44|10|44	25741868,20844743,25324626,23757202,23940558,14724163,18547414,27217144,23251617,24980784,16569251,20333795,20510605,15768050,17221838,26173102,33790997,30809121,34967580,28010732,27081525,24403877,35477782,16169467	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112840862	112840862	T	G	het		QUAL=24;DP=138;QD=0.17	APC	synonymous,3'UTR	APC:ENST00000509732.6:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000507379.6:synonymous_variant:LOW:exon14/14:c.5214T>G:p.Ser1738=:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000713638.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*3250T>G::,APC:ENST00000504915.3:synonymous_variant:LOW:exon17/17:c.5322T>G:p.Ser1774=:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000713639.1:synonymous_variant:LOW:exon15/15:c.4950T>G:p.Ser1650=:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000512211.7:synonymous_variant:LOW:exon16/16:c.5268T>G:p.Ser1756=:PF16635 [Unstructured region on APC between SAMP and APC_crr]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42245 [benign DISEASE=Hereditary cancer-predisposing syndrome,not provided,Familial colorectal cancer,APC-Associated Polyposis Disorders,Familial adenomatous polyposis 1,Carcinoma of colon,not specified GENE=APC];			rs866006	0.60280	0.53522,0.66933,0.81925,0.61467,0.73071	28136,	35389	60397	0.1690	0.24			/2.0>1.3/0.0>0.0	COSV57321636,COSV57325918	APC|0.00|0.00|0.00|0.00|31|25|31|23,CTC-554D6.1|0.00|0.00|0.00|0.00|31|25|31|23	25741868,20844743,23757202,23940558,11818965,27217144,16569251,20333795,21995949,27087319,14616385,15122587,21110124,27081525,35477782	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112841059	112841059	T	A	het		QUAL=24;DP=192;QD=0.13	APC	missense,3'UTR	APC:ENST00000509732.6:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000507379.6:missense_variant:MODERATE:exon14/14:c.5411T>A:p.Val1804Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000257430.9:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000713638.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*3447T>A::,APC:ENST00000504915.3:missense_variant:MODERATE:exon17/17:c.5519T>A:p.Val1840Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000713639.1:missense_variant:MODERATE:exon15/15:c.5147T>A:p.Val1716Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000508376.6:missense_variant:MODERATE:exon17/17:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr],APC:ENST00000512211.7:missense_variant:MODERATE:exon16/16:c.5465T>A:p.Val1822Asp:PF16635 [Unstructured region on APC between SAMP and APC_crr]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	21030 [benign DISEASE=not provided,Hereditary cancer-predisposing syndrome,Familial multiple polyposis syndrome,not specified,Classic or attenuated familial adenomatous polyposis,Familial adenomatous polyposis 1,Familial colorectal cancer,APC-Associated Polyposis Disorders GENE=APC];			rs459552	0.82012	0.95661,0.81200,0.90220,0.76132,0.79348	51880,	21029	27371	2.3600	12.61	0.190	0.05	/2.2>1.3/0.4>0.0	COSV57321643	APC|0.00|0.00|0.00|0.00|-22|-2|34|-2,CTC-554D6.1|0.00|0.00|0.00|0.00|-22|-2|34|-2	25741868,26451011,20357209,20844743,24728327,23946381,21819567,30337837,23757202,25372392,18992263,23940558,14724163,32708070,22703879,29458332,20149637,24039736,27217144,31485167,19453261,19619005,24078348,18708403,24980784,16569251,20333795,20510605,21995949,27028212,27087319,17221838,14616385,11221825,17556698,18375958,20301519,23159591,23576677,25941542,28410400,31723073,19888426,26809274,29963112,30239722,25653542,22528324,34967580,28010732,26213617,33240400,33769591,23516639,29273807,32053874,27081525,31406247,36224396,25243319,18343606,36581621	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	112841474	112841474	G	A	het		QUAL=19;DP=517;QD=0.04	APC	synonymous,3'UTR	APC:ENST00000509732.6:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000507379.6:synonymous_variant:LOW:exon14/14:c.5826G>A:p.Pro1942=:PF05923 [APC repeat],APC:ENST00000257430.9:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000713638.1:3_prime_UTR_variant:MODIFIER:exon15/15:c.*3862G>A::,APC:ENST00000504915.3:synonymous_variant:LOW:exon17/17:c.5934G>A:p.Pro1978=:PF05923 [APC repeat],APC:ENST00000713639.1:synonymous_variant:LOW:exon15/15:c.5562G>A:p.Pro1854=:PF05923 [APC repeat],APC:ENST00000508376.6:synonymous_variant:LOW:exon17/17:c.5880G>A:p.Pro1960=:PF05923 [APC repeat],APC:ENST00000512211.7:synonymous_variant:LOW:exon16/16:c.5880G>A:p.Pro1960=:PF05923 [APC repeat]		611731_[GENE=APC_PHENOS=Colorectal cancer, somatic, 114500 (3); Brain tumor-polyposis syndrome 2, 175100 (3), Autosomal dominant; Desmoid disease, hereditary, 135290 (3), Autosomal dominant; Adenoma, periampullary, somatic, 175100 (3); Hepatoblastoma, somatic, 114550 (3); Gastric cancer, somatic, 613659 (3); Gastric adenocarcinoma and proximal polyposis of the stomach, 619182 (3), Autosomal dominant; Gardner syndrome, 175100 (3), Autosomal dominant; Adenomatous polyposis coli, 175100 (3), Autosomal dominant]	42247 [benign DISEASE=Hereditary cancer-predisposing syndrome,Carcinoma of colon,Familial colorectal cancer,APC-Associated Polyposis Disorders,not specified,Familial adenomatous polyposis 1,not provided GENE=APC];			rs465899	0.60276	0.53836,0.66964,0.82068,0.61285,0.73018	28088,	35435	60375	-0.1460	7.30			/0.0>2.0/1.1>0.0	COSV57321652	APC|0.00|0.00|0.00|0.00|2|39|2|0,CTC-554D6.1|0.00|0.00|0.00|0.00|2|39|2|0	25741868,20844743,25324626,23757202,27217144,16569251,20333795,27087319,15768050,17221838,14616385,25941542,33790997,30809121,28010732,25250560,27081525,24403877,35477782	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					APC (inh=AD oe_syn=1.11 oe_mis=0.99 oe_lof=0.10)
chr5	132557287	132557287	G	A	hom	off-target	QUAL=24;DP=66;QD=0.36	RAD50	5'UTR	RAD50:ENST00000378823.8:5_prime_UTR_variant:MODIFIER:exon1/25:c.-38G>A::	regulatory_region_variant:open_chromatin_region	604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]				rs4526098	0.92971	0.76245,0.97197,0.99981,0.99668,0.98820	66617,	8357	10705	2.2570	14.76			/6.0>5.5/0.0>0.0	COSV99528532		24743186,29879995,20805886,28541483,34967580,19917125	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132579521	132579521	G	A	het	off-target;low_conf_region	QUAL=24;DP=146;QD=0.16	RAD50	splice_region&intron	RAD50:ENST00000378823.8:splice_region_variant&intron_variant:LOW:intron4/24:c.551+19G>A::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	259870 [benign DISEASE=Familial cancer of breast,Nijmegen breakage syndrome-like disorder,not provided,Hereditary cancer-predisposing syndrome,not specified GENE=RAD50];	CS139954 [CLASS=DFP MUT=ALT PHEN="Acute lymphoblastic leukaemia decreased risk" GENE=RAD50];		rs17166050	0.18119	0.11559,0.14566,0.17638,0.21466,0.22492	2701,	22157	124539	-0.1920	1.03			/2.4>3.5/0.0>0.0	COSV99528535	RAD50|0.00|0.00|0.00|0.00|-25|-19|-19|-12	25741868,18614543,16724073,24079363,24093751,21356067,35126453,26014697,33969541,19917125	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132589791	132589791	G	C	het		QUAL=25;DP=67;QD=0.37	RAD50	missense	RAD50:ENST00000378823.8:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	216618 [uncertain significance DISEASE=Nijmegen breakage syndrome-like disorder,not provided,Hereditary cancer-predisposing syndrome GENE=RAD50];			rs55653181	0.00002	0.00000,0.00000,0.00000,0.00004,0.00000	0,	3	152249	6.4160	22.30	0.264	0.22	/0.0>0.0/0.0>0.0		RAD50|0.00|0.00|0.00|0.00|9|-10|46|43	28202063	1	16	0	0 / 1					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132595760	132595760	A	-	het	mosaic	QUAL=0;DP=927;QD=0.00;AF=0.03;MQM=60;SAP=3;ABP=0;SAR=16;SAF=16	RAD50	frameshift	RAD50:ENST00000378823.8:frameshift_variant:HIGH:exon13/25:c.2165del:p.Lys722ArgfsTer14:		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	408407 [pathogenic DISEASE=Hereditary cancer-predisposing syndrome GENE=RAD50];	CD2036440 [CLASS=DM MUT=ALT PHEN="Breast cancer" GENE=RAD50];		rs397507178	0.00003	0.00005,0.00007,0.00000,0.00001,0.00000	0,	4	150308	-0.1260	21.90			/0.0>0.0/0.0>0.0	COSV54758496	RAD50|0.00|0.00|0.00|0.00|-3|-49|-18|50	26689913,26824983,16385572,19409520,25452441,32832836,35768433,29566657,29739316,36140642,33378670,29785153,29726012,30755392,31742824	0	9	523	0 / 3					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132604212	132604212	T	G	het	off-target	QUAL=24;DP=43;QD=0.56	RAD50	intron	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron15/24:c.2524+166T>G::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	1224961 [benign DISEASE=not provided GENE=RAD50];			rs12187537	0.16153	0.06426,0.13935,0.17842,0.20762,0.21458	2316,	19955	127631	0.0490	9.73			/6.2>5.7/0.0>0.0	COSV54749162	RAD50|0.00|0.00|0.00|0.00|-25|11|28|-45	18614543,26622944	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132608437	132608437	G	A	het	off-target	QUAL=22;DP=4;QD=5.50	RAD50	intron	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron16/24:c.2719-178G>A::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	1291971 [benign DISEASE=not provided GENE=RAD50];		MIR (SINE/MIR)	rs2522394	0.32670	0.62393,0.20440,0.17702,0.21453,0.23683	10715,	28230	102344	-0.0730	1.09			/5.9>5.6/0.0>0.0		RAD50|0.00|0.00|0.00|0.00|13|42|-15|26	19840389,26622944	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	132638371	132638371	T	A	het	off-target	QUAL=25;DP=221;QD=0.11	RAD50,TH2LCRR	intron,intron&non_coding_transcript	RAD50:ENST00000378823.8:intron_variant:MODIFIER:intron23/24:c.3618+148T>A::,TH2LCRR:ENST00000457489.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.29-106A>T::,TH2LCRR:ENST00000435042.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.283-106A>T::		604040_[GENE=RAD50_PHENOS=Nijmegen breakage syndrome-like disorder, 613078 (3), Autosomal recessive]	1269272 [benign DISEASE=not provided GENE=RAD50];			rs7737470	0.22229	0.25427,0.16739,0.17761,0.21570,0.23278	3897,	26024	118320	0.1150	2.17			/4.0>3.6/0.0>0.0,/0.0>0.0/0.0>0.0		RAD50|0.00|0.00|0.00|0.00|19|-49|44|-49	20159242,18846228,18614543,23146381,25935106,23982189	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70), TH2LCRR (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr5	176906125	176906125	C	T	het	off-target	QUAL=24;DP=243;QD=0.10	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron13/14:c.1913-78G>A::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron13/14:c.1913-78G>A::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron13/14:c.1415-78G>A::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron9/10:c.803-78G>A::						rs2292256	0.57727	0.81086,0.42427,0.49129,0.49679,0.50145	27066,	33655	64287	0.8360	14.08			/0.0>0.0/0.0>0.0		UIMC1|0.00|0.00|0.00|0.00|-2|28|14|-14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176907194	176907194	C	T	het	off-target	QUAL=24;DP=625;QD=0.04	UIMC1	splice_region&intron	UIMC1:ENST00000377227.8:splice_region_variant&intron_variant:LOW:intron12/14:c.1849-17G>A::,UIMC1:ENST00000511320.6:splice_region_variant&intron_variant:LOW:intron12/14:c.1849-17G>A::,UIMC1:ENST00000506128.5:splice_region_variant&intron_variant:LOW:intron12/14:c.1351-17G>A::,UIMC1:ENST00000510698.2:splice_region_variant&intron_variant:LOW:intron8/10:c.739-17G>A::						rs2292255	0.58031	0.82203,0.42475,0.49012,0.49676,0.50062	27450,	33314	63798	-3.9000	0.00			13.0>12.0/13.0>12.0/0.0>0.0	COSV65894272	UIMC1|0.00|0.00|0.00|0.00|-24|-17|16|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr5	176911287	176911287	C	T	het	off-target	QUAL=24;DP=322;QD=0.07	UIMC1	intron	UIMC1:ENST00000377227.8:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:ENST00000511320.6:intron_variant:MODIFIER:intron11/14:c.1676+24G>A::,UIMC1:ENST00000506128.5:intron_variant:MODIFIER:intron11/14:c.1178+24G>A::,UIMC1:ENST00000510698.2:intron_variant:MODIFIER:intron7/10:c.566+24G>A::	regulatory_region_variant:enhancer					rs17078630	0.02352	0.00667,0.01697,0.00000,0.03734,0.00456	57,	3465	148587	-2.9070	0.02			/0.0>2.8/0.0>0.0		UIMC1|0.00|0.00|0.02|0.00|-2|24|20|16	26848770	33	1501	0	4 / 276					UIMC1 (inh=n/a oe_syn=1.03 oe_mis=0.90 oe_lof=0.44)
chr6	35452851	35452851	A	C	het	off-target	QUAL=24;DP=8;QD=3.00	FANCE,MKRN6P	intron,downstream_gene	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron1/9:c.248+58A>C::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron1/7:c.248+58A>C::,MKRN6P:ENST00000436521.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	929571 [benign DISEASE=not provided GENE=FANCE];			rs9470029	0.61855	0.58045,0.66303,0.53384,0.63850,0.63904	29227,	35695	58061	-2.3380	3.24			/0.0>0.0/0.0>0.0	COSV57691516	FANCE|0.00|0.00|0.00|0.00|-28|25|14|-29	33863951	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MKRN6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35455712	35455712	A	G	het	off-target	QUAL=25;DP=636;QD=0.04	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron1/9:c.249-35A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron1/7:c.249-35A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261434 [benign DISEASE=Fanconi anemia complementation group E,not specified,not provided GENE=FANCE];			rs7757405	0.74141	0.86549,0.76473,0.68447,0.67378,0.74314	42370,	27963	39309	1.6900	7.97			/0.0>2.3/0.0>0.0	COSV57690099	FANCE|0.00|0.00|0.00|0.00|35|-24|1|49	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35455885	35455885	A	C	het		QUAL=24;DP=100;QD=0.24	FANCE	synonymous	FANCE:ENST00000229769.3:synonymous_variant:LOW:exon2/10:c.387A>C:p.Pro129=:,FANCE:ENST00000696264.1:synonymous_variant:LOW:exon2/8:c.387A>C:p.Pro129=:		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261435 [benign DISEASE=Fanconi anemia complementation group E,not specified,not provided GENE=FANCE];			rs4713867	0.74308	0.87087,0.76674,0.68549,0.67360,0.74336	42628,	27785	39085	-1.1030	0.25			/0.0>0.0/0.0>0.0	COSV57690669	FANCE|0.00|0.00|0.00|0.00|-29|2|-7|-29	25741868,32708070,14695169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35456411	35456411	A	G	het	off-target	QUAL=24;DP=106;QD=0.23	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron2/9:c.855+58A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron2/7:c.855+58A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	929575 [benign DISEASE=not provided GENE=FANCE];			rs3800377	0.71522	0.86383,0.73577,0.54926,0.64992,0.67490	39653,	29436	43298	-1.5070	0.03			/0.0>0.0/0.0>0.0		FANCE|0.00|0.00|0.00|0.00|-14|9|-50|-7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35456491	35456491	A	G	het	off-target	QUAL=26;DP=24;QD=1.08	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron2/9:c.855+138A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron2/7:c.855+138A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	1279735 [benign DISEASE=not provided GENE=FANCE];			rs4713868	0.74174	0.86532,0.76488,0.68548,0.67402,0.74178	42258,	27935	39153	-0.0720	3.62			/0.0>0.0/1.1>0.0		FANCE|0.00|0.00|0.00|0.00|44|25|-10|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	35457639	35457639	A	G	het	off-target	QUAL=24;DP=832;QD=0.03	FANCE	intron	FANCE:ENST00000229769.3:intron_variant:MODIFIER:intron3/9:c.900+39A>G::,FANCE:ENST00000696264.1:intron_variant:MODIFIER:intron3/7:c.900+39A>G::		613976_[GENE=FANCE_PHENOS=Fanconi anemia, complementation group E, 600901 (3), Autosomal recessive]	261436 [benign DISEASE=Fanconi anemia complementation group E,not specified,not provided GENE=FANCE];			rs13214239	0.42511	0.13849,0.52123,0.35421,0.55900,0.42724	16463,	31715	87415	-0.6330	0.19			/7.2>7.9/0.0>0.0	COSV57690016	FANCE|0.00|0.00|0.00|0.00|-10|13|44|-39	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCE (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.56)
chr6	130827597	130827597	G	A	het	off-target	QUAL=24;DP=42;QD=0.57	SMLR1	missense	SMLR1:ENST00000541421.2:missense_variant:MODERATE:exon1/2:c.184G>A:p.Val62Met:	regulatory_region_variant:TF_binding_site					rs1044303	0.37136	0.43169,0.43561,0.65016,0.29225,0.48750	11134,	34092	95406	4.5270	24.40		0.26	/0.9>1.3/0.0>0.0	COSV73407205	SMLR1|0.00|0.00|0.00|0.00|2|38|-29|-1	25025429	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827723	130827723	A	T	het		QUAL=25;DP=373;QD=0.07	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+72A>T::	regulatory_region_variant:TF_binding_site					rs9388856	0.37145	0.43185,0.43618,0.64760,0.29227,0.48771	11136,	34155	95483	0.2310	1.59			/2.5>4.0/0.4>0.0		SMLR1|0.00|0.00|0.00|0.00|50|2|50|45	20189245,26045716	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827751	130827751	-	AT	het	off-target	QUAL=25;DP=705;QD=0.04	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+113_238+114dup::	regulatory_region_variant:TF_binding_site					rs113795427	0.39407	0.51903,0.43948,0.63328,0.29184,0.48382	12534,	34378	91406		2.85			/0.0>0.0/0.0>0.0		SMLR1|0.03|0.00|0.00|0.00|22|37|21|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr6	130827886	130827886	C	T	het	off-target	QUAL=26;DP=331;QD=0.08	SMLR1	intron	SMLR1:ENST00000541421.2:intron_variant:MODIFIER:intron1/1:c.238+235C>T::	regulatory_region_variant:TF_binding_site,TF_binding_site_variant					rs72998266	0.13374	0.19959,0.17127,0.08240,0.09736,0.11998	1658,	17030	131782	-0.4330	1.61			/2.2>2.3/0.0>0.0		SMLR1|0.00|0.00|0.00|0.00|23|-10|-22|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMLR1 (inh=n/a oe_syn=1.20 oe_mis=0.93 oe_lof=0.36)
chr7	5987144	5987144	T	C	hom		QUAL=24;DP=15;QD=1.60	PMS2	missense,intron	PMS2:ENST00000265849.12:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000699930.2:missense_variant:MODERATE:exon11/15:c.1513A>G:p.Lys505Glu:,PMS2:ENST00000699811.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699752.1:missense_variant:MODERATE:exon10/14:c.1465A>G:p.Lys489Glu:,PMS2:ENST00000699818.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699754.1:missense_variant:MODERATE:exon9/13:c.1423A>G:p.Lys475Glu:,PMS2:ENST00000699760.1:missense_variant:MODERATE:exon9/13:c.1303A>G:p.Lys435Glu:,PMS2:ENST00000699761.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699762.1:missense_variant:MODERATE:exon10/14:c.1048A>G:p.Lys350Glu:,PMS2:ENST00000699821.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699766.1:missense_variant:MODERATE:exon11/15:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000699768.1:missense_variant:MODERATE:exon11/14:c.1621A>G:p.Lys541Glu:,PMS2:ENST00000699839.1:missense_variant:MODERATE:exon12/16:c.1807A>G:p.Lys603Glu:,PMS2:ENST00000699823.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699837.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000699825.1:missense_variant:MODERATE:exon10/14:c.1060A>G:p.Lys354Glu:,PMS2:ENST00000699840.2:missense_variant:MODERATE:exon11/15:c.1618A>G:p.Lys540Glu:,PMS2:ENST00000699827.1:missense_variant:MODERATE:exon10/14:c.1453A>G:p.Lys485Glu:,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron7/7:c.803+10182A>G::,PMS2:ENST00000642292.1:missense_variant:MODERATE:exon10/14:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000642456.1:missense_variant:MODERATE:exon11/15:c.1216A>G:p.Lys406Glu:,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron7/10:c.804-4153A>G::		600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	135065 [benign DISEASE=not specified,Lynch syndrome,Hereditary nonpolyposis colorectal neoplasms,Mismatch repair cancer syndrome 4,Lynch syndrome 4 GENE=PMS2];			rs2228006	0.86532	0.92507,0.77100,0.91419,0.84537,0.89474	57167,	17295	20487	1.5020	5.54	0.161	0.06	/0.0>0.0/0.0>0.0	COSV56223170		25741868,24033266,24728327,26811195,22523087,22594646,16619239,21487324,32708070,22703879,29458332,26900293,24689082,27900359,32756484,16774946,29434720,18723338,15256438,8993976,29963112,16472587,14756672,24027009,20186689,24072394,28122645,33863951,33240400,36277983,34247610,28926134,31160353	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5997349	5997349	G	C	hom		QUAL=24;DP=26;QD=0.92	PMS2	synonymous,intron	PMS2:ENST00000265849.12:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:ENST00000699930.2:synonymous_variant:LOW:exon7/15:c.672C>G:p.Ser224=:,PMS2:ENST00000699811.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699752.1:synonymous_variant:LOW:exon7/14:c.780C>G:p.Ser260=:,PMS2:ENST00000699818.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+1759C>G::,PMS2:ENST00000699760.1:synonymous_variant:LOW:exon5/13:c.462C>G:p.Ser154=:,PMS2:ENST00000699761.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699762.1:synonymous_variant:LOW:exon6/14:c.207C>G:p.Ser69=:,PMS2:ENST00000699821.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000699766.1:synonymous_variant:LOW:exon7/15:c.780C>G:p.Ser260=:,PMS2:ENST00000699768.1:synonymous_variant:LOW:exon7/14:c.780C>G:p.Ser260=:,PMS2:ENST00000699839.1:synonymous_variant:LOW:exon8/16:c.966C>G:p.Ser322=:,PMS2:ENST00000699823.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000699837.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000699825.1:synonymous_variant:LOW:exon7/14:c.375C>G:p.Ser125=:,PMS2:ENST00000699840.2:synonymous_variant:LOW:exon7/15:c.777C>G:p.Ser259=:,PMS2:ENST00000699827.1:synonymous_variant:LOW:exon6/14:c.612C>G:p.Ser204=:,PMS2:ENST00000699952.1:synonymous_variant:LOW:exon7/8:c.780C>G:p.Ser260=:,PMS2:ENST00000642292.1:synonymous_variant:LOW:exon6/14:c.375C>G:p.Ser125=:,PMS2:ENST00000642456.1:synonymous_variant:LOW:exon7/15:c.375C>G:p.Ser125=:,PMS2:ENST00000382321.5:synonymous_variant:LOW:exon7/11:c.780C>G:p.Ser260=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	36693 [benign DISEASE=Lynch syndrome 4,Hereditary cancer-predisposing syndrome,not specified,not provided,Mismatch repair cancer syndrome 4,Endometrial carcinoma,Lynch syndrome,Hereditary nonpolyposis colorectal neoplasms GENE=PMS2];	CM2410083 [CLASS=DP MUT=ALT PHEN="Pairs matching count association with" GENE=PMS2];		rs1805319	0.81683	0.84326,0.73615,0.91440,0.81215,0.81240	50628,	22326	27712	-2.2610	0.00			/0.0>0.0/0.0>0.0	COSV56223185	PMS2|0.00|0.00|0.00|0.00|47|19|-23|19	25741868,23757202,16619239,26900293,18268114,15256438,8993976,16472587,20205264,182681,19132747,34247610	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5997426	5997426	-	A	hom	low_conf_region	QUAL=24;DP=40;QD=0.60	PMS2	splice_region&intron,intron	PMS2:ENST00000265849.12:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:ENST00000699930.2:splice_region_variant&intron_variant:LOW:intron6/14:c.598-4dup::,PMS2:ENST00000699811.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699752.1:splice_region_variant&intron_variant:LOW:intron6/13:c.706-4dup::,PMS2:ENST00000699818.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+1681dup::,PMS2:ENST00000699760.1:splice_region_variant&intron_variant:LOW:intron4/12:c.388-4dup::,PMS2:ENST00000699761.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699762.1:splice_region_variant&intron_variant:LOW:intron5/13:c.133-4dup::,PMS2:ENST00000699821.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000699766.1:splice_region_variant&intron_variant:LOW:intron6/14:c.706-4dup::,PMS2:ENST00000699768.1:splice_region_variant&intron_variant:LOW:intron6/13:c.706-4dup::,PMS2:ENST00000699839.1:splice_region_variant&intron_variant:LOW:intron7/15:c.892-4dup::,PMS2:ENST00000699823.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000699837.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000699825.1:splice_region_variant&intron_variant:LOW:intron6/13:c.301-4dup::,PMS2:ENST00000699840.2:splice_region_variant&intron_variant:LOW:intron6/14:c.703-4dup::,PMS2:ENST00000699827.1:splice_region_variant&intron_variant:LOW:intron5/13:c.538-4dup::,PMS2:ENST00000699952.1:splice_region_variant&intron_variant:LOW:intron6/7:c.706-4dup::,PMS2:ENST00000642292.1:splice_region_variant&intron_variant:LOW:intron5/13:c.301-4dup::,PMS2:ENST00000642456.1:splice_region_variant&intron_variant:LOW:intron6/14:c.301-4dup::,PMS2:ENST00000382321.5:splice_region_variant&intron_variant:LOW:intron6/10:c.706-4dup::	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]	198429 [benign(replaced by megSAP based on classifications:9x1,2x2,1x3) DISEASE=Hereditary cancer-predisposing syndrome,Lynch syndrome 1,Lynch syndrome 4,not specified,Hereditary nonpolyposis colorectal neoplasms,not provided,Lynch syndrome GENE=PMS2];			rs60794673	0.10145	0.10501,0.11438,0.02866,0.11056,0.03859	656,	12198	119658		2.25			/11.6>11.6/0.0>0.0		PMS2|0.00|0.00|0.00|0.00|-3|-30|-47|-23	25741868,24033266,33240400	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	5998990	5998990	A	-	hom	off-target	QUAL=24;DP=48;QD=0.50	PMS2	intron	PMS2:ENST00000265849.12:intron_variant:MODIFIER:intron6/14:c.705+118del::,PMS2:ENST00000699930.2:intron_variant:MODIFIER:intron6/14:c.597+226del::,PMS2:ENST00000699811.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699752.1:intron_variant:MODIFIER:intron6/13:c.705+118del::,PMS2:ENST00000699818.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron6/12:c.705+118del::,PMS2:ENST00000699760.1:intron_variant:MODIFIER:intron4/12:c.387+118del::,PMS2:ENST00000699761.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699762.1:intron_variant:MODIFIER:intron5/13:c.133-1567del::,PMS2:ENST00000699821.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000699766.1:intron_variant:MODIFIER:intron6/14:c.705+118del::,PMS2:ENST00000699768.1:intron_variant:MODIFIER:intron6/13:c.705+118del::,PMS2:ENST00000699839.1:intron_variant:MODIFIER:intron7/15:c.891+118del::,PMS2:ENST00000699823.1:intron_variant:MODIFIER:intron5/13:c.300+118del::,PMS2:ENST00000699837.1:intron_variant:MODIFIER:intron5/13:c.300+118del::,PMS2:ENST00000699825.1:intron_variant:MODIFIER:intron6/13:c.300+118del::,PMS2:ENST00000699840.2:intron_variant:MODIFIER:intron6/14:c.702+118del::,PMS2:ENST00000699827.1:intron_variant:MODIFIER:intron5/13:c.538-1567del::,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron6/7:c.705+118del::,PMS2:ENST00000642292.1:intron_variant:MODIFIER:intron5/13:c.300+118del::,PMS2:ENST00000642456.1:intron_variant:MODIFIER:intron6/14:c.300+118del::,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron6/10:c.705+118del::		600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]			AluSx3 (SINE/Alu)	rs11289444	0.73545	0.74299,0.69511,0.81074,0.73680,0.71872	36439,	29029	36657	0.5950	0.82			/1.6>1.2/0.0>0.0		PMS2|0.00|0.00|0.00|0.00|-3|-5|-5|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98)
chr7	6008925	6008925	G	A	het	off-target	QUAL=24;DP=49;QD=0.49	PMS2,Y_RNA,AIMP2	intron,5'UTR,upstream_gene	PMS2:ENST00000265849.12:intron_variant:MODIFIER:intron1/14:c.23+72C>T::,PMS2:ENST00000699930.2:intron_variant:MODIFIER:intron1/14:c.23+72C>T::,PMS2:ENST00000699811.1:intron_variant:MODIFIER:intron1/14:c.-553+72C>T::,PMS2:ENST00000699752.1:intron_variant:MODIFIER:intron1/13:c.23+72C>T::,PMS2:ENST00000699818.1:5_prime_UTR_variant:MODIFIER:exon1/15:c.-501C>T::,PMS2:ENST00000699754.1:intron_variant:MODIFIER:intron1/12:c.23+72C>T::,PMS2:ENST00000699760.1:intron_variant:MODIFIER:intron1/12:c.-53+72C>T::,PMS2:ENST00000699761.1:intron_variant:MODIFIER:intron1/14:c.-325+72C>T::,PMS2:ENST00000699762.1:intron_variant:MODIFIER:intron1/13:c.-378+72C>T::,PMS2:ENST00000699766.1:intron_variant:MODIFIER:intron1/14:c.23+72C>T::,PMS2:ENST00000699768.1:intron_variant:MODIFIER:intron1/13:c.23+72C>T::,PMS2:ENST00000699839.1:intron_variant:MODIFIER:intron1/15:c.23+72C>T::,PMS2:ENST00000699823.1:intron_variant:MODIFIER:intron1/13:c.-190+72C>T::,PMS2:ENST00000699837.1:intron_variant:MODIFIER:intron1/13:c.-275+72C>T::,PMS2:ENST00000699825.1:intron_variant:MODIFIER:intron1/13:c.-378+72C>T::,PMS2:ENST00000699840.2:intron_variant:MODIFIER:intron1/14:c.23+72C>T::,PMS2:ENST00000699827.1:intron_variant:MODIFIER:intron1/13:c.23+72C>T::,PMS2:ENST00000699952.1:intron_variant:MODIFIER:intron1/7:c.23+72C>T::,PMS2:ENST00000642292.1:intron_variant:MODIFIER:intron1/13:c.-243+72C>T::,PMS2:ENST00000642456.1:intron_variant:MODIFIER:intron1/14:c.-378+72C>T::,PMS2:ENST00000382321.5:intron_variant:MODIFIER:intron1/10:c.23+72C>T::,PMS2:ENST00000699821.1:upstream_gene_variant:MODIFIER::::,Y_RNA:ENST00000365120.1:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000400479.6:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000223029.8:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000395236.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]&600859_[GENE=AIMP2_PHENOS=Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessive]	1169336 [benign DISEASE=Hereditary nonpolyposis colorectal neoplasms,not provided GENE=PMS2];	CS1714329 [CLASS=R MUT=ALT PHEN="Colorectal cancer non-polyposis" GENE=PMS2];		rs3735295	0.22612	0.31678,0.15086,0.16000,0.18811,0.23146	4258,	25889	117749	1.0220	7.83			/0.0>0.0/0.0>0.0		PMS2|0.00|0.00|0.00|0.00|-28|-18|-27|-10	28499365,23424144,34997843	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98), AIMP2 (inh=AR oe_syn=1.21 oe_mis=1.17 oe_lof=0.46)
chr7	6009173	6009173	G	C	het	off-target	QUAL=24;DP=10;QD=2.40	PMS2,Y_RNA,AIMP2	upstream_gene	PMS2:ENST00000265849.12:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699930.2:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699811.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699752.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699818.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699754.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699760.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699761.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699762.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699821.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699766.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699768.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699839.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699823.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699837.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699825.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699840.2:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699827.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000699952.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000642292.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000642456.1:upstream_gene_variant:MODIFIER::::,PMS2:ENST00000382321.5:upstream_gene_variant:MODIFIER::::,Y_RNA:ENST00000365120.1:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000400479.6:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000223029.8:upstream_gene_variant:MODIFIER::::,AIMP2:ENST00000395236.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600259_[GENE=PMS2_PHENOS=Lynch syndrome 4, 614337 (3); Mismatch repair cancer syndrome 4, 619101 (3), Autosomal recessive]&600859_[GENE=AIMP2_PHENOS=Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessive]	91280 [benign DISEASE=Lynch syndrome GENE=PMS2];			rs3735296	0.16225	0.22912,0.10754,0.06560,0.13796,0.14449	2217,	20245	127427	0.1400	6.82						24689082	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PMS2 (inh=AR+AD oe_syn=1.10 oe_mis=1.07 oe_lof=0.98), AIMP2 (inh=AR oe_syn=1.21 oe_mis=1.17 oe_lof=0.46)
chr7	129203328	129203328	C	T	hom	off-target	QUAL=24;DP=12;QD=2.00	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron1/11:c.332-56C>T::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1244213 [benign DISEASE=not provided GENE=SMO];			rs2566871	0.49190	0.47430,0.47247,0.40646,0.52348,0.43988	18516,	37797	77293	-1.2520	0.93			/1.4>2.3/1.2>0.0	COSV50824292	SMO|0.00|0.00|0.00|0.00|14|-34|-10|14	31209431	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205177	129205177	C	T	hom	off-target	QUAL=24;DP=130;QD=0.18	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron2/11:c.538-26C>T::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1275728 [benign DISEASE=not provided,Hamartoma of hypothalamus GENE=SMO];			rs2703091	0.78473	0.68684,0.74364,0.74313,0.84373,0.76632	47279,	24742	32726	0.0620	5.78			/2.5>1.3/0.0>0.0	COSV99976307	SMO|0.00|0.00|0.00|0.00|-26|26|31|27	28833756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205436	129205436	G	C	hom	off-target	QUAL=24;DP=34;QD=0.71	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron3/11:c.747+24G>C::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1268093 [benign DISEASE=Hamartoma of hypothalamus,not provided GENE=SMO];			rs2075777	0.78453	0.68668,0.74333,0.74341,0.84356,0.76474	47313,	24767	32791	-0.0750	0.55			/0.0>0.0/0.0>0.0		SMO|0.00|0.00|0.01|0.01|-18|-27|20|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205484	129205484	G	A	hom	off-target	QUAL=24;DP=39;QD=0.62	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron3/11:c.747+72G>A::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1290719 [benign DISEASE=not provided GENE=SMO];			rs2566872	0.78460	0.68644,0.74287,0.74217,0.84364,0.76729	47290,	24752	32760	-0.1160	2.10			/0.0>0.0/0.3>0.0	COSV50827858	SMO|0.00|0.00|0.09|0.00|7|49|7|-28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129205861	129205861	C	T	hom	off-target	QUAL=25;DP=24;QD=1.04	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron4/11:c.920+79C>T::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1221870 [benign DISEASE=not provided GENE=SMO];			rs2075778	0.78572	0.69067,0.74362,0.74137,0.84369,0.76618	47412,	24703	32597	0.1800	2.46			/0.0>0.0/9.7>7.0	COSV99976190	SMO|0.00|0.00|0.04|0.00|25|-10|-50|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206066	129206066	T	C	hom	off-target	QUAL=25;DP=4;QD=6.25	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron4/11:c.921-84T>C::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1259833 [benign DISEASE=not provided GENE=SMO];			rs2075779	0.78578	0.69104,0.74372,0.74158,0.84365,0.76588	47432,	24705	32597	-0.2590	2.44			/0.5>0.0/1.8>0.0	COSV50841276			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206487	129206487	G	C	hom		QUAL=24;DP=708;QD=0.03	SMO	synonymous	SMO:ENST00000249373.8:synonymous_variant:LOW:exon6/12:c.1164G>C:p.Gly388=:PF01534 [Frizzled/Smoothened family membrane region]		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	403462 [benign DISEASE=Hamartoma of hypothalamus,not specified,not provided GENE=SMO];			rs2228617	0.78654	0.69111,0.74500,0.75426,0.84389,0.76775	47490,	24649	32467	1.1650	8.28			/0.0>0.0/0.0>0.0	COSV50829466	SMO|0.00|0.00|0.00|0.00|-23|22|-9|-5	24033266,30334169,27236920,25189937,23826113,28833756	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206628	129206628	A	G	hom	off-target	QUAL=24;DP=670;QD=0.04	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron6/11:c.1264+41A>G::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1281387 [benign DISEASE=not provided,Hamartoma of hypothalamus GENE=SMO];			rs2735842	0.78584	0.69116,0.74362,0.74197,0.84363,0.76640	47411,	24692	32570	0.2220	5.07			/0.0>0.0/0.0>0.0	COSV50829472	SMO|0.00|0.00|0.00|0.00|-40|40|-1|-41	27236920	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129206716	129206716	-	AG	hom	off-target	QUAL=18;DP=649;QD=0.03	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron6/11:c.1264+130_1264+131dup::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]	1277300 [benign DISEASE=not provided GENE=SMO];			rs10622446	0.78531	0.68995,0.74362,0.74165,0.84340,0.76566	47311,	24703	32621		10.95			/0.0>2.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	129211961	129211961	G	A	het	off-target	QUAL=24;DP=58;QD=0.41	SMO	intron	SMO:ENST00000249373.8:intron_variant:MODIFIER:intron11/11:c.1937-63G>A::		601500_[GENE=SMO_PHENOS=Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)]				rs73230586	0.00018	0.00014,0.00000,0.00000,0.00029,0.00000	0,	28	152216	0.8380	5.29			/0.0>0.0/2.0>0.0		SMO|0.00|0.00|0.00|0.00|2|37|-15|-16		0	32	0	0 / 4					SMO (inh=AR oe_syn=0.99 oe_mis=0.75 oe_lof=0.46)
chr7	142749281	142749281	A	C	hom	off-target	QUAL=25;DP=76;QD=0.33	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000492062.2:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	1169050 [benign DISEASE=Hereditary pancreatitis,not provided GENE=PRSS1];			rs4726576	0.55511	0.55983,0.58756,0.22815,0.57838,0.31684	21910,	37091	64845	-3.0540	0.02						30832275,26820620,26784911,30467200,24458023,36206743,36386424,31506327,27653516	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749351	142749351	C	A	het	off-target	QUAL=13;DP=111;QD=0.12	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000492062.2:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs796363879	0.38892	0.45175,0.39391,0.14609,0.38121,0.22099	0,	47103	74011	-0.0630	5.04							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142749360	142749360	G	A	het	off-target	QUAL=9;DP=111;QD=0.08	PRSS1	upstream_gene	PRSS1:ENST00000486171.5:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000492062.2:upstream_gene_variant:MODIFIER::::,PRSS1:ENST00000311737.12:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs576859120	0.39206	0.45402,0.39684,0.15257,0.38471,0.22693	0,	48600	75360	0.6120	12.30							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751804	142751804	C	T	het	mosaic;low_conf_region	QUAL=0;DP=1073;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=24	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon4/6:c.273C>T:p.Asn91=:PF00089 [Trypsin],PRSS1:ENST00000492062.2:synonymous_variant:LOW:exon3/5:c.231C>T:p.Asn77=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon3/5:c.231C>T:p.Asn77=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	1789545 [likely benign DISEASE=Hereditary pancreatitis GENE=PRSS1];			rs555535168	0.00444	0.00552,0.00432,0.00152,0.00406,0.00270	0,	542	121634	5.9520	8.68			/0.0>0.0/0.0>0.0	COSV105883384,COSV61196330	PRSS1|0.00|0.02|0.00|0.00|41|-30|-21|26		0	11649	4198	0 / 1635					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751878	142751878	A	T	het	mosaic	QUAL=0;DP=998;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon4/6:c.347A>T:p.Lys116Met:PF00089 [Trypsin],PRSS1:ENST00000492062.2:missense_variant:MODERATE:exon3/5:c.305A>T:p.Lys102Met:PF00089 [Trypsin],PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon3/5:c.305A>T:p.Lys102Met:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	3222797 [uncertain significance DISEASE=Hereditary pancreatitis GENE=PRSS1];			rs778568523	0.00858	0.01483,0.00718,0.00135,0.00643,0.00230	0,	898	103722	-1.2550	0.10	0.392	0.25	/2.0>2.0/0.0>0.0		PRSS1|0.04|0.00|0.00|0.00|48|2|-2|46		0	1000	2935	0 / 586					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751879	142751879	G	T	het	mosaic	QUAL=0;DP=998;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	missense	PRSS1:ENST00000486171.5:missense_variant:MODERATE:exon4/6:c.348G>T:p.Lys116Asn:PF00089 [Trypsin],PRSS1:ENST00000492062.2:missense_variant:MODERATE:exon3/5:c.306G>T:p.Lys102Asn:PF00089 [Trypsin],PRSS1:ENST00000311737.12:missense_variant:MODERATE:exon3/5:c.306G>T:p.Lys102Asn:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	3222798 [uncertain significance DISEASE=Hereditary pancreatitis GENE=PRSS1];			rs1373631104	0.00840	0.01459,0.00690,0.00113,0.00626,0.00230	0,	879	103771	0.1220	3.42	0.247	0.17	/0.0>0.0/0.0>0.0		PRSS1|0.09|0.00|0.00|0.00|47|-34|-30|45		0	1000	2924	0 / 588					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751901	142751901	T	C	het	mosaic	QUAL=0;DP=1009;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon4/6:c.370T>C:p.Leu124=:PF00089 [Trypsin],PRSS1:ENST00000492062.2:synonymous_variant:LOW:exon3/5:c.328T>C:p.Leu110=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon3/5:c.328T>C:p.Leu110=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	2503991 [likely benign DISEASE=not specified GENE=PRSS1];			rs747546710	0.00234	0.00473,0.00172,0.00042,0.00124,0.00141	0,	285	121515	2.6340	8.23			/0.0>0.0/0.0>0.0	COSV61190485	PRSS1|0.16|0.00|0.00|0.00|25|9|18|-2		0	614	881	0 / 522					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142751903	142751903	A	G	het	mosaic	QUAL=0;DP=1009;QD=0.00;AF=0.05;MQM=50;SAP=3;ABP=0;SAR=25;SAF=25	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon4/6:c.372A>G:p.Leu124=:PF00089 [Trypsin],PRSS1:ENST00000492062.2:synonymous_variant:LOW:exon3/5:c.330A>G:p.Leu110=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon3/5:c.330A>G:p.Leu110=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	1730048 [likely benign DISEASE=not specified,Hereditary pancreatitis GENE=PRSS1];			rs771259654	0.00169	0.00359,0.00120,0.00042,0.00083,0.00093	0,	211	124509	0.6840	2.43			/0.0>0.8/0.0>0.0	COSV61190491	PRSS1|0.01|0.00|0.00|0.00|-27|23|21|-4		0	599	532	0 / 522					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752462	142752462	T	C	hom		QUAL=24;DP=109;QD=0.22	PRSS1	synonymous	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.528T>C:p.Asp176=:PF00089 [Trypsin],PRSS1:ENST00000492062.2:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:PF00089 [Trypsin],PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.486T>C:p.Asp162=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	239391 [benign/likely benign DISEASE=not specified,Hereditary pancreatitis,not provided GENE=PRSS1];			rs6666	0.42733	0.51720,0.42176,0.19755,0.40960,0.25896	1831,	59643	84837	-3.8310	0.12			/0.0>0.0/0.0>0.0	COSV61190814	PRSS1|0.00|0.00|0.00|0.00|-31|-19|23|-31	25741868,24458023,33202925,36386424,31506327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752564	142752564	T	C	het		QUAL=10;DP=326;QD=0.03	PRSS1	synonymous,splice_region&intron	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon5/6:c.630T>C:p.Cys210=:PF00089 [Trypsin],PRSS1:ENST00000492062.2:splice_region_variant&intron_variant:LOW:intron4/4:c.574+14T>C::,PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon4/5:c.588T>C:p.Cys196=:PF00089 [Trypsin]		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	826034 [benign DISEASE=Hereditary pancreatitis GENE=PRSS1];			rs751264273	0.39939	0.44685,0.40910,0.17304,0.39776,0.24859	0,	52159	78437	2.0850	9.47			/0.0>0.0/0.0>0.0	COSV61192554	PRSS1|0.00|0.00|0.00|0.00|-17|-2|3|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752718	142752718	T	C	het	off-target	QUAL=26;DP=79;QD=0.33	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-150T>C::,PRSS1:ENST00000492062.2:intron_variant:MODIFIER:intron4/4:c.575-150T>C::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-150T>C::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs377684105	0.41280	0.47398,0.41643,0.18672,0.40250,0.25689	0,	57826	82258	-0.6350	1.17			/6.8>6.5/0.0>0.0	COSV61191941	PRSS1|0.00|0.00|0.00|0.00|-42|12|41|-28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752752	142752752	A	G	het	off-target	QUAL=25;DP=148;QD=0.17	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-116A>G::,PRSS1:ENST00000492062.2:intron_variant:MODIFIER:intron4/4:c.575-116A>G::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-116A>G::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs370565903	0.41653	0.47536,0.42145,0.19583,0.40634,0.26779	0,	60273	84429	-4.3710	0.57			/0.0>0.0/0.0>4.3		PRSS1|0.00|0.00|0.00|0.00|-22|21|-1|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142752760	142752760	G	A	het	off-target	QUAL=24;DP=148;QD=0.16	PRSS1	intron	PRSS1:ENST00000486171.5:intron_variant:MODIFIER:intron5/5:c.634-108G>A::,PRSS1:ENST00000492062.2:intron_variant:MODIFIER:intron4/4:c.575-108G>A::,PRSS1:ENST00000311737.12:intron_variant:MODIFIER:intron4/4:c.592-108G>A::		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]				rs1293060442	0.41709	0.47553,0.42183,0.19657,0.40715,0.26973	0,	60704	84838	1.3030	7.01			/0.0>0.0/0.0>0.0		PRSS1|0.00|0.00|0.00|0.00|-30|0|40|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr7	142753014	142753014	T	C	hom		QUAL=25;DP=357;QD=0.07	PRSS1	synonymous,3'UTR	PRSS1:ENST00000486171.5:synonymous_variant:LOW:exon6/6:c.780T>C:p.Asn260=:,PRSS1:ENST00000492062.2:3_prime_UTR_variant:MODIFIER:exon5/5:c.*142T>C::,PRSS1:ENST00000311737.12:synonymous_variant:LOW:exon5/5:c.738T>C:p.Asn246=:		276000_[GENE=PRSS1_PHENOS=Pancreatitis, hereditary, 167800 (3), Autosomal dominant]	258803 [benign/likely benign DISEASE=not provided,Hereditary pancreatitis,not specified GENE=PRSS1];			rs6667	0.52706	0.46376,0.57497,0.22521,0.57686,0.30917	21021,	36363	70355	0.2440	1.96			/0.0>0.0/0.0>1.4	COSV61193305	PRSS1|0.00|0.00|0.00|0.00|14|-45|14|-45	25741868,12011155,9633818,11842279,24458023,36386424,31506327,14526128	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PRSS1 (inh=AD oe_syn=1.56 oe_mis=1.50 oe_lof=1.31)
chr8	89943130	89943130	C	T	het	off-target	QUAL=25;DP=112;QD=0.22	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron14/16:c.2184+123G>A::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron14/16:c.2184+123G>A::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron15/16:c.1938+123G>A::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron16/17:c.1938+123G>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron13/14:c.1938+123G>A::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron12/13:c.1872+123G>A::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron12/13:c.1959+123G>A::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron13/14:c.2115+123G>A::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron14/15:c.2184+123G>A::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron15/16:c.1938+123G>A::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron14/15:c.1938+123G>A::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron14/14:c.2184+123G>A::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron14/16:c.2184+123G>A::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	1177037 [benign DISEASE=not provided,Microcephaly, normal intelligence and immunodeficiency GENE=NBN];			rs7840099	0.33330	0.31490,0.35198,0.45096,0.32209,0.43805	8324,	33389	100089	0.1550	1.99			/2.7>3.6/0.0>0.0	COSV55372468	NBN|0.00|0.00|0.00|0.00|30|-1|30|-17	20734064,21987080,20004634,26045716,26622944,24396275	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89943396	89943396	T	A	het	off-target	QUAL=24;DP=31;QD=0.77	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron13/16:c.2071-30A>T::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron13/16:c.2071-30A>T::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron14/16:c.1825-30A>T::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron15/17:c.1825-30A>T::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron12/14:c.1825-30A>T::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron11/13:c.1759-30A>T::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron11/13:c.1846-30A>T::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron12/14:c.2002-30A>T::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron13/15:c.2071-30A>T::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron14/16:c.1825-30A>T::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron13/15:c.1825-30A>T::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron13/14:c.2071-30A>T::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron13/16:c.2071-30A>T::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	258769 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,Acute lymphoid leukemia,not provided,Microcephaly, normal intelligence and immunodeficiency GENE=NBN];			rs3736639	0.33373	0.31676,0.35254,0.45045,0.32212,0.43753	8517,	33674	101236	-0.7230	0.65			/0.9>0.8/0.0>0.0	COSV55378350	NBN|0.00|0.00|0.00|0.00|-49|-30|-49|-40	25741868,20734064,20004634,19523210,27936167,19917125,24396275	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89946194	89946194	T	C	het		QUAL=24;DP=47;QD=0.51	NBN	synonymous,intron	NBN:ENST00000697292.1:synonymous_variant:LOW:exon13/17:c.2016A>G:p.Pro672=:,NBN:ENST00000697293.1:synonymous_variant:LOW:exon13/17:c.2016A>G:p.Pro672=:,NBN:ENST00000517337.2:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:ENST00000697298.1:synonymous_variant:LOW:exon15/18:c.1770A>G:p.Pro590=:,NBN:ENST00000697299.1:synonymous_variant:LOW:exon12/15:c.1770A>G:p.Pro590=:,NBN:ENST00000697304.1:synonymous_variant:LOW:exon11/14:c.1704A>G:p.Pro568=:,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron11/13:c.1846-2828A>G::,NBN:ENST00000697308.1:synonymous_variant:LOW:exon12/15:c.1947A>G:p.Pro649=:,NBN:ENST00000265433.8:synonymous_variant:LOW:exon13/16:c.2016A>G:p.Pro672=:,NBN:ENST00000523444.2:synonymous_variant:LOW:exon14/17:c.1770A>G:p.Pro590=:,NBN:ENST00000409330.5:synonymous_variant:LOW:exon13/16:c.1770A>G:p.Pro590=:,NBN:ENST00000697309.1:synonymous_variant:LOW:exon13/15:c.2016A>G:p.Pro672=:,NBN:ENST00000697310.1:synonymous_variant:LOW:exon13/17:c.2016A>G:p.Pro672=:		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	183696 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Acute lymphoid leukemia,Microcephaly, normal intelligence and immunodeficiency,not provided,Hereditary cancer-predisposing syndrome,not specified GENE=NBN];			rs1061302	0.30815	0.23009,0.34150,0.45148,0.32157,0.43758	7460,	31896	105112	-2.5830	0.47			/0.0>0.0/0.0>0.0	COSV55371426	NBN|0.04|0.00|0.00|0.00|6|-43|6|30	25741868,24033266,20386703,32461785,20004634,19523210,20478923,20571895,29416357,19393077,24166361,30799775,26402912,35637613,33403820,28402931,21908578,30272267,28647780,22864661,27936167,19917125,24396275,28288557	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89946302	89946302	T	C	het		QUAL=24;DP=36;QD=0.67	NBN	splice_region&intron,intron	NBN:ENST00000697292.1:splice_region_variant&intron_variant:LOW:intron12/16:c.1915-7A>G::,NBN:ENST00000697293.1:splice_region_variant&intron_variant:LOW:intron12/16:c.1915-7A>G::,NBN:ENST00000517337.2:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:ENST00000697298.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1669-7A>G::,NBN:ENST00000697299.1:splice_region_variant&intron_variant:LOW:intron11/14:c.1669-7A>G::,NBN:ENST00000697304.1:splice_region_variant&intron_variant:LOW:intron10/13:c.1603-7A>G::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron11/13:c.1846-2936A>G::,NBN:ENST00000697308.1:splice_region_variant&intron_variant:LOW:intron11/14:c.1846-7A>G::,NBN:ENST00000265433.8:splice_region_variant&intron_variant:LOW:intron12/15:c.1915-7A>G::,NBN:ENST00000523444.2:splice_region_variant&intron_variant:LOW:intron13/16:c.1669-7A>G::,NBN:ENST00000409330.5:splice_region_variant&intron_variant:LOW:intron12/15:c.1669-7A>G::,NBN:ENST00000697309.1:splice_region_variant&intron_variant:LOW:intron12/14:c.1915-7A>G::,NBN:ENST00000697310.1:splice_region_variant&intron_variant:LOW:intron12/16:c.1915-7A>G::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	258768 [benign DISEASE=Hereditary breast ovarian cancer syndrome,Acute lymphoid leukemia,not provided,Microcephaly, normal intelligence and immunodeficiency,not specified GENE=NBN];			rs2308962	0.33263	0.31379,0.35184,0.45164,0.32196,0.43792	8458,	33592	101338	-1.9330	0.08			3.9>3.3/3.9>3.3/0.0>0.0,/3.9>3.3/0.0>0.0	COSV55371846	NBN|0.03|0.01|0.00|0.00|-25|-7|-31|-1	25741868,24033266,20004634,19523210,24396275	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89955483	89955483	A	G	het		QUAL=24;DP=37;QD=0.65	NBN	synonymous	NBN:ENST00000697292.1:synonymous_variant:LOW:exon10/17:c.1197T>C:p.Asp399=:,NBN:ENST00000697293.1:synonymous_variant:LOW:exon10/17:c.1197T>C:p.Asp399=:,NBN:ENST00000517337.2:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:ENST00000697298.1:synonymous_variant:LOW:exon12/18:c.951T>C:p.Asp317=:,NBN:ENST00000697299.1:synonymous_variant:LOW:exon9/15:c.951T>C:p.Asp317=:,NBN:ENST00000697304.1:synonymous_variant:LOW:exon8/14:c.885T>C:p.Asp295=:,NBN:ENST00000697307.1:synonymous_variant:LOW:exon10/14:c.1197T>C:p.Asp399=:,NBN:ENST00000697308.1:synonymous_variant:LOW:exon10/15:c.1197T>C:p.Asp399=:,NBN:ENST00000265433.8:synonymous_variant:LOW:exon10/16:c.1197T>C:p.Asp399=:,NBN:ENST00000523444.2:synonymous_variant:LOW:exon11/17:c.951T>C:p.Asp317=:,NBN:ENST00000409330.5:synonymous_variant:LOW:exon10/16:c.951T>C:p.Asp317=:,NBN:ENST00000697309.1:synonymous_variant:LOW:exon10/15:c.1197T>C:p.Asp399=:,NBN:ENST00000697310.1:synonymous_variant:LOW:exon10/17:c.1197T>C:p.Asp399=:		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	183701 [benign DISEASE=not specified,Microcephaly, normal intelligence and immunodeficiency,Hereditary cancer-predisposing syndrome,Hereditary breast ovarian cancer syndrome,not provided,Acute lymphoid leukemia GENE=NBN];			rs709816	0.50940	0.76833,0.52216,0.64864,0.36097,0.52389	22042,	33251	74481	-0.0610	0.77			/0.0>0.0/0.0>0.0	COSV55371961	NBN|0.00|0.00|0.01|0.00|-9|-46|-46|2	25741868,24033266,20003265,20386703,19276285,32461785,16091150,21987080,16620382,19523210,20478923,20571895,22933979,25542228,28610420,29416357,35164849,24166361,30799775,28356832,35637613,36139526,26045716,26064273,30272267,36976737,28647780,26101473,25176580,22864661,27936167,19917125,24396275,28288557,25755792	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89955634	89955634	G	T	het	off-target	QUAL=24;DP=51;QD=0.47	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron9/16:c.1125-79C>A::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron9/16:c.1125-79C>A::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron10/16:c.879-79C>A::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron11/17:c.879-79C>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron8/14:c.879-79C>A::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron7/13:c.813-79C>A::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron9/13:c.1125-79C>A::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron9/14:c.1125-79C>A::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron9/15:c.1125-79C>A::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron10/16:c.879-79C>A::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron9/15:c.879-79C>A::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron9/14:c.1125-79C>A::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron9/16:c.1125-79C>A::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	1239473 [benign DISEASE=not specified,not provided GENE=NBN];			rs1805786	0.33077	0.30682,0.35052,0.45166,0.32207,0.43745	8373,	33487	101635	0.6450	5.62			/0.0>0.0/0.0>0.0	COSV55376816	NBN|0.00|0.00|0.00|0.00|-31|17|47|8	19276285,19523210	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89958634	89958634	G	T	het	off-target	QUAL=24;DP=31;QD=0.77	NBN	intron	NBN:ENST00000697292.1:intron_variant:MODIFIER:intron9/16:c.1124+91C>A::,NBN:ENST00000697293.1:intron_variant:MODIFIER:intron9/16:c.1124+91C>A::,NBN:ENST00000517337.2:intron_variant:MODIFIER:intron10/16:c.878+91C>A::,NBN:ENST00000697298.1:intron_variant:MODIFIER:intron11/17:c.878+91C>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron8/14:c.878+91C>A::,NBN:ENST00000697304.1:intron_variant:MODIFIER:intron7/13:c.812+91C>A::,NBN:ENST00000697307.1:intron_variant:MODIFIER:intron9/13:c.1124+91C>A::,NBN:ENST00000697308.1:intron_variant:MODIFIER:intron9/14:c.1124+91C>A::,NBN:ENST00000265433.8:intron_variant:MODIFIER:intron9/15:c.1124+91C>A::,NBN:ENST00000523444.2:intron_variant:MODIFIER:intron10/16:c.878+91C>A::,NBN:ENST00000409330.5:intron_variant:MODIFIER:intron9/15:c.878+91C>A::,NBN:ENST00000697309.1:intron_variant:MODIFIER:intron9/14:c.1124+91C>A::,NBN:ENST00000697310.1:intron_variant:MODIFIER:intron9/16:c.1124+91C>A::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	1177038 [benign DISEASE=not provided,not specified,Microcephaly, normal intelligence and immunodeficiency GENE=NBN];			rs1805818	0.33051	0.30670,0.35044,0.45132,0.32200,0.43677	8375,	33485	101757	0.1280	2.24			/0.0>0.0/0.0>0.0	COSV55373610	NBN|0.00|0.00|0.00|0.00|-2|7|8|7	20004634,19523210,24396275	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89958707	89958707	G	A	het	off-target	QUAL=24;DP=48;QD=0.50	NBN	splice_region&intron	NBN:ENST00000697292.1:splice_region_variant&intron_variant:LOW:intron9/16:c.1124+18C>T::,NBN:ENST00000697293.1:splice_region_variant&intron_variant:LOW:intron9/16:c.1124+18C>T::,NBN:ENST00000517337.2:splice_region_variant&intron_variant:LOW:intron10/16:c.878+18C>T::,NBN:ENST00000697298.1:splice_region_variant&intron_variant:LOW:intron11/17:c.878+18C>T::,NBN:ENST00000697299.1:splice_region_variant&intron_variant:LOW:intron8/14:c.878+18C>T::,NBN:ENST00000697304.1:splice_region_variant&intron_variant:LOW:intron7/13:c.812+18C>T::,NBN:ENST00000697307.1:splice_region_variant&intron_variant:LOW:intron9/13:c.1124+18C>T::,NBN:ENST00000697308.1:splice_region_variant&intron_variant:LOW:intron9/14:c.1124+18C>T::,NBN:ENST00000265433.8:splice_region_variant&intron_variant:LOW:intron9/15:c.1124+18C>T::,NBN:ENST00000523444.2:splice_region_variant&intron_variant:LOW:intron10/16:c.878+18C>T::,NBN:ENST00000409330.5:splice_region_variant&intron_variant:LOW:intron9/15:c.878+18C>T::,NBN:ENST00000697309.1:splice_region_variant&intron_variant:LOW:intron9/14:c.1124+18C>T::,NBN:ENST00000697310.1:splice_region_variant&intron_variant:LOW:intron9/16:c.1124+18C>T::		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	199080 [benign DISEASE=Microcephaly, normal intelligence and immunodeficiency,not specified,Hereditary breast ovarian cancer syndrome,not provided,Acute lymphoid leukemia GENE=NBN];			rs2234744	0.30824	0.23020,0.34114,0.45114,0.32164,0.43750	7476,	31914	105180	-0.3950	1.19			/0.0>0.0/0.0>0.0	COSV55373621	NBN|0.00|0.00|0.00|0.00|39|18|18|-1	25741868,19276285,20004634,19523210,27936167,19917125,24396275	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89978251	89978251	C	G	het		QUAL=24;DP=828;QD=0.03	NBN	missense	NBN:ENST00000697292.1:missense_variant:MODERATE:exon5/17:c.553G>C:p.Glu185Gln:,NBN:ENST00000697293.1:missense_variant:MODERATE:exon5/17:c.553G>C:p.Glu185Gln:,NBN:ENST00000517337.2:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:ENST00000697298.1:missense_variant:MODERATE:exon7/18:c.307G>C:p.Glu103Gln:,NBN:ENST00000697299.1:missense_variant:MODERATE:exon4/15:c.307G>C:p.Glu103Gln:,NBN:ENST00000697304.1:missense_variant:MODERATE:exon5/14:c.553G>C:p.Glu185Gln:,NBN:ENST00000697307.1:missense_variant:MODERATE:exon5/14:c.553G>C:p.Glu185Gln:,NBN:ENST00000697308.1:missense_variant:MODERATE:exon5/15:c.553G>C:p.Glu185Gln:,NBN:ENST00000265433.8:missense_variant:MODERATE:exon5/16:c.553G>C:p.Glu185Gln:,NBN:ENST00000523444.2:missense_variant:MODERATE:exon6/17:c.307G>C:p.Glu103Gln:,NBN:ENST00000409330.5:missense_variant:MODERATE:exon5/16:c.307G>C:p.Glu103Gln:,NBN:ENST00000697309.1:missense_variant:MODERATE:exon5/15:c.553G>C:p.Glu185Gln:,NBN:ENST00000697310.1:missense_variant:MODERATE:exon5/17:c.553G>C:p.Glu185Gln:	regulatory_region_variant:open_chromatin_region	602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	134876 [benign DISEASE=Acute lymphoid leukemia,Hereditary cancer-predisposing syndrome,Hereditary breast ovarian cancer syndrome,not specified,Microcephaly, normal intelligence and immunodeficiency,not provided GENE=NBN];	CM034886 [CLASS=DP MUT=ALT PHEN="Lung cancer association with" GENE=NBN];		rs1805794	0.31046	0.23736,0.34194,0.45163,0.32193,0.43716	7545,	32098	104808	2.2150	13.66	0.103	0.06	/0.0>0.0/2.2>0.4	COSV55371261,COSV55372457,COSV55375647	NBN|0.00|0.00|0.00|0.00|2|33|-33|-31	25741868,24033266,20734064,24728327,34711928,28827732,32728337,23284679,18191955,26514363,16465622,16857995,18701435,19109789,19124499,20150366,21129811,21700777,23720673,31584889,20386703,18830263,29458332,32957448,19276285,24062231,22300735,31374908,18579371,18768505,23719583,20805886,19584272,21927616,35312585,19706757,29732392,32014908,18638378,25178586,19367277,29963112,33800431,21647442,20004634,19523210,20478923,20571895,22933979,25542228,28610420,29416357,35164849,19393077,24166361,30799775,24113799,26998278,12917199,21166880,21656575,22413803,22430443,23283743,23381647,23979977,25073514,26493193,27845421,28356832,28476809,29433451,32234891,35207542,24382701,24093751,35637613,28345844,34295994,32778093,36632296,36139526,28402931,26622786,21908578,30197789,26064273,20975951,21864546,22631660,26974709,35639187,26622944,22070649,34990726,24594932,26101473,25176580,21215087,22864661,27936167,19917125,24396275,34926254,18394656,22313875,17991492,22245109,15921821,19022265	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	89982791	89982791	C	T	het		QUAL=24;DP=19;QD=1.26	NBN	synonymous,5'UTR,intron	NBN:ENST00000697292.1:synonymous_variant:LOW:exon2/17:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697293.1:synonymous_variant:LOW:exon2/17:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000517337.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:ENST00000697298.1:5_prime_UTR_variant:MODIFIER:exon3/18:c.-195G>A::,NBN:ENST00000697299.1:intron_variant:MODIFIER:intron1/14:c.-75-1268G>A::,NBN:ENST00000697304.1:synonymous_variant:LOW:exon2/14:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697307.1:synonymous_variant:LOW:exon2/14:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697308.1:synonymous_variant:LOW:exon2/15:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000265433.8:synonymous_variant:LOW:exon2/16:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000523444.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-195G>A::,NBN:ENST00000409330.5:5_prime_UTR_variant:MODIFIER:exon2/16:c.-145G>A::,NBN:ENST00000697309.1:synonymous_variant:LOW:exon2/15:c.102G>A:p.Leu34=:PF00498 [FHA domain],NBN:ENST00000697310.1:synonymous_variant:LOW:exon2/17:c.102G>A:p.Leu34=:PF00498 [FHA domain]		602667_[GENE=NBN_PHENOS=Leukemia, acute lymphoblastic, 613065 (3); Aplastic anemia, 609135 (3); Nijmegen breakage syndrome, 251260 (3), Autosomal recessive]	183697 [benign DISEASE=not specified,Hereditary breast ovarian cancer syndrome,Acute lymphoid leukemia,Microcephaly, normal intelligence and immunodeficiency,not provided,Hereditary cancer-predisposing syndrome GENE=NBN];			rs1063045	0.33277	0.31374,0.35185,0.45108,0.32199,0.43742	8479,	33623	101417	-0.1370	3.08			/0.0>0.0/0.0>0.0	COSV55371979	NBN|0.00|0.00|0.00|0.00|-16|18|34|-38	25741868,24033266,20386703,19276285,21987080,20004634,17496786,19523210,20478923,19393077,30799775,26402912,22841127,35637613,24645271,18059179,22864661,27936167,19917125,24396275,15921821,18612309,17001621,18023021	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NBN (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.74)
chr8	106223973	106223973	A	C	hom	off-target	QUAL=24;DP=15;QD=1.60		intergenic	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393979	0.62246	0.33056,0.65391,0.84134,0.73295,0.84647	32110,	30439	57413	-0.9390	3.01							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr8	106224052	106224052	G	T	hom		QUAL=19;DP=650;QD=0.03		intergenic	::intergenic_variant:MODIFIER::::					LTR33 (LTR/ERVL)	rs1393978	0.56186	0.27517,0.61654,0.83813,0.65945,0.82342	26593,	32189	66577	-0.5960	0.84							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	5919543	5919543	-	AC	het	off-target	QUAL=24;DP=47;QD=0.51	BRD10	3'UTR	BRD10:ENST00000381461.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*139_*140dup::,BRD10:ENST00000399933.8:3_prime_UTR_variant:MODIFIER:exon8/8:c.*139_*140dup::						rs375745414	0.08653	0.06445,0.09121,0.01242,0.09672,0.07969	494,	10079	116835		6.31			/2.9>2.9/0.0>0.0		KIAA2026|0.00|0.00|0.00|0.00|8|-21|17|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRD10 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)
chr9	5921881	5921881	G	A	het		QUAL=24;DP=427;QD=0.06	BRD10	missense	BRD10:ENST00000381461.6:missense_variant:MODERATE:exon7/7:c.4025C>T:p.Thr1342Ile:,BRD10:ENST00000399933.8:missense_variant:MODERATE:exon8/8:c.4115C>T:p.Thr1372Ile:			3235661 [uncertain significance DISEASE=not specified GENE=BRD10];			rs72697396	0.00003	0.00000,0.00000,0.00000,0.00006,0.00000	0,	4	152296	2.5130	11.53	0.027	0.11	/2.8>3.2/0.0>0.0		KIAA2026|0.00|0.00|0.00|0.00|-6|39|2|-23		0	34	0	0 / 5					BRD10 (inh=n/a oe_syn=1.46 oe_mis=1.38 oe_lof=0.22)
chr9	17235645	17235645	T	-	het	off-target	QUAL=25;DP=40;QD=0.63	CNTLN	splice_region&intron	CNTLN:ENST00000380641.4:splice_region_variant&intron_variant:LOW:intron3/6:c.535-7del::,CNTLN:ENST00000380647.8:splice_region_variant&intron_variant:LOW:intron3/25:c.535-7del::						rs67017076	0.81743	0.95350,0.86110,0.99864,0.73348,0.93382	51904,	20500	27764	1.4780	7.38			/9.7>8.6/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|16|-8|18|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273880	17273880	A	G	het		QUAL=24;DP=66;QD=0.36	CNTLN	splice_region&intron	CNTLN:ENST00000380641.4:splice_region_variant&intron_variant:LOW:intron6/6:c.983+14A>G::,CNTLN:ENST00000380647.8:splice_region_variant&intron_variant:LOW:intron6/25:c.983+14A>G::						rs12376938	0.23516	0.17317,0.23894,0.08375,0.26649,0.36258	4466,	26813	116261	-1.4110	0.14			/0.0>0.0/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|-13|-36|-15|-14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17273928	17273928	C	G	het	off-target	QUAL=24;DP=16;QD=1.50	CNTLN	intron	CNTLN:ENST00000380641.4:intron_variant:MODIFIER:intron6/6:c.983+62C>G::,CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron6/25:c.983+62C>G::						rs12379655	0.29355	0.32134,0.27710,0.33366,0.27169,0.41438	6604,	31343	107215	-2.0210	0.02			/0.0>0.0/0.0>0.0	COSV52090650,COSV52097738	CNTLN|0.00|0.00|0.00|0.00|29|8|1|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17298549	17298549	C	G	het	off-target	QUAL=24;DP=7;QD=3.43	CNTLN	3'UTR,intron	CNTLN:ENST00000380641.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*167C>G::,CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron7/25:c.1146+197C>G::						rs3739490	0.25018	0.23067,0.24138,0.08330,0.26410,0.36107	4888,	28222	113882	-1.2110	0.22			/3.1>2.8/0.0>5.4				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17308971	17308972	TG	-	hom	off-target	QUAL=24;DP=379;QD=0.06	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron7/25:c.1147-86_1147-85del::					L2d2 (LINE/L2)	rs66758062	0.79203	0.64501,0.81503,0.81425,0.86088,0.71619	48078,	23529	31427	0.2650	0.68			/0.0>0.0/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|-46|28|-27|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17330560	17330560	T	A	het	off-target	QUAL=24;DP=22;QD=1.09	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron8/25:c.1342-72T>A::						rs3765040	0.59373	0.56620,0.59819,0.72847,0.61227,0.34919	27041,	36066	61686	-0.0680	0.51			/0.0>0.0/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|46|40|-39|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17332487	17332487	T	-	het	off-target	QUAL=27;DP=47;QD=0.57	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron9/25:c.1519-105del::	regulatory_region_variant:enhancer					rs3084508	0.23767	0.19727,0.23397,0.08602,0.25871,0.36842	4337,	26946	114252	0.7440	10.43			/9.0>9.0/0.0>0.0	COSV52096250	CNTLN|0.00|0.00|0.00|0.00|30|41|-39|24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17332487	17332488	TT	-	het	off-target	QUAL=27;DP=47;QD=0.57	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron9/25:c.1519-106_1519-105del::	regulatory_region_variant:enhancer					rs3084508	0.59163	0.56367,0.59813,0.72659,0.61093,0.34779	26315,	36068	61224	1.0530	12.95			/9.0>9.0/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|30|-1|-15|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17342385	17342385	C	T	hom		QUAL=24;DP=30;QD=0.80	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon12/26:c.1827C>T:p.Asp609=:						rs1442527	0.95655	0.84891,0.98405,1.00000,0.99941,0.99876	69951,	5671	6613	2.1420	4.31			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394449	17394449	T	-	hom	off-target	QUAL=25;DP=2;QD=12.50	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron14/25:c.2080-81del::	regulatory_region_variant:enhancer											0.1480				/3.0>2.3/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|42|-37|-42|-37		0	0	0	0 / 0					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394459	17394459	A	G	het	off-target	QUAL=21;DP=2;QD=10.50	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron14/25:c.2080-75A>G::	regulatory_region_variant:enhancer					rs72705794	0.02450	0.00515,0.02157,0.00019,0.03352,0.00601	63,	3606	148576	2.1820	10.11			/3.0>2.2/1.6>9.8		CNTLN|0.00|0.00|0.00|0.00|28|31|-1|-48		38	647	0	2 / 101					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394467	17394467	G	A	hom	off-target	QUAL=25;DP=2;QD=12.50	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron14/25:c.2080-67G>A::	regulatory_region_variant:enhancer					rs7035357	0.81791	0.70517,0.82890,0.81832,0.87432,0.73807	51362,	21712	27704	2.7480	14.36			/0.0>0.0/0.0>0.0	COSV52068764	CNTLN|0.00|0.00|0.00|0.00|48|1|-49|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394538	17394538	C	T	hom		QUAL=25;DP=41;QD=0.61	CNTLN	missense	CNTLN:ENST00000380647.8:missense_variant:MODERATE:exon15/26:c.2084C>T:p.Thr695Ile:	regulatory_region_variant:enhancer					rs7035276	0.81788	0.70514,0.82857,0.81857,0.87426,0.73845	51333,	21722	27698	0.3660	12.83	0.063		/0.0>0.0/0.0>1.8	COSV52066811	CNTLN|0.00|0.00|0.00|0.00|5|-4|-4|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17394998	17394998	T	C	hom		QUAL=24;DP=67;QD=0.36	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon15/26:c.2544T>C:p.His848=:	regulatory_region_variant:enhancer					rs3739489	0.87050	0.78301,0.86438,0.82143,0.91644,0.86955	57950,	16561	19705	0.5350	5.45			/5.4>4.6/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|-49|10|9|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17395110	17395110	C	T	hom	off-target;low_conf_region	QUAL=24;DP=145;QD=0.17	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron15/25:c.2615+41C>T::	regulatory_region_variant:enhancer					rs3739488	0.81811	0.70558,0.82905,0.81820,0.87431,0.74056	51383,	21685	27669	3.8150	16.01			/0.0>0.3/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|5|-19|-41|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17409193	17409193	A	G	het	off-target	QUAL=24;DP=9;QD=2.67	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron15/25:c.2616-100A>G::						rs62559023	0.00286	0.00065,0.00373,0.00019,0.00423,0.00435	1,	434	151892	0.0590	0.60			/0.0>0.0/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|41|50|-1|-8		2	333	0	1 / 57					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17409368	17409368	G	A	hom		QUAL=24;DP=384;QD=0.06	CNTLN	synonymous	CNTLN:ENST00000380647.8:synonymous_variant:LOW:exon16/26:c.2691G>A:p.Thr897=:						rs2780211	0.86785	0.78368,0.85895,0.82092,0.91447,0.84552	57561,	16879	20101	0.6420	7.57			/0.0>0.0/0.0>0.0	COSV52096895			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17457515	17457515	A	-	hom	low_conf_region	QUAL=24;DP=4;QD=6.00	CNTLN	splice_acceptor&inframe_deletion	CNTLN:ENST00000380647.8:splice_acceptor_variant&inframe_deletion:HIGH:intron18/25:c.3115-2del:p.?:					(TATATT)n (Simple_repeat)	rs35399020	0.79561	0.59048,0.79627,0.67244,0.90444,0.77273	49354,	21411	30859	0.1530	3.08			/1.0>1.8/0.0>0.0	COSV52086669			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17457856	17457856	A	G	hom	off-target	QUAL=24;DP=233;QD=0.10	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron19/25:c.3306+141A>G::						rs2197152	0.69273	0.56832,0.64844,0.92758,0.74632,0.69394	37192,	30760	46638	-0.7660	0.49			/6.2>6.3/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|12|-1|30|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17464404	17464404	G	C	hom	off-target	QUAL=25;DP=316;QD=0.08	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron20/25:c.3405-93G>C::						rs1442532	0.96678	0.90488,0.97728,0.92016,0.99923,0.95651	70708,	4545	5015	0.0040	1.94			/0.0>0.4/1.9>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494735	17494735	C	T	het	off-target	QUAL=24;DP=58;QD=0.41	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4119+7669C>T::					Tigger3b (DNA/TcMar-Tigger)	rs7861498	0.35951	0.30207,0.45593,0.52345,0.36316,0.31432	10120,	34385	97317	-0.6620	2.23			/0.0>0.0/0.0>0.0	COSV52071433	CNTLN|0.00|0.00|0.00|0.00|50|-23|-24|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	17494877	17494878	TT	-	hom	off-target;low_conf_region	QUAL=13;DP=72;QD=0.18	CNTLN	intron	CNTLN:ENST00000380647.8:intron_variant:MODIFIER:intron25/25:c.4120-7654_4120-7653del::					Tigger3b (DNA/TcMar-Tigger), AluSx (SINE/Alu)	rs35224903	0.05801	0.03485,0.06396,0.01622,0.06696,0.01154	40,	3556	59046	0.1770	0.37			/0.0>0.0/0.0>0.0		CNTLN|0.00|0.00|0.00|0.00|33|31|24|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNTLN (inh=n/a oe_syn=1.29 oe_mis=1.26 oe_lof=0.98)
chr9	21975018	21975018	C	T	hom	off-target	QUAL=23;DP=31;QD=0.74	CDKN2A	intron,upstream_gene	CDKN2A:ENST00000579755.2:intron_variant:MODIFIER:intron1/2:c.194-3810G>A::,CDKN2A:ENST00000530628.2:intron_variant:MODIFIER:intron1/2:c.194-3810G>A::,CDKN2A:ENST00000498628.6:intron_variant:MODIFIER:intron1/2:c.-3-3810G>A::,CDKN2A:ENST00000494262.5:intron_variant:MODIFIER:intron2/3:c.-3-3810G>A::,CDKN2A:ENST00000304494.10:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000579122.1:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000578845.2:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000498124.1:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000479692.2:upstream_gene_variant:MODIFIER::::,CDKN2A:ENST00000497750.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	600160_[GENE=CDKN2A_PHENOS={Melanoma and neural system tumor syndrome}, 155755 (3), Autosomal dominant; {Melanoma, cutaneous malignant, 2}, 155601 (3), Autosomal dominant; {Melanoma-pancreatic cancer syndrome}, 606719 (3), Autosomal dominant]	873184 [benign DISEASE=not provided,Squamous cell lung carcinoma GENE=CDKN2A];			rs3814960	0.50314	0.23247,0.47574,0.64811,0.62595,0.61676	21585,	33352	75566	-0.1700	5.94			/0.0>3.7/0.0>0.0	COSV58720858	CDKN2A|0.00|0.00|0.00|0.00|-2|-39|-2|-20,RP11-145E5.5|0.00|0.00|0.00|0.00|46|-12|0|21	27055116,18761660,20386740,25280564,21355081,27414035,20381282	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDKN2A (inh=AD oe_syn=1.09 oe_mis=1.28 oe_lof=0.20)
chr9	35074920	35074920	T	C	hom		QUAL=25;DP=64;QD=0.39	FANCG,VCP	splice_region&intron,upstream_gene	FANCG:ENST00000378643.8:splice_region_variant&intron_variant:LOW:intron12/13:c.1636+7A>G::,FANCG:ENST00000448890.2:splice_region_variant&intron_variant:LOW:intron13/14:c.1636+7A>G::,FANCG:ENST00000696710.1:splice_region_variant&intron_variant:LOW:intron12/13:c.1630+7A>G::,FANCG:ENST00000696715.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1636+7A>G::,VCP:ENST00000679902.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000678650.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000677257.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000358901.11:upstream_gene_variant:MODIFIER::::,VCP:ENST00000448530.6:upstream_gene_variant:MODIFIER::::,VCP:ENST00000679647.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000681335.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000417448.2:upstream_gene_variant:MODIFIER::::,VCP:ENST00000679862.1:upstream_gene_variant:MODIFIER::::		601023_[GENE=VCP_PHENOS=Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant]&602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive]	259477 [benign DISEASE=not specified,Fanconi anemia complementation group G,Inclusion Body Myopathy, Dominant,Amyotrophic Lateral Sclerosis, Dominant,Fanconi anemia,not provided GENE=FANCG];	CS2129783 [CLASS=DM? MUT=ALT PHEN="Fanconi anaemia" GENE=FANCG];		rs587118	0.35236	0.09089,0.45780,0.00540,0.49662,0.23487	12186,	29231	98525	0.4790	9.78			/0.0>0.0/0.0>0.0	COSV62719986	FANCG|0.02|0.00|0.00|0.07|23|45|1|7	25741868,32888493,17618707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=AR oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	35077444	35077444	T	C	hom	off-target	QUAL=24;DP=150;QD=0.16	FANCG,VCP	intron,upstream_gene	FANCG:ENST00000378643.8:intron_variant:MODIFIER:intron4/13:c.511-45A>G::,FANCG:ENST00000448890.2:intron_variant:MODIFIER:intron5/14:c.511-45A>G::,FANCG:ENST00000696710.1:intron_variant:MODIFIER:intron4/13:c.511-45A>G::,FANCG:ENST00000696715.1:intron_variant:MODIFIER:intron4/12:c.511-45A>G::,VCP:ENST00000679902.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000678650.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000677257.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000358901.11:upstream_gene_variant:MODIFIER::::,VCP:ENST00000448530.6:upstream_gene_variant:MODIFIER::::,VCP:ENST00000679647.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000681335.1:upstream_gene_variant:MODIFIER::::,VCP:ENST00000679862.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	601023_[GENE=VCP_PHENOS=Frontotemporal dementia and/or amyotrophic lateral sclerosis 6, 613954 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2Y, 616687 (3), Autosomal dominant; Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3), Autosomal dominant]&602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive]	259478 [benign DISEASE=not specified,Fanconi anemia complementation group G,not provided GENE=FANCG];			rs554098	0.75266	0.74033,0.79474,0.46103,0.77975,0.70721	43341,	27628	37564	-1.4080	0.71			/0.0>0.0/0.0>1.5	COSV62719498	FANCG|0.01|0.00|0.00|0.00|-12|-47|35|-4	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VCP (inh=AD oe_syn=1.12 oe_mis=0.28 oe_lof=0.03), FANCG (inh=AR oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	35079364	35079364	G	T	hom	off-target	QUAL=19;DP=176;QD=0.11	FANCG	intron	FANCG:ENST00000378643.8:intron_variant:MODIFIER:intron1/13:c.84+77C>A::,FANCG:ENST00000448890.2:intron_variant:MODIFIER:intron2/14:c.84+77C>A::,FANCG:ENST00000696710.1:intron_variant:MODIFIER:intron1/13:c.84+77C>A::,FANCG:ENST00000696715.1:intron_variant:MODIFIER:intron1/12:c.84+77C>A::	regulatory_region_variant:promoter	602956_[GENE=FANCG_PHENOS=Fanconi anemia, complementation group G, 614082 (3), Autosomal recessive]	1177024 [benign DISEASE=not provided,Fanconi anemia complementation group G GENE=FANCG];			rs504082	0.54515	0.27394,0.65723,0.08346,0.70675,0.47618	25883,	31155	69187	-0.0480	5.71			/0.0>5.6/0.0>0.0	COSV66213684	FANCG|0.04|0.00|0.00|0.00|-2|44|-2|24	32888493,32888494,17618707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCG (inh=AR oe_syn=1.00 oe_mis=0.96 oe_lof=0.78)
chr9	87447908	87447908	A	G	hom		QUAL=24;DP=530;QD=0.05		intergenic	::intergenic_variant:MODIFIER::::						rs12682834	0.59616	0.48384,0.64239,0.70559,0.62928,0.74668	27523,	35597	61403	-0.5610	0.38						19956101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr9	95447312	95447312	G	A	het		QUAL=24;DP=71;QD=0.34	PTCH1	missense	PTCH1:ENST00000331920.11:missense_variant:MODERATE:exon23/24:c.3944C>T:p.Pro1315Leu:,PTCH1:ENST00000437951.6:missense_variant:MODERATE:exon23/24:c.3941C>T:p.Pro1314Leu:,PTCH1:ENST00000711046.1:missense_variant:MODERATE:exon23/24:c.3746C>T:p.Pro1249Leu:,PTCH1:ENST00000430669.6:missense_variant:MODERATE:exon23/23:c.3746C>T:p.Pro1249Leu:,PTCH1:ENST00000692981.1:missense_variant:MODERATE:exon22/23:c.3491C>T:p.Pro1164Leu:,PTCH1:ENST00000429896.6:missense_variant:MODERATE:exon23/24:c.3491C>T:p.Pro1164Leu:	regulatory_region_variant:enhancer	601309_[GENE=PTCH1_PHENOS=Basal cell nevus syndrome 1, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant]	41663 [benign DISEASE=Holoprosencephaly 7,Hereditary cancer-predisposing syndrome,Basal cell nevus syndrome 1,Gorlin syndrome,not provided,not specified GENE=PTCH1];			rs357564	0.32983	0.23208,0.38746,0.56319,0.33662,0.47175	8748,	32662	101914	9.5400	25.40	0.443	0.13	/7.9>7.5/0.0>0.0	COSV59463357	PTCH1|0.00|0.00|0.00|0.00|-16|-7|2|16	25741868,24033266,24728327,23757202,19937600,22703879,26893459,21811255,20583170,34944636,34021172,30214282,30334169,31209431,24073265,20346027,22221699,27825128,22677152,31204176,24260604,33298892,23826113,31669095,36870116,18059179,27591082,35047024,27081528,29498494,35361970	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95469942	95469942	A	-	het		QUAL=24;DP=106;QD=0.23	PTCH1	splice_region&intron	PTCH1:ENST00000331920.11:splice_region_variant&intron_variant:LOW:intron12/23:c.1729-11del::,PTCH1:ENST00000437951.6:splice_region_variant&intron_variant:LOW:intron12/23:c.1726-11del::,PTCH1:ENST00000711046.1:splice_region_variant&intron_variant:LOW:intron12/23:c.1531-11del::,PTCH1:ENST00000430669.6:splice_region_variant&intron_variant:LOW:intron12/22:c.1531-11del::,PTCH1:ENST00000692981.1:splice_region_variant&intron_variant:LOW:intron11/22:c.1276-11del::,PTCH1:ENST00000429896.6:splice_region_variant&intron_variant:LOW:intron12/23:c.1276-11del::		601309_[GENE=PTCH1_PHENOS=Basal cell nevus syndrome 1, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant]	1290901 [benign/likely benign DISEASE=Gorlin syndrome,not provided,Hereditary cancer-predisposing syndrome GENE=PTCH1];			rs779000277	0.00079	0.00017,0.00059,0.00000,0.00146,0.00000	0,	120	151994	0.9180	0.25			/8.7>8.0/0.0>0.0	COSV59495096	PTCH1|0.00|0.00|0.00|0.00|49|-14|25|-14		0	93	4	0 / 17					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr9	95476908	95476908	G	C	hom	off-target	QUAL=24;DP=42;QD=0.57	PTCH1	intron,downstream_gene	PTCH1:ENST00000331920.11:intron_variant:MODIFIER:intron10/23:c.1504-51C>G::,PTCH1:ENST00000437951.6:intron_variant:MODIFIER:intron10/23:c.1501-51C>G::,PTCH1:ENST00000711046.1:intron_variant:MODIFIER:intron10/23:c.1306-51C>G::,PTCH1:ENST00000430669.6:intron_variant:MODIFIER:intron10/22:c.1306-51C>G::,PTCH1:ENST00000692981.1:intron_variant:MODIFIER:intron9/22:c.1051-51C>G::,PTCH1:ENST00000429896.6:intron_variant:MODIFIER:intron10/23:c.1051-51C>G::,PTCH1:ENST00000468211.6:downstream_gene_variant:MODIFIER::::		601309_[GENE=PTCH1_PHENOS=Basal cell nevus syndrome 1, 109400 (3), Autosomal dominant; Basal cell carcinoma, somatic, 605462 (3); Holoprosencephaly 7, 610828 (3), Autosomal dominant]	1280181 [benign DISEASE=not provided GENE=PTCH1];			rs574688	0.19542	0.05268,0.24333,0.08629,0.26413,0.28020	3669,	22402	122446	0.2170	3.10			/0.0>0.0/0.0>0.0	COSV100107392	PTCH1|0.00|0.00|0.01|0.00|1|-18|38|-46	34021172,29498494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH1 (inh=AD oe_syn=1.25 oe_mis=0.84 oe_lof=0.02)
chr10	43100333	43100333	G	T	hom	off-target	QUAL=23;DP=10;QD=2.30	RET	intron	RET:ENST00000713926.1:intron_variant:MODIFIER:intron1/18:c.74-126G>T::,RET:ENST00000638465.2:intron_variant:MODIFIER:intron1/2:c.74-126G>T::,RET:ENST00000640619.2:intron_variant:MODIFIER:intron1/2:c.74-126G>T::,RET:ENST00000683278.2:intron_variant:MODIFIER:intron1/2:c.74-126G>T::,RET:ENST00000684216.2:intron_variant:MODIFIER:intron1/2:c.74-126G>T::,RET:ENST00000340058.6:intron_variant:MODIFIER:intron1/18:c.74-126G>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron1/19:c.74-126G>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron1/16:c.74-126G>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	677050 [benign DISEASE=Multiple endocrine neoplasia, type 2,not provided GENE=RET];	CS045982 [CLASS=DP MUT=ALT PHEN="Thyroid cancer association with" GENE=RET];		rs2565206	0.38150	0.58974,0.32066,0.11176,0.32994,0.19788	12401,	33052	93796	-0.0150	1.27			/6.6>6.7/0.0>0.0		RET|0.00|0.00|0.00|0.00|8|-49|-33|-7	23820649,34950210,22312249,32228166,23059849,20860806,21995290,32411094,22584707,16816022,28930629,37835559	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43100389	43100389	T	-	het	off-target	QUAL=24;DP=48;QD=0.50	RET	intron	RET:ENST00000713926.1:intron_variant:MODIFIER:intron1/18:c.74-57del::,RET:ENST00000638465.2:intron_variant:MODIFIER:intron1/2:c.74-57del::,RET:ENST00000640619.2:intron_variant:MODIFIER:intron1/2:c.74-57del::,RET:ENST00000683278.2:intron_variant:MODIFIER:intron1/2:c.74-57del::,RET:ENST00000684216.2:intron_variant:MODIFIER:intron1/2:c.74-57del::,RET:ENST00000340058.6:intron_variant:MODIFIER:intron1/18:c.74-57del::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron1/19:c.74-57del::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron1/16:c.74-57del::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1258537 [benign DISEASE=not provided GENE=RET];			rs57003029	0.25165	0.25689,0.23947,0.11707,0.27482,0.12130	4411,	28228	110180	-0.5180	0.22			/0.0>0.0/0.0>0.0		RET|0.00|0.00|0.00|0.00|25|28|-21|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43100520	43100520	A	G	hom		QUAL=24;DP=351;QD=0.07	RET	synonymous	RET:ENST00000713926.1:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000638465.2:synonymous_variant:LOW:exon2/3:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000640619.2:synonymous_variant:LOW:exon2/3:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000683278.2:synonymous_variant:LOW:exon2/3:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000684216.2:synonymous_variant:LOW:exon2/3:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000340058.6:synonymous_variant:LOW:exon2/19:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000355710.8:synonymous_variant:LOW:exon2/20:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1],RET:ENST00000615310.5:synonymous_variant:LOW:exon2/17:c.135A>G:p.Ala45=:PF17756 [RET Cadherin like domain 1]		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	167589 [benign DISEASE=not provided,Pheochromocytoma,Multiple endocrine neoplasia, type 2,Multiple endocrine neoplasia type 2A,Hirschsprung disease, susceptibility to, 1,Multiple endocrine neoplasia type 2B,not specified GENE=RET];			rs1800858	0.78528	0.94915,0.75648,0.54854,0.74228,0.70835	47935,	23565	32657	-2.1930	0.02			/0.2>0.4/0.0>0.0	COSV60686024	RET|0.00|0.00|0.00|0.00|-2|-36|17|4	30409984,17267408,32708070,20532249,34950210,19138047,18091754,15759212,22312249,24897126,29131865,8001158,10090908,10521317,10528857,10922382,11950855,16091499,18284634,20123584,20454948,21349203,23059849,23084198,23527089,26102504,31644668,34981673,35359901,22648184,32364585,23840513,37189693,24651702,26191299,30072953,33827484,32411094,27174043,16443855,22584707,35078996,28930629,18436345,23441071,37835559,37490568	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43106301	43106301	T	C	hom	off-target	QUAL=24;DP=56;QD=0.43	RET	intron,downstream_gene	RET:ENST00000713926.1:intron_variant:MODIFIER:intron4/18:c.739-75T>C::,RET:ENST00000340058.6:intron_variant:MODIFIER:intron4/18:c.868-75T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron4/19:c.868-75T>C::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron4/16:c.867+1108T>C::,RET:ENST00000638465.2:downstream_gene_variant:MODIFIER::::,RET:ENST00000640619.2:downstream_gene_variant:MODIFIER::::,RET:ENST00000683278.2:downstream_gene_variant:MODIFIER::::,RET:ENST00000684216.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1222122 [benign DISEASE=not provided GENE=RET];			rs2742243	0.76373	0.87370,0.74997,0.54322,0.74214,0.70851	44994,	26198	35944	-1.7550	0.63			/0.0>0.0/0.0>0.0	COSV60698036	RET|0.00|0.00|0.00|0.00|-3|30|5|-17	24144365,32913965	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43108942	43108942	A	T	hom	off-target	QUAL=23;DP=136;QD=0.17	RET	intron	RET:ENST00000713926.1:intron_variant:MODIFIER:intron5/18:c.935-89A>T::,RET:ENST00000340058.6:intron_variant:MODIFIER:intron5/18:c.1064-89A>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron5/19:c.1064-89A>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron4/16:c.868-2265A>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1277152 [benign DISEASE=not provided GENE=RET];			rs1864404	0.78454	0.94599,0.75873,0.54398,0.74229,0.70783	47860,	23664	32786	-0.0510	1.24			/0.0>3.4/7.0>2.4		RET|0.01|0.00|0.00|0.00|-4|48|-34|-4	22584707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43114918	43114918	G	A	hom	off-target	QUAL=24;DP=77;QD=0.31	RET	intron	RET:ENST00000713926.1:intron_variant:MODIFIER:intron11/18:c.1872+182G>A::,RET:ENST00000340058.6:intron_variant:MODIFIER:intron11/18:c.2136+182G>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron11/19:c.2136+182G>A::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron9/16:c.1740+182G>A::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1226080 [benign DISEASE=not provided GENE=RET];			rs1864400	0.82436	0.90804,0.80213,0.49727,0.81474,0.70897	52197,	20932	26702	-2.8890	0.26			/0.0>0.0/0.0>0.0	COSV60687565	RET|0.00|0.00|0.00|0.00|-9|25|-9|24	25310821,32851260	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43116417	43116417	T	C	hom	off-target	QUAL=24;DP=27;QD=0.89	RET	intron	RET:ENST00000713926.1:intron_variant:MODIFIER:intron11/18:c.1873-167T>C::,RET:ENST00000340058.6:intron_variant:MODIFIER:intron11/18:c.2137-167T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron11/19:c.2137-167T>C::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron9/16:c.1741-167T>C::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	677053 [benign DISEASE=not provided GENE=RET];			rs2256550	0.55741	0.66319,0.49059,0.29301,0.55732,0.30981	24366,	36054	67322	-1.4090	5.60			/4.4>3.5/0.0>0.0	COSV60688429	RET|0.00|0.00|0.00|0.00|-29|7|48|-34	24144365	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43116778	43116778	C	T	het	off-target;low_conf_region	QUAL=24;DP=326;QD=0.07	RET	intron	RET:ENST00000713926.1:intron_variant:MODIFIER:intron12/18:c.2020+47C>T::,RET:ENST00000340058.6:intron_variant:MODIFIER:intron12/18:c.2284+47C>T::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron12/19:c.2284+47C>T::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron10/16:c.1888+47C>T::		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	261396 [benign DISEASE=Multiple endocrine neoplasia type 2B,not specified,not provided GENE=RET];			rs760466	0.19218	0.05737,0.19999,0.05571,0.28178,0.12987	3404,	21929	120795	-0.9730	0.38			/0.0>0.0/0.5>0.0	COSV60689537	RET|0.00|0.00|0.00|0.00|45|30|-47|9	25741868,34981673,32411094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43118395	43118395	G	T	hom		QUAL=25;DP=776;QD=0.03	RET	synonymous	RET:ENST00000713926.1:synonymous_variant:LOW:exon13/19:c.2043G>T:p.Leu681=:PF07714 [Protein tyrosine and serine/threonine kinase],RET:ENST00000340058.6:synonymous_variant:LOW:exon13/19:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine and serine/threonine kinase],RET:ENST00000355710.8:synonymous_variant:LOW:exon13/20:c.2307G>T:p.Leu769=:PF07714 [Protein tyrosine and serine/threonine kinase],RET:ENST00000615310.5:synonymous_variant:LOW:exon11/17:c.1911G>T:p.Leu637=:PF07714 [Protein tyrosine and serine/threonine kinase]		164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	167590 [benign DISEASE=Multiple endocrine neoplasia, type 2,Multiple endocrine neoplasia type 2A,not provided,Pheochromocytoma,Multiple endocrine neoplasia type 2B,not specified GENE=RET];			rs1800861	0.78475	0.88311,0.76607,0.49515,0.76706,0.62131	47440,	24528	32752	1.2810	4.88			/0.0>0.0/0.0>0.0	COSV60687116	RET|0.00|0.00|0.00|0.00|-20|-22|-8|36	24033266,30089490,19379518,20565774,22024213,32708070,26829565,20532249,34950210,32368160,19138047,8084609,22312249,24897126,25330015,25736215,28946813,32228166,34769224,21349203,23059849,23084198,23527089,34981673,33342844,35359901,22648184,23840513,24651702,33827484,32411094,27174043,32458635,22584707,37273678,35454858,32913965,31263477,35477782,28930629,37835559,37490568	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43120057	43120057	G	A	het	off-target	QUAL=24;DP=444;QD=0.05	RET	intron	RET:ENST00000713926.1:intron_variant:MODIFIER:intron14/18:c.2344-24G>A::,RET:ENST00000340058.6:intron_variant:MODIFIER:intron14/18:c.2608-24G>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron14/19:c.2608-24G>A::,RET:ENST00000615310.5:intron_variant:MODIFIER:intron12/16:c.2212-24G>A::	regulatory_region_variant:open_chromatin_region	164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	24956 [benign DISEASE=not provided,Multiple endocrine neoplasia type 2B,not specified,Multiple endocrine neoplasia, type 2 GENE=RET];	CS116395 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2472737	0.20253	0.14995,0.19311,0.23071,0.22744,0.15768	3284,	24250	121350	-0.3050	4.97			/0.0>0.0/0.0>0.0	COSV60686346	RET|0.00|0.00|0.00|0.00|24|-39|34|23	25741868,23757202,24144365,22312249,24897126,34769224,34981673,11302967,16118333,34006365,37835559	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43126769	43126769	T	C	hom	off-target	QUAL=24;DP=43;QD=0.56	RET	3'UTR,intron	RET:ENST00000713926.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*15T>C::,RET:ENST00000340058.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*15T>C::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron19/19:c.3187+47T>C::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*15T>C::	regulatory_region_variant:open_chromatin_region	164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	165056 [benign DISEASE=Pheochromocytoma,not specified,RET-related disorder,not provided,Multiple endocrine neoplasia, type 2,Multiple endocrine neoplasia type 2A,Multiple endocrine neoplasia type 2B GENE=RET];	CS032426 [CLASS=DP MUT=ALT PHEN="Hirschsprung disease association with" GENE=RET];		rs2075912	0.83091	0.91495,0.80537,0.49961,0.82301,0.71108	53076,	20296	25732	1.4280	15.58			/0.9>0.1/0.0>0.0	COSV60689472	RET|0.00|0.00|0.00|0.03|-21|-47|19|-47	25741868,24033266,27798940,29131865,20454948,34981673,22648184,37189693,32411094,31247956	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43126920	43126920	T	A	hom	off-target	QUAL=24;DP=43;QD=0.56	RET	3'UTR,intron	RET:ENST00000713926.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*166T>A::,RET:ENST00000340058.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*166T>A::,RET:ENST00000355710.8:intron_variant:MODIFIER:intron19/19:c.3187+198T>A::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*166T>A::	regulatory_region_variant:open_chromatin_region	164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	1230253 [benign DISEASE=not provided GENE=RET];			rs2075913	0.75752	0.81575,0.75890,0.40332,0.76562,0.55097	44267,	26738	36898	3.1000	22.10			/7.0>6.8/0.0>2.1	COSV60699882	RET|0.00|0.00|0.00|0.00|-42|-2|10|44	32139661	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	43128364	43128364	C	T	het	off-target	QUAL=24;DP=504;QD=0.05	RET	3'UTR,downstream_gene	RET:ENST00000355710.8:3_prime_UTR_variant:MODIFIER:exon20/20:c.*95C>T::,RET:ENST00000615310.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*1610C>T::,RET:ENST00000713926.1:downstream_gene_variant:MODIFIER::::,RET:ENST00000340058.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	164761_[GENE=RET_PHENOS={Hirschsprung disease, susceptibility to, 1}, 142623 (3), Autosomal dominant; Multiple endocrine neoplasia IIA, 171400 (3), Autosomal dominant; {Hirschsprung disease, protection against}, 142623 (3), Autosomal dominant; Medullary thyroid carcinoma, 155240 (3), Autosomal dominant; Pheochromocytoma, 171300 (3), Autosomal dominant; Multiple endocrine neoplasia IIB, 162300 (3), Autosomal dominant]	299903 [benign DISEASE=Hirschsprung disease, susceptibility to, 1,Multiple endocrine neoplasia,Pheochromocytoma,Renal hypodysplasia/aplasia 1,not provided GENE=RET];			rs17028	0.16804	0.04137,0.17471,0.23116,0.21968,0.14449	2708,	20144	126550	0.3030	12.13			/1.2>0.3/0.0>0.0	COSV60689480	RET|0.00|0.00|0.00|0.00|14|43|20|38	22369086,20532249,21841314,32139661,29131865,34981673,37189693	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RET (inh=AD oe_syn=1.01 oe_mis=0.90 oe_lof=0.04)
chr10	86876022	86876022	C	A	het		QUAL=25;DP=70;QD=0.36	BMPR1A	missense,5'UTR	BMPR1A:ENST00000713669.1:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:,BMPR1A:ENST00000713670.1:5_prime_UTR_variant:MODIFIER:exon3/11:c.-208C>A::,BMPR1A:ENST00000372037.8:missense_variant:MODERATE:exon3/13:c.4C>A:p.Pro2Thr:,BMPR1A:ENST00000713672.1:missense_variant:MODERATE:exon2/12:c.4C>A:p.Pro2Thr:,BMPR1A:ENST00000713673.1:5_prime_UTR_variant:MODIFIER:exon3/12:c.-134C>A::,BMPR1A:ENST00000480152.3:missense_variant:MODERATE:exon4/14:c.4C>A:p.Pro2Thr:,BMPR1A:ENST00000713675.1:missense_variant:MODERATE:exon4/14:c.4C>A:p.Pro2Thr:		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	41782 [benign DISEASE=Juvenile polyposis syndrome,not provided,Generalized juvenile polyposis/juvenile polyposis coli,not specified,Hereditary cancer-predisposing syndrome GENE=BMPR1A];			rs11528010	0.40437	0.66013,0.34876,0.70345,0.25201,0.31465	15021,	31432	90550	3.2000	14.97	0.206	0.08	/0.0>0.0/0.0>0.0	COSV64406247,COSV64409048	BMPR1A|0.00|0.00|0.00|0.00|23|-37|13|-37	25741868,24728327,26293461,22703879,29458332,26900293,19502417,22886282,16436638,33032550,37530996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86890006	86890006	C	T	het	off-target;low_conf_region	QUAL=24;DP=53;QD=0.45	BMPR1A,RNU1-19P	intron,downstream_gene	BMPR1A:ENST00000713669.1:intron_variant:MODIFIER:intron3/12:c.68-56C>T::,BMPR1A:ENST00000713670.1:intron_variant:MODIFIER:intron3/10:c.-144-9788C>T::,BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron3/12:c.68-56C>T::,BMPR1A:ENST00000713672.1:intron_variant:MODIFIER:intron2/11:c.68-56C>T::,BMPR1A:ENST00000713673.1:intron_variant:MODIFIER:intron3/11:c.-70-2121C>T::,BMPR1A:ENST00000480152.3:intron_variant:MODIFIER:intron4/13:c.68-56C>T::,BMPR1A:ENST00000713675.1:intron_variant:MODIFIER:intron4/13:c.68-56C>T::,RNU1-19P:ENST00000363306.1:downstream_gene_variant:MODIFIER::::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	1292350 [benign DISEASE=not provided GENE=BMPR1A];			rs7087358	0.44806	0.68420,0.37111,0.70938,0.30872,0.39354	17490,	33160	83938	-0.1980	4.99			/0.0>0.0/0.0>0.0		BMPR1A|0.00|0.00|0.00|0.00|20|44|-44|49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17), RNU1-19P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr10	86918991	86918991	A	T	hom	off-target	QUAL=24;DP=6;QD=4.00	BMPR1A	intron	BMPR1A:ENST00000713669.1:intron_variant:MODIFIER:intron9/12:c.863-181A>T::,BMPR1A:ENST00000713670.1:intron_variant:MODIFIER:intron7/10:c.392-181A>T::,BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron9/12:c.869-181A>T::,BMPR1A:ENST00000713672.1:intron_variant:MODIFIER:intron8/11:c.869-181A>T::,BMPR1A:ENST00000713673.1:intron_variant:MODIFIER:intron8/11:c.569-181A>T::,BMPR1A:ENST00000480152.3:intron_variant:MODIFIER:intron10/13:c.869-181A>T::,BMPR1A:ENST00000713675.1:intron_variant:MODIFIER:intron10/13:c.869-181A>T::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	1292661 [benign DISEASE=not provided GENE=BMPR1A];			rs1240188	0.95801	0.97917,0.94976,0.96626,0.94607,0.97988	69924,	6083	6397	-0.4140	2.01			/1.6>2.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86923241	86923241	-	A	het	off-target	QUAL=24;DP=559;QD=0.04	BMPR1A	intron	BMPR1A:ENST00000713669.1:intron_variant:MODIFIER:intron11/12:c.1337-353_1337-352insA::,BMPR1A:ENST00000713670.1:intron_variant:MODIFIER:intron9/10:c.866-135_866-134insA::,BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron11/12:c.1343-135_1343-134insA::,BMPR1A:ENST00000713672.1:intron_variant:MODIFIER:intron10/11:c.1343-135_1343-134insA::,BMPR1A:ENST00000713673.1:intron_variant:MODIFIER:intron10/11:c.1043-135_1043-134insA::,BMPR1A:ENST00000480152.3:intron_variant:MODIFIER:intron12/13:c.1343-135_1343-134insA::,BMPR1A:ENST00000713675.1:intron_variant:MODIFIER:intron12/13:c.1343-135_1343-134insA::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	1292436 [benign DISEASE=not provided GENE=BMPR1A];			rs79853893	0.14612	0.05995,0.19358,0.65901,0.13309,0.15622	2576,	17074	129884		12.33			/0.5>0.0/0.0>0.0		BMPR1A|0.00|0.00|0.06|0.00|29|-1|29|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86923242	86923242	-	GTATATA	het	off-target	QUAL=24;DP=559;QD=0.04	BMPR1A	intron	BMPR1A:ENST00000713669.1:intron_variant:MODIFIER:intron11/12:c.1337-351_1337-350insTATATAG::,BMPR1A:ENST00000713670.1:intron_variant:MODIFIER:intron9/10:c.866-133_866-132insTATATAG::,BMPR1A:ENST00000372037.8:intron_variant:MODIFIER:intron11/12:c.1343-133_1343-132insTATATAG::,BMPR1A:ENST00000713672.1:intron_variant:MODIFIER:intron10/11:c.1343-133_1343-132insTATATAG::,BMPR1A:ENST00000713673.1:intron_variant:MODIFIER:intron10/11:c.1043-133_1043-132insTATATAG::,BMPR1A:ENST00000480152.3:intron_variant:MODIFIER:intron12/13:c.1343-133_1343-132insTATATAG::,BMPR1A:ENST00000713675.1:intron_variant:MODIFIER:intron12/13:c.1343-133_1343-132insTATATAG::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	1181594 [benign DISEASE=not provided GENE=BMPR1A];			rs370827935	0.14627	0.06005,0.19389,0.65881,0.13318,0.15661	2573,	17075	129701		11.08			/0.5>0.5/0.0>0.0		BMPR1A|0.00|0.00|0.01|0.00|0|-2|0|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	86923365	86923365	T	C	het	off-target	QUAL=24;DP=621;QD=0.04	BMPR1A	intron,splice_region&intron	BMPR1A:ENST00000713669.1:intron_variant:MODIFIER:intron11/12:c.1337-229T>C::,BMPR1A:ENST00000713670.1:splice_region_variant&intron_variant:LOW:intron9/10:c.866-11T>C::,BMPR1A:ENST00000372037.8:splice_region_variant&intron_variant:LOW:intron11/12:c.1343-11T>C::,BMPR1A:ENST00000713672.1:splice_region_variant&intron_variant:LOW:intron10/11:c.1343-11T>C::,BMPR1A:ENST00000713673.1:splice_region_variant&intron_variant:LOW:intron10/11:c.1043-11T>C::,BMPR1A:ENST00000480152.3:splice_region_variant&intron_variant:LOW:intron12/13:c.1343-11T>C::,BMPR1A:ENST00000713675.1:splice_region_variant&intron_variant:LOW:intron12/13:c.1343-11T>C::		601299_[GENE=BMPR1A_PHENOS=Polyposis syndrome, hereditary mixed, 2, 610069 (3); Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant]	259286 [benign DISEASE=Juvenile polyposis syndrome,not provided,Hereditary cancer-predisposing syndrome,not specified,Generalized juvenile polyposis/juvenile polyposis coli GENE=BMPR1A];			rs7074064	0.40230	0.66199,0.33362,0.69852,0.25089,0.31489	14930,	31281	90837	-0.2270	1.80			10.6>9.9/10.6>9.9/0.0>0.0,/10.6>9.9/0.0>0.0		BMPR1A|0.00|0.00|0.00|0.00|-28|11|11|48	25741868,26293461,16385451,23555554,35037836	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BMPR1A (inh=AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.17)
chr10	87893929	87893929	A	G	het	off-target	QUAL=25;DP=4;QD=6.25	PTEN	intron	PTEN:ENST00000688308.1:intron_variant:MODIFIER:intron2/9:c.80-96A>G::,PTEN:ENST00000693560.1:intron_variant:MODIFIER:intron2/9:c.599-96A>G::,PTEN:ENST00000700029.2:intron_variant:MODIFIER:intron1/9:c.80-96A>G::,PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron1/8:c.80-96A>G::,PTEN:ENST00000713839.1:intron_variant:MODIFIER:intron1/9:c.80-96A>G::,PTEN:ENST00000700021.1:intron_variant:MODIFIER:intron1/7:c.80-96A>G::,PTEN:ENST00000472832.3:intron_variant:MODIFIER:intron1/7:c.80-96A>G::	regulatory_region_variant:enhancer	601728_[GENE=PTEN_PHENOS={Glioma susceptibility 2}, 613028 (3), Autosomal dominant; {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant]	440219 [benign DISEASE=not specified,not provided GENE=PTEN];			rs1903858	0.38777	0.47217,0.44559,0.50736,0.32811,0.29846	11905,	33764	90902	-0.7510	0.59			/5.3>4.9/0.0>0.0	COSV64292778	PTEN|0.00|0.00|0.00|0.00|1|35|-5|-10	18805939,22562547,27187382,24959314,21633361,19625176,26082156,32537792,32583210,24132918,32547095,19421400,26220040,25419146,23930209,25881591,16574322,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	87931195	87931195	-	TTATC	het	off-target	QUAL=24;DP=55;QD=0.44	PTEN	intron	PTEN:ENST00000688308.1:intron_variant:MODIFIER:intron5/9:c.253+109_253+110insTCTTA::,PTEN:ENST00000693560.1:intron_variant:MODIFIER:intron5/9:c.772+109_772+110insTCTTA::,PTEN:ENST00000700029.2:intron_variant:MODIFIER:intron4/9:c.253+109_253+110insTCTTA::,PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron4/8:c.253+109_253+110insTCTTA::,PTEN:ENST00000713839.1:intron_variant:MODIFIER:intron5/9:c.346+109_346+110insTCTTA::,PTEN:ENST00000700021.1:intron_variant:MODIFIER:intron3/7:c.208+109_208+110insTCTTA::,PTEN:ENST00000472832.3:intron_variant:MODIFIER:intron4/7:c.253+109_253+110insTCTTA::	regulatory_region_variant:enhancer	601728_[GENE=PTEN_PHENOS={Glioma susceptibility 2}, 613028 (3), Autosomal dominant; {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant]	1292390 [benign DISEASE=not specified,not provided GENE=PTEN];			rs1799734	0.39355	0.48365,0.44819,0.50408,0.33443,0.29892	12106,	35251	91633		4.91			/0.0>2.4/0.0>0.0		PTEN|0.00|0.00|0.00|0.00|-20|-1|-13|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	87961150	87961150	T	G	het	off-target	QUAL=24;DP=29;QD=0.83	PTEN	intron,3'UTR	PTEN:ENST00000688308.1:intron_variant:MODIFIER:intron9/9:c.1026+32T>G::,PTEN:ENST00000693560.1:intron_variant:MODIFIER:intron9/9:c.1545+32T>G::,PTEN:ENST00000700029.2:intron_variant:MODIFIER:intron9/9:c.1119+32T>G::,PTEN:ENST00000371953.8:intron_variant:MODIFIER:intron8/8:c.1026+32T>G::,PTEN:ENST00000713839.1:intron_variant:MODIFIER:intron9/9:c.1119+32T>G::,PTEN:ENST00000700021.1:intron_variant:MODIFIER:intron7/7:c.981+32T>G::,PTEN:ENST00000472832.3:3_prime_UTR_variant:MODIFIER:exon8/8:c.*23T>G::	regulatory_region_variant:enhancer	601728_[GENE=PTEN_PHENOS={Glioma susceptibility 2}, 613028 (3), Autosomal dominant; {Meningioma}, 607174 (3), Autosomal dominant; Cowden syndrome 1, 158350 (3), Autosomal dominant; Lhermitte-Duclos disease, 158350 (3), Autosomal dominant; Prostate cancer, somatic, 176807 (3); Macrocephaly/autism syndrome, 605309 (3), Autosomal dominant]	92810 [benign DISEASE=Hereditary cancer-predisposing syndrome,Cowden syndrome 1,Macrocephaly-autism syndrome,not specified,PTEN hamartoma tumor syndrome,not provided GENE=PTEN];	CS1815672 [CLASS=R MUT=ALT PHEN="Cowden disease" GENE=PTEN];		rs555895	0.39973	0.50188,0.45197,0.50559,0.33572,0.30012	12672,	35409	91233	-0.8500	0.69			/0.0>0.0/0.0>1.2	COSV64292683	PTEN|0.00|0.00|0.00|0.00|39|36|-5|-28	25741868,23757202,18805939,17033968,23068025,26541596,25361012,19421400,21869887,26220040,25419146,16574322	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTEN (inh=AD oe_syn=1.02 oe_mis=0.33 oe_lof=0.24)
chr10	102504350	102504350	C	T	hom		QUAL=23;DP=416;QD=0.06	SUFU,ACTR1A	splice_region&intron,upstream_gene	SUFU:ENST00000369902.8:splice_region_variant&intron_variant:LOW:intron1/11:c.182+16C>T::,SUFU:ENST00000369899.6:splice_region_variant&intron_variant:LOW:intron1/10:c.182+16C>T::,SUFU:ENST00000423559.2:splice_region_variant&intron_variant:LOW:intron1/9:c.182+16C>T::,ACTR1A:ENST00000369905.9:upstream_gene_variant:MODIFIER::::,ACTR1A:ENST00000487599.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome 2, 620343 (3); {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation]	260689 [benign DISEASE=Gorlin syndrome,Familial meningioma,not provided,Joubert syndrome 32,not specified,Medulloblastoma GENE=SUFU];			rs2274351	0.46110	0.31763,0.41115,0.32129,0.54703,0.48715	17119,	35800	81854	-0.1750	15.06			/0.0>0.0/0.0>0.0	COSV64013811	SUFU|0.00|0.00|0.03|0.00|-22|-38|-22|50	25741868,36121873,26192919,22508808	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTR1A (inh=n/a oe_syn=0.79 oe_mis=0.44 oe_lof=0.13), SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102509460	102509460	G	A	hom	off-target	QUAL=24;DP=6;QD=4.00	SUFU	intron	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron2/11:c.317+157G>A::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron2/10:c.317+157G>A::,SUFU:ENST00000423559.2:intron_variant:MODIFIER:intron2/9:c.317+157G>A::	regulatory_region_variant:open_chromatin_region	607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome 2, 620343 (3); {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation]	677130 [benign DISEASE=not provided GENE=SUFU];			rs2281880	0.46177	0.31758,0.41096,0.32346,0.54770,0.48774	17175,	35787	81751	-0.3310	1.61			/0.0>0.0/0.0>0.0	COSV64014869	SUFU|0.00|0.00|0.00|0.00|27|-9|-10|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102597065	102597065	A	G	hom	off-target	QUAL=24;DP=74;QD=0.32	SUFU	intron	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron6/11:c.757-75A>G::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron6/10:c.757-75A>G::,SUFU:ENST00000423559.2:intron_variant:MODIFIER:intron6/9:c.757-75A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome 2, 620343 (3); {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation]	1246567 [benign DISEASE=not provided GENE=SUFU];			rs10786690	0.99268	0.97549,0.99791,0.99922,0.99975,0.99958	74941,	1094	1114	-0.0720	4.94			/0.0>0.0/0.0>0.0	COSV100882930	SUFU|0.00|0.00|0.00|0.00|-32|45|-9|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102618932	102618935	GTGT	-	het	off-target;low_conf_region	QUAL=25;DP=58;QD=0.43	SUFU	intron,downstream_gene	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron10/11:c.1296+1548_1296+1551del::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron10/10:c.1297-90_1297-87del::,SUFU:ENST00000423559.2:downstream_gene_variant:MODIFIER::::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome 2, 620343 (3); {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation]			(GT)n (Simple_repeat)	rs59259635	0.12832	0.08527,0.10911,0.09848,0.14663,0.16092	973,	13671	106083	0.2690	0.54			/0.0>0.0/7.4>7.4		SUFU|0.00|0.00|0.00|0.00|-13|-4|8|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102618932	102618937	GTGTGT	-	het	off-target;low_conf_region	QUAL=25;DP=58;QD=0.43	SUFU	intron,downstream_gene	SUFU:ENST00000369902.8:intron_variant:MODIFIER:intron10/11:c.1296+1546_1296+1551del::,SUFU:ENST00000369899.6:intron_variant:MODIFIER:intron10/10:c.1297-92_1297-87del::,SUFU:ENST00000423559.2:downstream_gene_variant:MODIFIER::::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome 2, 620343 (3); {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation]			(GT)n (Simple_repeat)	rs59259635	0.05566	0.07946,0.04048,0.06328,0.04847,0.02919	166,	6446	115006	0.2690	0.50			/0.0>0.0/7.4>7.4		SUFU|0.00|0.00|0.00|0.00|-28|-13|-5|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102627262	102627262	T	C	het		QUAL=24;DP=1199;QD=0.02	SUFU	splice_region&intron	SUFU:ENST00000369902.8:splice_region_variant&intron_variant:LOW:intron11/11:c.1365+19T>C::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome 2, 620343 (3); {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation]	260688 [benign DISEASE=Familial meningioma,not specified,Gorlin syndrome,Joubert syndrome 32,not provided,Medulloblastoma GENE=SUFU];			rs12414407	0.68285	0.75243,0.63337,0.74701,0.65572,0.71121	35758,	32428	48278	0.4520	7.00			/7.4>7.8/0.0>0.0	COSV64017850	SUFU|0.00|0.00|0.00|0.00|-19|12|-15|11	25741868,26627480,23538333,34300206,24067507,27617143	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr10	102630175	102630175	T	G	hom		QUAL=24;DP=1406;QD=0.02	SUFU	3'UTR	SUFU:ENST00000369902.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*20T>G::		607035_[GENE=SUFU_PHENOS={Meningioma, familial, susceptibility to}, 607174 (3), Autosomal dominant; Joubert syndrome 32, 617757 (3), Autosomal recessive; Basal cell nevus syndrome 2, 620343 (3); {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation]	1175161 [benign DISEASE=not provided,Gorlin syndrome,Joubert syndrome 32,not specified GENE=SUFU];			rs4917980	0.99831	0.99427,0.99954,1.00000,0.99991,1.00000	75890,	255	257	1.4220	16.35			/3.1>4.9/0.0>0.0	COSV100883278			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUFU (inh=AR+AD oe_syn=0.92 oe_mis=0.68 oe_lof=0.00)
chr11	13081343	13081343	C	A	het	off-target	QUAL=24;DP=1475;QD=0.02		intergenic	::intergenic_variant:MODIFIER::::						rs2727397	0.58597	0.64411,0.64459,0.15113,0.59138,0.45233	26785,	35449	62899	0.0480	6.08							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	13081459	13081459	G	A	het	off-target	QUAL=25;DP=4;QD=6.25		intergenic	::intergenic_variant:MODIFIER::::						rs2727395	0.58584	0.64381,0.64486,0.15043,0.59139,0.45262	26806,	35447	62961	0.4590	2.16							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr11	22624479	22624479	G	A	hom	off-target	QUAL=24;DP=25;QD=0.96	FANCF	3'UTR	FANCF:ENST00000327470.6:3_prime_UTR_variant:MODIFIER:exon1/1:c.*207C>T::		613897_[GENE=FANCF_PHENOS=Fanconi anemia, complementation group F, 603467 (3), Autosomal recessive]	304197 [benign DISEASE=Fanconi anemia complementation group F,not provided GENE=FANCF];			rs4447177	0.71258	0.41634,0.73198,0.88992,0.83476,0.82067	41384,	25623	43719	-0.3340	1.71			/0.0>0.9/0.0>0.0		FANCF|0.00|0.00|0.00|0.00|-12|16|8|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCF (inh=AR oe_syn=1.43 oe_mis=1.38 oe_lof=0.00)
chr11	64804546	64804546	T	C	hom		QUAL=24;DP=110;QD=0.22	MEN1,MAP4K2	missense,upstream_gene	MEN1:ENST00000377316.6:missense_variant:MODERATE:exon8/8:c.1456A>G:p.Thr486Ala:,MEN1:ENST00000315422.9:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000413626.2:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000377313.7:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala:,MEN1:ENST00000450708.7:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000394376.7:missense_variant:MODERATE:exon10/10:c.1612A>G:p.Thr538Ala:,MEN1:ENST00000377321.5:missense_variant:MODERATE:exon10/10:c.1516A>G:p.Thr506Ala:,MEN1:ENST00000377326.7:missense_variant:MODERATE:exon9/9:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000312049.11:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000710881.1:missense_variant:MODERATE:exon10/10:c.1636A>G:p.Thr546Ala:,MEN1:ENST00000424912.2:missense_variant:MODERATE:exon11/11:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000429702.6:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MEN1:ENST00000672304.1:missense_variant:MODERATE:exon11/11:c.1747A>G:p.Thr583Ala:,MEN1:ENST00000440873.6:missense_variant:MODERATE:exon10/10:c.1621A>G:p.Thr541Ala:,MAP4K2:ENST00000294066.7:upstream_gene_variant:MODIFIER::::,MAP4K2:ENST00000377350.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	134640 [benign DISEASE=Multiple endocrine neoplasia, type 1,not specified,not provided GENE=MEN1];			rs2959656	0.89735	0.71343,0.90268,0.70105,0.99597,0.98571	62591,	11415	15625	0.1390	1.60	0.302	0.05	/0.0>0.0/0.0>0.0	COSV53639974		25741868,24033266,24728327,23757202,32708070,22703879,26307114,564891,9215689,18775714,27185868,28899949,33240400,28969599,30214228,34750164	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=AD oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64804931	64804931	C	G	het	off-target	QUAL=24;DP=15;QD=1.60	MEN1,MAP4K2	intron,upstream_gene	MEN1:ENST00000377316.6:intron_variant:MODIFIER:intron7/7:c.1186-115G>C::,MEN1:ENST00000315422.9:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000413626.2:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000377313.7:intron_variant:MODIFIER:intron9/9:c.1365+103G>C::,MEN1:ENST00000450708.7:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000394376.7:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000377321.5:intron_variant:MODIFIER:intron9/9:c.1245+103G>C::,MEN1:ENST00000377326.7:intron_variant:MODIFIER:intron8/8:c.1350+103G>C::,MEN1:ENST00000312049.11:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000710881.1:intron_variant:MODIFIER:intron9/9:c.1365+103G>C::,MEN1:ENST00000424912.2:intron_variant:MODIFIER:intron10/10:c.1350+103G>C::,MEN1:ENST00000429702.6:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MEN1:ENST00000672304.1:intron_variant:MODIFIER:intron10/10:c.1476+103G>C::,MEN1:ENST00000440873.6:intron_variant:MODIFIER:intron9/9:c.1350+103G>C::,MAP4K2:ENST00000294066.7:upstream_gene_variant:MODIFIER::::,MAP4K2:ENST00000377350.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	1245707 [benign DISEASE=not provided GENE=MEN1];			rs654440	0.31985	0.08666,0.28053,0.00963,0.47240,0.25446	10209,	28262	103516	1.6130	7.62			/1.9>1.8/0.0>0.6		MEN1|0.00|0.00|0.00|0.00|23|-8|-1|3	27366707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=AD oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	64805085	64805085	A	G	hom		QUAL=24;DP=74;QD=0.32	MEN1,MAP4K2	intron,synonymous,upstream_gene	MEN1:ENST00000377316.6:intron_variant:MODIFIER:intron7/7:c.1186-269T>C::,MEN1:ENST00000315422.9:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000413626.2:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000377313.7:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000450708.7:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000394376.7:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000377321.5:synonymous_variant:LOW:exon9/10:c.1194T>C:p.His398=:PF05053 [Menin],MEN1:ENST00000377326.7:synonymous_variant:LOW:exon8/9:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000312049.11:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000710881.1:synonymous_variant:LOW:exon9/10:c.1314T>C:p.His438=:PF05053 [Menin],MEN1:ENST00000424912.2:synonymous_variant:LOW:exon10/11:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000429702.6:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MEN1:ENST00000672304.1:synonymous_variant:LOW:exon10/11:c.1425T>C:p.His475=:PF05053 [Menin],MEN1:ENST00000440873.6:synonymous_variant:LOW:exon9/10:c.1299T>C:p.His433=:PF05053 [Menin],MAP4K2:ENST00000294066.7:upstream_gene_variant:MODIFIER::::,MAP4K2:ENST00000377350.7:upstream_gene_variant:MODIFIER::::		613733_[GENE=MEN1_PHENOS=Lipoma, somatic (3); Angiofibroma, somatic (3); Multiple endocrine neoplasia 1, 131100 (3), Autosomal dominant; Carcinoid tumor of lung (3); Adrenal adenoma, somatic (3); Parathyroid adenoma, somatic (3)]	167288 [benign DISEASE=not provided,not specified,Multiple endocrine neoplasia, type 1 GENE=MEN1];			rs540012	0.97797	0.92304,0.99269,1.00000,0.99982,1.00000	72937,	3102	3356	-0.3010	1.01			/0.0>0.0/0.7>1.4			32708070,26307114,28899949,28969599,34750164	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP4K2 (inh=AD oe_syn=1.12 oe_mis=0.79 oe_lof=0.50), MEN1 (inh=AD oe_syn=0.93 oe_mis=0.53 oe_lof=0.04)
chr11	94479765	94479765	A	-	het	mosaic	QUAL=338;DP=507;QD=0.67;AF=0.12;MQM=60;SAP=3;ABP=937;SAR=10;SAF=10	MRE11	splice_region&intron	MRE11:ENST00000323929.8:splice_region_variant&intron_variant:LOW:intron4/19:c.315-4del::,MRE11:ENST00000407439.7:splice_region_variant&intron_variant:LOW:intron4/19:c.324-4del::,MRE11:ENST00000323977.7:splice_region_variant&intron_variant:LOW:intron4/18:c.315-4del::,MRE11:ENST00000393241.8:splice_region_variant&intron_variant:LOW:intron4/19:c.315-4del::,MRE11:ENST00000540013.5:splice_region_variant&intron_variant:LOW:intron4/7:c.315-4del::		600814_[GENE=MRE11_PHENOS=Ataxia-telangiectasia-like disorder 1, 604391 (3), Autosomal recessive]	140809 [benign/likely benign DISEASE=Ataxia-telangiectasia-like disorder 1,Ataxia-telangiectasia-like disorder,not provided,Hereditary cancer-predisposing syndrome GENE=MRE11];			rs35062043	0.00005	0.00002,0.00014,0.00000,0.00005,0.00000	0,	8	147024	0.6600	1.75			/8.8>7.2/0.0>0.0		MRE11A|0.00|0.11|0.00|0.00|-13|-3|-12|32	19383352,35853939	0	74	958	0 / 15	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			MRE11 (inh=AR oe_syn=1.11 oe_mis=0.98 oe_lof=0.60)
chr11	108244634	108244634	T	-	hom	off-target	QUAL=24;DP=314;QD=0.08	ATM	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron7/63:c.663-144del::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron7/63:c.663-144del::,ATM:ENST00000531525.3:intron_variant:MODIFIER:intron6/29:c.663-144del::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron6/62:c.663-144del::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron7/63:c.663-144del::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron6/62:c.663-144del::	regulatory_region_variant:open_chromatin_region	607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1257474 [benign DISEASE=not provided,not specified GENE=ATM];			rs11298747	0.97919	0.99327,0.96361,0.99534,0.97174,0.98195	72310,	3047	3139	-0.8530	0.13			/6.2>5.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108250683	108250683	-	T	hom	off-target;low_conf_region	QUAL=25;DP=17;QD=1.47	ATM	splice_region&intron	ATM:ENST00000601453.3:splice_region_variant&intron_variant:LOW:intron10/63:c.1236-3dup::,ATM:ENST00000452508.7:splice_region_variant&intron_variant:LOW:intron10/63:c.1236-3dup::,ATM:ENST00000531525.3:splice_region_variant&intron_variant:LOW:intron9/29:c.1236-3dup::,ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron9/62:c.1236-3dup::,ATM:ENST00000713844.1:splice_region_variant&intron_variant:LOW:intron10/63:c.1236-3dup::,ATM:ENST00000278616.10:splice_region_variant&intron_variant:LOW:intron9/62:c.1236-3dup::	regulatory_region_variant:open_chromatin_region	607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	181847 [benign/likely benign DISEASE=not specified,not provided,Familial cancer of breast,Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,Breast neoplasm GENE=ATM];			rs34325032	0.53983	0.43489,0.62379,0.43445,0.56742,0.65291	20785,	35236	65472		0.45			/12.1>12.1/0.0>0.0		ATM|0.01|0.00|0.00|0.00|25|18|47|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108258930	108258930	A	G	het	off-target	QUAL=24;DP=16;QD=1.50	ATM	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::,ATM:ENST00000531525.3:intron_variant:MODIFIER:intron15/29:c.2377-56A>G::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron16/63:c.2377-56A>G::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron15/62:c.2377-56A>G::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1177614 [benign DISEASE=not specified,not provided,Ataxia-telangiectasia syndrome,Hereditary breast ovarian cancer syndrome GENE=ATM];			rs672655	0.49433	0.27594,0.60674,0.42066,0.56725,0.60390	20115,	34937	76891	2.1810	17.18			/0.0>0.0/0.0>0.0	COSV53757995	ATM|0.00|0.00|0.00|0.00|-21|3|38|31	25010664,18433505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108279481	108279481	T	-	het		QUAL=25;DP=98;QD=0.26	ATM	splice_region&intron	ATM:ENST00000601453.3:splice_region_variant&intron_variant:LOW:intron23/63:c.3285-9del::,ATM:ENST00000452508.7:splice_region_variant&intron_variant:LOW:intron23/63:c.3285-9del::,ATM:ENST00000531525.3:splice_region_variant&intron_variant:LOW:intron22/29:c.3285-9del::,ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron22/62:c.3285-9del::,ATM:ENST00000713844.1:splice_region_variant&intron_variant:LOW:intron23/63:c.3285-9del::,ATM:ENST00000278616.10:splice_region_variant&intron_variant:LOW:intron22/62:c.3285-9del::	regulatory_region_variant:enhancer	607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	181857 [benign/likely benign DISEASE=Hereditary cancer-predisposing syndrome,Hereditary breast ovarian cancer syndrome,not specified,not provided,Familial cancer of breast,Ataxia-telangiectasia syndrome GENE=ATM];		(TTTG)n (Simple_repeat)	rs1799757	0.10631	0.02394,0.09164,0.00790,0.14453,0.07620	1202,	13771	135973	0.5080	2.86			/7.4>7.3/0.0>0.0		ATM|0.00|0.00|0.00|0.00|21|44|43|44	25741868,24033266,30781715,36039053,33240400,19347964	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108280980	108280980	-	A	het	off-target;low_conf_region	QUAL=24;DP=77;QD=0.31	ATM	splice_region&intron	ATM:ENST00000601453.3:splice_region_variant&intron_variant:LOW:intron24/63:c.3403-13dup::,ATM:ENST00000452508.7:splice_region_variant&intron_variant:LOW:intron24/63:c.3403-13dup::,ATM:ENST00000531525.3:splice_region_variant&intron_variant:LOW:intron23/29:c.3403-13dup::,ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron23/62:c.3403-13dup::,ATM:ENST00000713844.1:splice_region_variant&intron_variant:LOW:intron24/63:c.3403-13dup::,ATM:ENST00000278616.10:splice_region_variant&intron_variant:LOW:intron23/62:c.3403-13dup::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	181858 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,not specified,not provided,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Breast and/or ovarian cancer GENE=ATM];			rs3218681	0.55133	0.46049,0.62710,0.39533,0.57456,0.64360	23487,	36693	68087		0.65			/7.9>7.8/0.0>0.0		ATM|0.00|0.05|0.00|0.00|-15|15|-36|23	25741868,24033266,29879995,19222838	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108284670	108284670	G	A	het	off-target	QUAL=24;DP=15;QD=1.60	ATM	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron27/63:c.3993+197G>A::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron27/63:c.3993+197G>A::,ATM:ENST00000531525.3:intron_variant:MODIFIER:intron26/29:c.3993+197G>A::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron26/62:c.3993+197G>A::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron27/63:c.3993+197G>A::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron26/62:c.3993+197G>A::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1226443 [benign DISEASE=not provided GENE=ATM];			rs654005	0.53687	0.42238,0.61970,0.38628,0.56826,0.65008	22457,	36661	70371	-0.8670	1.10			/1.8>4.8/0.0>0.0		ATM|0.00|0.00|0.00|0.00|4|1|21|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108299544	108299544	G	A	het	off-target	QUAL=24;DP=18;QD=1.33	ATM	intron,downstream_gene	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron34/63:c.5006-170G>A::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron34/63:c.5006-170G>A::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron33/62:c.5006-170G>A::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron34/63:c.5006-170G>A::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron33/62:c.5006-170G>A::,ATM:ENST00000531525.3:downstream_gene_variant:MODIFIER::::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1261675 [benign DISEASE=not provided GENE=ATM];		AluSx (SINE/Alu)	rs1150203	0.50194	0.30867,0.60668,0.37146,0.56765,0.60404	20402,	35449	75665	-1.5540	0.72			/7.3>6.9/0.0>0.0		ATM|0.00|0.00|0.00|0.00|-12|-36|-12|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60)
chr11	108304667	108304667	T	C	het		QUAL=24;DP=14;QD=1.71	ATM,C11orf65	splice_region&intron,downstream_gene	ATM:ENST00000601453.3:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::,ATM:ENST00000452508.7:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::,ATM:ENST00000675843.1:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,ATM:ENST00000713844.1:splice_region_variant&intron_variant:LOW:intron37/63:c.5497-8T>C::,ATM:ENST00000278616.10:splice_region_variant&intron_variant:LOW:intron36/62:c.5497-8T>C::,C11orf65:ENST00000525729.5:downstream_gene_variant:MODIFIER::::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	132706 [benign/likely benign DISEASE=Ataxia-telangiectasia syndrome,not specified,Hereditary breast ovarian cancer syndrome,Malignant tumor of breast,Triple-negative breast carcinoma,not provided,Familial cancer of breast,Hereditary cancer-predisposing syndrome GENE=ATM];			rs3092829	0.02148	0.00524,0.02320,0.00116,0.03290,0.00621	36,	3199	149041	1.2810	8.39			10.0>8.7/10.0>8.7/0.0>0.0	COSV53727999	ATM|0.00|0.00|0.00|0.00|1|8|7|29	25741868,30781715,22529920,18433505,18701470	83	3175	0	13 / 568	1	"[1] Ilnaz Sepahi 29-03-2016 batch import"			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108304735	108304735	G	A	het		QUAL=24;DP=30;QD=0.80	ATM,C11orf65	missense,downstream_gene	ATM:ENST00000601453.3:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000452508.7:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000675843.1:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000713844.1:missense_variant:MODERATE:exon38/64:c.5557G>A:p.Asp1853Asn:,ATM:ENST00000278616.10:missense_variant:MODERATE:exon37/63:c.5557G>A:p.Asp1853Asn:,C11orf65:ENST00000525729.5:downstream_gene_variant:MODIFIER::::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	128458 [benign DISEASE=Ataxia-telangiectasia syndrome,not provided,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Hereditary breast ovarian cancer syndrome,not specified GENE=ATM];	CM077896 [CLASS=DP MUT=ALT PHEN="Breast cancer bilateral association with" GENE=ATM];		rs1801516	0.10633	0.02400,0.09059,0.00791,0.14466,0.07581	1205,	13766	135962	5.9270	23.40	0.118	0.18	/2.6>0.0/0.0>0.0	COSV53728020	ATM|0.12|0.00|0.00|0.00|45|1|-39|1	25741868,24033266,24728327,21504893,34711928,34862210,33390813,28499365,30089490,30781715,29178884,26648445,19536092,24756757,18559551,24531918,23238918,26870349,16465622,31584889,22792358,27608007,25077817,28844157,33112566,29458332,28206966,28324443,31095341,24218030,24642353,19276285,24062231,27258253,21983787,34950210,19094228,23697595,18579371,18768505,21877955,32039725,21332318,32547144,31914346,22927776,32597209,25591549,24980573,25837821,22276117,29433565,22537351,34898573,30194396,29963112,26857527,29753029,35255575,25849217,29788924,24105688,29691986,25530832,17582598,23154078,17132159,19286843,18433505,17623063,18701470,19348699,34643693,15756685,16496408,18264724,20799949,21327466,24599715,26627042,27057881,30384829,31756226,32674635,33545302,9711876,10425038,23313170,34683108,32625092,22438227,24392023,27105923,31658756,32418335,36551737,30231410,25380778,37206490,33031470,35008368,29657992,25879635,32724790,34012291,29890168,34290314,36358854,20531418,33240400,34125377,24790730,19347964,29888979	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108312687	108312688	CT	-	het	off-target	QUAL=24;DP=24;QD=1.00	ATM,C11orf65	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron41/63:c.6006+191_6006+192del::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron41/63:c.6006+191_6006+192del::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron40/62:c.6006+191_6006+192del::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron41/63:c.6006+191_6006+192del::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron40/62:c.6006+191_6006+192del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-3617_641-3616del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1253719 [benign DISEASE=not provided GENE=ATM];		MIRb (SINE/MIR)	rs10588462	0.52288	0.36843,0.61613,0.43459,0.56784,0.64988	21631,	36117	72433	0.0960	1.60			/0.0>0.0/0.0>0.0		ATM|0.00|0.00|0.00|0.00|-27|18|38|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108317616	108317619	TATA	-	het	off-target	QUAL=18;DP=10;QD=1.80	ATM,C11orf65	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron44/63:c.6347+129_6347+132del::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron44/63:c.6347+129_6347+132del::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron43/62:c.6347+129_6347+132del::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron44/63:c.6347+129_6347+132del::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron43/62:c.6347+129_6347+132del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-8548_641-8545del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1251334 [benign DISEASE=not provided GENE=ATM];		(TA)n (Simple_repeat)	rs376158749	0.26870	0.09926,0.23451,0.29831,0.33400,0.42842	3135,	14431	56341	2.7870	2.69			/0.0>0.0/0.0>0.0		ATM|0.00|0.00|0.00|0.00|46|-8|43|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108325250	108325250	T	-	hom	off-target;low_conf_region	QUAL=24;DP=27;QD=0.89	ATM,C11orf65	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron46/63:c.6573-42del::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron46/63:c.6573-42del::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron45/62:c.6573-42del::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron46/63:c.6573-42del::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron45/62:c.6573-42del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-16179del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1252304 [benign DISEASE=not provided,not specified GENE=ATM];		(T)n (Simple_repeat)	rs11366542	0.64896	0.46575,0.76836,0.78583,0.69700,0.81045	20247,	30673	38497	1.3490	1.96			/0.0>0.0/0.0>0.0		ATM|0.01|0.00|0.00|0.00|36|1|39|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108325986	108325988	ATT	-	het	off-target;low_conf_region	QUAL=24;DP=23;QD=1.04	ATM,C11orf65	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron47/63:c.6808-60_6808-58del::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron47/63:c.6808-60_6808-58del::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron46/62:c.6808-60_6808-58del::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron47/63:c.6808-60_6808-58del::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron46/62:c.6808-60_6808-58del::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-16917_641-16915del::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	633055 [benign DISEASE=Ataxia-telangiectasia syndrome,not provided,not specified,Hereditary breast ovarian cancer syndrome GENE=ATM];			rs3212322	0.50075	0.30029,0.60820,0.41411,0.56712,0.60316	20285,	35346	75688	3.0460	3.44			/0.0>0.0/0.0>0.0		ATM|0.00|0.00|0.00|0.00|42|36|40|-15	18433505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108347469	108347469	T	C	het	off-target	QUAL=24;DP=8;QD=3.00	ATM,C11orf65	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron60/63:c.8671+104T>C::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron60/63:c.8671+104T>C::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron59/62:c.8671+104T>C::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron60/63:c.8671+104T>C::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron59/62:c.8671+104T>C::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.641-38398A>G::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+7446A>G::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1177615 [benign DISEASE=not specified,Ataxia-telangiectasia syndrome,not provided GENE=ATM];			rs227075	0.62075	0.68531,0.66167,0.44745,0.57753,0.65286	29581,	35170	57632	0.0580	2.50			/0.0>0.0/0.0>0.0		ATM|0.00|0.00|0.00|0.00|34|5|6|34,C11orf65|0.00|0.00|0.00|0.00|47|-37|-32|-11	32408300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108353970	108353970	G	A	het	off-target	QUAL=24;DP=3;QD=8.00	ATM,C11orf65	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron61/63:c.8786+90G>A::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron61/63:c.8786+90G>A::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8786+90G>A::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron61/63:c.8786+90G>A::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron60/62:c.8786+90G>A::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31950C>T::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+945C>T::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1192463 [benign DISEASE=Ataxia-telangiectasia syndrome,not provided,not specified GENE=ATM];		FLAM_A (SINE/Alu)	rs179108	0.99978	0.99959,0.99993,1.00000,1.00000,1.00000	75949,	33	33	-0.4880	0.91			/3.2>2.5/0.0>0.0,/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354070	108354070	A	C	het	off-target	QUAL=28;DP=8;QD=3.50	ATM,C11orf65	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron61/63:c.8786+190A>C::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron61/63:c.8786+190A>C::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8786+190A>C::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron61/63:c.8786+190A>C::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron60/62:c.8786+190A>C::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31850T>G::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+845T>G::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]			(AC)n (Simple_repeat)	rs678526	0.11218	0.06038,0.13945,0.07976,0.13640,0.16949	844,	11260	102470	-2.4860	0.60			/0.0>0.0/0.0>0.0,/0.3>0.0/0.0>0.0	COSV53731754	ATM|0.00|0.00|0.00|0.00|46|38|-26|38,C11orf65|0.00|0.00|0.00|0.00|-5|-22|1|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354756	108354756	C	T	het	off-target	QUAL=24;DP=159;QD=0.15	ATM,C11orf65	intron	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron61/63:c.8787-55C>T::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron60/62:c.8787-55C>T::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+31164G>A::,C11orf65:ENST00000615746.4:intron_variant:MODIFIER:intron11/12:c.*1196+159G>A::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1177616 [benign DISEASE=not specified,Hereditary breast ovarian cancer syndrome,Ataxia-telangiectasia syndrome,not provided GENE=ATM];			rs664982	0.53733	0.41588,0.62351,0.43571,0.56867,0.65004	22541,	36615	70345	-1.7010	0.13			/0.0>0.0/2.6>1.6,/0.0>0.0/3.4>0.0	COSV53733871	ATM|0.00|0.00|0.00|0.00|-18|-9|-50|13,C11orf65|0.00|0.00|0.00|0.00|17|50|7|1	31548641,19584272,25010664,19193393,12466288,20004998,16622469,28756982,34522244,28825373,21058196	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	108354934	108354934	A	G	het	off-target	QUAL=24;DP=275;QD=0.09	ATM,C11orf65	intron,3'UTR	ATM:ENST00000601453.3:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,ATM:ENST00000452508.7:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,ATM:ENST00000675843.1:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,ATM:ENST00000713844.1:intron_variant:MODIFIER:intron62/63:c.8850+60A>G::,ATM:ENST00000278616.10:intron_variant:MODIFIER:intron61/62:c.8850+60A>G::,C11orf65:ENST00000525729.5:intron_variant:MODIFIER:intron6/6:c.640+30986T>C::,C11orf65:ENST00000615746.4:3_prime_UTR_variant:MODIFIER:exon11/13:c.*1177T>C::		607585_[GENE=ATM_PHENOS=Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)]	1169174 [benign DISEASE=Ataxia-telangiectasia syndrome,not provided,Hereditary breast ovarian cancer syndrome,not specified GENE=ATM];			rs664143	0.61801	0.67645,0.66125,0.44535,0.57736,0.65249	29318,	35350	58092	-0.6960	0.53			/5.9>4.6/0.0>0.0,/0.0>0.0/0.0>0.0	COSV53746535	ATM|0.05|0.00|0.00|0.00|-16|5|-17|7,C11orf65|0.00|0.00|0.00|0.00|29|-40|-19|2	34540891,22665904,19536092,19115993,24218030,29879995,32408300,19584272,19193393,23318652,25196645,12466288,17151932,17582598,29246212,32329754,17132159,17431766,28756982,22203481,26094126,30514381,36316110,28642860,36233089,22767148,27905519,33918597,21058196,33507988,34650388,24177593,20171797,17222938,37425424	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATM (inh=AR+AD oe_syn=1.05 oe_mis=0.92 oe_lof=0.60), C11ORF65 (inh=AR+AD oe_syn=0.84 oe_mis=0.92 oe_lof=1.22)
chr11	125627571	125627571	G	T	het	off-target;low_conf_region	QUAL=24;DP=108;QD=0.22	CHEK1,STT3A	intron,downstream_gene	CHEK1:ENST00000438015.7:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000711049.1:intron_variant:MODIFIER:intron2/12:c.337+738G>T::,CHEK1:ENST00000427383.6:intron_variant:MODIFIER:intron2/11:c.337+738G>T::,CHEK1:ENST00000428830.6:intron_variant:MODIFIER:intron2/13:c.66-36G>T::,CHEK1:ENST00000278916.8:intron_variant:MODIFIER:intron2/11:c.66-36G>T::,CHEK1:ENST00000544373.5:intron_variant:MODIFIER:intron2/11:c.7+738G>T::,CHEK1:ENST00000532449.6:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,CHEK1:ENST00000534070.5:intron_variant:MODIFIER:intron2/12:c.66-36G>T::,STT3A:ENST00000392708.9:downstream_gene_variant:MODIFIER::::,STT3A:ENST00000649491.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	601134_[GENE=STT3A_PHENOS=Congenital disorder of glycosylation, type Iw, autosomal dominant, 619714 (3), Autosomal dominant; Congenital disorder of glycosylation, type Iw, autosomal recessive, 615596 (3), Autosomal recessive]&603078_[GENE=CHEK1_PHENOS=Oocyte/zygote/embryo maturation arrest 21, 620610 (3), Autosomal dominant]				rs491528	0.31512	0.37145,0.24175,0.42195,0.29452,0.34874	7815,	32274	104116	-0.6450	1.63			/0.0>0.0/0.0>0.0	COSV54022242	CHEK1|0.00|0.00|0.00|0.00|38|-4|48|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STT3A (inh=AR oe_syn=0.85 oe_mis=0.50 oe_lof=0.31), CHEK1 (inh=AD oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125644678	125644678	G	A	het	off-target	QUAL=24;DP=107;QD=0.22	CHEK1	intron	CHEK1:ENST00000438015.7:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000711049.1:intron_variant:MODIFIER:intron10/12:c.1281+35G>A::,CHEK1:ENST00000427383.6:intron_variant:MODIFIER:intron10/11:c.1281+35G>A::,CHEK1:ENST00000428830.6:intron_variant:MODIFIER:intron11/13:c.1233+35G>A::,CHEK1:ENST00000278916.8:intron_variant:MODIFIER:intron11/11:c.1233+35G>A::,CHEK1:ENST00000544373.5:intron_variant:MODIFIER:intron10/11:c.951+35G>A::,CHEK1:ENST00000532449.6:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::,CHEK1:ENST00000534070.5:intron_variant:MODIFIER:intron11/12:c.1233+35G>A::		603078_[GENE=CHEK1_PHENOS=Oocyte/zygote/embryo maturation arrest 21, 620610 (3), Autosomal dominant]				rs521102	0.45415	0.28192,0.56692,0.40124,0.52213,0.54787	16580,	35846	82940	0.6180	7.58			/3.1>2.8/0.0>0.0		CHEK1|0.00|0.00|0.00|0.00|39|-34|-35|-46	22665904,29928473,27905519	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=AD oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr11	125655300	125655300	A	G	hom		QUAL=24;DP=59;QD=0.41	CHEK1	missense	CHEK1:ENST00000438015.7:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000711049.1:missense_variant:MODERATE:exon12/13:c.1459A>G:p.Ile487Val:,CHEK1:ENST00000427383.6:missense_variant:MODERATE:exon12/12:c.1459A>G:p.Ile487Val:,CHEK1:ENST00000428830.6:missense_variant:MODERATE:exon13/14:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000278916.8:missense_variant:MODERATE:exon12/12:c.1309A>G:p.Ile437Val:,CHEK1:ENST00000544373.5:missense_variant:MODERATE:exon12/12:c.1129A>G:p.Ile377Val:,CHEK1:ENST00000532449.6:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:,CHEK1:ENST00000534070.5:missense_variant:MODERATE:exon13/13:c.1411A>G:p.Ile471Val:		603078_[GENE=CHEK1_PHENOS=Oocyte/zygote/embryo maturation arrest 21, 620610 (3), Autosomal dominant]	496139 [benign DISEASE=not provided,CHEK1-related disorder GENE=CHEK1];			rs506504	0.97474	0.99310,0.97399,0.99981,0.96405,0.97805	72370,	3725	3847	1.2110	15.35	0.053	0.06	/0.0>0.0/0.0>5.3			18805967,29458332	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK1 (inh=AD oe_syn=1.07 oe_mis=0.68 oe_lof=0.61)
chr12	57749071	57749071	C	A	het	off-target	QUAL=24;DP=108;QD=0.22	TSPAN31,CDK4,MIR6759	3'UTR,intron,downstream_gene,upstream_gene	TSPAN31:ENST00000547992.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1781C>A::,TSPAN31:ENST00000257910.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1781C>A::,CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron7/7:c.819+111G>T::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron6/6:c.*131+111G>T::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron3/3:c.30+111G>T::,TSPAN31:ENST00000547472.5:downstream_gene_variant:MODIFIER::::,MIR6759:ENST00000638110.1:upstream_gene_variant:MODIFIER::::		123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]	1182049 [benign DISEASE=not provided GENE=CDK4];			rs2069506	0.26479	0.08179,0.25628,0.65549,0.31449,0.49149	6737,	26823	111887	0.2050	5.55			/0.2>0.7/0.0>0.0,/3.9>5.0/0.0>2.9		CDK4|0.00|0.00|0.00|0.00|4|0|2|9	18174243,19258477,18281541	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr12	57750882	57750882	C	T	het	off-target	QUAL=24;DP=162;QD=0.15	CDK4,TSPAN31,MIR6759,MARCHF9	intron,downstream_gene,upstream_gene	CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron4/7:c.522+41G>A::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron3/6:c.265-211G>A::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron1/3:c.-158+1293G>A::,TSPAN31:ENST00000547992.5:downstream_gene_variant:MODIFIER::::,TSPAN31:ENST00000257910.8:downstream_gene_variant:MODIFIER::::,TSPAN31:ENST00000547472.5:downstream_gene_variant:MODIFIER::::,MIR6759:ENST00000638110.1:upstream_gene_variant:MODIFIER::::,MARCHF9:ENST00000266643.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]	1292556 [benign DISEASE=not provided GENE=CDK4];			rs2069502	0.26570	0.08207,0.25582,0.65217,0.31574,0.49439	6783,	26863	111733	0.5710	11.30			/2.1>4.6/0.0>0.0	COSV56983640	CDK4|0.00|0.00|0.00|0.00|44|26|26|41	19258477,23761422,24743186,34641739,28806841,25765001,23160276,23406874,23150009,23567489	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr12	57751373	57751373	C	T	het	off-target	QUAL=24;DP=416;QD=0.06	CDK4,TSPAN31,MIR6759,MARCHF9	intron,downstream_gene,upstream_gene	CDK4:ENST00000257904.11:intron_variant:MODIFIER:intron2/7:c.219-31G>A::,CDK4:ENST00000312990.10:intron_variant:MODIFIER:intron2/6:c.219-31G>A::,CDK4:ENST00000549606.5:intron_variant:MODIFIER:intron1/3:c.-158+802G>A::,TSPAN31:ENST00000547992.5:downstream_gene_variant:MODIFIER::::,TSPAN31:ENST00000257910.8:downstream_gene_variant:MODIFIER::::,TSPAN31:ENST00000547472.5:downstream_gene_variant:MODIFIER::::,MIR6759:ENST00000638110.1:upstream_gene_variant:MODIFIER::::,MARCHF9:ENST00000266643.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	123829_[GENE=CDK4_PHENOS={Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant]	1249096 [benign DISEASE=not provided GENE=CDK4];			rs2270777	0.33299	0.16808,0.33377,0.15670,0.43874,0.23755	9608,	31405	101399	-1.0380	6.96			/0.0>0.0/0.0>0.0	COSV56985436	CDK4|0.07|0.00|0.00|0.00|1|-31|-25|-9	18174243,19258477,18507837,23567489,35835914	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN31 (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.26), CDK4 (inh=AD oe_syn=1.26 oe_mis=0.68 oe_lof=0.31), MIR6759 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MARCHF9 (inh=n/a oe_syn=0.68 oe_mis=0.69 oe_lof=0.15)
chr13	32316435	32316435	G	A	het	off-target	QUAL=24;DP=118;QD=0.20	BRCA2,ZAR1L	5'UTR,upstream_gene	BRCA2:ENST00000544455.6:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,BRCA2:ENST00000713678.1:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,BRCA2:ENST00000530893.7:5_prime_UTR_variant:MODIFIER:exon2/27:c.-391G>A::,BRCA2:ENST00000700202.2:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,BRCA2:ENST00000380152.8:5_prime_UTR_variant:MODIFIER:exon2/27:c.-26G>A::,BRCA2:ENST00000713680.1:5_prime_UTR_variant:MODIFIER:exon2/26:c.-26G>A::,ZAR1L:ENST00000533490.7:upstream_gene_variant:MODIFIER::::,ZAR1L:ENST00000345108.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	125965 [benign DISEASE=Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial, susceptibility to, 2,Familial cancer of breast,not specified,Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,not provided GENE=BRCA2];	CR068211 [CLASS=DFP MUT=ALT PHEN="Breast cancer sporadic protection against" GENE=BRCA2];		rs1799943	0.21320	0.10564,0.18948,0.38680,0.26631,0.27893	3886,	24667	119713	0.5460	8.76			/0.0>0.0/0.0>0.0	COSV61525225	BRCA2|0.00|0.02|0.04|0.00|20|-13|-44|19	25741868,19276285,23663450,22513257,12466288,21161372,19644020,26979245,33499154,16760289,24337145,21702907,21356067,18724707,21939546,23767878,18694767,33643918,34295994,28944232,34287479,19012493,22809218,32284662,23755158,17945002,28076423,24938600,29460995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZAR1L (inh=AD oe_syn=0.79 oe_mis=0.65 oe_lof=0.30), BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32326796	32326796	T	A	het	off-target	QUAL=24;DP=4;QD=6.00	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron7/26:c.631+183T>A::,BRCA2:ENST00000713678.1:intron_variant:MODIFIER:intron7/26:c.631+183T>A::,BRCA2:ENST00000530893.7:intron_variant:MODIFIER:intron7/26:c.262+183T>A::,BRCA2:ENST00000700202.2:intron_variant:MODIFIER:intron7/26:c.631+183T>A::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron7/26:c.631+183T>A::,BRCA2:ENST00000713680.1:intron_variant:MODIFIER:intron7/25:c.631+183T>A::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	209652 [benign DISEASE=not specified,not provided,Breast-ovarian cancer, familial, susceptibility to, 2 GENE=BRCA2];			rs3752451	0.33385	0.28391,0.32551,0.49884,0.34958,0.40856	8620,	33413	101071	0.0330	1.86			/0.0>0.0/0.0>1.0		BRCA2|0.00|0.00|0.00|0.00|-28|4|-34|3	25741868,19276285,35908255	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32329548	32329548	C	T	het	off-target	QUAL=24;DP=44;QD=0.55	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron8/26:c.681+56C>T::,BRCA2:ENST00000713678.1:intron_variant:MODIFIER:intron8/26:c.681+56C>T::,BRCA2:ENST00000530893.7:intron_variant:MODIFIER:intron8/26:c.312+56C>T::,BRCA2:ENST00000700202.2:intron_variant:MODIFIER:intron8/26:c.681+56C>T::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron8/26:c.681+56C>T::,BRCA2:ENST00000713680.1:intron_variant:MODIFIER:intron8/25:c.681+56C>T::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	126192 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary breast ovarian cancer syndrome,not provided,Hereditary cancer-predisposing syndrome,not specified GENE=BRCA2];			rs2126042	0.20523	0.24964,0.20412,0.08301,0.18833,0.12671	3387,	24396	120706	-0.2650	6.96			/0.0>0.0/0.0>0.0	COSV66457755	BRCA2|0.00|0.00|0.00|0.00|-50|22|-48|2	25741868,19276285,17428325,21161372,19644020,10923033,21356067,18694767,33643918,28944232,28076423,30323354	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32331128	32331128	G	A	hom	off-target	QUAL=24;DP=131;QD=0.18	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron9/26:c.793+98G>A::,BRCA2:ENST00000713678.1:intron_variant:MODIFIER:intron9/26:c.793+98G>A::,BRCA2:ENST00000530893.7:intron_variant:MODIFIER:intron9/26:c.424+98G>A::,BRCA2:ENST00000700202.2:intron_variant:MODIFIER:intron9/26:c.793+98G>A::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron9/26:c.793+98G>A::,BRCA2:ENST00000713680.1:intron_variant:MODIFIER:intron9/25:c.793+98G>A::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	209936 [benign DISEASE=not provided,Breast-ovarian cancer, familial, susceptibility to, 2 GENE=BRCA2];		AluSx (SINE/Alu)	rs206073	0.97864	0.92595,0.99246,0.99981,0.99969,0.99937	72612,	3001	3235	-0.1220	0.15			/0.0>3.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32336191	32336191	T	C	het	off-target	QUAL=25;DP=55;QD=0.45	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron10/26:c.1910-74T>C::,BRCA2:ENST00000713678.1:intron_variant:MODIFIER:intron10/26:c.1910-74T>C::,BRCA2:ENST00000530893.7:intron_variant:MODIFIER:intron10/26:c.1541-74T>C::,BRCA2:ENST00000700202.2:intron_variant:MODIFIER:intron10/26:c.1910-74T>C::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron10/26:c.1910-74T>C::,BRCA2:ENST00000713680.1:intron_variant:MODIFIER:intron10/25:c.1910-74T>C::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	209687 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,Breast-ovarian cancer, familial, susceptibility to, 2,not provided GENE=BRCA2];			rs2320236	0.19439	0.21288,0.19843,0.08311,0.18824,0.12598	3028,	23526	122594	1.7040	12.14			/4.6>5.2/0.0>0.0		BRCA2|0.00|0.00|0.00|0.00|36|8|36|-33	21161372	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32337751	32337751	A	G	het		QUAL=24;DP=75;QD=0.32	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000713678.1:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000530893.7:synonymous_variant:LOW:exon11/27:c.3027A>G:p.Lys1009=:,BRCA2:ENST00000700202.2:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.3396A>G:p.Lys1132=:,BRCA2:ENST00000713680.1:synonymous_variant:LOW:exon11/26:c.3396A>G:p.Lys1132=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	126010 [benign DISEASE=Hereditary cancer-predisposing syndrome,not provided,not specified,Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 2,Fanconi anemia complementation group D1,Familial cancer of breast GENE=BRCA2];	CM2110542 [CLASS=DM? MUT=ALT PHEN="Breast cancer" GENE=BRCA2];		rs1801406	0.28412	0.23026,0.22415,0.39791,0.31648,0.29312	6327,	30540	108832	0.2330	3.94			/0.9>0.0/0.0>0.0	COSV66448451	BRCA2|0.00|0.00|0.00|0.00|-8|-3|48|-29	25741868,16857995,18830263,19692168,19902366,28415781,19276285,21346221,21987080,21161372,19644020,27478808,20807450,12474142,18431501,23767878,33643918,34295994,28944232,32284662,29884136,33814932,27273131,25304112,33462484,26840129,28076423,35686104,36329109	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32338918	32338918	A	G	hom		QUAL=24;DP=692;QD=0.03	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:,BRCA2:ENST00000713678.1:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:,BRCA2:ENST00000530893.7:synonymous_variant:LOW:exon11/27:c.4194A>G:p.Leu1398=:,BRCA2:ENST00000700202.2:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.4563A>G:p.Leu1521=:,BRCA2:ENST00000713680.1:synonymous_variant:LOW:exon11/26:c.4563A>G:p.Leu1521=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	132779 [benign DISEASE=Malignant tumor of breast,not provided,BRCA2-related disorder,Familial cancer of breast,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,not specified GENE=BRCA2];			rs206075	0.97863	0.92597,0.99248,0.99981,0.99969,0.99938	73014,	3015	3255	0.0760	2.15			/6.1>7.1/0.0>0.0	COSV101203861		25741868,24033266,18414213,32708070,27478808,1517275,1684755,9971877,12552570,15744044,16847550,19941162,20104584,22034289,23767878,33643918,28944232,35908255,32327675,35300046,28076423,29997359,35686104,31962039,36329109	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32340868	32340868	G	C	hom		QUAL=25;DP=26;QD=0.96	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000713678.1:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000530893.7:synonymous_variant:LOW:exon11/27:c.6144G>C:p.Val2048=:,BRCA2:ENST00000700202.2:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon11/27:c.6513G>C:p.Val2171=:,BRCA2:ENST00000713680.1:synonymous_variant:LOW:exon11/26:c.6513G>C:p.Val2171=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	132780 [benign DISEASE=Hereditary cancer-predisposing syndrome,Malignant tumor of breast,Fanconi anemia complementation group D1,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary breast ovarian cancer syndrome,not specified,not provided,Familial cancer of breast GENE=BRCA2];			rs206076	0.97850	0.92550,0.99249,0.99981,0.99969,0.99938	73012,	3034	3276	-0.8640	0.10			/0.0>0.0/0.0>0.0	COSV66458663		25741868,18414213,27478808,9971877,15744044,16847550,20127978,21156238,33643918,28439188,35908255,32284662,32327675,35300046,28076423,29997359,35686104,31962039,36329109,30254663	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32346707	32346707	T	C	hom	off-target	QUAL=24;DP=4;QD=6.00	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron12/26:c.6938-120T>C::,BRCA2:ENST00000713678.1:intron_variant:MODIFIER:intron12/26:c.6938-120T>C::,BRCA2:ENST00000530893.7:intron_variant:MODIFIER:intron12/26:c.6569-120T>C::,BRCA2:ENST00000700202.2:intron_variant:MODIFIER:intron12/26:c.6938-120T>C::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron12/26:c.6938-120T>C::,BRCA2:ENST00000713680.1:intron_variant:MODIFIER:intron12/25:c.6938-120T>C::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	209939 [benign DISEASE=not provided,not specified,Breast-ovarian cancer, familial, susceptibility to, 2 GENE=BRCA2];			rs206080	0.97853	0.92579,0.99242,0.99981,0.99969,0.99813	72918,	3024	3266	-2.1790	0.17			/0.0>0.0/0.0>0.0		BRCA2|0.00|0.00|0.00|0.00|-19|17|19|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32355095	32355095	A	G	het		QUAL=24;DP=38;QD=0.63	BRCA2	synonymous	BRCA2:ENST00000544455.6:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:,BRCA2:ENST00000713678.1:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:,BRCA2:ENST00000530893.7:synonymous_variant:LOW:exon14/27:c.6873A>G:p.Ser2291=:,BRCA2:ENST00000700202.2:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:,BRCA2:ENST00000380152.8:synonymous_variant:LOW:exon14/27:c.7242A>G:p.Ser2414=:,BRCA2:ENST00000713680.1:synonymous_variant:LOW:exon14/26:c.7242A>G:p.Ser2414=:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	126133 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary breast ovarian cancer syndrome,Fanconi anemia complementation group D1,not provided,Familial cancer of breast GENE=BRCA2];			rs1799955	0.22132	0.21581,0.18291,0.39547,0.21913,0.21950	3839,	25994	118468	0.0960	5.72			/4.4>4.3/0.0>0.0	COSV66447569	BRCA2|0.00|0.00|0.00|0.00|12|2|20|-30	25741868,16857995,18830263,21987080,22430443,17428325,21161372,19644020,27478808,22034289,20807450,18431501,19471317,12955716,17018160,17686308,21042765,22713736,21356067,23767878,33643918,34295994,28944232,33004033,29884136,18059179,28334899,25304112,28076423,36329109	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32355250	32355250	T	C	hom		QUAL=24;DP=598;QD=0.04	BRCA2	missense	BRCA2:ENST00000544455.6:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000713678.1:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000530893.7:missense_variant:MODERATE:exon14/27:c.7028T>C:p.Val2343Ala:,BRCA2:ENST00000700202.2:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000380152.8:missense_variant:MODERATE:exon14/27:c.7397T>C:p.Val2466Ala:,BRCA2:ENST00000713680.1:missense_variant:MODERATE:exon14/26:c.7397T>C:p.Val2466Ala:		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	133738 [benign DISEASE=not specified,not provided,Hereditary breast ovarian cancer syndrome,BRCA2-related cancer predisposition,Breast-ovarian cancer, familial, susceptibility to, 2,Breast ductal adenocarcinoma GENE=BRCA2];			rs169547	0.98057	0.93275,0.99301,0.99981,0.99975,0.99959	73292,	2767	2959	2.4910	8.68	0.091	0.05	/0.0>0.2/0.0>0.0	COSV66451785		25741868,24033266,24728327,32708070,29458332,27900359,34203389,23961350,27478808,8665505,27698805,31203256,33643918,25802882,26092435,28944232,35908255,33240400,35456488,32327675,35300046,31131559,28076423,26358132,29997359,35686104,31962039,25923920,36329109	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32362509	32362509	T	C	hom	off-target	QUAL=24;DP=63;QD=0.38	BRCA2	splice_region&intron	BRCA2:ENST00000544455.6:splice_region_variant&intron_variant:LOW:intron16/26:c.7806-14T>C::,BRCA2:ENST00000713678.1:splice_region_variant&intron_variant:LOW:intron16/26:c.7806-14T>C::,BRCA2:ENST00000530893.7:splice_region_variant&intron_variant:LOW:intron16/26:c.7437-14T>C::,BRCA2:ENST00000700202.2:splice_region_variant&intron_variant:LOW:intron16/26:c.7806-14T>C::,BRCA2:ENST00000380152.8:splice_region_variant&intron_variant:LOW:intron16/26:c.7806-14T>C::,BRCA2:ENST00000713680.1:splice_region_variant&intron_variant:LOW:intron16/25:c.7806-14T>C::	regulatory_region_variant:enhancer	600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	126158 [benign DISEASE=not specified,not provided,Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary breast ovarian cancer syndrome,Familial cancer of breast,Fanconi anemia complementation group D1,Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome GENE=BRCA2];	CS147979 [CLASS=FP MUT=ALT PHEN="Alternative splicing" GENE=BRCA2];		rs9534262	0.53712	0.56685,0.53634,0.57121,0.52109,0.47988	22039,	37547	70343	-1.4060	6.47			8.3>7.9/8.3>7.9/0.0>0.0	COSV66447577	BRCA2|0.00|0.02|0.00|0.00|34|14|14|33	25741868,24033266,22382497,21161372,19644020,21702907,24123850,18694767,33643918,35908255,29884136,26852130,35300046,28076423,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	32379251	32379251	T	C	hom	off-target	QUAL=24;DP=254;QD=0.09	BRCA2	intron	BRCA2:ENST00000544455.6:intron_variant:MODIFIER:intron21/26:c.8755-66T>C::,BRCA2:ENST00000713678.1:intron_variant:MODIFIER:intron21/26:c.8755-66T>C::,BRCA2:ENST00000530893.7:intron_variant:MODIFIER:intron21/26:c.8386-66T>C::,BRCA2:ENST00000700202.2:intron_variant:MODIFIER:intron21/26:c.8755-66T>C::,BRCA2:ENST00000380152.8:intron_variant:MODIFIER:intron21/26:c.8755-66T>C::,BRCA2:ENST00000713680.1:intron_variant:MODIFIER:intron20/25:c.8599-66T>C::		600185_[GENE=BRCA2_PHENOS=Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Autosomal dominant, Somatic mutation; {Prostate cancer}, 176807 (3), Autosomal dominant, Somatic mutation; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Autosomal dominant, Somatic mutation]	126190 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 2,Hereditary cancer-predisposing syndrome,not provided,Hereditary breast ovarian cancer syndrome,not specified GENE=BRCA2];			rs4942486	0.51742	0.50058,0.52984,0.57046,0.51956,0.47838	20438,	37783	73363	-1.1820	0.98			/0.0>0.0/0.0>0.0	COSV66457232	BRCA2|0.00|0.00|0.00|0.00|-5|12|-42|-25	25741868,24097068,22382497,26637267,28250428,21161372,18694767,33643918,32040442,35908255,32284662,30926973,34290314,29507422,28334899,33462484,28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA2 (inh=AR+AD oe_syn=0.99 oe_mis=1.09 oe_lof=0.51)
chr13	79192053	79192053	A	G	het		QUAL=24;DP=825;QD=0.03		intergenic	::intergenic_variant:MODIFIER::::						rs2988039	0.40613	0.70012,0.38676,0.67559,0.25262,0.35869	15659,	30401	90249	-0.9400	3.29							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr14	45137184	45137184	A	G	het		QUAL=24;DP=53;QD=0.45	FANCM,FKBP3	missense,3'UTR,upstream_gene	FANCM:ENST00000267430.10:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000556250.6:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000556036.6:missense_variant:MODERATE:exon2/11:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000542564.6:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696676.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*38A>G::,FANCM:ENST00000554030.2:missense_variant:MODERATE:exon2/2:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696662.1:missense_variant:MODERATE:exon2/10:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696649.1:missense_variant:MODERATE:exon2/22:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696643.1:missense_variant:MODERATE:exon2/9:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FANCM:ENST00000696682.1:missense_variant:MODERATE:exon2/10:c.624A>G:p.Ile208Met:PF00270 [DEAD/DEAH box helicase],FKBP3:ENST00000396062.4:upstream_gene_variant:MODIFIER::::,FKBP3:ENST00000216330.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	609644_[GENE=FANCM_PHENOS=Premature ovarian failure 15, 618096 (3), Autosomal recessive; Spermatogenic failure 28, 618086 (3), Autosomal recessive]	241326 [benign/likely benign DISEASE=not specified,Fanconi anemia,Premature ovarian failure 15,not provided GENE=FANCM];	CM2212569 [CLASS=DM? MUT=ALT PHEN="Azoospermia non-obstructive" GENE=FANCM];		rs45547534	0.01051	0.00296,0.01340,0.00000,0.01648,0.00849	11,	1579	150699	0.0190	24.10	0.117	0.27	/0.0>0.0/0.0>0.0	COSV53531926	FANCM|0.13|0.00|0.00|0.00|-47|-42|49|-42	29351780	11	1115	0	2 / 158	2	"[2] Ilnaz Sepahi 12-10-2016 batch import"			FKBP3 (inh=n/a oe_syn=1.05 oe_mis=1.00 oe_lof=0.54), FANCM (inh=AR oe_syn=1.00 oe_mis=1.01 oe_lof=0.46)
chr14	67823655	67823655	T	G	het	off-target	QUAL=24;DP=523;QD=0.05	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000460526.6:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+28T>G::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+28T>G::			1264893 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided GENE=RAD51B];			rs17783124	0.32368	0.34347,0.25278,0.07479,0.35391,0.23943	8319,	32584	102846	0.1820	4.67			/3.4>0.8/2.3>0.0		RAD51B|0.00|0.00|0.00|0.01|-28|-49|-33|-28	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67823709	67823709	T	C	het	off-target	QUAL=24;DP=26;QD=0.92	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000460526.6:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+82T>C::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+82T>C::			1270487 [benign DISEASE=not provided GENE=RAD51B];			rs28604984	0.32378	0.34350,0.25291,0.07474,0.35397,0.23922	8326,	32591	102845	0.2040	2.04			/0.2>0.0/0.0>0.0		RAD51B|0.00|0.00|0.00|0.00|6|50|6|-39	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67823747	67823747	G	A	het	off-target	QUAL=25;DP=35;QD=0.71	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000460526.6:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+120G>A::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+120G>A::			1271766 [benign DISEASE=not provided GENE=RAD51B];			rs28623567	0.32404	0.34390,0.25304,0.07538,0.35409,0.23953	8338,	32594	102778	0.9070	14.06			/8.7>7.9/1.1>5.2		RAD51B|0.00|0.00|0.00|0.00|12|-27|-3|18	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67823803	67823803	T	G	het	off-target	QUAL=24;DP=24;QD=1.00	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000460526.6:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron2/10:c.84+176T>G::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron2/11:c.84+176T>G::			1259949 [benign DISEASE=not provided GENE=RAD51B];			rs8006089	0.36341	0.46673,0.27351,0.14878,0.35551,0.24430	10655,	33963	96823	0.0840	9.80			/0.0>0.0/0.0>0.0		RAD51B|0.00|0.00|0.00|0.00|-44|22|-44|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67835050	67835050	-	A	het	off-target	QUAL=24;DP=253;QD=0.09	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000460526.6:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron3/10:c.199-22dup::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron3/11:c.199-22dup::			1270868 [benign DISEASE=not provided GENE=RAD51B];			rs34564590	0.37268	0.49671,0.27838,0.14793,0.35633,0.24366	11283,	33975	95173		9.51			/0.0>0.0/0.0>0.0		RAD51B|0.00|0.01|0.00|0.00|46|30|46|30	29879995,27149063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67864953	67864953	C	T	hom	off-target	QUAL=6;DP=555;QD=0.01	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron4/10:c.316-50C>T::,RAD51B:ENST00000460526.6:intron_variant:MODIFIER:intron4/10:c.316-50C>T::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron4/10:c.316-50C>T::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron4/10:c.316-50C>T::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron4/11:c.316-50C>T::						rs200308660	0.00000	0.00000,0.00000,0.00000,0.00000,0.00000	0,	0	50988	-0.6080	0.58			/0.0>0.0/0.0>0.0		RAD51B|0.00|0.00|0.00|0.00|9|50|50|49		0	0	0	0 / 0					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	67864958	67864958	A	T	hom	off-target;low_conf_region	QUAL=25;DP=546;QD=0.05	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000460526.6:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron4/10:c.316-45A>T::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron4/11:c.316-45A>T::			1264510 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not provided GENE=RAD51B];			rs1474939	0.95038	0.93593,0.96385,0.95205,0.95355,0.94682	45553,	5012	5018	-0.7160	0.53			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	68477457	68477457	C	T	het	off-target	QUAL=24;DP=19;QD=1.26	RAD51B	intron	RAD51B:ENST00000471583.6:intron_variant:MODIFIER:intron10/10:c.1037-191C>T::,RAD51B:ENST00000460526.6:intron_variant:MODIFIER:intron10/10:c.1036+9207C>T::,RAD51B:ENST00000487861.5:intron_variant:MODIFIER:intron10/10:c.1036+9207C>T::,RAD51B:ENST00000487270.5:intron_variant:MODIFIER:intron10/10:c.1036+9207C>T::,RAD51B:ENST00000488612.5:intron_variant:MODIFIER:intron10/11:c.1036+9207C>T::	regulatory_region_variant:open_chromatin_region					rs36094690	0.00809	0.00279,0.00608,0.00019,0.01345,0.00665	7,	1217	150993	-0.4100	0.17			/0.0>0.0/0.0>0.0		RAD51B|0.00|0.00|0.00|0.00|16|-24|-20|41		17	668	0	1 / 107					RAD51B (inh=n/a oe_syn=0.95 oe_mis=0.86 oe_lof=1.14)
chr14	103699416	103699416	G	A	het		QUAL=24;DP=918;QD=0.03	KLC1,XRCC3	intron,missense	KLC1:ENST00000348520.10:intron_variant:MODIFIER:intron13/14:c.1651-1239G>A::,KLC1:ENST00000334553.11:intron_variant:MODIFIER:intron15/16:c.1849-1239G>A::,KLC1:ENST00000555836.5:intron_variant:MODIFIER:intron15/16:c.1822-1239G>A::,KLC1:ENST00000557450.5:intron_variant:MODIFIER:intron13/14:c.1624-1239G>A::,KLC1:ENST00000452929.6:intron_variant:MODIFIER:intron14/15:c.1782-1239G>A::,KLC1:ENST00000554280.5:intron_variant:MODIFIER:intron14/15:c.1755-1239G>A::,XRCC3:ENST00000554913.5:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000555055.6:missense_variant:MODERATE:exon8/10:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000352127.11:missense_variant:MODERATE:exon7/9:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000553264.5:missense_variant:MODERATE:exon6/8:c.722C>T:p.Thr241Met:PF08423 [Rad51],XRCC3:ENST00000554974.5:missense_variant:MODERATE:exon2/4:c.107C>T:p.Thr36Met:PF08423 [Rad51]		600675_[GENE=XRCC3_PHENOS={Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; {Melanoma, cutaneous malignant, 6}, 613972 (3)]	8944 [benign DISEASE=XRCC3-related disorder,not provided,Melanoma, cutaneous malignant, susceptibility to, 6 GENE=KLC1];	CM003625 [CLASS=DFP MUT=ALT PHEN="Melanoma association with" GENE=XRCC3];		rs861539	0.29761	0.20893,0.25899,0.06541,0.37547,0.23406	7378,	30462	106718	0.7970	8.55	0.031	0.09	/3.3>1.6/0.0>0.0,/0.0>0.0/2.0>0.0	COSV57974380	XRCC3|0.01|0.00|0.00|0.00|29|47|-5|-39	30409984,26451011,21708280,21514219,25928231,34540891,28827732,31516756,30781715,21658613,32233832,26029010,18191955,22655231,16465622,16857995,18701435,19109789,19124499,20150366,21700777,23720673,24500421,25231222,27415837,31584889,23565320,26263974,21487324,24701578,34491229,18830263,21347786,27608007,31395900,24315498,28717179,34837895,20226869,19902366,28415781,29458332,21195504,23443124,26159902,28206966,32957448,28324443,27258253,29719630,30235774,18086758,31175773,34950210,31374908,31629678,23697595,18579371,18768505,21877955,23663450,19127255,18194558,21332318,27053949,25452763,22868256,35691022,28033528,24756092,18990748,19815090,21183201,21561390,21974800,25529925,27460091,27571987,28749454,29035403,29139108,31446980,31914346,33273562,24325908,19706757,28983784,21047201,24939416,29732392,25589620,30584056,25178586,17557904,21617942,18410587,22726897,18708406,18582155,19367277,21749698,30712190,21647442,18188695,20004634,21104022,23539294,24642895,24728564,26339569,26549042,26590607,26801223,2745524	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KLC1 (inh=n/a oe_syn=1.01 oe_mis=0.52 oe_lof=0.23), XRCC3 (inh=AD oe_syn=1.06 oe_mis=0.92 oe_lof=1.13)
chr14	104773454	104773454	C	A	het	mosaic	QUAL=0;DP=303;QD=0.00;AF=0.06;MQM=60;SAP=3;ABP=0;SAR=10;SAF=8	AKT1	splice_donor,intron	AKT1:ENST00000554581.5:splice_donor_variant:HIGH:intron8/12:c.828+1G>T:p.?:,AKT1:ENST00000407796.7:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000649815.2:splice_donor_variant:HIGH:intron10/14:c.828+1G>T:p.?:,AKT1:ENST00000349310.7:splice_donor_variant:HIGH:intron10/14:c.828+1G>T:p.?:,AKT1:ENST00000714123.1:intron_variant:MODIFIER:intron8/12:c.703-75G>T::,AKT1:ENST00000402615.6:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000714130.1:splice_donor_variant:HIGH:intron11/15:c.828+1G>T:p.?:,AKT1:ENST00000555528.5:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000683722.1:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000555458.6:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000553797.2:splice_donor_variant:HIGH:intron10/14:c.903+1G>T:p.?:,AKT1:ENST00000554192.6:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:,AKT1:ENST00000554848.5:splice_donor_variant:HIGH:intron9/13:c.828+1G>T:p.?:	regulatory_region_variant:CTCF_binding_site	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3), Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]				rs1892515544						5.7320	34.00			9.0>0.5/1.1>1.8/9.0>0.5,/1.1>1.8/9.0>0.5		AKT1|0.00|0.00|0.36|0.99|22|50|2|1		0	1	1	0 / 1					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104776629	104776629	T	C	het	off-target	QUAL=25;DP=134;QD=0.19	AKT1	intron	AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron3/12:c.287+30A>G::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000714123.1:intron_variant:MODIFIER:intron4/12:c.287+30A>G::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000714130.1:intron_variant:MODIFIER:intron6/15:c.287+30A>G::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000555458.6:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron5/14:c.287+30A>G::,AKT1:ENST00000554192.6:intron_variant:MODIFIER:intron4/13:c.287+30A>G::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron4/13:c.287+30A>G::		164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3), Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]	1272355 [benign DISEASE=not provided GENE=AKT1];			rs2494735	0.48875	0.70582,0.51980,0.64600,0.35473,0.57761	20070,	34244	77810	-3.6570	0.01			/0.0>0.0/0.4>0.0	COSV62573175	AKT1|0.00|0.00|0.00|0.00|30|43|-43|30	28822116,28050343,19461960	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104792555	104792555	C	T	hom	off-target	QUAL=25;DP=112;QD=0.22	AKT1	intron	AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron1/12:c.46+43G>A::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000714123.1:intron_variant:MODIFIER:intron2/12:c.46+43G>A::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000714130.1:intron_variant:MODIFIER:intron4/15:c.46+43G>A::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000555458.6:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron3/14:c.46+43G>A::,AKT1:ENST00000554192.6:intron_variant:MODIFIER:intron2/13:c.46+43G>A::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron2/13:c.46+43G>A::	regulatory_region_variant:open_chromatin_region	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3), Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]	1182199 [benign DISEASE=not provided GENE=AKT1];			rs2494748	0.48152	0.25838,0.50373,0.21252,0.60929,0.39967	19613,	34011	78859	-0.8470	0.26			/0.0>0.0/0.0>0.0	COSV62573228	AKT1|0.00|0.00|0.00|0.00|43|4|-21|43	22929028,36376304,32888494,30275531,35213538,30595370,34594039,32203549	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr14	104792556	104792556	A	G	hom	off-target	QUAL=24;DP=112;QD=0.21	AKT1	intron	AKT1:ENST00000554581.5:intron_variant:MODIFIER:intron1/12:c.46+42T>C::,AKT1:ENST00000407796.7:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000649815.2:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000349310.7:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000714123.1:intron_variant:MODIFIER:intron2/12:c.46+42T>C::,AKT1:ENST00000402615.6:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000714130.1:intron_variant:MODIFIER:intron4/15:c.46+42T>C::,AKT1:ENST00000555528.5:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000683722.1:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000555458.6:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000553797.2:intron_variant:MODIFIER:intron3/14:c.46+42T>C::,AKT1:ENST00000554192.6:intron_variant:MODIFIER:intron2/13:c.46+42T>C::,AKT1:ENST00000554848.5:intron_variant:MODIFIER:intron2/13:c.46+42T>C::	regulatory_region_variant:open_chromatin_region	164730_[GENE=AKT1_PHENOS=Breast cancer, somatic, 114480 (3); Cowden syndrome 6, 615109 (3), Autosomal dominant; Colorectal cancer, somatic, 114500 (3); Proteus syndrome, somatic, 176920 (3); Ovarian cancer, somatic, 167000 (3)]	1238585 [benign DISEASE=not provided GENE=AKT1];			rs2494749	0.87165	0.88826,0.79460,0.34204,0.92409,0.65642	58840,	14900	19522	-1.6150	0.54			/0.0>0.0/0.0>0.0	COSV62573234	AKT1|0.00|0.00|0.00|0.00|-18|-28|42|-3	29023587	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AKT1 (inh=AD oe_syn=1.05 oe_mis=0.46 oe_lof=0.14)
chr15	40701377	40701377	T	-	het	off-target;low_conf_region	QUAL=23;DP=25;QD=0.92	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron3/8:c.225+190del::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron3/7:c.225+190del::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron3/9:c.225+190del::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron3/9:c.225+190del::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron3/9:c.225+190del::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron3/9:c.225+190del::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]	1227276 [benign DISEASE=not provided GENE=RAD51];		AluSx (SINE/Alu)	rs57054958	0.50833	0.50152,0.57137,0.74175,0.47255,0.63442	10738,	34116	53770	0.1210	0.05			/3.7>4.1/0.0>0.0		RAD51|0.00|0.00|0.00|0.00|44|20|-33|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40701777	40701779	TTT	-	het	off-target;low_conf_region	QUAL=25;DP=71;QD=0.35	RAD51	intron,splice_region&intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron3/8:c.225+599_225+601del::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron3/7:c.225+599_225+601del::,RAD51:ENST00000382643.7:splice_region_variant&intron_variant:LOW:intron3/9:c.226-6_226-4del::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron3/9:c.225+599_225+601del::,RAD51:ENST00000645673.2:splice_region_variant&intron_variant:LOW:intron3/9:c.226-6_226-4del::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron3/9:c.225+599_225+601del::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]	3043549 [likely benign DISEASE=RAD51-related disorder GENE=RAD51];		AluSc (SINE/Alu)	rs35383252	0.02173	0.00762,0.02560,0.08084,0.02001,0.07782	6,	1406	63844	0.2630	5.29			/0.0>0.0/0.0>0.0		RAD51|0.11|0.00|0.00|0.00|30|0|30|23		174	768	0	14 / 130					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40706144	40706144	T	G	het	off-target	QUAL=24;DP=100;QD=0.24	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron3/8:c.226-33T>G::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron3/7:c.225+4943T>G::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron3/9:c.226-33T>G::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron4/9:c.347-2881T>G::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron3/9:c.226-33T>G::	regulatory_region_variant:open_chromatin_region	179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]	1255257 [benign DISEASE=not provided GENE=RAD51];			rs45457497	0.22310	0.24095,0.35076,0.67105,0.15495,0.30983	4781,	24382	118206	1.4560	6.34			/0.0>0.0/0.0>0.0	COSV51111815	RAD51|0.00|0.00|0.00|0.00|1|-22|33|-14	25918678	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	40729372	40729372	-	A	het	off-target;low_conf_region	QUAL=30;DP=79;QD=0.38	RAD51	intron	RAD51:ENST00000423169.6:intron_variant:MODIFIER:intron7/8:c.645-108dup::,RAD51:ENST00000557850.5:intron_variant:MODIFIER:intron5/7:c.354-108dup::,RAD51:ENST00000382643.7:intron_variant:MODIFIER:intron7/9:c.648-108dup::,RAD51:ENST00000267868.8:intron_variant:MODIFIER:intron7/9:c.645-108dup::,RAD51:ENST00000645673.2:intron_variant:MODIFIER:intron7/9:c.648-108dup::,RAD51:ENST00000532743.6:intron_variant:MODIFIER:intron7/9:c.645-108dup::		179617_[GENE=RAD51_PHENOS=Mirror movements 2, 614508 (3), Autosomal dominant; {Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation; Fanconi anemia, complementation group R, 617244 (3), Autosomal dominant]			AluYm1 (SINE/Alu)	rs60375696	0.07913	0.07901,0.05623,0.12953,0.08010,0.09885	295,	4489	59107		0.93			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51 (inh=AD oe_syn=1.10 oe_mis=0.45 oe_lof=0.33)
chr15	43408229	43408229	G	A	het	off-target	QUAL=25;DP=404;QD=0.06	TUBGCP4,TP53BP1	3'UTR,intron,downstream_gene	TUBGCP4:ENST00000564079.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3015G>A::,TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron26/27:c.5601-141C>T::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron26/27:c.5586-141C>T::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron25/26:c.5451-141C>T::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron26/27:c.5595-141C>T::,TUBGCP4:ENST00000260383.11:downstream_gene_variant:MODIFIER::::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]			AluJb (SINE/Alu)	rs45585139	0.17531	0.33360,0.17746,0.27029,0.09338,0.17620	3248,	20182	125502	1.4850	2.57			/0.0>0.0/0.0>0.0		TP53BP1|0.00|0.00|0.00|0.00|36|-40|2|4,TUBGCP4|0.00|0.00|0.00|0.00|12|-27|-10|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43408288	43408288	G	A	het	off-target	QUAL=24;DP=3;QD=8.00	TUBGCP4,TP53BP1	3'UTR,intron,downstream_gene	TUBGCP4:ENST00000564079.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3074G>A::,TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron26/27:c.5601-200C>T::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron26/27:c.5586-200C>T::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron25/26:c.5451-200C>T::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron26/27:c.5595-200C>T::,TUBGCP4:ENST00000260383.11:downstream_gene_variant:MODIFIER::::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]			AluJb (SINE/Alu)	rs117655500	0.02202	0.00573,0.01792,0.00019,0.03118,0.00895	58,	3236	148864	-0.5230	0.46			/0.0>0.0/0.0>0.0,/0.9>1.2/0.0>0.0		TP53BP1|0.00|0.00|0.00|0.00|-23|22|-3|49,TUBGCP4|0.00|0.00|0.00|0.00|-47|48|8|7		37	451	0	6 / 46					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43409749	43409749	A	-	het		QUAL=24;DP=88;QD=0.27	TUBGCP4,TP53BP1	3'UTR,splice_region&intron,downstream_gene	TUBGCP4:ENST00000564079.6:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4545del::,TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron24/27:c.5306-8del::,TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron24/27:c.5291-8del::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron23/26:c.5156-8del::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron24/27:c.5300-8del::,TUBGCP4:ENST00000260383.11:downstream_gene_variant:MODIFIER::::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]				rs56813954	0.22839	0.11716,0.28469,0.34578,0.26565,0.26428	4174,	25537	114479	0.7380	2.23			/0.0>0.0/0.0>0.0,/6.0>6.6/0.0>0.0		TP53BP1|0.00|0.00|0.00|0.00|-36|-39|5|28,TUBGCP4|0.00|0.00|0.00|0.00|-24|3|8|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43413472	43413472	C	T	het	off-target	QUAL=24;DP=63;QD=0.38	TP53BP1,TUBGCP4	intron,downstream_gene	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron23/27:c.5090-138G>A::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron23/27:c.5075-138G>A::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron22/26:c.4940-138G>A::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron23/27:c.5090-144G>A::,TUBGCP4:ENST00000564079.6:downstream_gene_variant:MODIFIER::::		609610_[GENE=TUBGCP4_PHENOS=Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessive]				rs12908460	0.16824	0.17135,0.14341,0.00135,0.18790,0.18864	2336,	20929	126569	0.7620	16.21			/7.7>4.3/0.0>0.0		TP53BP1|0.00|0.00|0.00|0.00|-2|42|-2|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TUBGCP4 (inh=AR oe_syn=0.95 oe_mis=0.62 oe_lof=0.50), TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43415610	43415610	A	T	het		QUAL=24;DP=81;QD=0.30	TP53BP1	synonymous	TP53BP1:ENST00000382044.9:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:,TP53BP1:ENST00000263801.7:synonymous_variant:LOW:exon23/28:c.5058T>A:p.Ser1686=:,TP53BP1:ENST00000382039.7:synonymous_variant:LOW:exon22/27:c.4923T>A:p.Ser1641=:,TP53BP1:ENST00000450115.6:synonymous_variant:LOW:exon23/28:c.5073T>A:p.Ser1691=:						rs2230451	0.16826	0.17124,0.14423,0.00135,0.18795,0.18711	2339,	20932	126592	0.1790	7.32			/0.0>0.0/0.0>0.0	COSV55501344	TP53BP1|0.00|0.00|0.00|0.00|-2|34|4|-16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43420139	43420139	A	G	het	off-target	QUAL=24;DP=123;QD=0.20	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron21/27:c.4681+166T>C::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron21/27:c.4666+166T>C::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron20/26:c.4531+166T>C::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron21/27:c.4681+166T>C::						rs62021180	0.16852	0.17202,0.14443,0.00135,0.18800,0.18773	2338,	20969	126529	0.2160	6.82			/1.5>1.6/0.0>0.0		TP53BP1|0.00|0.00|0.00|0.00|-30|-42|4|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43427999	43427999	C	T	het	off-target	QUAL=24;DP=356;QD=0.07	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron18/27:c.3828+17G>A::,TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron18/27:c.3813+17G>A::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron18/26:c.3828+17G>A::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron18/27:c.3828+17G>A::						rs550239	0.28164	0.65014,0.21536,0.39764,0.10676,0.22938	10197,	22266	108812	0.2330	14.45			/0.0>0.0/0.0>0.0	COSV55496522	TP53BP1|0.00|0.00|0.00|0.00|-50|17|17|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43428335	43428335	G	C	hom	off-target	QUAL=24;DP=58;QD=0.41	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron17/27:c.3676-167C>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron17/27:c.3661-167C>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron17/26:c.3676-167C>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron17/27:c.3676-167C>G::						rs2249952	0.46059	0.85446,0.36215,0.39845,0.29500,0.43436	20925,	28149	81977	-0.6650	1.02			/0.0>0.0/0.0>0.0	COSV55506772	TP53BP1|0.00|0.00|0.00|0.00|-25|43|-24|-11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43432448	43432448	T	G	hom		QUAL=24;DP=386;QD=0.06	TP53BP1	missense	TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon17/28:c.3406A>C:p.Lys1136Gln:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon17/27:c.3421A>C:p.Lys1141Gln:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon17/28:c.3421A>C:p.Lys1141Gln:				CM067476 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs2602141	0.45995	0.85155,0.36173,0.39876,0.29503,0.44037	20848,	28252	82128	3.6770	17.80	0.083	0.07	/0.0>0.0/0.7>0.6	COSV55496532	TP53BP1|0.00|0.00|0.06|0.00|-12|-2|-12|46	21807602,20106900,21212151,23349013,16741161,21303977,26130668,15987456,20686496,24761925,26693075,24603722,28487205,24316395	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43438288	43438288	A	G	het	off-target	QUAL=24;DP=895;QD=0.03	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron16/27:c.3176+36T>C::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron16/26:c.3191+36T>C::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron16/27:c.3191+36T>C::						rs16957730	0.17481	0.19433,0.14587,0.00135,0.18798,0.18703	2507,	21571	125495	1.4740	3.70			/0.0>0.0/0.0>0.0		TP53BP1|0.00|0.00|0.00|0.00|16|-41|-14|36	27462919	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43447489	43447489	A	-	het	low_conf_region	QUAL=17;DP=23;QD=0.74	TP53BP1	splice_region&intron	TP53BP1:ENST00000382044.9:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4del::,TP53BP1:ENST00000263801.7:splice_region_variant&intron_variant:LOW:intron12/27:c.2702-4del::,TP53BP1:ENST00000382039.7:splice_region_variant&intron_variant:LOW:intron12/26:c.2717-4del::,TP53BP1:ENST00000450115.6:splice_region_variant&intron_variant:LOW:intron12/27:c.2717-4del::						rs749575788	0.02331	0.06930,0.01148,0.00586,0.00469,0.00115	13,	1222	52292	-0.3980	0.09			/12.0>11.9/0.0>0.0		TP53BP1|0.00|0.00|0.00|0.00|-3|-36|-35|-33		61	3183	0	24 / 865					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43456106	43456106	A	G	hom		QUAL=24;DP=894;QD=0.03	TP53BP1	synonymous	TP53BP1:ENST00000382044.9:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000263801.7:synonymous_variant:LOW:exon12/28:c.2487T>C:p.Asp829=:,TP53BP1:ENST00000382039.7:synonymous_variant:LOW:exon12/27:c.2502T>C:p.Asp834=:,TP53BP1:ENST00000450115.6:synonymous_variant:LOW:exon12/28:c.2502T>C:p.Asp834=:						rs690367	0.46385	0.86688,0.36382,0.39915,0.29503,0.42381	21404,	27779	81589	1.4440	3.32			/0.0>0.0/0.0>0.0	COSV55496541,COSV55506600	TP53BP1|0.00|0.00|0.00|0.00|31|-26|7|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43469723	43469723	A	C	het	off-target	QUAL=25;DP=34;QD=0.74	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron11/27:c.1389+135T>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron11/27:c.1374+135T>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron11/26:c.1389+135T>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron11/27:c.1389+135T>G::					L1MB7 (LINE/L1)	rs7181783	0.17478	0.19420,0.14552,0.00135,0.18829,0.18696	2505,	21602	125648	1.4250	11.46			/0.0>0.0/0.0>0.0		TP53BP1|0.00|0.00|0.00|0.00|14|1|-41|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43469998	43469998	C	T	het		QUAL=24;DP=207;QD=0.12	TP53BP1	missense	TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon11/28:c.1234G>A:p.Gly412Ser:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon11/27:c.1249G>A:p.Gly417Ser:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon11/28:c.1249G>A:p.Gly417Ser:	regulatory_region_variant:TF_binding_site,TF_binding_site_variant			CM107902 [CLASS=DP MUT=ALT PHEN="Basal cell carcinoma reduced risk association with" GENE=TP53BP1];		rs689647	0.28206	0.65018,0.21469,0.39679,0.10671,0.23631	10247,	22375	109117	1.3850	16.39	0.074	0.07	/0.0>0.0/0.0>0.0	COSV55496549,COSV55506613	TP53BP1|0.00|0.00|0.00|0.00|-2|47|3|0	20805886,21303977,21368091,15987456,20686496,24603722,24316395	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43475576	43475576	G	C	hom		QUAL=24;DP=116;QD=0.21	TP53BP1	missense	TP53BP1:ENST00000382044.9:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000263801.7:missense_variant:MODERATE:exon9/28:c.1059C>G:p.Asp353Glu:,TP53BP1:ENST00000382039.7:missense_variant:MODERATE:exon9/27:c.1074C>G:p.Asp358Glu:,TP53BP1:ENST00000450115.6:missense_variant:MODERATE:exon9/28:c.1074C>G:p.Asp358Glu:				CM067475 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=TP53BP1];		rs560191	0.46346	0.86675,0.36368,0.39803,0.29479,0.42427	21371,	27762	81620	0.1670	13.03	0.235	0.07	/4.0>3.0/0.8>2.5	COSV55496034	TP53BP1|0.00|0.00|0.00|0.00|29|-3|-11|9	29551738,21807602,20106900,20385987,24820515,21212151,23349013,20805886,16741161,21303977,33906323,25532599,26130668,15987456,20646866,20686496,26693075,25937777,24603722,36976737,24316395,26076430,26823859	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43480838	43480838	A	C	het	off-target	QUAL=24;DP=723;QD=0.03	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron5/27:c.499+57T>G::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron5/27:c.484+57T>G::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron5/26:c.499+57T>G::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron5/27:c.499+57T>G::						rs7173383	0.17473	0.19406,0.14540,0.00135,0.18815,0.18670	2498,	21607	125653	-0.0460	1.59			/7.4>5.9/0.0>0.0		TP53BP1|0.00|0.00|0.00|0.00|-7|-40|0|30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	43491802	43491802	C	T	hom	off-target	QUAL=25;DP=722;QD=0.03	TP53BP1	intron	TP53BP1:ENST00000382044.9:intron_variant:MODIFIER:intron3/27:c.287-49G>A::,TP53BP1:ENST00000263801.7:intron_variant:MODIFIER:intron3/27:c.272-49G>A::,TP53BP1:ENST00000382039.7:intron_variant:MODIFIER:intron3/26:c.287-49G>A::,TP53BP1:ENST00000450115.6:intron_variant:MODIFIER:intron3/27:c.287-49G>A::	regulatory_region_variant:open_chromatin_region					rs555252	0.96490	0.88013,0.99124,0.99942,0.99938,0.97000	71120,	4738	5346	0.0420	4.54			/7.0>5.5/7.8>1.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53BP1 (inh=AR oe_syn=1.00 oe_mis=0.84 oe_lof=0.16)
chr15	75351274	75351274	-	T	hom	off-target;low_conf_region	QUAL=24;DP=185;QD=0.13	NEIL1,MIR631,MAN2C1	intron,downstream_gene	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-818dup::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-818dup::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-818dup::,MIR631:ENST00000384904.1:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000569482.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000565683.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000563622.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000267978.10:downstream_gene_variant:MODIFIER::::		154580_[GENE=MAN2C1_PHENOS=Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive]				rs11422837	0.39696	0.24103,0.41467,0.48972,0.46841,0.54056	10950,	26158	73006		0.62			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	75351842	75351842	G	A	het	off-target	QUAL=24;DP=4;QD=6.00	NEIL1,MIR631,MAN2C1	intron,downstream_gene	NEIL1:ENST00000355059.9:intron_variant:MODIFIER:intron2/9:c.435-269G>A::,NEIL1:ENST00000564784.5:intron_variant:MODIFIER:intron3/10:c.435-269G>A::,NEIL1:ENST00000569035.5:intron_variant:MODIFIER:intron2/9:c.435-269G>A::,MIR631:ENST00000384904.1:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000569482.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000565683.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000563622.5:downstream_gene_variant:MODIFIER::::,MAN2C1:ENST00000267978.10:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	154580_[GENE=MAN2C1_PHENOS=Congenital disorder of deglycosylation 2, 619775 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs5745916	0.01779	0.00431,0.01615,0.00019,0.02505,0.00704	34,	2639	149461	-0.8210	0.79			/0.3>0.7/0.0>0.0		NEIL1|0.00|0.00|0.00|0.00|17|-38|-10|42	31415677	28	1508	0	2 / 200					NEIL1 (inh=n/a oe_syn=1.20 oe_mis=1.05 oe_lof=0.64), MIR631 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MAN2C1 (inh=AR oe_syn=0.99 oe_mis=0.98 oe_lof=0.85)
chr15	90803400	90803400	-	A	hom	off-target	QUAL=24;DP=24;QD=1.00	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron17/21:c.3359-121_3359-120insA::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron17/21:c.3359-121_3359-120insA::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron17/22:c.3359-121_3359-120insA::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3358+5063_3358+5064insA::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron17/21:c.3359-121_3359-120insA::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	210529 [benign/likely benign DISEASE=not specified,not provided GENE=BLM];			rs11377009	0.67237	0.65181,0.74620,0.84269,0.65980,0.66771	34669,	32780	49760		0.39			/0.0>2.2/0.0>0.0		BLM|0.00|0.00|0.00|0.00|2|-16|3|-9	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90804072	90804072	G	A	hom	off-target	QUAL=24;DP=268;QD=0.09	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron18/21:c.3559-95G>A::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron18/21:c.3559-95G>A::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron18/22:c.3559-95G>A::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3359-5065G>A::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron18/21:c.3559-95G>A::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	1239684 [benign DISEASE=not provided GENE=BLM];			rs2301602	0.63132	0.58228,0.72283,0.81376,0.63131,0.64001	30660,	34631	56035	-0.4040	0.43			/0.0>0.0/0.0>0.0		BLM|0.00|0.00|0.00|0.00|-9|34|-3|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90804525	90804525	A	G	hom	off-target	QUAL=24;DP=323;QD=0.07	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron19/21:c.3751+166A>G::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron19/21:c.3751+166A>G::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron19/22:c.3751+166A>G::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3359-4612A>G::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron19/21:c.3751+166A>G::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	1252270 [benign DISEASE=not provided GENE=BLM];		AluJb (SINE/Alu)	rs454060	0.66425	0.64000,0.74277,0.81644,0.65819,0.64796	33839,	33280	51030	-2.2290	0.88			/3.9>3.9/0.0>0.0		BLM|0.00|0.00|0.00|0.00|-40|-20|39|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90804554	90804554	C	T	hom	off-target	QUAL=24;DP=232;QD=0.10	BLM	intron	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron19/21:c.3751+195C>T::,BLM:ENST00000681142.1:intron_variant:MODIFIER:intron19/21:c.3751+195C>T::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron19/22:c.3751+195C>T::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron17/19:c.3359-4583C>T::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron19/21:c.3751+195C>T::		604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	1178809 [benign DISEASE=not provided GENE=BLM];		AluJb (SINE/Alu)	rs405610	0.38401	0.19546,0.53407,0.55310,0.43656,0.48506	12378,	33612	93630	0.3440	8.26			/0.0>0.0/0.0>0.0		BLM|0.00|0.00|0.00|0.00|41|-9|13|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr15	90815041	90815041	-	GAA	het	off-target;low_conf_region	QUAL=24;DP=5;QD=4.80	BLM	intron,downstream_gene	BLM:ENST00000355112.8:intron_variant:MODIFIER:intron21/21:c.4077-59_4077-57dup::,BLM:ENST00000648453.1:intron_variant:MODIFIER:intron22/22:c.*39-59_*39-57dup::,BLM:ENST00000560509.5:intron_variant:MODIFIER:intron19/19:c.3684-59_3684-57dup::,BLM:ENST00000680772.1:intron_variant:MODIFIER:intron21/21:c.4077-59_4077-57dup::,BLM:ENST00000681142.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	604610_[GENE=BLM_PHENOS=Bloom syndrome, 210900 (3), Autosomal recessive]	210530 [benign/likely benign DISEASE=not provided,Bloom syndrome,not specified GENE=BLM];			rs10685387	0.63875	0.61504,0.71829,0.81274,0.62854,0.61550	31223,	34398	54770		1.04			/0.0>0.0/1.5>0.0		BLM|0.00|0.00|0.00|0.00|30|-27|-27|-34	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BLM (inh=AR oe_syn=0.91 oe_mis=0.91 oe_lof=0.56)
chr16	3589138	3589138	A	G	het		QUAL=24;DP=62;QD=0.39	SLX4	synonymous	SLX4:ENST00000294008.4:synonymous_variant:LOW:exon12/15:c.4500T>C:p.Asn1500=:		613278_[GENE=SLX4_PHENOS=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive]	262053 [benign DISEASE=Fanconi anemia,not specified,not provided,Fanconi anemia complementation group P GENE=SLX4];			rs3810812	0.63864	0.87488,0.61942,0.71600,0.51209,0.77352	33045,	31009	54941	0.7530	2.51			/0.0>0.0/0.0>0.0	COSV53564459	SLX4|0.00|0.00|0.00|0.00|4|26|-19|28	25741868,32708070,22401137,22911665	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	3589229	3589229	G	A	het		QUAL=24;DP=69;QD=0.35	SLX4	missense	SLX4:ENST00000294008.4:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:		613278_[GENE=SLX4_PHENOS=Fanconi anemia, complementation group P, 613951 (3), Autosomal recessive]	885261 [uncertain significance DISEASE=not provided,Fanconi anemia complementation group P,Fanconi anemia GENE=SLX4];	CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4];		rs72778139	0.00009	0.00005,0.00007,0.00000,0.00015,0.00000	0,	14	152274	0.6280	16.52	0.112	0.12	/1.6>2.3/0.0>0.0	COSV53560456	SLX4|0.00|0.00|0.00|0.00|17|-30|16|10	22401137,23840564,23211700	0	28	0	0 / 5					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	23621158	23621158	C	T	het	off-target	QUAL=25;DP=33;QD=0.76	PALB2	intron	PALB2:ENST00000566069.6:intron_variant:MODIFIER:intron10/11:c.3113+204G>A::,PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron10/12:c.3113+204G>A::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron10/12:c.2228+204G>A::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron10/12:c.2228+204G>A::,PALB2:ENST00000713774.1:intron_variant:MODIFIER:intron10/10:c.3113+204G>A::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron11/12:c.2228+204G>A::,PALB2:ENST00000697377.2:intron_variant:MODIFIER:intron10/12:c.2957+204G>A::,PALB2:ENST00000561514.3:intron_variant:MODIFIER:intron10/12:c.3119+204G>A::,PALB2:ENST00000697379.2:intron_variant:MODIFIER:intron11/13:c.3119+204G>A::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron6/8:c.647+204G>A::		610355_[GENE=PALB2_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 5}, 620442 (3), Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3), Autosomal dominant; Fanconi anemia, complementation group N, 610832 (3), Autosomal recessive]	1181215 [benign DISEASE=not provided GENE=PALB2];		AluSz (SINE/Alu)	rs8060124	0.18232	0.22373,0.19273,0.19256,0.14937,0.20773	2645,	22430	124324	-0.6370	0.29			/0.0>0.0/0.0>0.0	COSV55167095	PALB2|0.00|0.00|0.00|0.00|48|24|12|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	23629146	23629146	G	A	het	off-target	QUAL=24;DP=22;QD=1.09	PALB2	intron	PALB2:ENST00000566069.6:intron_variant:MODIFIER:intron6/11:c.2586+58C>T::,PALB2:ENST00000261584.9:intron_variant:MODIFIER:intron6/12:c.2586+58C>T::,PALB2:ENST00000568219.5:intron_variant:MODIFIER:intron6/12:c.1701+58C>T::,PALB2:ENST00000697374.1:intron_variant:MODIFIER:intron6/12:c.1701+58C>T::,PALB2:ENST00000713774.1:intron_variant:MODIFIER:intron6/10:c.2586+58C>T::,PALB2:ENST00000697376.1:intron_variant:MODIFIER:intron7/12:c.1701+58C>T::,PALB2:ENST00000697377.2:intron_variant:MODIFIER:intron7/12:c.2592+58C>T::,PALB2:ENST00000561514.3:intron_variant:MODIFIER:intron6/12:c.2592+58C>T::,PALB2:ENST00000697379.2:intron_variant:MODIFIER:intron7/13:c.2592+58C>T::,PALB2:ENST00000697383.1:intron_variant:MODIFIER:intron2/8:c.120+58C>T::		610355_[GENE=PALB2_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 5}, 620442 (3), Autosomal dominant; {Pancreatic cancer, susceptibility to, 3}, 613348 (3), Autosomal dominant; Fanconi anemia, complementation group N, 610832 (3), Autosomal recessive]	126663 [benign DISEASE=not specified,Familial cancer of breast,Hereditary breast ovarian cancer syndrome,Breast-ovarian cancer, familial, susceptibility to, 5,not provided GENE=PALB2];			rs249954	0.31069	0.43740,0.29091,0.36547,0.23760,0.31102	7873,	31467	104747	0.3290	2.29			/0.0>0.0/0.0>0.0	COSV55164558	PALB2|0.00|0.00|0.00|0.00|49|34|49|-13	29879995,35008387,32894086,23318652,30799775,22332084,21356067,28419251,18794107,26981788,30362319,18446436,22052327,23935836,19921424,20122277,19635604,23453885,30309218	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			PALB2 (inh=AR+AD oe_syn=1.06 oe_mis=0.97 oe_lof=0.76)
chr16	68737469	68737469	C	T	hom		QUAL=24;DP=129;QD=0.19	CDH1	splice_region&intron	CDH1:ENST00000261769.10:splice_region_variant&intron_variant:LOW:intron1/15:c.48+6C>T::,CDH1:ENST00000422392.6:splice_region_variant&intron_variant:LOW:intron1/14:c.48+6C>T::	regulatory_region_variant:open_chromatin_region	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3)]	136692 [benign DISEASE=Malignant tumor of prostate,not provided,Familial cancer of breast,CDH1-related diffuse gastric and lobular breast cancer syndrome,Hereditary diffuse gastric adenocarcinoma,Blepharocheilodontic syndrome 1,Hereditary cancer-predisposing syndrome,not specified GENE=CDH1];			rs3743674	0.80465	0.66269,0.79918,0.77276,0.88438,0.78367	50036,	22371	29727	-0.1320	7.20			8.6>8.2/0.0>0.0/8.6>8.2	COSV55733220	CDH1|0.00|0.00|0.00|0.00|-8|-5|-6|-10	25741868,24033266,21686129,22875147,21356067,27192129,20632448,29295527,33465060,23431106,31600923,30895400,30642281,33240400,30641862,24684952,36910346,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25)
chr16	68737515	68737515	-	GCCCCAGCCCCGT	hom	off-target	QUAL=25;DP=104;QD=0.24	CDH1,RNA5SP429	intron,upstream_gene	CDH1:ENST00000261769.10:intron_variant:MODIFIER:intron1/15:c.48+62_48+63insCGTGCCCCAGCCC::,CDH1:ENST00000422392.6:intron_variant:MODIFIER:intron1/14:c.48+62_48+63insCGTGCCCCAGCCC::,RNA5SP429:ENST00000363688.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3)]	1243608 [benign DISEASE=not provided GENE=CDH1];			rs45625236	0.80718	0.68719,0.79206,0.77014,0.87350,0.78182	47790,	23762	28508		7.19			/0.0>2.1/0.0>0.0	COSV55741627	CDH1|0.00|0.00|0.00|0.00|0|-5|0|-31	21686129,35686104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), RNA5SP429 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	68823538	68823538	T	C	het		QUAL=24;DP=1165;QD=0.02	CDH1,FTLP14	synonymous,downstream_gene	CDH1:ENST00000261769.10:synonymous_variant:LOW:exon13/16:c.2076T>C:p.Ala692=:,CDH1:ENST00000422392.6:synonymous_variant:LOW:exon12/15:c.1893T>C:p.Ala631=:,FTLP14:ENST00000562087.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	192090_[GENE=CDH1_PHENOS=Ovarian cancer, somatic, 167000 (3); Blepharocheilodontic syndrome 1, 119580 (3), Autosomal dominant; Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate, 137215 (3), Autosomal dominant; Endometrial carcinoma, somatic, 608089 (3); Breast cancer, lobular, somatic, 114480 (3)]	142770 [benign DISEASE=Familial cancer of breast,not specified,CDH1-related diffuse gastric and lobular breast cancer syndrome,Malignant tumor of prostate,Blepharocheilodontic syndrome 1,not provided,Hereditary diffuse gastric adenocarcinoma,Hereditary cancer-predisposing syndrome GENE=CDH1];	CM1414917 [CLASS=DP MUT=ALT PHEN="Gastric cancer early-onset diffuse association with" GENE=CDH1];		rs1801552	0.69860	0.88423,0.65290,0.63605,0.62824,0.65660	38079,	30021	45809	0.0880	6.26			/5.3>4.5/0.0>0.0	COSV55728161	CDH1|0.00|0.00|0.00|0.00|-7|12|7|-30	25741868,24033266,20844743,33195260,32708070,26285011,22535324,21356067,28419251,21459793,27192129,19965908,24838934,28151848,29295527,33465060,33888005,23431106,23555086,31600923,30895400,31638990,35267574,18059179,30642281,34503274,30641862,24684952,25150394,35686104,19269290	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CDH1 (inh=AD oe_syn=0.99 oe_mis=0.91 oe_lof=0.25), FTLP14 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr16	81782975	81782975	C	G	hom	off-target	QUAL=24;DP=6;QD=4.00	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2968C>G::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2968C>G::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2968C>G::	regulatory_region_variant:open_chromatin_region	600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs6564919	0.76723	0.69915,0.79863,0.79136,0.78521,0.88299	45040,	26625	35407	-0.4630	2.22			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783128	81783128	C	T	het		QUAL=24;DP=429;QD=0.06	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2815C>T::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2815C>T::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2815C>T::	regulatory_region_variant:open_chromatin_region	600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs8045964	0.42059	0.41162,0.36574,0.28361,0.43237,0.63394	13640,	36553	87937	-0.4400	1.46			/7.5>7.1/0.0>0.0	COSV63869127		19956101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783182	81783182	T	A	hom	off-target	QUAL=24;DP=746;QD=0.03	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2761T>A::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2761T>A::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2761T>A::	regulatory_region_variant:open_chromatin_region	600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs4476171	0.99939	0.99798,1.00000,1.00000,1.00000,0.99834	76076,	93	93	-1.8100	0.00			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	81783213	81783213	C	T	het	off-target	QUAL=24;DP=726;QD=0.03	PLCG2	intron	PLCG2:ENST00000563193.2:intron_variant:MODIFIER:intron1/13:c.-47-2730C>T::,PLCG2:ENST00000564138.6:intron_variant:MODIFIER:intron1/32:c.-47-2730C>T::,PLCG2:ENST00000697564.1:intron_variant:MODIFIER:intron1/30:c.-47-2730C>T::	regulatory_region_variant:open_chromatin_region	600220_[GENE=PLCG2_PHENOS=Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominant; Familial cold autoinflammatory syndrome 3, 614468 (3), Autosomal dominant]				rs72834729	0.34233	0.27430,0.43155,0.50734,0.35209,0.24782	9235,	33581	99997	-1.2660	0.73			/0.0>0.0/0.0>0.0		PLCG2|0.00|0.00|0.00|0.00|3|-36|-49|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLCG2 (inh=AD oe_syn=1.36 oe_mis=0.92 oe_lof=0.18)
chr16	89738447	89738447	C	T	het	off-target	QUAL=24;DP=37;QD=0.65	ZNF276,FANCA	3'UTR,downstream_gene	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*201C>T::,ZNF276:ENST00000568064.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*538C>T::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*201C>T::,FANCA:ENST00000389301.8:3_prime_UTR_variant:MODIFIER:exon43/43:c.*154G>A::,FANCA:ENST00000568369.6:3_prime_UTR_variant:MODIFIER:exon43/43:c.*251G>A::,FANCA:ENST00000564475.6:downstream_gene_variant:MODIFIER::::,FANCA:ENST00000696287.1:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	321323 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs1230	0.53602	0.74243,0.54803,0.97994,0.39298,0.62163	24317,	32921	70595	-0.4200	3.29			/0.3>1.1/0.0>0.0,/0.0>1.8/0.0>0.0	COSV57073486	FANCA|0.00|0.00|0.00|0.00|-3|39|-1|39,ZNF276|0.00|0.00|0.00|0.00|-16|46|-7|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89738853	89738853	A	G	hom	off-target	QUAL=24;DP=367;QD=0.07	ZNF276,FANCA	3'UTR,intron,synonymous,downstream_gene	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*607A>G::,FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron42/42:c.4260+29T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron42/42:c.4264+29T>C::,FANCA:ENST00000564475.6:synonymous_variant:LOW:exon42/42:c.4293T>C:p.His1431=:,FANCA:ENST00000696287.1:synonymous_variant:LOW:exon41/41:c.4164T>C:p.His1388=:,ZNF276:ENST00000568064.5:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255266 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided GENE=FANCA];			rs1800359	0.72311	0.92845,0.70360,0.98592,0.59573,0.82326	41730,	26642	42160	-6.7440	0.05			/3.9>4.9/0.0>0.0,/0.0>0.0/0.0>0.0	COSV57066846	FANCA|0.00|0.00|0.00|0.13|49|29|-36|29,ZNF276|0.00|0.00|0.00|0.00|-48|10|9|-45	25741868,23637625,19578364,26540268,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89739569	89739569	G	A	het	off-target	QUAL=24;DP=181;QD=0.13	ZNF276,FANCA	3'UTR,splice_region&intron,downstream_gene	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1323G>A::,FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron39/42:c.3935-16C>T::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron39/42:c.3935-16C>T::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron39/41:c.3935-16C>T::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron38/40:c.3806-16C>T::,ZNF276:ENST00000568064.5:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255264 [benign DISEASE=Fanconi anemia,not specified,not provided,Fanconi anemia complementation group A GENE=FANCA];			rs1061646	0.41033	0.53846,0.48476,0.74252,0.29977,0.49170	14131,	34132	89664	0.3980	2.97			8.2>8.4/8.2>8.4/0.0>0.0,/0.0>0.0/0.0>0.0	COSV57068489	FANCA|0.00|0.00|0.00|0.00|-16|40|-42|-8,ZNF276|0.00|0.00|0.00|0.00|9|1|-18|37	25741868,18701435,18056155,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89739939	89739939	A	T	het	off-target	QUAL=22;DP=48;QD=0.46	ZNF276,FANCA	3'UTR,intron,downstream_gene	ZNF276:ENST00000289816.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,ZNF276:ENST00000443381.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1693A>T::,FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron39/42:c.3934+55T>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron39/41:c.3934+55T>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron38/40:c.3805+55T>A::,ZNF276:ENST00000568064.5:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	135541 [benign DISEASE=not specified,not provided,Fanconi anemia complementation group A GENE=FANCA];			rs7195906	0.54243	0.76229,0.55077,0.98049,0.39439,0.62319	25010,	32507	69617	-0.7080	0.93	0.084		/1.6>1.4/0.0>0.0,/0.0>0.0/0.0>1.0	COSV57065786	FANCA|0.00|0.00|0.01|0.00|5|-11|-45|-11,ZNF276|0.00|0.00|0.00|0.00|40|-41|-6|-41	24728327	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89744788	89744788	T	C	het	off-target	QUAL=24;DP=55;QD=0.44	FANCA,ZNF276	intron,downstream_gene	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron36/42:c.3626+171A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron36/42:c.3626+171A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron36/41:c.3626+171A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron35/40:c.3497+171A>G::,ZNF276:ENST00000289816.9:downstream_gene_variant:MODIFIER::::,ZNF276:ENST00000443381.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1243121 [benign DISEASE=not provided GENE=FANCA];		AluSg4 (SINE/Alu)	rs9923733	0.54463	0.76409,0.55867,0.98169,0.39591,0.62063	25064,	32425	69023	-0.6340	3.44			/0.0>0.6/0.0>0.8		FANCA|0.00|0.00|0.00|0.00|-1|-12|-1|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZNF276 (inh=AR oe_syn=1.48 oe_mis=1.27 oe_lof=0.47), FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89748809	89748809	C	T	het	off-target	QUAL=24;DP=159;QD=0.15	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron32/42:c.3240-42G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron32/41:c.3240-42G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron31/40:c.3111-42G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255254 [benign DISEASE=Fanconi anemia complementation group A,not specified,Fanconi anemia,not provided GENE=FANCA];	CS137887 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs1800345	0.41369	0.54249,0.48926,0.75748,0.30093,0.49605	14368,	34126	89092	-0.7150	0.22			/0.0>0.0/2.7>0.0		FANCA|0.02|0.00|0.00|0.00|-28|49|3|49	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89752083	89752083	T	C	het	off-target	QUAL=24;DP=751;QD=0.03	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron31/42:c.3066+55A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron31/41:c.3066+55A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron30/40:c.2937+55A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1235276 [benign DISEASE=not provided GENE=FANCA];			rs3743860	0.47316	0.55600,0.51448,0.76467,0.39148,0.60374	17843,	36231	80075	-0.1620	1.25			/2.1>1.6/0.0>0.9	COSV59795426	FANCA|0.00|0.00|0.00|0.00|9|-20|43|-20	31209889,32352494,29785010,29617998,30054594,35964923,37642678	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89765102	89765102	C	A	het	off-target	QUAL=24;DP=973;QD=0.02	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron27/42:c.2602-36G>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron27/41:c.2602-36G>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron27/40:c.2602-36G>T::	regulatory_region_variant:promoter,TF_binding_site_variant	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255248 [benign DISEASE=Fanconi anemia complementation group A,not provided,not specified GENE=FANCA];			rs2159116	0.12225	0.03802,0.12121,0.00444,0.17269,0.17137	1477,	15657	133633	-2.7020	1.28			/0.0>0.0/0.0>0.0	COSV59796461	FANCA|0.00|0.01|0.00|0.00|-9|-36|49|-36	25741868,20585627,20981448	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89767366	89767366	C	G	het	off-target	QUAL=24;DP=30;QD=0.80	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron26/42:c.2505-129G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron26/42:c.2505-129G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron26/41:c.2505-129G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron26/40:c.2505-129G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1251422 [benign DISEASE=not provided GENE=FANCA];			rs7203907	0.51774	0.67696,0.53902,0.98146,0.39530,0.62723	22322,	34110	73358	-0.4910	0.78			/0.0>0.0/0.0>0.0		FANCA|0.00|0.00|0.00|0.00|-17|47|-8|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89769915	89769915	C	T	het		QUAL=24;DP=96;QD=0.25	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000568369.6:missense_variant:MODERATE:exon26/43:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000564475.6:missense_variant:MODERATE:exon26/42:c.2426G>A:p.Gly809Asp:,FANCA:ENST00000696287.1:missense_variant:MODERATE:exon26/41:c.2426G>A:p.Gly809Asp:		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134254 [benign/likely benign DISEASE=not specified,not provided,Inborn genetic diseases,Fanconi anemia,Fanconi anemia complementation group A GENE=FANCA];	CM137288 [CLASS=R MUT=ALT PHEN="Fanconi anaemia" GENE=FANCA];		rs7195066	0.47248	0.66225,0.52390,0.98121,0.32130,0.62282	19562,	32698	80188	0.0770	13.46	0.198	0.07	/0.0>0.0/0.0>0.0	COSV59796193	FANCA|0.41|0.00|0.00|0.00|-34|-49|-44|42	25741868,24728327,20585627,20546537,18483556,19012493,23826176,23021409,24188633,36224396	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89770099	89770099	T	C	hom	off-target	QUAL=24;DP=138;QD=0.17	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron25/42:c.2316+67A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron25/42:c.2316+67A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron25/41:c.2316+67A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron25/40:c.2316+67A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180460 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs7200990	0.97143	0.99257,0.97817,0.99981,0.95650,0.98220	71884,	4220	4352	-0.2620	2.51			/7.7>4.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89770373	89770373	G	A	het	off-target	QUAL=24;DP=41;QD=0.59	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron24/42:c.2223-114C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron24/42:c.2223-114C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron24/41:c.2223-114C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron24/40:c.2223-114C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180461 [benign DISEASE=Fanconi anemia,Fanconi anemia complementation group A,not provided GENE=FANCA];			rs886952	0.52359	0.69679,0.54365,0.98124,0.39475,0.62428	22950,	33745	72469	-1.2700	0.55			/3.8>3.4/0.0>0.0		FANCA|0.00|0.00|0.02|0.00|-16|8|21|-38	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89771670	89771670	A	G	het		QUAL=24;DP=1060;QD=0.02	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron23/42:c.2151+8T>C::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron23/41:c.2151+8T>C::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron23/40:c.2151+8T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255245 [benign DISEASE=Fanconi anemia complementation group A,not specified,not provided,Fanconi anemia GENE=FANCA];			rs1800340	0.41445	0.51386,0.48715,0.75349,0.31078,0.59800	14251,	34436	88920	-1.3870	0.02			/0.0>0.0/0.0>0.3	COSV66881670	FANCA|0.00|0.00|0.00|0.00|4|2|4|2	25741868,32572023,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89775621	89775621	C	G	het	off-target	QUAL=24;DP=14;QD=1.71	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron21/42:c.1900+121G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron21/42:c.1900+121G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron21/41:c.1900+121G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron21/40:c.1900+121G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1225017 [benign DISEASE=not provided GENE=FANCA];			rs3785275	0.41650	0.55272,0.48369,0.75242,0.30169,0.50745	14637,	34091	88771	-0.4590	0.90			/3.8>4.2/2.5>0.0	COSV66881241	FANCA|0.01|0.00|0.00|0.00|-15|3|-15|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89778702	89778702	A	T	het	off-target	QUAL=25;DP=602;QD=0.04	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron20/42:c.1826+99T>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron20/42:c.1826+99T>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron20/41:c.1826+99T>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron20/40:c.1826+99T>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180464 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs7187436	0.50854	0.65700,0.53115,0.98098,0.39347,0.62674	21173,	33431	73231	-1.3470	0.50			/1.8>0.7/0.0>0.0		FANCA|0.00|0.00|0.00|0.00|12|13|-39|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89778786	89778786	A	G	het	off-target	QUAL=25;DP=601;QD=0.04	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron20/42:c.1826+15T>C::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron20/42:c.1826+15T>C::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron20/41:c.1826+15T>C::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron20/40:c.1826+15T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255241 [benign DISEASE=Fanconi anemia,not provided,Fanconi anemia complementation group A,not specified GENE=FANCA];			rs1800337	0.51792	0.67887,0.53917,0.98087,0.39444,0.62749	22371,	33918	73218	-1.3620	1.52			/0.0>0.0/4.2>0.0		FANCA|0.00|0.00|0.06|0.00|27|2|-23|2	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783072	89783072	C	T	hom		QUAL=25;DP=202;QD=0.12	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000568369.6:missense_variant:MODERATE:exon16/43:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000564475.6:missense_variant:MODERATE:exon16/42:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000696287.1:missense_variant:MODERATE:exon16/41:c.1501G>A:p.Gly501Ser:PF15865 [Fanconi anaemia group A protein N terminus]		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134244 [benign DISEASE=not specified,Fanconi anemia,Fanconi anemia complementation group A,not provided GENE=FANCA];	CM137880 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs2239359	0.51363	0.68468,0.52629,0.84595,0.38838,0.50916	21693,	34609	73855	-0.9650	0.30	0.261	0.06	/0.9>4.5/3.2>1.3	COSV66881058	FANCA|0.00|0.00|0.00|0.00|-25|30|31|0	25741868,23554684,24728327,17267408,26139146,24045675,33202820,25653542,19012493,23424144,31535215,18059179,28500464,23826176,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783175	89783175	C	T	het	off-target	QUAL=25;DP=80;QD=0.31	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron15/42:c.1471-73G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron15/42:c.1471-73G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron15/41:c.1471-73G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron15/40:c.1471-73G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180470 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs2239360	0.46343	0.68310,0.50478,0.76063,0.31159,0.59809	18724,	33001	81569	-1.8400	0.31			/0.0>0.0/0.6>0.0	COSV66881248	FANCA|0.00|0.00|0.00|0.00|-28|17|8|17	20837404,23350966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89783221	89783221	T	A	het	off-target	QUAL=24;DP=80;QD=0.30	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron15/42:c.1471-119A>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron15/42:c.1471-119A>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron15/41:c.1471-119A>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron15/40:c.1471-119A>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180471 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs12448860	0.51261	0.65970,0.53917,0.98085,0.39514,0.62521	21788,	34316	74060	0.0000	2.33			/0.8>2.7/0.0>0.0	COSV66882732	FANCA|0.00|0.00|0.00|0.00|-9|-29|27|-29	23350966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791292	89791292	A	G	het	off-target	QUAL=25;DP=43;QD=0.58	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron14/42:c.1359+111T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron14/42:c.1359+111T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron14/41:c.1359+111T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron14/40:c.1359+111T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1230103 [benign DISEASE=not provided GENE=FANCA];			rs8049660	0.47449	0.71857,0.51141,0.76475,0.31254,0.59751	19902,	32280	79836	-1.5800	2.07			/1.1>0.9/0.0>0.0		FANCA|0.00|0.00|0.00|0.00|13|-6|-39|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791556	89791556	T	C	het	off-target	QUAL=25;DP=547;QD=0.05	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron13/42:c.1226-20A>G::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron13/42:c.1226-20A>G::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron13/41:c.1226-20A>G::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron13/40:c.1226-20A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255232 [benign DISEASE=Fanconi anemia,Fanconi anemia complementation group A,not provided,not specified GENE=FANCA];			rs1800330	0.42544	0.55082,0.48933,0.76433,0.31169,0.59739	15206,	34279	87367	-5.4410	0.10			4.7>4.9/4.7>4.9/0.0>0.0	COSV66881251	FANCA|0.01|0.00|0.00|0.00|-46|-20|48|7	25741868,21850187,33863951,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791616	89791616	A	G	het	off-target	QUAL=24;DP=280;QD=0.09	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron13/42:c.1226-80T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron13/42:c.1226-80T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron13/41:c.1226-80T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron13/40:c.1226-80T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180472 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs6500450	0.53862	0.75147,0.54572,0.98098,0.39560,0.62459	24650,	32598	70154	-0.7840	0.87			/1.5>0.7/0.0>0.0	COSV66881253	FANCA|0.05|0.00|0.00|0.00|16|-12|16|27	33863951,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89791776	89791776	A	G	hom	off-target	QUAL=24;DP=31;QD=0.77	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron13/42:c.1225+151T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron13/42:c.1225+151T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron13/41:c.1225+151T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron13/40:c.1225+151T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180473 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs6500451	0.97159	0.99259,0.97834,0.99981,0.95676,0.98364	71860,	4196	4326	-0.7740	2.04			/1.5>0.4/0.0>0.0			23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792097	89792097	T	C	het	off-target	QUAL=24;DP=161;QD=0.15	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1084-29A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1084-29A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1084-29A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255229 [benign DISEASE=not provided,Fanconi anemia complementation group A,not specified GENE=FANCA];			rs6500452	0.40310	0.50538,0.47893,0.75889,0.30238,0.50104	13553,	34189	90765	-2.0850	0.10			/0.5>0.8/0.0>0.0	COSV66880734	FANCA|0.02|0.00|0.00|0.00|-7|-29|38|3	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792117	89792117	C	G	het	off-target	QUAL=24;DP=162;QD=0.15	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1084-49G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1084-49G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1084-49G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255230 [benign DISEASE=Fanconi anemia complementation group A,not provided,not specified GENE=FANCA];			rs1800287	0.53853	0.75074,0.54600,0.98090,0.39562,0.62443	24632,	32632	70176	-0.1090	1.57			/0.0>0.0/0.0>0.0	COSV66881254	FANCA|0.01|0.00|0.00|0.00|-27|-34|-27|18	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792249	89792249	C	G	het	off-target	QUAL=24;DP=27;QD=0.89	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1084-181G>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1084-181G>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1084-181G>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1084-181G>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1264276 [benign DISEASE=not provided GENE=FANCA];			rs6500453	0.53854	0.75029,0.54624,0.98137,0.39572,0.62676	24603,	32614	70110	0.9310	3.33			/3.0>5.1/0.0>0.0		FANCA|0.02|0.00|0.00|0.00|-4|-1|-35|1	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792351	89792351	C	T	het	off-target	QUAL=24;DP=51;QD=0.47	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron12/42:c.1083+120G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron12/42:c.1083+120G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron12/41:c.1083+120G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron12/40:c.1083+120G>A::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180474 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs17226159	0.12095	0.03793,0.11970,0.00444,0.17069,0.16929	1444,	15529	133849	-1.1480	10.00			/0.0>0.0/7.5>9.4		FANCA|0.00|0.00|0.24|0.00|3|-34|3|-34	23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792600	89792600	G	A	het	off-target	QUAL=24;DP=105;QD=0.23	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron11/42:c.1007-53C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron11/41:c.1007-53C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron11/40:c.1007-53C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1242487 [benign DISEASE=not provided GENE=FANCA];			rs3856	0.40464	0.50563,0.47908,0.80116,0.30328,0.51083	13305,	34116	89350	-0.0020	1.33			/0.0>0.0/0.0>0.0		FANCA|0.01|0.00|0.00|0.00|-28|39|25|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89792608	89792608	T	-	het	off-target	QUAL=24;DP=105;QD=0.23	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron11/42:c.1007-61del::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron11/41:c.1007-61del::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron11/40:c.1007-61del::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1289093 [benign DISEASE=not provided GENE=FANCA];			rs35617323	0.48479	0.56785,0.52475,0.98068,0.39416,0.62344	19173,	35131	78087	0.0480	0.93			/0.0>0.0/0.0>0.0		FANCA|0.01|0.00|0.00|0.00|-35|32|38|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89798903	89798903	T	C	het	off-target	QUAL=24;DP=31;QD=0.77	FANCA	intron,3'UTR,downstream_gene	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron10/42:c.893+263A>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron10/42:c.893+263A>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron10/41:c.893+263A>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron10/40:c.893+263A>G::,FANCA:ENST00000389302.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*176A>G::,FANCA:ENST00000563673.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*205A>G::,FANCA:ENST00000534992.5:downstream_gene_variant:MODIFIER::::,FANCA:ENST00000543736.5:downstream_gene_variant:MODIFIER::::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1218370 [likely benign DISEASE=not provided GENE=FANCA];			rs17226026	0.01229	0.00289,0.01165,0.00019,0.01546,0.05821	29,	1811	150225	-1.9270	0.25			/0.0>0.0/0.0>0.0		FANCA|0.00|0.00|0.00|0.00|-1|48|-17|48		28	1336	0	4 / 147					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799635	89799635	T	C	het		QUAL=24;DP=523;QD=0.05	FANCA	missense	FANCA:ENST00000389301.8:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000568369.6:missense_variant:MODERATE:exon9/43:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000564475.6:missense_variant:MODERATE:exon9/42:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000696287.1:missense_variant:MODERATE:exon9/41:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000389302.7:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000563673.5:missense_variant:MODERATE:exon9/10:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000534992.5:missense_variant:MODERATE:exon9/11:c.796A>G:p.Thr266Ala:PF15865 [Fanconi anaemia group A protein N terminus],FANCA:ENST00000543736.5:missense_variant:MODERATE:exon8/10:c.700A>G:p.Thr234Ala:PF15865 [Fanconi anaemia group A protein N terminus]		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	134294 [benign DISEASE=Malignant tumor of breast,not specified,Fanconi anemia complementation group A,Inborn genetic diseases,not provided,Fanconi anemia GENE=FANCA];	CM137879 [CLASS=DP MUT=ALT PHEN="Breast cancer association with" GENE=FANCA];		rs7190823	0.53114	0.71685,0.54450,0.98132,0.39904,0.62848	23670,	33474	71338	0.6710	7.20	0.084	0.05	/5.0>4.2/3.3>0.0		FANCA|0.00|0.00|0.19|0.00|3|-3|-30|28	25741868,24728327,20386703,26139146,23350966,25653542,19012493,30072632,29098742,23826176,23021409,24320210	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799752	89799752	A	G	het	off-target	QUAL=25;DP=76;QD=0.33	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron8/42:c.793-114T>C::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron8/42:c.793-114T>C::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron8/41:c.793-114T>C::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron8/40:c.793-114T>C::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron8/10:c.793-114T>C::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron8/9:c.793-114T>C::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron8/10:c.793-114T>C::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron7/9:c.697-114T>C::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1253922 [benign DISEASE=not provided GENE=FANCA];		AluYk4 (SINE/Alu)	rs7186192	0.65542	0.77410,0.65122,0.98552,0.56821,0.73746	33770,	32179	52427	-1.6560	0.74			/1.9>2.5/0.0>0.0	COSV66881257	FANCA|0.00|0.00|0.00|0.00|-32|-24|-3|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89799769	89799769	G	A	het	off-target	QUAL=24;DP=5;QD=4.80	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron8/42:c.793-131C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron8/42:c.793-131C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron8/41:c.793-131C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron8/40:c.793-131C>T::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron8/10:c.793-131C>T::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron8/9:c.793-131C>T::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron8/10:c.793-131C>T::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron7/9:c.697-131C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1194031 [likely benign DISEASE=not provided GENE=FANCA];		AluYk4 (SINE/Alu)	rs34427386	0.00744	0.00183,0.00281,0.00000,0.01204,0.00248	9,	1115	151153	-2.7840	0.63			/0.0>0.0/0.0>0.0		FANCA|0.00|0.00|0.00|0.00|-41|-48|7|-48		3	719	0	2 / 98					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89803156	89803156	G	A	het	off-target	QUAL=24;DP=740;QD=0.03	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron8/42:c.792+103C>T::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron8/42:c.792+103C>T::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron8/41:c.792+103C>T::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron8/40:c.792+103C>T::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron8/10:c.792+103C>T::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron8/9:c.792+103C>T::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron8/10:c.792+103C>T::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron7/9:c.696+103C>T::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1197847 [likely benign DISEASE=not provided GENE=FANCA];		L1MA5A (LINE/L1)	rs35506335	0.02424	0.00573,0.03090,0.00019,0.02941,0.07780	78,	3533	148501	-2.8750	0.07			/1.4>2.3/0.0>0.0		FANCA|0.00|0.00|0.00|0.00|-40|13|39|-11		31	1102	0	0 / 104					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89803353	89803353	T	C	hom	off-target	QUAL=23;DP=90;QD=0.26	FANCA	splice_region&intron	FANCA:ENST00000389301.8:splice_region_variant&intron_variant:LOW:intron7/42:c.710-12A>G::,FANCA:ENST00000568369.6:splice_region_variant&intron_variant:LOW:intron7/42:c.710-12A>G::,FANCA:ENST00000564475.6:splice_region_variant&intron_variant:LOW:intron7/41:c.710-12A>G::,FANCA:ENST00000696287.1:splice_region_variant&intron_variant:LOW:intron7/40:c.710-12A>G::,FANCA:ENST00000389302.7:splice_region_variant&intron_variant:LOW:intron7/10:c.710-12A>G::,FANCA:ENST00000563673.5:splice_region_variant&intron_variant:LOW:intron7/9:c.710-12A>G::,FANCA:ENST00000534992.5:splice_region_variant&intron_variant:LOW:intron7/10:c.710-12A>G::,FANCA:ENST00000543736.5:splice_region_variant&intron_variant:LOW:intron6/9:c.614-12A>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	255269 [benign DISEASE=Fanconi anemia complementation group A,not provided,not specified,Fanconi anemia GENE=FANCA];			rs1800286	0.71745	0.91660,0.69501,0.98649,0.59510,0.81457	41010,	27114	42980	-1.9470	6.54			9.1>9.8/9.1>9.8/0.0>0.0		FANCA|0.00|0.00|0.00|0.00|-12|-37|-12|-24	25741868,23021409	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89808087	89808089	ACC	-	hom	off-target	QUAL=25;DP=20;QD=1.25	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron6/42:c.596+205_596+207del::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron6/42:c.596+205_596+207del::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron6/41:c.596+205_596+207del::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron6/40:c.596+205_596+207del::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron6/10:c.596+205_596+207del::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron6/9:c.596+205_596+207del::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron6/10:c.596+205_596+207del::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron5/9:c.500+205_500+207del::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1225004 [benign DISEASE=not provided GENE=FANCA];		AluSx1 (SINE/Alu)	rs376278387	0.97881	0.95704,0.99090,0.99265,0.99082,0.91228	72602,	3213	3213	-0.3620	0.25			/0.0>0.6/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89808151	89808151	A	C	het	off-target	QUAL=24;DP=138;QD=0.17	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron6/42:c.596+143T>G::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron6/42:c.596+143T>G::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron6/41:c.596+143T>G::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron6/40:c.596+143T>G::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron6/10:c.596+143T>G::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron6/9:c.596+143T>G::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron6/10:c.596+143T>G::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron5/9:c.500+143T>G::		607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180476 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs11076627	0.46075	0.50818,0.51571,0.97724,0.38843,0.52031	17350,	35338	81970	0.4050	5.79			/2.4>2.2/0.0>0.0		FANCA|0.00|0.00|0.00|0.00|-1|-6|30|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr16	89808220	89808220	C	T	het	off-target	QUAL=25;DP=118;QD=0.21	FANCA	intron	FANCA:ENST00000389301.8:intron_variant:MODIFIER:intron6/42:c.596+74G>A::,FANCA:ENST00000568369.6:intron_variant:MODIFIER:intron6/42:c.596+74G>A::,FANCA:ENST00000564475.6:intron_variant:MODIFIER:intron6/41:c.596+74G>A::,FANCA:ENST00000696287.1:intron_variant:MODIFIER:intron6/40:c.596+74G>A::,FANCA:ENST00000389302.7:intron_variant:MODIFIER:intron6/10:c.596+74G>A::,FANCA:ENST00000563673.5:intron_variant:MODIFIER:intron6/9:c.596+74G>A::,FANCA:ENST00000534992.5:intron_variant:MODIFIER:intron6/10:c.596+74G>A::,FANCA:ENST00000543736.5:intron_variant:MODIFIER:intron5/9:c.500+74G>A::	regulatory_region_variant:open_chromatin_region	607139_[GENE=FANCA_PHENOS=Fanconi anemia, complementation group A, 227650 (3), Autosomal recessive]	1180477 [benign DISEASE=Fanconi anemia complementation group A,not provided GENE=FANCA];			rs1800285	0.53077	0.72130,0.54117,0.98146,0.39792,0.61644	23682,	33302	71314	-0.2360	2.91			/0.0>0.0/0.0>0.0		FANCA|0.00|0.00|0.00|0.00|-7|33|30|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FANCA (inh=AR oe_syn=1.57 oe_mis=1.55 oe_lof=1.15)
chr17	7674797	7674797	T	C	het	off-target	QUAL=24;DP=9;QD=2.67	TP53	intron	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron5/6:c.672+62A>G::,TP53:ENST00000714356.1:intron_variant:MODIFIER:intron5/9:c.555+62A>G::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron5/8:c.672+62A>G::,TP53:ENST00000504290.5:intron_variant:MODIFIER:intron2/7:c.276+62A>G::,TP53:ENST00000504937.5:intron_variant:MODIFIER:intron2/6:c.276+62A>G::,TP53:ENST00000510385.5:intron_variant:MODIFIER:intron2/7:c.276+62A>G::,TP53:ENST00000610623.4:intron_variant:MODIFIER:intron2/7:c.195+62A>G::,TP53:ENST00000618944.4:intron_variant:MODIFIER:intron2/7:c.195+62A>G::,TP53:ENST00000619186.4:intron_variant:MODIFIER:intron2/6:c.195+62A>G::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron5/9:c.555+62A>G::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron6/10:c.555+62A>G::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron6/11:c.672+62A>G::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron6/11:c.672+62A>G::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron6/11:c.555+62A>G::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron6/11:c.555+62A>G::,TP53:ENST00000714357.1:intron_variant:MODIFIER:intron6/10:c.672+62A>G::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron6/10:c.672+62A>G::,TP53:ENST00000604348.6:intron_variant:MODIFIER:intron6/10:c.651+62A>G::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron6/10:c.555+62A>G::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron6/10:c.672+62A>G::,TP53:ENST00000714408.1:intron_variant:MODIFIER:intron6/10:c.672+62A>G::,TP53:ENST00000714409.1:intron_variant:MODIFIER:intron6/9:c.672+62A>G::,TP53:ENST00000576024.2:intron_variant:MODIFIER:intron6/9:c.672+62A>G::,TP53:ENST00000714359.1:intron_variant:MODIFIER:intron6/10:c.672+62A>G::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Autosomal dominant, Somatic mutation; {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	256603 [benign DISEASE=not specified,Li-Fraumeni syndrome 1,Hereditary cancer-predisposing syndrome,not provided GENE=TP53];			rs1625895	0.83045	0.71300,0.88458,0.96641,0.87256,0.79859	52925,	20495	25795	0.2300	1.37			/3.8>0.0/9.6>8.2		TP53|0.00|0.00|0.00|0.00|-49|9|21|-1	25741868,27917368,18854777,34953598,16465622,18640487,19826048,19426493,19276375,28415781,33942220,24818791,21402718,25340731,19276285,30867801,25233467,30801535,19505915,35865244,29892419,21838531,12466288,17151932,17428325,36039053,17908995,18798306,19193430,28678827,34295994,17301252,17449902,17624591,19423538,21810023,23029260,23360829,29167767,30796655,31205533,31788124,32888145,34190520,35351459,25430047,30048458,31624379,31686737,33985476,25925845,35571038,27503997,37083525,23412385,37116145,34967580,21342648,33544795,32423484,25842861,34848757,31143958,21869887,32214837,32552660,33462484,22829776,25394431,20445773,32445942,33318152,36856940,36224396,29030886,30944658,16039051,18314326,19386249,37829618,37763132	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7675327	7675327	C	T	het	off-target	QUAL=25;DP=784;QD=0.03	TP53	intron,5'UTR	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron3/6:c.376-91G>A::,TP53:ENST00000714356.1:intron_variant:MODIFIER:intron3/9:c.259-91G>A::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron3/8:c.376-91G>A::,TP53:ENST00000504290.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-112G>A::,TP53:ENST00000504937.5:5_prime_UTR_variant:MODIFIER:exon1/7:c.-112G>A::,TP53:ENST00000510385.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-112G>A::,TP53:ENST00000610623.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-193G>A::,TP53:ENST00000618944.4:5_prime_UTR_variant:MODIFIER:exon1/8:c.-193G>A::,TP53:ENST00000619186.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-193G>A::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron3/9:c.259-91G>A::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron4/10:c.259-91G>A::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron4/11:c.376-91G>A::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron4/11:c.376-91G>A::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron4/11:c.259-91G>A::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron4/11:c.259-91G>A::,TP53:ENST00000714357.1:intron_variant:MODIFIER:intron4/10:c.376-91G>A::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron4/10:c.376-91G>A::,TP53:ENST00000604348.6:intron_variant:MODIFIER:intron4/10:c.376-112G>A::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron4/10:c.259-91G>A::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron4/10:c.376-91G>A::,TP53:ENST00000714408.1:intron_variant:MODIFIER:intron4/10:c.376-91G>A::,TP53:ENST00000714409.1:intron_variant:MODIFIER:intron4/9:c.376-91G>A::,TP53:ENST00000576024.2:intron_variant:MODIFIER:intron4/9:c.376-91G>A::,TP53:ENST00000714359.1:intron_variant:MODIFIER:intron4/10:c.376-91G>A::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Autosomal dominant, Somatic mutation; {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	440348 [benign DISEASE=not specified,Li-Fraumeni syndrome 1,not provided,Hereditary cancer-predisposing syndrome GENE=TP53];			rs2909430	0.83732	0.73651,0.88733,0.96667,0.87256,0.79983	53539,	19891	24669	0.3200	2.99			/0.9>1.9/0.0>0.0	COSV52668782		27917368,23761422,27246533,19276375,18678618,33942220,24818791,21402718,24218030,19276285,28542283,25233467,19888426,29963112,28976792,15450681,17301252,17449902,19423538,22962577,28364582,28373458,31205533,31788124,32882831,34591432,35351459,25925845,26503811,35923699,21342648,32899294,36164436,20352120,37239075,24177593,36733806,36581621,37763132	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7676154	7676154	G	C	het		QUAL=24;DP=573;QD=0.04	TP53	missense,upstream_gene	TP53:ENST00000413465.6:missense_variant:MODERATE:exon3/7:c.215C>G:p.Pro72Arg:,TP53:ENST00000714356.1:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg:,TP53:ENST00000359597.8:missense_variant:MODERATE:exon3/9:c.215C>G:p.Pro72Arg:,TP53:ENST00000610292.4:missense_variant:MODERATE:exon3/10:c.98C>G:p.Pro33Arg:,TP53:ENST00000620739.4:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:ENST00000420246.6:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000455263.6:missense_variant:MODERATE:exon4/12:c.215C>G:p.Pro72Arg:,TP53:ENST00000610538.4:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:ENST00000622645.4:missense_variant:MODERATE:exon4/12:c.98C>G:p.Pro33Arg:,TP53:ENST00000714357.1:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000445888.6:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000604348.6:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000619485.4:missense_variant:MODERATE:exon4/11:c.98C>G:p.Pro33Arg:,TP53:ENST00000269305.9:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000714408.1:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000714409.1:missense_variant:MODERATE:exon4/10:c.215C>G:p.Pro72Arg:,TP53:ENST00000576024.2:missense_variant:MODERATE:exon4/10:c.215C>G:p.Pro72Arg:,TP53:ENST00000714359.1:missense_variant:MODERATE:exon4/11:c.215C>G:p.Pro72Arg:,TP53:ENST00000504290.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000504937.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000510385.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000610623.4:upstream_gene_variant:MODIFIER::::,TP53:ENST00000618944.4:upstream_gene_variant:MODIFIER::::,TP53:ENST00000619186.4:upstream_gene_variant:MODIFIER::::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Autosomal dominant, Somatic mutation; {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	12351 [benign DISEASE=Bone marrow failure syndrome 5,Basal cell carcinoma, susceptibility to, 7,Li-Fraumeni syndrome 1,Bone osteosarcoma,Colorectal cancer,Familial cancer of breast,Hepatocellular carcinoma,Carcinoma of pancreas,Choroid plexus papilloma,Nasopharyngeal carcinoma,Glioma susceptibility 1,Adrenocortical carcinoma, hereditary,not specified,Acute myeloid leukemia,not provided,Lip and oral cavity carcinoma,Li-Fraumeni syndrome,TP53 POLYMORPHISM,Hereditary cancer-predisposing syndrome,Hereditary breast ovarian cancer syndrome GENE=TP53];			rs1042522	0.62678	0.38659,0.69952,0.57555,0.74501,0.52306	31776,	31733	56739	1.4380	12.91	0.368	0.07	/1.7>0.5/0.0>0.0	COSV52666208,COSV53098660	TP53|0.00|0.00|0.00|0.00|45|-18|3|40	25741868,30409984,34131278,23267696,26451011,31818908,24033266,24728327,24944790,21708280,21514219,23946381,28652652,30551681,34540891,22879966,22992668,23820649,27277665,27716216,25214541,25719551,20599859,28827732,30337837,30793520,30988702,26690118,20003265,35566612,26873362,23757202,33262486,30781715,24491308,32287273,32338278,18805939,18854777,30616520,30937706,18191955,23168575,18298806,22215955,22655231,24084248,29193749,27871254,26870349,16465622,16857995,19822020,27415837,27588484,29484706,19911060,20855462,25479941,33941312,18640487,19470478,21779510,24654968,26382048,26867771,30956778,34618298,21589938,23906684,18978339,30139066,30807515,32651972,28881764,18547414,18715757,18830263,19826048,23072573,32257953,20638924,20847277,21897271,27618021,28348449,32295184,19426493,19657586,20452958,21841506,24820515,27246533,21533266,24534481,31821471,19276375,18678618,32708070,22703879,28415781,29458332,26900293,33942220,24818791,27376129,25203442,32492903,34077778,21402718,28324443,24218030,25412941,2219465	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahpohla1 15.04.2019"			TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	7676326	7676341	CCCCAGCCCTCCAGGT	-	het	off-target;low_conf_region	QUAL=24;DP=26;QD=0.92	TP53	intron,upstream_gene	TP53:ENST00000413465.6:intron_variant:MODIFIER:intron2/6:c.96+41_97-54del::,TP53:ENST00000714356.1:intron_variant:MODIFIER:intron2/9:c.-22+41_-21-54del::,TP53:ENST00000359597.8:intron_variant:MODIFIER:intron2/8:c.96+41_97-54del::,TP53:ENST00000610292.4:intron_variant:MODIFIER:intron2/9:c.-22+41_-21-54del::,TP53:ENST00000620739.4:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:ENST00000420246.6:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:ENST00000455263.6:intron_variant:MODIFIER:intron3/11:c.96+41_97-54del::,TP53:ENST00000610538.4:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:ENST00000622645.4:intron_variant:MODIFIER:intron3/11:c.-22+41_-21-54del::,TP53:ENST00000714357.1:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000445888.6:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000604348.6:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000619485.4:intron_variant:MODIFIER:intron3/10:c.-22+41_-21-54del::,TP53:ENST00000269305.9:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000714408.1:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000714409.1:intron_variant:MODIFIER:intron3/9:c.96+41_97-54del::,TP53:ENST00000576024.2:intron_variant:MODIFIER:intron3/9:c.96+41_97-54del::,TP53:ENST00000714359.1:intron_variant:MODIFIER:intron3/10:c.96+41_97-54del::,TP53:ENST00000504290.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000504937.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000510385.5:upstream_gene_variant:MODIFIER::::,TP53:ENST00000610623.4:upstream_gene_variant:MODIFIER::::,TP53:ENST00000618944.4:upstream_gene_variant:MODIFIER::::,TP53:ENST00000619186.4:upstream_gene_variant:MODIFIER::::		191170_[GENE=TP53_PHENOS={Basal cell carcinoma 7}, 614740 (3), Autosomal dominant; {Adrenocortical carcinoma, pediatric}, 202300 (3), Autosomal dominant; Hepatocellular carcinoma, somatic, 114550 (3); Breast cancer, somatic, 114480 (3); Li-Fraumeni syndrome, 151623 (3), Autosomal dominant; Pancreatic cancer, somatic, 260350 (3); Nasopharyngeal carcinoma, somatic, 607107 (3); {Osteosarcoma}, 259500 (3), Somatic mutation; {Choroid plexus papilloma}, 260500 (3), Autosomal dominant; {Colorectal cancer}, 114500 (3), Autosomal dominant, Somatic mutation; {Glioma susceptibility 1}, 137800 (3), Autosomal dominant, Somatic mutation; Bone marrow failure syndrome 5, 618165 (3), Autosomal dominant]	440349 [benign DISEASE=Breast and/or ovarian cancer,Hereditary cancer-predisposing syndrome,not provided,not specified,Li-Fraumeni syndrome 1 GENE=TP53];			rs59758982	0.82686	0.73303,0.87568,0.96339,0.85639,0.79028	51944,	20946	26140	1.0620	1.47			/0.0>0.0/0.0>0.0			32000721,19471604,32888145,31772679,36123588,30816478	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TP53 (inh=AD oe_syn=1.07 oe_mis=0.82 oe_lof=0.20)
chr17	31226318	31226318	-	ACACAC	het	off-target	QUAL=24;DP=27;QD=0.89	NF1	intron,downstream_gene	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron17/56:c.2002-81_2002-76dup::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron18/58:c.2047-81_2047-76dup::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron17/57:c.2002-81_2002-76dup::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron18/58:c.2032-81_2032-76dup::,NF1:ENST00000431387.8:downstream_gene_variant:MODIFIER::::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	1220711 [benign DISEASE=not provided GENE=NF1];			rs59547221	0.10637	0.07430,0.14807,0.05155,0.12344,0.07225	905,	12904	123620		0.84			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31226467	31226467	G	A	hom		QUAL=24;DP=86;QD=0.28	NF1	synonymous,downstream_gene	NF1:ENST00000356175.7:synonymous_variant:LOW:exon18/57:c.2034G>A:p.Pro678=:,NF1:ENST00000696138.1:synonymous_variant:LOW:exon19/59:c.2079G>A:p.Pro693=:,NF1:ENST00000358273.9:synonymous_variant:LOW:exon18/58:c.2034G>A:p.Pro678=:,NF1:ENST00000691014.1:synonymous_variant:LOW:exon19/59:c.2064G>A:p.Pro688=:,NF1:ENST00000431387.8:downstream_gene_variant:MODIFIER::::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	183826 [benign DISEASE=Neurofibromatosis, familial spinal,Cafe-au-lait macules with pulmonary stenosis,Neurofibromatosis-Noonan syndrome,not specified,Hereditary cancer-predisposing syndrome,not provided,Cardiovascular phenotype,Neurofibromatosis, type 1 GENE=NF1];			rs2285892	0.42534	0.67348,0.43319,0.52440,0.29530,0.38335	15875,	32835	87259	-1.2810	3.58			/0.0>0.0/0.0>0.0	COSV62191601	NF1|0.02|0.00|0.00|0.00|-27|-32|-32|38	25741868,24033266,17668375,21354044,30283335,34449562	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31231064	31231064	T	C	hom	off-target	QUAL=22;DP=17;QD=1.29	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron24/56:c.3197+139T>C::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron25/58:c.3242+139T>C::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron24/57:c.3197+139T>C::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron25/58:c.3227+139T>C::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	561469 [benign DISEASE=not provided GENE=NF1];			rs2071009	0.46559	0.80816,0.44803,0.53540,0.29709,0.38486	20290,	30208	81252	-0.0860	0.91			/0.8>0.0/0.0>0.0		NF1|0.00|0.00|0.00|0.00|-33|36|16|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232570	31232570	G	C	hom	off-target	QUAL=24;DP=437;QD=0.05	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron25/56:c.3315-130G>C::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron26/58:c.3360-130G>C::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron25/57:c.3315-130G>C::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron26/58:c.3345-130G>C::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	561471 [benign DISEASE=not provided GENE=NF1];			rs2072131	0.46334	0.81386,0.44775,0.43985,0.29651,0.37593	20188,	30054	81576	-0.0560	2.55			/0.0>0.0/0.0>0.0	COSV62206709	NF1|0.00|0.00|0.00|0.00|3|-34|1|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31232914	31232914	C	A	hom	off-target	QUAL=24;DP=35;QD=0.69	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron26/56:c.3496+33C>A::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron27/58:c.3541+33C>A::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron26/57:c.3496+33C>A::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron27/58:c.3526+33C>A::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	257285 [benign DISEASE=Neurofibromatosis, type 1,not provided,Neurofibromatosis, familial spinal,not specified GENE=NF1];			rs2066736	0.40375	0.61081,0.42610,0.43907,0.29436,0.37385	13872,	33602	90594	0.2040	1.01			/0.0>0.0/0.0>0.0	COSV62196981	NF1|0.00|0.00|0.00|0.00|46|-32|-33|20	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31236058	31236058	-	G	hom	off-target;low_conf_region	QUAL=24;DP=342;QD=0.07	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron29/56:c.3974+37_3974+38insG::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron30/58:c.4019+37_4019+38insG::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron29/57:c.3974+37_3974+38insG::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron30/58:c.4004+37_4004+38insG::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	1250120 [benign DISEASE=Neurofibromatosis, type 1,not provided GENE=NF1];		(T)n (Simple_repeat)	rs1555615580	0.44281	0.71471,0.45887,0.44943,0.30350,0.38371	16426,	32293	81973		0.91			/2.3>2.8/0.0>0.0	COSV62200165	NF1|0.00|0.00|0.00|0.00|-37|43|-35|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31236067	31236067	-	G	hom	off-target;low_conf_region	QUAL=24;DP=319;QD=0.08	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron29/56:c.3974+46_3974+47insG::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron30/58:c.4019+46_4019+47insG::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron29/57:c.3974+46_3974+47insG::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron30/58:c.4004+46_4004+47insG::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	1292851 [benign DISEASE=not provided GENE=NF1];		(T)n (Simple_repeat)	rs56874702	0.45976	0.80274,0.45991,0.44214,0.29593,0.37375	19686,	30216	81770		0.58			/2.3>2.5/0.0>0.0		NF1|0.00|0.00|0.00|0.02|-46|34|-44|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31336154	31336154	A	C	hom	off-target	QUAL=24;DP=23;QD=1.04	NF1	intron	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron39/56:c.5944-179A>C::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron40/58:c.5989-179A>C::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron40/57:c.6007-179A>C::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron41/58:c.6037-179A>C::,NF1:ENST00000687027.1:intron_variant:MODIFIER:intron4/21:c.163-179A>C::,NF1:ENST00000693617.1:intron_variant:MODIFIER:intron6/23:c.571-179A>C::,NF1:ENST00000684826.1:intron_variant:MODIFIER:intron5/23:c.571-179A>C::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	561473 [benign DISEASE=not provided GENE=NF1];			rs10853138	0.89304	0.83271,0.88030,0.89067,0.91864,0.95213	60811,	14200	16268	-0.4210	3.14			/0.4>0.1/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31336607	31336607	-	A	hom	off-target;low_conf_region	QUAL=24;DP=38;QD=0.63	NF1	splice_region&intron	NF1:ENST00000356175.7:splice_region_variant&intron_variant:LOW:intron40/56:c.6085-17dup::,NF1:ENST00000696138.1:splice_region_variant&intron_variant:LOW:intron41/58:c.6130-17dup::,NF1:ENST00000358273.9:splice_region_variant&intron_variant:LOW:intron41/57:c.6148-17dup::,NF1:ENST00000691014.1:splice_region_variant&intron_variant:LOW:intron42/58:c.6178-17dup::,NF1:ENST00000687027.1:splice_region_variant&intron_variant:LOW:intron5/21:c.304-17dup::,NF1:ENST00000693617.1:splice_region_variant&intron_variant:LOW:intron7/23:c.712-17dup::,NF1:ENST00000684826.1:splice_region_variant&intron_variant:LOW:intron6/23:c.712-17dup::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	495785 [benign DISEASE=Hereditary cancer-predisposing syndrome,Cardiovascular phenotype,not provided GENE=NF1];			rs33925668	0.34199	0.45688,0.39686,0.41598,0.27733,0.24863	9278,	32502	98240		0.08			/1.7>1.7/0.0>0.0			20186797,10678181,23460398,27069254	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22)
chr17	31343172	31343172	C	G	hom	off-target	QUAL=24;DP=163;QD=0.15	NF1,AK4P1	intron,upstream_gene	NF1:ENST00000356175.7:intron_variant:MODIFIER:intron47/56:c.7126+37C>G::,NF1:ENST00000696138.1:intron_variant:MODIFIER:intron48/58:c.7171+37C>G::,NF1:ENST00000358273.9:intron_variant:MODIFIER:intron48/57:c.7189+37C>G::,NF1:ENST00000691014.1:intron_variant:MODIFIER:intron49/58:c.7219+37C>G::,NF1:ENST00000687027.1:intron_variant:MODIFIER:intron12/21:c.1345+37C>G::,NF1:ENST00000693617.1:intron_variant:MODIFIER:intron14/23:c.1753+37C>G::,NF1:ENST00000684826.1:intron_variant:MODIFIER:intron13/23:c.1753+37C>G::,AK4P1:ENST00000581275.2:upstream_gene_variant:MODIFIER::::		613113_[GENE=NF1_PHENOS=Watson syndrome, 193520 (3), Autosomal dominant; Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutation; Neurofibromatosis, familial spinal, 162210 (3), Autosomal dominant; Neurofibromatosis, type 1, 162200 (3), Autosomal dominant; Neurofibromatosis-Noonan syndrome, 601321 (3), Autosomal dominant]	257300 [benign DISEASE=not specified,Neurofibromatosis, familial spinal,Neurofibromatosis, type 1,not provided GENE=NF1];			rs7405740	0.88378	0.80051,0.87740,0.89093,0.91838,0.95217	59692,	15170	17694	-1.4250	1.33			/0.0>0.0/0.0>0.0		NF1|0.00|0.00|0.00|0.00|-37|-36|-37|-38	25741868,19417008	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NF1 (inh=AD oe_syn=0.94 oe_mis=0.52 oe_lof=0.22), AK4P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	35101468	35101468	A	G	het	off-target	QUAL=24;DP=57;QD=0.42	RAD51D,Vault	intron,upstream_gene	RAD51D:ENST00000345365.11:intron_variant:MODIFIER:intron8/9:c.739-103T>C::,RAD51D:ENST00000590016.6:intron_variant:MODIFIER:intron8/9:c.799-103T>C::,RAD51D:ENST00000586186.3:intron_variant:MODIFIER:intron7/8:c.604-103T>C::,RAD51D:ENST00000394589.8:intron_variant:MODIFIER:intron9/10:c.739-103T>C::,RAD51D:ENST00000592577.6:intron_variant:MODIFIER:intron8/9:c.382-103T>C::,RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron5/6:c.403-103T>C::,RAD51D:ENST00000587405.6:intron_variant:MODIFIER:intron6/7:c.382-103T>C::,RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron7/8:c.208-103T>C::,Vault:ENST00000516519.1:upstream_gene_variant:MODIFIER::::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	1269566 [benign DISEASE=not provided GENE=RAD51D];		MIR3 (SINE/MIR)	rs28363289	0.07845	0.03487,0.06707,0.04847,0.09333,0.14635	578,	10789	140309	0.3060	10.56			/6.8>6.9/0.0>0.0		RAD51D|0.00|0.00|0.00|0.00|4|-13|-12|50,RAD51L3-RFFL|0.00|0.00|0.00|0.00|4|-13|-12|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35106468	35106468	C	T	hom		QUAL=24;DP=85;QD=0.28	RAD51D	missense,5'UTR	RAD51D:ENST00000345365.11:missense_variant:MODERATE:exon6/10:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000590016.6:missense_variant:MODERATE:exon6/10:c.554G>A:p.Arg185Gln:PF08423 [Rad51],RAD51D:ENST00000586186.3:missense_variant:MODERATE:exon5/9:c.359G>A:p.Arg120Gln:,RAD51D:ENST00000394589.8:missense_variant:MODERATE:exon7/11:c.494G>A:p.Arg165Gln:PF08423 [Rad51],RAD51D:ENST00000592577.6:missense_variant:MODERATE:exon6/10:c.137G>A:p.Arg46Gln:PF08423 [Rad51],RAD51D:ENST00000335858.11:missense_variant:MODERATE:exon3/7:c.158G>A:p.Arg53Gln:PF21794 [],RAD51D:ENST00000587405.6:missense_variant:MODERATE:exon4/8:c.137G>A:p.Arg46Gln:PF08423 [Rad51],RAD51D:ENST00000460118.6:5_prime_UTR_variant:MODIFIER:exon5/9:c.-38G>A::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	142159 [benign DISEASE=Hereditary cancer-predisposing syndrome,not specified,Breast-ovarian cancer, familial, susceptibility to, 4,not provided GENE=RAD51D];	CM172631 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=RAD51D];		rs4796033	0.12106	0.03354,0.21750,0.04591,0.14404,0.14446	1455,	15517	133783	1.1790	13.90	0.127	0.06	/0.0>0.0/0.0>0.0	COSV104653496	RAD51D|0.00|0.00|0.00|0.00|-38|9|9|-10,RAD51L3-RFFL|0.00|0.00|0.00|0.00|-38|9|9|-10	25741868,29458332,22986143,23372765,22652533,26673457,30591675,22415235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahstaea1 08.05.2018: AF 15% in gnomAD und ExAC"			RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35106801	35106801	A	G	hom	off-target	QUAL=24;DP=359;QD=0.07	RAD51D	intron	RAD51D:ENST00000345365.11:intron_variant:MODIFIER:intron5/9:c.480+187T>C::,RAD51D:ENST00000590016.6:intron_variant:MODIFIER:intron5/9:c.540+187T>C::,RAD51D:ENST00000586186.3:intron_variant:MODIFIER:intron4/8:c.346-320T>C::,RAD51D:ENST00000394589.8:intron_variant:MODIFIER:intron6/10:c.480+187T>C::,RAD51D:ENST00000592577.6:intron_variant:MODIFIER:intron5/9:c.123+187T>C::,RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron2/6:c.145-320T>C::,RAD51D:ENST00000587405.6:intron_variant:MODIFIER:intron3/7:c.123+187T>C::,RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron4/8:c.-52+187T>C::		602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	679676 [benign DISEASE=not provided GENE=RAD51D];			rs936656	0.51051	0.53069,0.60058,0.57057,0.48280,0.61909	20042,	37517	74405	-3.7110	0.01			/6.5>5.7/0.0>0.0		RAD51D|0.01|0.00|0.00|0.00|45|-12|-47|2,RAD51L3-RFFL|0.01|0.00|0.00|0.00|45|-12|-47|2	22652533	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80)
chr17	35118530	35118530	G	A	het		QUAL=24;DP=132;QD=0.18	RAD51D,FNDC8	synonymous,intron,5'UTR,upstream_gene	RAD51D:ENST00000345365.11:synonymous_variant:LOW:exon3/10:c.234C>T:p.Ser78=:,RAD51D:ENST00000590016.6:intron_variant:MODIFIER:intron2/9:c.144+581C>T::,RAD51D:ENST00000586186.3:synonymous_variant:LOW:exon3/9:c.234C>T:p.Ser78=:,RAD51D:ENST00000394589.8:synonymous_variant:LOW:exon4/11:c.234C>T:p.Ser78=:,RAD51D:ENST00000592577.6:5_prime_UTR_variant:MODIFIER:exon3/10:c.-124C>T::,RAD51D:ENST00000335858.11:intron_variant:MODIFIER:intron2/6:c.144+581C>T::,RAD51D:ENST00000587405.6:intron_variant:MODIFIER:intron1/7:c.-95+2761C>T::,RAD51D:ENST00000460118.6:intron_variant:MODIFIER:intron2/8:c.-208+581C>T::,FNDC8:ENST00000158009.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	602954_[GENE=RAD51D_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)]	183785 [benign DISEASE=not provided,Breast-ovarian cancer, familial, susceptibility to, 4,Hereditary cancer-predisposing syndrome,not specified GENE=RAD51D];			rs9901455	0.15580	0.29955,0.12543,0.22703,0.08271,0.08603	2581,	18543	128443	1.6750	12.07			/2.0>1.5/0.0>0.0	COSV99338663	RAD51D|0.00|0.00|0.00|0.00|14|-3|-25|-29,RAD51L3-RFFL|0.00|0.00|0.00|0.00|5|-3|-25|-29	25741868,21822267,22986143,23372765,22652533,22415235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51D (inh=AD oe_syn=1.01 oe_mis=1.02 oe_lof=0.80), FNDC8 (inh=n/a oe_syn=0.99 oe_mis=0.91 oe_lof=0.69)
chr17	43051308	43051308	T	A	het	off-target	QUAL=24;DP=62;QD=0.39	BRCA1	intron	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron11/14:c.4390-191A>T::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron18/21:c.5200-191A>T::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron19/22:c.1966-191A>T::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron19/22:c.5278-191A>T::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron17/20:c.5152-191A>T::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron18/21:c.5200-191A>T::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron18/21:c.1852-191A>T::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron18/21:c.1828-191A>T::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron19/22:c.5278-191A>T::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron20/23:c.5341-191A>T::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron17/20:c.5155-191A>T::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron19/22:c.5272-191A>T::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron19/22:c.5278-191A>T::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron19/22:c.5278-191A>T::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron19/22:c.5278-191A>T::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron19/22:c.5275-191A>T::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron20/23:c.1828-191A>T::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron19/21:c.1966-191A>T::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron20/23:c.5344-191A>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron17/20:c.1840-191A>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron4/7:c.208-191A>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron7/10:c.751-191A>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-1118A>T::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron18/21:c.5137-191A>T::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron19/22:c.1966-191A>T::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209259 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided GENE=BRCA1];			rs8176297	0.31040	0.23236,0.27152,0.36911,0.33184,0.49356	7711,	31799	104907	-1.1500	0.29			/0.0>4.4/0.0>0.0	COSV58783637	BRCA1|0.00|0.00|0.00|0.00|-5|47|0|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43067543	43067543	C	T	het	off-target	QUAL=24;DP=32;QD=0.75	BRCA1	intron,downstream_gene	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron8/14:c.4186+65G>A::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron15/21:c.4996+65G>A::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron16/22:c.1762+65G>A::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron16/22:c.5074+65G>A::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron14/20:c.4948+65G>A::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron15/21:c.4996+65G>A::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron15/21:c.1648+65G>A::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron15/21:c.1624+65G>A::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron16/22:c.5074+65G>A::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron17/23:c.5137+65G>A::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron14/20:c.4951+65G>A::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron16/22:c.5068+65G>A::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron16/22:c.5074+65G>A::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron16/22:c.5074+65G>A::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron16/22:c.5074+65G>A::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron16/22:c.5071+65G>A::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron17/23:c.1624+65G>A::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron16/21:c.1762+65G>A::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron17/23:c.5140+65G>A::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron14/20:c.1636+65G>A::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-3592G>A::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron4/10:c.547+65G>A::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-17353G>A::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron15/21:c.4933+65G>A::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron16/22:c.1762+65G>A::,BRCA1:ENST00000700182.1:downstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	127126 [benign DISEASE=not specified,Breast-ovarian cancer, familial, susceptibility to, 1,not provided,Familial cancer of breast GENE=BRCA1];		AluSc (SINE/Alu)	rs8176235	0.24711	0.16899,0.26814,0.37150,0.25478,0.46061	5015,	27534	114452	0.1670	5.11			/0.0>0.0/1.6>0.0	COSV58786515	BRCA1|0.00|0.00|0.00|0.00|-2|43|-9|5	25741868,26926928,21989022	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43067763	43067763	T	C	het	off-target	QUAL=24;DP=35;QD=0.69	BRCA1	intron,downstream_gene	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron7/14:c.4099-68A>G::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron14/21:c.4909-68A>G::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron15/22:c.1675-68A>G::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron15/22:c.4987-68A>G::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron13/20:c.4861-68A>G::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron14/21:c.4909-68A>G::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron14/21:c.1561-68A>G::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron14/21:c.1537-68A>G::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron15/22:c.4987-68A>G::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron16/23:c.5050-68A>G::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron13/20:c.4864-68A>G::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron15/22:c.4981-68A>G::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron15/22:c.4987-68A>G::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron15/22:c.4987-68A>G::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron15/22:c.4987-68A>G::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron15/22:c.4984-68A>G::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron16/23:c.1537-68A>G::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron15/21:c.1675-68A>G::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron16/23:c.5053-68A>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron13/20:c.1549-68A>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-3812A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron3/10:c.460-68A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-17573A>G::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron14/21:c.4846-68A>G::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron15/22:c.1675-68A>G::,BRCA1:ENST00000700182.1:downstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125746 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,Hereditary cancer-predisposing syndrome,not provided,Breast-ovarian cancer, familial, susceptibility to, 1 GENE=BRCA1];			rs8176234	0.31553	0.23378,0.32666,0.36855,0.33127,0.48789	7830,	32022	103434	-2.2540	0.55			/0.0>0.0/0.0>2.9	COSV58794203	BRCA1|0.00|0.00|0.01|0.00|21|-47|21|-30	25741868,17916242,35908255,28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43071077	43071077	T	C	het		QUAL=24;DP=435;QD=0.06	BRCA1	missense,intron	BRCA1:ENST00000497488.2:missense_variant:MODERATE:exon7/15:c.3949A>G:p.Ser1317Gly:,BRCA1:ENST00000489037.2:missense_variant:MODERATE:exon14/22:c.4759A>G:p.Ser1587Gly:,BRCA1:ENST00000478531.6:missense_variant:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000473961.6:missense_variant:MODERATE:exon13/21:c.4711A>G:p.Ser1571Gly:,BRCA1:ENST00000477152.6:missense_variant:MODERATE:exon14/22:c.4759A>G:p.Ser1587Gly:,BRCA1:ENST00000352993.7:missense_variant:MODERATE:exon14/22:c.1411A>G:p.Ser471Gly:,BRCA1:ENST00000493919.6:missense_variant:MODERATE:exon14/22:c.1387A>G:p.Ser463Gly:,BRCA1:ENST00000494123.6:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon16/24:c.4900A>G:p.Ser1634Gly:,BRCA1:ENST00000634433.2:missense_variant:MODERATE:exon13/21:c.4714A>G:p.Ser1572Gly:,BRCA1:ENST00000476777.6:missense_variant:MODERATE:exon15/23:c.4831A>G:p.Ser1611Gly:,BRCA1:ENST00000470026.6:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000713676.1:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000618469.2:missense_variant:MODERATE:exon15/23:c.4837A>G:p.Ser1613Gly:,BRCA1:ENST00000461574.2:missense_variant:MODERATE:exon15/23:c.4834A>G:p.Ser1612Gly:,BRCA1:ENST00000644555.2:missense_variant:MODERATE:exon16/24:c.1387A>G:p.Ser463Gly:,BRCA1:ENST00000468300.5:missense_variant:MODERATE:exon15/22:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000644379.2:missense_variant:MODERATE:exon16/24:c.4903A>G:p.Ser1635Gly:,BRCA1:ENST00000484087.6:missense_variant:MODERATE:exon13/21:c.1399A>G:p.Ser467Gly:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-7126A>G::,BRCA1:ENST00000591534.5:missense_variant:MODERATE:exon3/11:c.310A>G:p.Ser104Gly:,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-20887A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon14/22:c.4696A>G:p.Ser1566Gly:,BRCA1:ENST00000491747.6:missense_variant:MODERATE:exon15/23:c.1525A>G:p.Ser509Gly:,BRCA1:ENST00000700182.1:missense_variant:MODERATE:exon14/14:c.1444A>G:p.Ser482Gly:		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41827 [benign DISEASE=Malignant tumor of breast,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Fanconi anemia, complementation group S,Pancreatic cancer, susceptibility to, 4,Familial cancer of breast,Breast carcinoma,BRCA1-related cancer predisposition,not provided,Hereditary breast ovarian cancer syndrome,not specified GENE=BRCA1];	CM1210129 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799966	0.31783	0.23700,0.32951,0.37022,0.33219,0.49211	8007,	32310	103720	-0.1940	6.90	0.252	0.08	/0.0>0.0/0.0>0.0	COSV58783381	BRCA1|0.00|0.00|0.00|0.00|11|17|0|-34	25741868,24033266,24728327,34711928,21204206,18559551,32606887,26901225,30693270,18830263,22703879,29458332,24062231,19482343,32039725,21890493,28771511,24933103,33810047,22430443,34319543,32219892,21161372,21597964,23961350,27478808,28415599,33499154,27698805,31203256,20104584,20807450,25896959,10728701,12955716,17341484,21702907,21990134,21356067,15617999,23767878,17308087,18694767,28439188,32606146,26183948,22921312,21989022,17916242,24986639,15235020,29492227,32100578,30832521,17585057,22136207,15726418,9333265,9523200,10951344,15689452,25735359,32424803,21447777,17719744,23674270,15350310,21765009,18992264,15004537,27008870,25802882,26092435,32324802,31658756,31123752,28944232,25653542,22503699,30541318,27899611,35908255,33004033,32284662,26414677,29657992,28672935,34094541,32203205,33240400,35456488,35300046,31131559,36831624,34242281,28076423,31205572,33507988,29997359,25602962,31962039,35693198,26052455,25923920,33547301,37025588,18558292,21504591,23749302,31706072,36329109,21712546,9326340,30765603,2	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43074584	43074584	G	C	het	off-target	QUAL=24;DP=13;QD=1.85	BRCA1,RPL21P4	intron,upstream_gene	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron5/14:c.3597-63C>G::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron12/21:c.4407-63C>G::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron13/22:c.1173-63C>G::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron13/22:c.4485-63C>G::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron11/20:c.4359-63C>G::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron12/21:c.4407-63C>G::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron12/21:c.1059-63C>G::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron12/21:c.1035-63C>G::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron13/22:c.4485-63C>G::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron14/23:c.4548-63C>G::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron11/20:c.4362-63C>G::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron13/22:c.4479-63C>G::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron13/22:c.4485-63C>G::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron13/22:c.4485-63C>G::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron13/22:c.4485-63C>G::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron13/22:c.4482-63C>G::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron14/23:c.1035-63C>G::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron13/21:c.1173-63C>G::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron14/23:c.4551-63C>G::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron11/20:c.1047-63C>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-10633C>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-63C>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-24394C>G::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron12/21:c.4344-63C>G::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron13/22:c.1173-63C>G::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron12/13:c.1092-63C>G::,RPL21P4:ENST00000497954.1:upstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209374 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not specified,not provided GENE=BRCA1];			rs273900734	0.31651	0.23461,0.32967,0.36925,0.33110,0.49233	7942,	32250	103944	0.0020	2.65			/3.0>5.5/4.7>3.3	COSV58794229	BRCA1|0.00|0.00|0.00|0.00|0|-33|34|-2	25741868,28944232,35908255,28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43074658	43074658	A	T	het	off-target	QUAL=23;DP=35;QD=0.66	BRCA1,RPL21P4	intron,upstream_gene	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron5/14:c.3597-137T>A::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron12/21:c.4407-137T>A::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron13/22:c.1173-137T>A::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron13/22:c.4485-137T>A::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron11/20:c.4359-137T>A::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron12/21:c.4407-137T>A::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron12/21:c.1059-137T>A::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron12/21:c.1035-137T>A::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron13/22:c.4485-137T>A::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron14/23:c.4548-137T>A::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron11/20:c.4362-137T>A::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron13/22:c.4479-137T>A::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron13/22:c.4485-137T>A::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron13/22:c.4485-137T>A::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron13/22:c.4485-137T>A::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron13/22:c.4482-137T>A::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron14/23:c.1035-137T>A::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron13/21:c.1173-137T>A::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron14/23:c.4551-137T>A::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron11/20:c.1047-137T>A::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-10707T>A::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-137T>A::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-24468T>A::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron12/21:c.4344-137T>A::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron13/22:c.1173-137T>A::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron12/13:c.1092-137T>A::,RPL21P4:ENST00000497954.1:upstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209375 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not specified,not provided GENE=BRCA1];			rs2236762	0.45173	0.68840,0.37634,0.37002,0.34047,0.52076	17307,	34043	83331	-0.5760	0.08			/0.0>0.0/0.0>0.0	COSV58801011	BRCA1|0.00|0.00|0.00|0.00|-21|-6|7|30	19276285,34648354,36284733	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43074720	43074724	GGGTT	-	het	off-target	QUAL=25;DP=35;QD=0.71	BRCA1,RPL21P4	intron,upstream_gene	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron5/14:c.3597-203_3597-199del::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron12/21:c.4407-203_4407-199del::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron13/22:c.1173-203_1173-199del::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron13/22:c.4485-203_4485-199del::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron11/20:c.4359-203_4359-199del::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron12/21:c.4407-203_4407-199del::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron12/21:c.1059-203_1059-199del::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron12/21:c.1035-203_1035-199del::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron13/22:c.4485-203_4485-199del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron14/23:c.4548-203_4548-199del::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron11/20:c.4362-203_4362-199del::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron13/22:c.4479-203_4479-199del::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron13/22:c.4485-203_4485-199del::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron13/22:c.4485-203_4485-199del::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron13/22:c.4485-203_4485-199del::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron13/22:c.4482-203_4482-199del::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron14/23:c.1035-203_1035-199del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron13/21:c.1173-203_1173-199del::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron14/23:c.4551-203_4551-199del::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron11/20:c.1047-203_1047-199del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-10773_5-10769del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-203_-43-199del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-24534_-98-24530del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron12/21:c.4344-203_4344-199del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron13/22:c.1173-203_1173-199del::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron12/13:c.1092-203_1092-199del::,RPL21P4:ENST00000497954.1:upstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209376 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided GENE=BRCA1];			rs34250703	0.29898	0.17887,0.31948,0.36628,0.33005,0.49086	7306,	30759	106383	0.9620	9.09			/0.0>0.0/0.0>0.0		BRCA1|0.00|0.00|0.00|0.00|34|-32|-31|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43079499	43079499	C	T	het	off-target	QUAL=24;DP=110;QD=0.22	BRCA1,RPL21P4	intron,non_coding_transcript_exon	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron4/14:c.3470-2885G>A::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron11/21:c.4280-2885G>A::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron12/22:c.1046-2885G>A::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron12/22:c.4358-2885G>A::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron10/20:c.4232-2885G>A::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron11/21:c.4280-2885G>A::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron11/21:c.932-2885G>A::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron11/21:c.908-2885G>A::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron12/22:c.4358-2885G>A::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron12/23:c.4358-100G>A::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron10/20:c.4235-2885G>A::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron12/22:c.4352-2885G>A::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron12/22:c.4358-2885G>A::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron12/22:c.4358-2885G>A::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron12/22:c.4358-2885G>A::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron12/22:c.4358-2888G>A::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron13/23:c.908-2885G>A::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron12/21:c.1049-2888G>A::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron12/23:c.4358-100G>A::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron10/20:c.923-2888G>A::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-15548G>A::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-4978G>A::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-29309G>A::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron11/21:c.4217-2885G>A::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron12/22:c.1049-2888G>A::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron11/13:c.968-2888G>A::,RPL21P4:ENST00000497954.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.198C>T::	regulatory_region_variant:enhancer	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209399 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary breast ovarian cancer syndrome,not provided GENE=BRCA1];			rs8176193	0.31646	0.23428,0.32929,0.36973,0.33078,0.49253	7934,	32233	103897	0.5280	6.26			/4.6>4.9/0.0>0.0,/0.0>0.0/1.2>1.7	COSV58789905	BRCA1|0.00|0.00|0.00|0.00|-17|25|-2|-26	33126731,26012346	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43082453	43082453	A	G	het		QUAL=24;DP=34;QD=0.71	BRCA1,RPL21P4	synonymous,intron,downstream_gene	BRCA1:ENST00000497488.2:synonymous_variant:LOW:exon4/15:c.3420T>C:p.Ser1140=:,BRCA1:ENST00000489037.2:synonymous_variant:LOW:exon11/22:c.4230T>C:p.Ser1410=:,BRCA1:ENST00000478531.6:synonymous_variant:LOW:exon12/23:c.996T>C:p.Ser332=:,BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000473961.6:synonymous_variant:LOW:exon10/21:c.4182T>C:p.Ser1394=:,BRCA1:ENST00000477152.6:synonymous_variant:LOW:exon11/22:c.4230T>C:p.Ser1410=:,BRCA1:ENST00000352993.7:synonymous_variant:LOW:exon11/22:c.882T>C:p.Ser294=:,BRCA1:ENST00000493919.6:synonymous_variant:LOW:exon11/22:c.858T>C:p.Ser286=:,BRCA1:ENST00000494123.6:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000634433.2:synonymous_variant:LOW:exon10/21:c.4185T>C:p.Ser1395=:,BRCA1:ENST00000476777.6:synonymous_variant:LOW:exon12/23:c.4302T>C:p.Ser1434=:,BRCA1:ENST00000470026.6:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000713676.1:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000618469.2:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000461574.2:synonymous_variant:LOW:exon12/23:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000644555.2:synonymous_variant:LOW:exon13/24:c.858T>C:p.Ser286=:,BRCA1:ENST00000468300.5:synonymous_variant:LOW:exon12/22:c.999T>C:p.Ser333=:,BRCA1:ENST00000644379.2:synonymous_variant:LOW:exon12/24:c.4308T>C:p.Ser1436=:,BRCA1:ENST00000484087.6:synonymous_variant:LOW:exon10/21:c.873T>C:p.Ser291=:,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-18502T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-7932T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-98-32263T>C::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon11/22:c.4167T>C:p.Ser1389=:,BRCA1:ENST00000491747.6:synonymous_variant:LOW:exon12/23:c.999T>C:p.Ser333=:,BRCA1:ENST00000700182.1:synonymous_variant:LOW:exon11/14:c.918T>C:p.Ser306=:,RPL21P4:ENST00000497954.1:downstream_gene_variant:MODIFIER::::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125703 [benign DISEASE=not specified,Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Familial cancer of breast,Hereditary breast ovarian cancer syndrome,not provided,Pancreatic cancer, susceptibility to, 4,Fanconi anemia, complementation group S GENE=BRCA1];	CM1719086 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1060915	0.30062	0.18027,0.32009,0.36862,0.33168,0.49170	7439,	30851	106385	0.1030	2.30	0.058		/0.0>0.0/0.0>0.0	COSV58783806	BRCA1|0.00|0.00|0.00|0.00|6|-13|6|-49	25741868,24033266,21161372,21597964,19644020,27478808,20807450,19471317,21702907,21356067,23767878,21191178,17916242,24986639,22136207,26092435,31658756,31123752,28944232,22503699,35908255,33004033,35300046,36831624,28076423,37191028,29997359,31934565,31962039,35693198,36329109,37609195	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), RPL21P4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	43091983	43091983	T	C	het		QUAL=24;DP=100;QD=0.24	BRCA1	missense,intron	BRCA1:ENST00000497488.2:missense_variant:MODERATE:exon2/15:c.2660A>G:p.Lys887Arg:,BRCA1:ENST00000489037.2:missense_variant:MODERATE:exon9/22:c.3470A>G:p.Lys1157Arg:,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron10/22:c.785-951A>G::,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000473961.6:missense_variant:MODERATE:exon8/21:c.3422A>G:p.Lys1141Arg:,BRCA1:ENST00000477152.6:missense_variant:MODERATE:exon9/22:c.3470A>G:p.Lys1157Arg:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-951A>G::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron9/21:c.647-951A>G::,BRCA1:ENST00000494123.6:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000634433.2:missense_variant:MODERATE:exon8/21:c.3425A>G:p.Lys1142Arg:,BRCA1:ENST00000476777.6:missense_variant:MODERATE:exon10/23:c.3545A>G:p.Lys1182Arg:,BRCA1:ENST00000470026.6:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000713676.1:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000618469.2:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000461574.2:missense_variant:MODERATE:exon10/23:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron11/23:c.647-951A>G::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.788-951A>G::,BRCA1:ENST00000644379.2:missense_variant:MODERATE:exon10/24:c.3548A>G:p.Lys1183Arg:,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.665-951A>G::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28032A>G::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-17462A>G::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+33288A>G::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.3407A>G:p.Lys1136Arg:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.788-951A>G::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.707-951A>G::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41818 [benign DISEASE=Hereditary cancer-predisposing syndrome,Breast-ovarian cancer, familial, susceptibility to, 1,Fanconi anemia, complementation group S,Pancreatic cancer, susceptibility to, 4,Familial cancer of breast,Breast carcinoma,BRCA1-related cancer predisposition,not specified,not provided,Hereditary breast ovarian cancer syndrome GENE=BRCA1];	CM058359 [CLASS=DP MUT=ALT PHEN="Breast cancer protection against association with" GENE=BRCA1];		rs16942	0.31544	0.23251,0.32807,0.36929,0.33013,0.49315	7893,	32174	104082	-0.3190	1.22	0.067	0.06	/0.0>0.0/1.4>0.5	COSV58784397	BRCA1|0.00|0.00|0.00|0.00|14|-16|35|14	25741868,24728327,33126731,21204206,18830263,26012346,22703879,29458332,30594178,26559640,19482343,32039725,20233625,21766209,25178586,21890493,22430443,21161372,21597964,19644020,23961350,27478808,28415599,33499154,27698805,31203256,20104584,20807450,21702907,21990134,12872265,18694767,28439188,32606146,21708019,16026807,23313170,22136207,23674270,15923272,25802882,30075112,32324802,24052750,31658756,31123752,28944232,25653542,22503699,35908255,33004033,26414677,33875706,28672935,34094541,25771414,27273131,33240400,29785135,33462484,35456488,24244370,35300046,31131559,32459809,26052370,28076423,29997359,33407290,25602962,34608183,31962039,35693198,26052455,25923920,36922933,21504591,36329109,31911673,37609195	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43092919	43092919	G	A	het		QUAL=24;DP=116;QD=0.21	BRCA1	missense,intron	BRCA1:ENST00000497488.2:missense_variant:MODERATE:exon2/15:c.1724C>T:p.Pro575Leu:,BRCA1:ENST00000489037.2:missense_variant:MODERATE:exon9/22:c.2534C>T:p.Pro845Leu:,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron10/22:c.784+1825C>T::,BRCA1:ENST00000357654.9:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000473961.6:missense_variant:MODERATE:exon8/21:c.2486C>T:p.Pro829Leu:,BRCA1:ENST00000477152.6:missense_variant:MODERATE:exon9/22:c.2534C>T:p.Pro845Leu:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-1887C>T::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron9/21:c.646+1825C>T::,BRCA1:ENST00000494123.6:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000471181.7:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000634433.2:missense_variant:MODERATE:exon8/21:c.2489C>T:p.Pro830Leu:,BRCA1:ENST00000476777.6:missense_variant:MODERATE:exon10/23:c.2609C>T:p.Pro870Leu:,BRCA1:ENST00000470026.6:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000713676.1:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000618469.2:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000461574.2:missense_variant:MODERATE:exon10/23:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron11/23:c.646+1825C>T::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1825C>T::,BRCA1:ENST00000644379.2:missense_variant:MODERATE:exon10/24:c.2612C>T:p.Pro871Leu:,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.664+1825C>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-28968C>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18398C>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32352C>T::,BRCA1:ENST00000493795.5:missense_variant:MODERATE:exon9/22:c.2471C>T:p.Pro824Leu:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1825C>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.706+1825C>T::	regulatory_region_variant:open_chromatin_region	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	41812 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Fanconi anemia, complementation group S,Pancreatic cancer, susceptibility to, 4,Familial cancer of breast,Breast carcinoma,BRCA1-related cancer predisposition,Hereditary cancer-predisposing syndrome,not provided,Hereditary breast ovarian cancer syndrome,not specified GENE=BRCA1];	CM096315 [CLASS=DFP MUT=ALT PHEN="Cervical cancer decreased risk association with" GENE=BRCA1];		rs799917	0.48743	0.81075,0.39029,0.37016,0.34073,0.52238	21276,	31573	77949	4.2470	16.51	0.140	0.04	/9.1>9.7/0.0>0.0	COSV58784386	BRCA1|0.01|0.00|0.00|0.00|-15|37|26|48	25741868,23554684,23614619,28698656,24728327,25114582,20332227,20003265,18937358,21204206,18559551,32606887,23973201,26263974,18830263,22778704,22703879,29458332,27859935,19276285,24062231,19482343,32039725,29209986,24756092,20843204,16111488,25178586,23293655,27073502,21890493,29963112,24933103,23619945,22430443,35637613,21161372,21597964,19644020,23961350,27478808,28415599,33499154,34008499,27698805,31203256,20104584,20807450,19471317,10923033,25896959,21702907,21990134,28678827,18694767,32606146,21708019,34295994,17916242,24986639,29492227,15743496,19484476,23749772,25266802,28744749,30820179,30832521,33850565,22136207,23996866,17719744,23674270,29582646,25652403,15923272,25802882,26092435,30075112,24052750,31658756,31123752,25759599,28944232,25653542,29099791,22503699,30541318,32284927,30322005,35908255,19012493,22035854,35899106,29921024,21286719,26414677,31938277,27221928,35858847,28672935,34094541,27273131,33240400,29785135,36268271,35456488,26850014,35411188,24244370,35300046,23964347,31131559,3683162	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43093220	43093220	A	G	het		QUAL=24;DP=113;QD=0.21	BRCA1	synonymous,intron	BRCA1:ENST00000497488.2:synonymous_variant:LOW:exon2/15:c.1423T>C:p.Leu475=:,BRCA1:ENST00000489037.2:synonymous_variant:LOW:exon9/22:c.2233T>C:p.Leu745=:,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron10/22:c.784+1524T>C::,BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:ENST00000473961.6:synonymous_variant:LOW:exon8/21:c.2185T>C:p.Leu729=:,BRCA1:ENST00000477152.6:synonymous_variant:LOW:exon9/22:c.2233T>C:p.Leu745=:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.671-2188T>C::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron9/21:c.646+1524T>C::,BRCA1:ENST00000494123.6:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:,BRCA1:ENST00000634433.2:synonymous_variant:LOW:exon8/21:c.2188T>C:p.Leu730=:,BRCA1:ENST00000476777.6:synonymous_variant:LOW:exon10/23:c.2308T>C:p.Leu770=:,BRCA1:ENST00000470026.6:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:ENST00000713676.1:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:ENST00000618469.2:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:ENST00000461574.2:synonymous_variant:LOW:exon10/23:c.2311T>C:p.Leu771=:,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron11/23:c.646+1524T>C::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1524T>C::,BRCA1:ENST00000644379.2:synonymous_variant:LOW:exon10/24:c.2311T>C:p.Leu771=:,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.664+1524T>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-29269T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18699T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+32051T>C::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon9/22:c.2170T>C:p.Leu724=:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1524T>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.706+1524T>C::	regulatory_region_variant:open_chromatin_region	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125554 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Familial cancer of breast,not specified,not provided,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome,Pancreatic cancer, susceptibility to, 4,Fanconi anemia, complementation group S GENE=BRCA1];	CM1719261 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs16940	0.29932	0.17966,0.31946,0.36833,0.32954,0.49231	7355,	30780	106486	-0.4420	1.20			/0.0>0.0/1.6>4.1	COSV58786443	BRCA1|0.00|0.00|0.00|0.00|-2|43|-2|15	25741868,17697348,18830263,19276285,25178586,22430443,33534415,21161372,21597964,19644020,27478808,20104584,20807450,21702907,23767878,21989022,34295994,24986639,15923272,26092435,30075112,31123752,28944232,35908255,33004033,32284662,27273131,35300046,31131559,36831624,28076423,29997359,31962039,35693198,36329109,37609195	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43093449	43093449	G	A	het		QUAL=25;DP=58;QD=0.43	BRCA1	synonymous,intron	BRCA1:ENST00000497488.2:synonymous_variant:LOW:exon2/15:c.1194C>T:p.Ser398=:,BRCA1:ENST00000489037.2:synonymous_variant:LOW:exon9/22:c.2004C>T:p.Ser668=:,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron10/22:c.784+1295C>T::,BRCA1:ENST00000357654.9:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:ENST00000473961.6:synonymous_variant:LOW:exon8/21:c.1956C>T:p.Ser652=:,BRCA1:ENST00000477152.6:synonymous_variant:LOW:exon9/22:c.2004C>T:p.Ser668=:,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron9/21:c.670+2397C>T::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron9/21:c.646+1295C>T::,BRCA1:ENST00000494123.6:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:ENST00000471181.7:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:,BRCA1:ENST00000634433.2:synonymous_variant:LOW:exon8/21:c.1959C>T:p.Ser653=:,BRCA1:ENST00000476777.6:synonymous_variant:LOW:exon10/23:c.2079C>T:p.Ser693=:,BRCA1:ENST00000470026.6:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:ENST00000713676.1:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:ENST00000618469.2:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:ENST00000461574.2:synonymous_variant:LOW:exon10/23:c.2082C>T:p.Ser694=:,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron11/23:c.646+1295C>T::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron10/21:c.787+1295C>T::,BRCA1:ENST00000644379.2:synonymous_variant:LOW:exon10/24:c.2082C>T:p.Ser694=:,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron8/20:c.664+1295C>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.5-29498C>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-18928C>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+31822C>T::,BRCA1:ENST00000493795.5:synonymous_variant:LOW:exon9/22:c.1941C>T:p.Ser647=:,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron10/22:c.787+1295C>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron9/13:c.706+1295C>T::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125536 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary breast ovarian cancer syndrome,not provided,not specified,Familial cancer of breast,Hereditary cancer-predisposing syndrome,Pancreatic cancer, susceptibility to, 4,Fanconi anemia, complementation group S GENE=BRCA1];	CM1719085 [CLASS=R MUT=ALT PHEN="Breast cancer" GENE=BRCA1];		rs1799949	0.31567	0.23313,0.32840,0.36945,0.33021,0.49315	7899,	32187	104027	-0.0010	3.05			/3.1>3.6/0.0>0.0	COSV58784419	BRCA1|0.00|0.00|0.00|0.00|-14|20|17|-20	25741868,24033266,19276285,34203389,21161372,19644020,27478808,33499154,20104584,20807450,12955716,21702907,22713736,28439188,21989022,24986639,16760288,15923272,25633036,30075112,24052750,28944232,29773799,35908255,33004033,26414677,27273131,33462484,32557794,35300046,36831624,28076423,29997359,31962039,29848177,36329109	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahstaea1 10.08.2018: AF"			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43097077	43097077	A	G	het	off-target	QUAL=24;DP=43;QD=0.56	BRCA1	intron	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron1/14:c.-218-2217T>C::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron7/21:c.515+167T>C::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron8/22:c.590+167T>C::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron7/20:c.545-2217T>C::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron7/21:c.515+167T>C::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron8/21:c.593+167T>C::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron7/21:c.452+167T>C::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron8/23:c.593+167T>C::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron7/20:c.548-2217T>C::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron8/22:c.590+167T>C::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron9/23:c.452+167T>C::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron8/21:c.593+167T>C::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron8/23:c.593+167T>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron7/20:c.548-2217T>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+28105T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-22556T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+28194T>C::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron7/21:c.452+167T>C::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron8/22:c.593+167T>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron7/13:c.512+167T>C::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	209451 [benign DISEASE=Breast-ovarian cancer, familial, susceptibility to, 1,not provided GENE=BRCA1];		L1PREC2 (LINE/L1)	rs8176145	0.31539	0.23243,0.32831,0.36877,0.33009,0.49254	7892,	32161	104075	-0.7490	1.12			/3.0>3.7/0.0>0.0		BRCA1|0.00|0.00|0.00|0.00|-20|-41|-20|29	17916242	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43097347	43097347	A	-	het	off-target	QUAL=24;DP=70;QD=0.34	BRCA1	intron	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron1/14:c.-218-2487del::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron6/21:c.470-58del::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron7/22:c.545-58del::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron7/20:c.544+2428del::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron6/21:c.470-58del::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron6/21:c.407-58del::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron7/23:c.548-58del::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron7/20:c.547+2428del::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron7/22:c.545-58del::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron8/23:c.407-58del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron7/21:c.548-58del::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron7/23:c.548-58del::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron7/20:c.547+2428del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+27835del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-22826del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+27924del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron6/21:c.407-58del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron7/22:c.548-58del::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron6/13:c.467-58del::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125889 [benign DISEASE=Hereditary breast ovarian cancer syndrome,not specified,Breast-ovarian cancer, familial, susceptibility to, 1,not provided,Hereditary cancer-predisposing syndrome GENE=BRCA1];	CD1727436 [CLASS=DM? MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=BRCA1];		rs8176144	0.29963	0.17998,0.31944,0.36857,0.32972,0.49171	7389,	30767	106461	0.8980	16.02			/1.8>1.8/0.0>0.0		BRCA1|0.00|0.00|0.00|0.00|-16|-42|13|-50	25741868,21989022,35908255	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43099629	43099629	T	A	het	off-target	QUAL=24;DP=242;QD=0.10	BRCA1	intron	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron1/14:c.-218-4769A>T::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron6/21:c.469+146A>T::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron7/22:c.544+146A>T::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron7/20:c.544+146A>T::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron6/21:c.469+146A>T::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron7/21:c.547+146A>T::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron6/21:c.406+146A>T::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron7/23:c.547+146A>T::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron7/20:c.547+146A>T::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron7/22:c.544+146A>T::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron8/23:c.406+146A>T::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron7/21:c.547+146A>T::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron7/23:c.547+146A>T::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron7/20:c.547+146A>T::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+25553A>T::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-43-25108A>T::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+25642A>T::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron6/21:c.406+146A>T::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron7/22:c.547+146A>T::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron6/13:c.466+146A>T::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125879 [benign DISEASE=not provided,Breast-ovarian cancer, familial, susceptibility to, 1,Hereditary cancer-predisposing syndrome GENE=BRCA1];		L2d (LINE/L2)	rs8176140	0.31546	0.23249,0.32844,0.37008,0.33012,0.49273	7895,	32149	104027	1.2360	14.65			/0.0>0.0/0.0>0.0		BRCA1|0.00|0.00|0.00|0.00|-17|46|2|13	28076423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43104073	43104086	AAAAAAAAGAAAAG	-	het	off-target;low_conf_region	QUAL=24;DP=12;QD=2.00	BRCA1	intron	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron1/14:c.-218-9226_-218-9213del::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron5/21:c.363+36_363+49del::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron6/20:c.441+36_441+49del::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron5/21:c.363+36_363+49del::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron5/21:c.300+36_300+49del::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron6/23:c.441+36_441+49del::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron6/20:c.441+36_441+49del::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron7/23:c.300+36_300+49del::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron6/21:c.441+36_441+49del::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron6/23:c.441+36_441+49del::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron6/20:c.441+36_441+49del::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+21096_4+21109del::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-44+21185_-44+21198del::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+21185_-99+21198del::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron5/21:c.300+36_300+49del::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron6/22:c.441+36_441+49del::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron5/13:c.363+36_363+49del::		113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	225705 [benign/likely benign DISEASE=not provided,Breast-ovarian cancer, familial, susceptibility to, 1,not specified,Familial cancer of breast,Pancreatic cancer, susceptibility to, 4,Fanconi anemia, complementation group S GENE=BRCA1];		Alu (SINE/Alu), (AAG)n (Simple_repeat)	rs373413425	0.30707	0.22202,0.32137,0.36150,0.32611,0.48515	7278,	30904	102586	1.8490	1.21			/4.9>4.9/0.0>0.0		BRCA1|0.00|0.00|0.00|0.00|50|-42|48|50	25741868,28439188	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73)
chr17	43124230	43124230	A	G	het	off-target	QUAL=24;DP=43;QD=0.56	BRCA1,NBR2	intron,upstream_gene	BRCA1:ENST00000497488.2:intron_variant:MODIFIER:intron1/14:c.-219+1041T>C::,BRCA1:ENST00000489037.2:intron_variant:MODIFIER:intron1/21:c.-19-115T>C::,BRCA1:ENST00000478531.6:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000357654.9:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000473961.6:intron_variant:MODIFIER:intron1/20:c.-19-115T>C::,BRCA1:ENST00000477152.6:intron_variant:MODIFIER:intron1/21:c.-19-115T>C::,BRCA1:ENST00000352993.7:intron_variant:MODIFIER:intron1/21:c.-19-115T>C::,BRCA1:ENST00000493919.6:intron_variant:MODIFIER:intron1/21:c.-106-115T>C::,BRCA1:ENST00000494123.6:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000471181.7:intron_variant:MODIFIER:intron1/23:c.-19-115T>C::,BRCA1:ENST00000634433.2:intron_variant:MODIFIER:intron1/20:c.-19-115T>C::,BRCA1:ENST00000476777.6:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000470026.6:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000713676.1:intron_variant:MODIFIER:intron1/22:c.-6-128T>C::,BRCA1:ENST00000618469.2:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000461574.2:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000644555.2:intron_variant:MODIFIER:intron1/23:c.-305-115T>C::,BRCA1:ENST00000468300.5:intron_variant:MODIFIER:intron1/21:c.-19-115T>C::,BRCA1:ENST00000644379.2:intron_variant:MODIFIER:intron1/23:c.-19-115T>C::,BRCA1:ENST00000484087.6:intron_variant:MODIFIER:intron1/20:c.-19-115T>C::,BRCA1:ENST00000586385.5:intron_variant:MODIFIER:intron1/7:c.4+952T>C::,BRCA1:ENST00000591534.5:intron_variant:MODIFIER:intron1/10:c.-44+1041T>C::,BRCA1:ENST00000591849.5:intron_variant:MODIFIER:intron1/4:c.-99+1041T>C::,BRCA1:ENST00000493795.5:intron_variant:MODIFIER:intron1/21:c.-106-115T>C::,BRCA1:ENST00000491747.6:intron_variant:MODIFIER:intron1/22:c.-19-115T>C::,BRCA1:ENST00000700182.1:intron_variant:MODIFIER:intron1/13:c.-19-115T>C::,NBR2:ENST00000657841.1:upstream_gene_variant:MODIFIER::::,NBR2:ENST00000467245.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	113705_[GENE=BRCA1_PHENOS=Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Multifactorial, Autosomal dominant; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)]	125468 [benign DISEASE=not specified,not provided,Breast-ovarian cancer, familial, susceptibility to, 1 GENE=BRCA1];			rs3765640	0.31649	0.23300,0.33059,0.36926,0.33176,0.49233	7949,	32234	103948	-0.1120	4.55			/0.0>0.0/0.0>0.0	COSV58789216	BRCA1|0.00|0.00|0.01|0.00|9|-42|9|2	21766209,28439188,34287479,35908255,29997359,31962039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRCA1 (inh=AR+AD oe_syn=0.96 oe_mis=0.95 oe_lof=0.73), NBR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	58692526	58692526	G	A	het	off-target	QUAL=24;DP=23;QD=1.04	TEX14,IGBP1C,RAD51C	upstream_gene	TEX14:ENST00000349033.10:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000389934.7:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000240361.12:upstream_gene_variant:MODIFIER::::,IGBP1C:ENST00000583666.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000583539.5:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000461271.6:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697686.1:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697690.1:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000337432.9:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000421782.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697694.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	605792_[GENE=TEX14_PHENOS=Spermatogenic failure 23, 617707 (3), Autosomal recessive]&602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	1250767 [benign DISEASE=not provided GENE=RAD51C];			rs16943176	0.18465	0.13659,0.17653,0.17681,0.21157,0.13910	2775,	22559	124123	0.8640	8.51						31905201,25343521,21980511,26406419,29659014,22843497	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TEX14 (inh=AR oe_syn=0.96 oe_mis=1.04 oe_lof=0.78), IGBP1C (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	58692618	58692618	C	T	het	off-target	QUAL=25;DP=987;QD=0.03	RAD51C,TEX14,IGBP1C	5'UTR,upstream_gene	RAD51C:ENST00000583539.5:5_prime_UTR_variant:MODIFIER:exon1/8:c.-26C>T::,RAD51C:ENST00000461271.6:5_prime_UTR_variant:MODIFIER:exon1/8:c.-274C>T::,RAD51C:ENST00000697686.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-221C>T::,RAD51C:ENST00000697690.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-26C>T::,RAD51C:ENST00000337432.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-26C>T::,TEX14:ENST00000349033.10:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000389934.7:upstream_gene_variant:MODIFIER::::,TEX14:ENST00000240361.12:upstream_gene_variant:MODIFIER::::,IGBP1C:ENST00000583666.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000421782.3:upstream_gene_variant:MODIFIER::::,RAD51C:ENST00000697694.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	605792_[GENE=TEX14_PHENOS=Spermatogenic failure 23, 617707 (3), Autosomal recessive]&602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	324173 [benign/likely benign DISEASE=RAD51C-related disorder,Fanconi anemia,Breast and Ovarian Cancer Susceptibility,not specified,not provided GENE=RAD51C];			rs12946397	0.18459	0.13663,0.17636,0.17705,0.21158,0.13898	2768,	22561	124119	-3.2430	0.74			/1.2>2.8/0.0>0.0	COSV53625930	RAD51C|0.00|0.00|0.00|0.00|15|14|-17|14	29879995,31905201,25343521,21980511,26406419,22843497	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TEX14 (inh=AR oe_syn=0.96 oe_mis=1.04 oe_lof=0.78), IGBP1C (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	58720846	58720846	T	C	het	off-target	QUAL=24;DP=27;QD=0.89	RAD51C	intron	RAD51C:ENST00000583539.5:intron_variant:MODIFIER:intron6/7:c.904+34T>C::,RAD51C:ENST00000461271.6:intron_variant:MODIFIER:intron6/7:c.553+34T>C::,RAD51C:ENST00000697686.1:intron_variant:MODIFIER:intron6/9:c.553+34T>C::,RAD51C:ENST00000697690.1:intron_variant:MODIFIER:intron6/6:c.904+34T>C::,RAD51C:ENST00000337432.9:intron_variant:MODIFIER:intron6/8:c.904+34T>C::,RAD51C:ENST00000697694.1:intron_variant:MODIFIER:intron6/8:c.553+34T>C::		602774_[GENE=RAD51C_PHENOS={Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3); Fanconi anemia, complementation group O, 613390 (3), Autosomal recessive]	1275824 [benign DISEASE=not provided,Fanconi anemia complementation group O,not specified GENE=RAD51C];			rs28363318	0.29735	0.27114,0.26096,0.00231,0.34500,0.17937	7206,	30828	106904	0.2890	5.40			/0.9>1.4/0.0>0.0		RAD51C|0.00|0.00|0.00|0.00|-34|-33|38|-30	29879995,26406419,21392410	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAD51C (inh=AR+AD oe_syn=0.97 oe_mis=0.98 oe_lof=1.03)
chr17	61683138	61683138	A	G	hom	off-target	QUAL=24;DP=7;QD=3.43	BRIP1	3'UTR,downstream_gene	BRIP1:ENST00000682755.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*158T>C::,BRIP1:ENST00000259008.7:3_prime_UTR_variant:MODIFIER:exon20/20:c.*158T>C::,BRIP1:ENST00000683039.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*158T>C::,BRIP1:ENST00000682453.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*158T>C::,BRIP1:ENST00000682989.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*999T>C::,BRIP1:ENST00000577598.5:downstream_gene_variant:MODIFIER::::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	324344 [benign DISEASE=not provided,Fanconi anemia complementation group J GENE=BRIP1];		AluSg (SINE/Alu)	rs1978111	0.60638	0.65565,0.73446,0.72102,0.58310,0.45976	28545,	35020	59792	0.4260	0.49			/0.9>1.8/0.0>0.0		BRIP1|0.00|0.00|0.00|0.00|-15|-11|33|-11	19935797	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61683635	61683635	A	G	hom		QUAL=24;DP=197;QD=0.12	BRIP1	synonymous,3'UTR,downstream_gene	BRIP1:ENST00000682755.1:synonymous_variant:LOW:exon18/18:c.3189T>C:p.Tyr1063=:,BRIP1:ENST00000259008.7:synonymous_variant:LOW:exon20/20:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000683039.1:synonymous_variant:LOW:exon21/21:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000682453.1:synonymous_variant:LOW:exon21/21:c.3411T>C:p.Tyr1137=:,BRIP1:ENST00000682989.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*502T>C::,BRIP1:ENST00000577598.5:downstream_gene_variant:MODIFIER::::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	183702 [benign DISEASE=not specified,Hereditary breast ovarian cancer syndrome,Ovarian neoplasm,Fanconi anemia complementation group J,not provided,Hereditary cancer-predisposing syndrome,Familial cancer of breast GENE=BRIP1];			rs4986763	0.60501	0.65144,0.73410,0.72119,0.58302,0.45920	28414,	35145	60047	3.2750	7.15			/3.5>3.2/0.0>0.0	COSV51995377	BRIP1|0.00|0.00|0.00|0.00|-1|-11|-16|9	25741868,24033266,27415837,28415781,19276285,20693321,21356067,19935797,23473757,23644138,28968953,26790966,24301948,29138235,27542272,31214711	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61685753	61685753	A	T	het	off-target	QUAL=24;DP=22;QD=1.09	BRIP1	intron,3'UTR	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron17/17:c.2683+83T>A::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron19/19:c.2905+83T>A::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron20/20:c.2905+83T>A::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron20/20:c.2905+83T>A::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1613T>A::,BRIP1:ENST00000577598.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3T>A::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1275841 [benign DISEASE=not specified,not provided,Hereditary breast ovarian cancer syndrome GENE=BRIP1];			rs4988357	0.33874	0.35273,0.29903,0.49034,0.34821,0.26266	8939,	33645	100577	3.8370	19.72			/4.8>4.6/0.0>0.0	COSV51997887	BRIP1|0.00|0.00|0.00|0.00|-32|-15|-32|9	19935797	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61685986	61685986	A	G	hom		QUAL=24;DP=12;QD=2.00	BRIP1	missense,intron	BRIP1:ENST00000682755.1:missense_variant:MODERATE:exon17/18:c.2533T>C:p.Ser845Pro:,BRIP1:ENST00000259008.7:missense_variant:MODERATE:exon19/20:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000683039.1:missense_variant:MODERATE:exon20/21:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000682453.1:missense_variant:MODERATE:exon20/21:c.2755T>C:p.Ser919Pro:,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1846T>C::,BRIP1:ENST00000577598.5:missense_variant:MODERATE:exon18/18:c.2755T>C:p.Ser919Pro:		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	133756 [benign DISEASE=Fanconi anemia complementation group J,Familial cancer of breast,not specified,not provided,Ovarian neoplasm,Hereditary breast ovarian cancer syndrome,Hereditary cancer-predisposing syndrome GENE=BRIP1];			rs4986764	0.61199	0.67202,0.73893,0.72104,0.58372,0.45937	29085,	34796	58942	0.2010	6.85	0.088	0.06	/1.0>0.8/0.0>0.0	COSV51995396,COSV99369284	BRIP1|0.00|0.00|0.00|0.00|-40|-22|-4|11	25741868,24033266,24728327,20150366,26901225,28415781,29458332,19276285,15113441,32894086,34050209,19138047,23318652,33928715,21356067,19935797,23473757,23644138,29466248,28968953,19127258,26921362,26790966,25653542,19012493,24301948,33240400,29221171,29138235,27542272,17504528,24137204,31214711,37561379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61686104	61686104	T	C	hom		QUAL=24;DP=114;QD=0.21	BRIP1	synonymous,intron	BRIP1:ENST00000682755.1:synonymous_variant:LOW:exon17/18:c.2415A>G:p.Glu805=:,BRIP1:ENST00000259008.7:synonymous_variant:LOW:exon19/20:c.2637A>G:p.Glu879=:,BRIP1:ENST00000683039.1:synonymous_variant:LOW:exon20/21:c.2637A>G:p.Glu879=:,BRIP1:ENST00000682453.1:synonymous_variant:LOW:exon20/21:c.2637A>G:p.Glu879=:,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron18/18:c.2610-1964A>G::,BRIP1:ENST00000577598.5:synonymous_variant:LOW:exon18/18:c.2637A>G:p.Glu879=:		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	183703 [benign DISEASE=not specified,Hereditary cancer-predisposing syndrome,Hereditary breast ovarian cancer syndrome,not provided,Familial cancer of breast,Ovarian neoplasm,Fanconi anemia complementation group J GENE=BRIP1];			rs4986765	0.74246	0.90386,0.83070,0.89301,0.65657,0.71915	43212,	26464	39158	-0.1910	5.23			/0.0>0.0/0.0>0.0		BRIP1|0.00|0.00|0.00|0.00|9|38|1|-42	25741868,24033266,32708070,19276285,21356067,17342202,19935797,28968953,26790966,34967580,29138235,27542272,25592580,31214711	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61742809	61742809	C	A	het	off-target	QUAL=24;DP=6;QD=4.00	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron14/17:c.2157+204G>T::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron16/19:c.2379+204G>T::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron17/20:c.2379+204G>T::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron17/20:c.2379+204G>T::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron16/18:c.2379+204G>T::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron15/17:c.2379+204G>T::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron16/16:c.2379+204G>T::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron17/17:c.2439+204G>T::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	679668 [benign DISEASE=not provided GENE=BRIP1];		Tigger1 (DNA/TcMar-Tigger)	rs12937232	0.77146	0.83307,0.57786,0.78232,0.76542,0.80498	45879,	25610	34770	-0.4190	7.52			/3.8>3.4/0.0>0.0		BRIP1|0.00|0.00|0.00|0.00|21|30|25|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61780448	61780448	C	G	het	off-target	QUAL=24;DP=14;QD=1.71	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron10/17:c.1573-47G>C::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron12/19:c.1795-47G>C::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron13/20:c.1795-47G>C::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron13/20:c.1795-47G>C::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron12/18:c.1795-47G>C::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron11/17:c.1795-47G>C::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron12/16:c.1795-47G>C::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron12/17:c.1795-47G>C::	regulatory_region_variant:TF_binding_site	605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	262005 [benign DISEASE=not specified,not provided GENE=BRIP1];		AluJb (SINE/Alu)	rs4988351	0.77758	0.85334,0.63214,0.82077,0.75629,0.79531	46475,	25296	33824	0.1520	1.91			/1.3>5.1/0.0>0.0	COSV51993354	BRIP1|0.00|0.00|0.02|0.00|20|-47|20|-1	25741868,26790966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahfausu1 2022-12-02 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2022-06-22 Batch import from command line. GCHBOC VUS-Task-Force classification  [1] ahfausu1 2021-03-02 Batch import from command line. GCHBOC VUS-Task-Force classification "			BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61799424	61799425	AG	-	hom	off-target	QUAL=24;DP=12;QD=2.00	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron6/17:c.919-126_919-125del::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron8/19:c.1141-126_1141-125del::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron9/20:c.1141-126_1141-125del::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron9/20:c.1141-126_1141-125del::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron8/18:c.1141-126_1141-125del::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron7/17:c.1141-126_1141-125del::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron8/16:c.1141-126_1141-125del::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron8/17:c.1141-126_1141-125del::		605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	676467 [benign DISEASE=not provided GENE=BRIP1];			rs5821340	0.98888	0.96066,0.99745,1.00000,0.99991,0.99979	74461,	1631	1693	0.0000	1.43			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr17	61801161	61801161	-	A	het	off-target	QUAL=25;DP=16;QD=1.56	BRIP1	intron	BRIP1:ENST00000682755.1:intron_variant:MODIFIER:intron6/17:c.919-1863dup::,BRIP1:ENST00000259008.7:intron_variant:MODIFIER:intron8/19:c.1140+91dup::,BRIP1:ENST00000683039.1:intron_variant:MODIFIER:intron9/20:c.1140+91dup::,BRIP1:ENST00000682453.1:intron_variant:MODIFIER:intron9/20:c.1140+91dup::,BRIP1:ENST00000682989.1:intron_variant:MODIFIER:intron8/18:c.1140+91dup::,BRIP1:ENST00000577598.5:intron_variant:MODIFIER:intron7/17:c.1140+91dup::,BRIP1:ENST00000584322.2:intron_variant:MODIFIER:intron8/16:c.1140+91dup::,BRIP1:ENST00000683381.1:intron_variant:MODIFIER:intron8/17:c.1140+91dup::	regulatory_region_variant:open_chromatin_region	605882_[GENE=BRIP1_PHENOS=Fanconi anemia, complementation group J, 609054 (3); {Breast cancer, early-onset, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation]	1282406 [benign DISEASE=not provided GENE=BRIP1];			rs11390869	0.79182	0.89543,0.63368,0.81975,0.75942,0.78349	48234,	23742	31604		3.14			/2.6>2.6/0.0>0.0		BRIP1|0.00|0.00|0.00|0.00|-41|-39|32|-11	26790966	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	2	"[2] auto-classification 20.11.2017  "			BRIP1 (inh=AR+AD oe_syn=0.94 oe_mis=0.87 oe_lof=0.59)
chr18	22415790	22415790	T	C	hom		QUAL=24;DP=9;QD=2.67	CTAGE1,ATP7BP1	synonymous,upstream_gene,downstream_gene	CTAGE1:ENST00000391403.4:synonymous_variant:LOW:exon1/1:c.2022A>G:p.Pro674=:,CTAGE1:ENST00000525417.1:upstream_gene_variant:MODIFIER::::,ATP7BP1:ENST00000603437.1:downstream_gene_variant:MODIFIER::::						rs9946145	0.75354	0.37172,0.84788,0.82224,0.91390,0.80146	47661,	19299	37489	-0.4070	1.25			/3.8>6.3/0.0>4.4	COSV66942792	CTAGE1|0.00|0.00|0.00|0.00|-5|-2|0|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a), ATP7BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	22416048	22416048	G	A	het		QUAL=24;DP=86;QD=0.28	CTAGE1,ATP7BP1	synonymous,upstream_gene,downstream_gene	CTAGE1:ENST00000391403.4:synonymous_variant:LOW:exon1/1:c.1764C>T:p.Leu588=:,CTAGE1:ENST00000525417.1:upstream_gene_variant:MODIFIER::::,ATP7BP1:ENST00000603437.1:downstream_gene_variant:MODIFIER::::						rs7227477	0.49210	0.47432,0.57425,0.61391,0.47606,0.44417	18484,	37831	77201	0.4950	0.26			/5.6>4.9/0.0>0.0	COSV66942794	CTAGE1|0.00|0.00|0.00|0.00|25|-42|-11|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTAGE1 (inh=n/a oe_syn=1.20 oe_mis=1.39 oe_lof=n/a), ATP7BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	22975256	22975256	T	C	hom	off-target	QUAL=24;DP=70;QD=0.34	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron6/18:c.428+37T>C::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron6/17:c.428+37T>C::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron6/18:c.428+37T>C::	regulatory_region_variant:enhancer	604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673936 [benign DISEASE=Jawad syndrome,Seckel syndrome 2,not provided GENE=RBBP8];			rs2336916	0.94410	0.85712,0.96847,0.91786,0.98444,0.93349	68074,	7535	8507	-1.1550	0.49			/6.7>5.1/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22982555	22982555	G	A	hom	off-target	QUAL=24;DP=8;QD=3.00	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron7/18:c.604+162G>A::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron7/18:c.604+162G>A::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron7/17:c.604+162G>A::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron7/18:c.604+162G>A::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	669107 [benign DISEASE=not provided GENE=RBBP8];			rs7407415	0.99797	0.99295,0.99935,1.00000,0.99999,0.99959	75868,	305	309	-0.2960	0.25			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22984838	22984840	TCA	-	het	off-target;low_conf_region	QUAL=24;DP=32;QD=0.75	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron7/17:c.605-41_605-39del::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron7/18:c.605-41_605-39del::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	1263878 [benign DISEASE=Seckel syndrome 2,Jawad syndrome,not provided GENE=RBBP8];			rs3052770	0.50536	0.22462,0.56451,0.46902,0.63860,0.54761	21816,	33004	75012	-0.3020	0.32			/0.0>0.0/0.0>0.0		RBBP8|0.00|0.00|0.00|0.00|20|49|49|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22996218	22996218	G	T	het	off-target	QUAL=24;DP=5;QD=4.80	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron12/18:c.1940-156G>T::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron12/18:c.1940-156G>T::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron12/17:c.1940-156G>T::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron12/18:c.1940-156G>T::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673956 [benign DISEASE=not provided GENE=RBBP8];		L1MB8 (LINE/L1)	rs4471804	0.51165	0.83835,0.44156,0.52319,0.36123,0.45091	23177,	31441	74253	-0.6430	3.00			/0.0>0.0/0.0>0.0		RBBP8|0.00|0.00|0.00|0.00|13|4|-46|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	22997493	22997493	T	A	het	off-target	QUAL=24;DP=18;QD=1.33	RBBP8	intron	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron13/18:c.2029-127T>A::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron13/18:c.2029-127T>A::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron13/17:c.2029-127T>A::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron13/18:c.2029-127T>A::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673333 [benign DISEASE=not provided GENE=RBBP8];			rs2305886	0.48841	0.16189,0.55896,0.47217,0.63890,0.54934	21424,	31427	77799	-0.2240	0.25			/0.9>0.1/0.0>0.0		RBBP8|0.00|0.00|0.00|0.00|18|3|26|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54)
chr18	23006282	23006282	C	T	het	off-target	QUAL=24;DP=530;QD=0.05	RBBP8,RN7SL745P	intron,downstream_gene	RBBP8:ENST00000327155.10:intron_variant:MODIFIER:intron15/18:c.2288-81C>T::,RBBP8:ENST00000399722.6:intron_variant:MODIFIER:intron15/18:c.2288-81C>T::,RBBP8:ENST00000399725.6:intron_variant:MODIFIER:intron15/17:c.2288-81C>T::,RBBP8:ENST00000360790.9:intron_variant:MODIFIER:intron15/18:c.2303-81C>T::,RN7SL745P:ENST00000484900.3:downstream_gene_variant:MODIFIER::::		604124_[GENE=RBBP8_PHENOS=Seckel syndrome 2, 606744 (3), Autosomal recessive; Jawad syndrome, 251255 (3), Autosomal recessive; Pancreatic carcinoma, somatic (3)]	673981 [benign DISEASE=not provided GENE=RBBP8];			rs72889626	0.17757	0.05393,0.25754,0.39447,0.20364,0.19464	3075,	20802	124834	-3.4810	0.04			/4.9>5.8/1.8>0.7		RBBP8|0.00|0.00|0.00|0.00|42|-4|-2|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RBBP8 (inh=AR oe_syn=0.99 oe_mis=1.00 oe_lof=0.54), RN7SL745P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr18	51058485	51058485	-	TT	hom	off-target;low_conf_region	QUAL=26;DP=180;QD=0.14	SMAD4	intron	SMAD4:ENST00000588860.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000398417.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000589076.6:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000589941.2:intron_variant:MODIFIER:intron8/12:c.904+44_904+45dup::,SMAD4:ENST00000714261.1:intron_variant:MODIFIER:intron8/12:c.943+44_943+45dup::,SMAD4:ENST00000714264.1:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000342988.8:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000590061.2:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000593223.2:intron_variant:MODIFIER:intron7/10:c.904+44_904+45dup::,SMAD4:ENST00000714266.1:intron_variant:MODIFIER:intron6/10:c.691+44_691+45dup::,SMAD4:ENST00000714268.1:intron_variant:MODIFIER:intron6/10:c.874+44_874+45dup::,SMAD4:ENST00000714269.1:intron_variant:MODIFIER:intron7/11:c.904+44_904+45dup::,SMAD4:ENST00000714270.1:intron_variant:MODIFIER:intron8/12:c.982+44_982+45dup::,SMAD4:ENST00000714272.1:intron_variant:MODIFIER:intron7/11:c.880+44_880+45dup::,SMAD4:ENST00000588745.5:intron_variant:MODIFIER:intron4/7:c.667+3507_667+3508dup::		600993_[GENE=SMAD4_PHENOS=Pancreatic cancer, somatic, 260350 (3); Myhre syndrome, 139210 (3), Autosomal dominant; Polyposis, juvenile intestinal, 174900 (3), Autosomal dominant; Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominant]	1227283 [benign DISEASE=not provided GENE=SMAD4];			rs386387676	0.33481	0.20542,0.36112,0.40825,0.39241,0.23622	7116,	28216	84336		13.48			/4.2>4.3/0.0>0.0	COSV61689656	SMAD4|0.00|0.00|0.01|0.00|-41|-29|-10|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMAD4 (inh=AD oe_syn=0.93 oe_mis=0.34 oe_lof=0.07)
chr19	17268649	17268649	G	A	het	off-target	QUAL=24;DP=14;QD=1.71	BABAM1,USHBP1	intron,upstream_gene	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron1/5:c.-13-145G>A::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron1/8:c.-51-107G>A::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron1/8:c.-13-145G>A::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron1/8:c.-13-145G>A::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron1/5:c.-51-107G>A::,USHBP1:ENST00000252597.8:upstream_gene_variant:MODIFIER::::,USHBP1:ENST00000431146.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter				AluSp (SINE/Alu)	rs2004800	0.11154	0.06675,0.20013,0.51183,0.09390,0.15982	1558,	13839	135051	-0.2070	2.59			/6.8>7.1/0.0>0.0	COSV53102212	BABAM1|0.00|0.00|0.00|0.00|16|-38|-10|15,CTD-2278I10.6|0.00|0.00|0.00|0.00|16|-38|-10|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USHBP1 (inh=n/a oe_syn=0.93 oe_mis=1.02 oe_lof=0.79), BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17268749	17268749	C	T	het	off-target	QUAL=24;DP=109;QD=0.22	BABAM1,USHBP1	intron,splice_region&intron,upstream_gene	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron1/5:c.-13-45C>T::,BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron1/8:c.-51-7C>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron1/8:c.-13-45C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron1/5:c.-51-7C>T::,USHBP1:ENST00000252597.8:upstream_gene_variant:MODIFIER::::,USHBP1:ENST00000431146.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter		1227766 [benign DISEASE=not provided GENE=BABAM1];	CS1518199 [CLASS=DFP MUT=ALT PHEN="Breast cancer association with" GENE=BABAM1];		rs10424178	0.22498	0.34478,0.13815,0.00174,0.19925,0.11146	4474,	25239	117767	-0.3220	2.42			/2.0>3.3/0.0>0.0		BABAM1|0.25|0.04|0.00|0.00|7|45|7|-43,CTD-2278I10.6|0.24|0.04|0.00|0.00|7|45|7|-43	26472073,21431873,34849858,23805179,32601453	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USHBP1 (inh=n/a oe_syn=0.93 oe_mis=1.02 oe_lof=0.79), BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17271696	17271696	A	T	het	off-target	QUAL=24;DP=49;QD=0.49	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.344+41A>T::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron3/8:c.344+41A>T::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.344+41A>T::						rs10420922	0.49400	0.67559,0.37917,0.31922,0.43630,0.36567	19710,	35647	76891	-0.5940	0.22			/0.0>0.0/1.8>0.0	COSV63921517	BABAM1|0.00|0.00|0.00|0.00|49|-41|-41|1,CTD-2278I10.6|0.00|0.00|0.00|0.00|49|-41|-41|1	19572197,21431873	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17273842	17273842	C	T	het	off-target	QUAL=24;DP=20;QD=1.20	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.344+2187C>T::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron3/8:c.345-62C>T::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron3/8:c.345-62C>T::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron3/8:c.345-62C>T::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.344+2187C>T::					AluSg7 (SINE/Alu)	rs113272353	0.17089	0.18283,0.10682,0.00193,0.18680,0.10641	2389,	21181	125943	-0.8570	2.13			/0.0>0.0/2.4>5.3		BABAM1|0.00|0.00|0.00|0.00|-1|-25|-2|-17,CTD-2278I10.6|0.00|0.00|0.00|0.00|-1|-25|-2|-17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17276367	17276367	A	G	het	off-target	QUAL=25;DP=96;QD=0.26	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.345-128A>G::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron6/8:c.570-128A>G::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron6/8:c.570-128A>G::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron6/8:c.570-128A>G::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.345-128A>G::						rs34084277	0.17071	0.18255,0.10668,0.00155,0.18680,0.10590	2380,	21188	126050	-0.1090	9.69			/5.0>4.9/0.0>0.0		BABAM1|0.03|0.00|0.01|0.00|-2|2|41|2,CTD-2278I10.6|0.03|0.00|0.01|0.00|-2|2|41|2	26231170,28115406,28362817,28472234,29531215,36224396	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17276445	17276445	G	A	het	off-target	QUAL=26;DP=102;QD=0.25	BABAM1	intron	BABAM1:ENST00000447614.6:intron_variant:MODIFIER:intron3/5:c.345-50G>A::,BABAM1:ENST00000359435.8:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000598188.6:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000601043.5:intron_variant:MODIFIER:intron6/8:c.570-50G>A::,BABAM1:ENST00000595632.5:intron_variant:MODIFIER:intron3/5:c.345-50G>A::						rs61634114	0.15943	0.14325,0.10246,0.00155,0.18686,0.10692	2113,	20014	127800	0.6530	9.61			/0.0>0.0/0.0>0.0		BABAM1|0.23|0.00|0.00|0.00|-12|15|41|-37,CTD-2278I10.6|0.21|0.00|0.00|0.00|-12|50|41|-37	21431873	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07)
chr19	17278839	17278839	C	T	het		QUAL=24;DP=98;QD=0.24	BABAM1,ANKLE1	splice_region&intron,upstream_gene	BABAM1:ENST00000447614.6:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,BABAM1:ENST00000359435.8:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000598188.6:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000601043.5:splice_region_variant&intron_variant:LOW:intron8/8:c.787-6C>T::,BABAM1:ENST00000595632.5:splice_region_variant&intron_variant:LOW:intron5/5:c.562-6C>T::,ANKLE1:ENST00000394458.7:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000594072.6:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000652132.1:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000404085.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer					rs10406920	0.17144	0.18467,0.10658,0.00154,0.18699,0.10768	2410,	21269	126091	0.7980	3.40			8.0>8.0/8.0>8.0/0.4>0.0	COSV63921267	BABAM1|0.01|0.00|0.00|0.00|29|-23|-43|42,CTD-2278I10.6|0.00|0.00|0.00|0.00|29|6|29|42	26848770,28115406,19572197,21431873,23805179,32601453	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr19	17278895	17278895	G	A	het		QUAL=25;DP=467;QD=0.05	BABAM1,ANKLE1	synonymous,upstream_gene	BABAM1:ENST00000447614.6:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,BABAM1:ENST00000359435.8:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000598188.6:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000601043.5:synonymous_variant:LOW:exon9/9:c.837G>A:p.Lys279=:,BABAM1:ENST00000595632.5:synonymous_variant:LOW:exon6/6:c.612G>A:p.Lys204=:,ANKLE1:ENST00000394458.7:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000594072.6:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000652132.1:upstream_gene_variant:MODIFIER::::,ANKLE1:ENST00000404085.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer			CM1010189 [CLASS=DP MUT=ALT PHEN="Ovarian cancer susceptibility to" GENE=BABAM1];		rs8170	0.17352	0.19159,0.10778,0.00154,0.18706,0.10725	2472,	21466	125796	3.0590	11.24			/0.0>0.0/4.7>0.0	COSV63920809	BABAM1|0.00|0.00|0.00|0.00|26|-27|6|-1,CTD-2278I10.6|0.00|0.00|0.00|0.00|26|-50|6|-1	23535729,23535825,23593120,24025454,24359602,24771903,24941967,26472073,26510858,27392074,22331459,23536562,27117709,27432226,27825120,32823908,27471560,26884359,21844186,22357627,23136140,24510657,24895409,25057183,25253900,25255808,25611573,26070784,28098224,31125336,24244489,26231170,22253144,20456938,22235027,24886216,25173882,20852631,27814745,21799032,26848770,28935272,26747452,25227710,28115406,18650832,23555315,29150481,21774837,27601076,23011509,27848153,29844822,23535730,22351618,23756864,20852633,19572197,21431873,28559747,29316957,23462924,28362817,25919761,22575968,25717406,33125686,29915430,26209509,32724790,25751625,27279675,23805179,23292081,25342391,31379942,24325915,32793750,22357538,24852375,23544013,29531215,23423317,22794196,33372680,32601453,27931260,25581431,28957321,26052370,35087569,27698005,25673085,29880983,23535733,24495414,24528085,32128252,31258768,23761956	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BABAM1 (inh=n/a oe_syn=1.00 oe_mis=0.77 oe_lof=0.07), ANKLE1 (inh=n/a oe_syn=0.91 oe_mis=0.87 oe_lof=1.04)
chr20	14186437	14186437	T	C	hom	off-target	QUAL=24;DP=17;QD=1.41	MACROD2	intron	MACROD2:ENST00000217246.8:intron_variant:MODIFIER:intron3/16:c.271+100709T>C::,MACROD2:ENST00000684519.1:intron_variant:MODIFIER:intron3/17:c.271+100709T>C::,MACROD2:ENST00000642719.1:intron_variant:MODIFIER:intron3/17:c.271+100709T>C::					L1PA16 (LINE/L1)	rs6042572	0.95250	0.93420,0.96729,0.98861,0.95206,0.95280	69076,	6858	7232	-0.6830	1.04			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=AD oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	14186637	14186637	A	G	hom		QUAL=25;DP=31;QD=0.81	MACROD2	intron	MACROD2:ENST00000217246.8:intron_variant:MODIFIER:intron3/16:c.271+100909A>G::,MACROD2:ENST00000684519.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::,MACROD2:ENST00000642719.1:intron_variant:MODIFIER:intron3/17:c.271+100909A>G::					L1PA16 (LINE/L1)	rs6074704	0.52581	0.29612,0.57683,0.54519,0.62471,0.56589	22726,	34498	72102	-0.5390	7.17			/0.0>0.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MACROD2 (inh=AD oe_syn=0.89 oe_mis=0.87 oe_lof=0.22)
chr20	49684453	49684453	C	T	hom	off-target	QUAL=25;DP=20;QD=1.25	B4GALT5	intron	B4GALT5:ENST00000371711.4:intron_variant:MODIFIER:intron1/8:c.116-27751G>A::	regulatory_region_variant:open_chromatin_region				AluY (SINE/Alu)	rs6019972	0.80950	0.83927,0.75922,0.82526,0.80173,0.87214	49817,	23191	28905	-2.1980	0.27			/1.8>4.7/0.0>0.0		B4GALT5|0.00|0.00|0.00|0.00|-4|8|-15|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
chr20	49684609	49684609	G	A	hom		QUAL=24;DP=1210;QD=0.02	B4GALT5	intron	B4GALT5:ENST00000371711.4:intron_variant:MODIFIER:intron1/8:c.116-27907C>T::	regulatory_region_variant:open_chromatin_region					rs6512586	0.49006	0.38736,0.46653,0.38775,0.54863,0.65162	18689,	37017	77413	-0.9890	0.49			/1.3>1.3/0.0>0.0	COSV65493865		19956101,33230300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					B4GALT5 (inh=n/a oe_syn=0.97 oe_mis=0.56 oe_lof=0.00)
chr22	28734312	28734312	C	T	het	off-target	QUAL=24;DP=108;QD=0.22	CHEK2	intron	CHEK2:ENST00000402731.6:intron_variant:MODIFIER:intron1/12:c.319+91G>A::,CHEK2:ENST00000425190.7:intron_variant:MODIFIER:intron1/13:c.-345+7457G>A::,CHEK2:ENST00000404276.6:intron_variant:MODIFIER:intron2/14:c.319+91G>A::,CHEK2:ENST00000348295.7:intron_variant:MODIFIER:intron2/13:c.319+91G>A::,CHEK2:ENST00000649563.1:intron_variant:MODIFIER:intron1/11:c.-72+7457G>A::,CHEK2:ENST00000405598.5:intron_variant:MODIFIER:intron3/15:c.319+91G>A::,CHEK2:ENST00000382580.6:intron_variant:MODIFIER:intron2/15:c.319+91G>A::,CHEK2:ENST00000650281.1:intron_variant:MODIFIER:intron3/15:c.319+91G>A::,CHEK2:ENST00000403642.5:intron_variant:MODIFIER:intron1/11:c.319+91G>A::		604373_[GENE=CHEK2_PHENOS=Prostate cancer, somatic, 176807 (3); Osteosarcoma, somatic, 259500 (3); Tumor predisposition syndrome 4, breast/prostate/colorectal, 609265 (3)]	1292603 [benign DISEASE=not provided GENE=CHEK2];		MER51A (LTR/ERV1)	rs1033667	0.29479	0.34569,0.33877,0.21371,0.28065,0.15955	6926,	30965	107211	-0.4970	1.45			/0.0>0.0/0.0>0.0	COSV60418297	CHEK2|0.00|0.00|0.00|0.00|22|15|-5|33	30793520,31428123,24098683,30753320,25631615,35192695,34887591,32042192,37673066	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK2 (inh=AD oe_syn=0.86 oe_mis=1.07 oe_lof=1.15)
chr22	28734825	28734825	-	A	het	off-target	QUAL=26;DP=188;QD=0.14	CHEK2	intron,upstream_gene	CHEK2:ENST00000425190.7:intron_variant:MODIFIER:intron1/13:c.-345+6943dup::,CHEK2:ENST00000404276.6:intron_variant:MODIFIER:intron1/14:c.-6-99dup::,CHEK2:ENST00000348295.7:intron_variant:MODIFIER:intron1/13:c.-6-99dup::,CHEK2:ENST00000649563.1:intron_variant:MODIFIER:intron1/11:c.-72+6943dup::,CHEK2:ENST00000405598.5:intron_variant:MODIFIER:intron2/15:c.-6-99dup::,CHEK2:ENST00000382580.6:intron_variant:MODIFIER:intron1/15:c.-6-99dup::,CHEK2:ENST00000650281.1:intron_variant:MODIFIER:intron2/15:c.-6-99dup::,CHEK2:ENST00000402731.6:upstream_gene_variant:MODIFIER::::,CHEK2:ENST00000403642.5:upstream_gene_variant:MODIFIER::::		604373_[GENE=CHEK2_PHENOS=Prostate cancer, somatic, 176807 (3); Osteosarcoma, somatic, 259500 (3); Tumor predisposition syndrome 4, breast/prostate/colorectal, 609265 (3)]	1292328 [benign DISEASE=not provided GENE=CHEK2];		(A)n (Simple_repeat)	rs201340887	0.33983	0.44376,0.36737,0.23171,0.30282,0.18028	7817,	30732	90072		0.51			/3.9>3.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHEK2 (inh=AD oe_syn=0.86 oe_mis=1.07 oe_lof=1.15)
